Sentence,class,file
Clin Chem  2013; 59:392-400; PMID:23358751; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Genome  Biol 2002; 3:H0034; PMID:12184808; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
PLoS  One 2012; 7:e38946; PMID:22723911; http://dx.doi.org/10.1371/journal.pone.0038946 28.,Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
RNA Biol 2013; 10:367- 70; PMID:23364352; http://dx.doi.org/10.4161/rna.23663.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Proc Natl Acad Sci USA 2008; 105:10513- 8; PMID:18663219; http://dx.doi.org/10.1073/ pnas.0804549105 31.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Viruses 2012; 4:1844- 64; PMID:23202444; http://dx.doi.org/10.3390/ v4101844 32.,Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
RNA Biology  2013; 10:1107-16; PMID: 23669076; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
"www.landesbioscience.com RNA Biology 1125RNA Biology 10:7, 1125–1135; July 2013; © 2013 Landes Bioscience ReseAR ch p ApeR ReseAR ch p ApeR *Correspondence to: Stefan Engelhardt; Email: stefan.engelhardt@tum.de; Fabian J. Theis; Email: fabian.theis@helmholtz-muenchen.de Submitted: 12/23/12; Revised: 05/03/13; Accepted: 05/06/13http://dx.doi.org/10.4161/rna.24955Introduction MicroRNAs (miRNAs) are small single-stranded non-coding  RNAs, which are endogenously expressed and predominantly downregulate the expression of mRNA targets.",Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
UTR data for all human genes (assembly GRCh37.p10) was downloaded from ENSEMBL BioMart (http://www.ensembl.org/).,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cell 2009; 136:215-33; PMID:19167326;  http://dx.doi.org/10.1016/j.cell.2009.01.002 2.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nat Rev Mol Cell Biol 2009; 10:141-8; PMID:19145236;  http://dx.doi.org/10.1038/nrm2619 3.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
"Annu Rev Biochem 2010; 79:351-79; PMID:20533884; http://dx.doi.org/10.1146/annurev- biochem-060308-103103 4. van Rooij E, Sutherland LB, Liu N, Williams AH,  McAnally J, Gerard RD, et al.",OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Proc Natl Acad Sci USA  2006; 103:18255-60; PMID:17108080; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nature 2008; 456:980-4; PMID:19043405;  http://dx.doi.org/10.1038/nature07511 6.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nat Med 2012; 18:74-82; PMID:22157681; http://dx.doi.org/10.1038/nm.2577 7.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
J Neurosci  2011; 31:14820-30; PMID:21994399; http://dx.doi.org/10.1523/JNEUROSCI.3883-11.2011 9.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nat Cell Biol 2011; 13:434-46; PMID:21441927;  http://dx.doi.org/10.1038/ncb2211 10.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Immunol Cell Biol 2012; 90:288- 92; PMID:22249200; http://dx.doi.org/10.1038/ icb.2011.114 11.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
J Mol Cell Cardiol 2012; 52:13- 20; PMID:21801730; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Mol Cell  2010; 40:762-73; PMID:21145484; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Mol Cell 2010; 38:140-53; PMID:20385095; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Circulation 2013; 127:2097- 106; PMID:23625957; http://dx.doi.org/10.1161/ CIRCULATIONAHA.112.000882 15.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Curr Opin Cell Biol 2009; 21:452-60;  PMID:19450959; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
RNA 2009; 15:21- 32; PMID:19029310; http://dx.doi.org/10.1261/ rna.1399509 19.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nature 2010; 466:835- 40; PMID:20703300; http://dx.doi.org/10.1038/nature09267 20.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nat Struct Mol Biol 2010;  17:1169-74; PMID:20924405; http://dx.doi.org/10.1038/nsmb.1921 21.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nat Rev Genet 2008; 9:102-14; PMID:18197166; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cell  2005; 120:15-20; PMID:15652477; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Genome Res 2009; 19:92-105; PMID:18955434;  http://dx.doi.org/10.1101/gr.082701.108 25.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
PLoS  Biol 2004; 2:e363; PMID:15502875; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nucleic Acids Res 2008; 36(Database issue):D149-53; PMID:18158296; http://dx.doi.org/10.1093/nar/ gkm995 27.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nature 2009; 460:479-86; PMID:19536157;  http://dx.doi.org/10.1038/nature08170 29.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cell 2010; 141:129- 41; PMID:20371350; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nat  Struct Mol Biol 2010; 17:909-15; PMID:20601959;  http://dx.doi.org/10.1038/nsmb.1838 31.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
PLoS Genet  2011; 7:e1002363; PMID:22102825; http://dx.doi.org/10.1371/journal.pgen.1002363 32.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
PLoS ONE 2010; 5(6):e11154; PMID:20614023;  http://dx.doi.org/10.1371/journal.pone.0011154 33.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
RNA  2011; 17:809-19; PMID:21441347; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nature  2008; 455:58-63; PMID:18668040; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Dev Biol 2004; 267:529- 35; PMID:15013811; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cell 1993; 75:843-54;  PMID:8252621; http://dx.doi.org/10.1016/0092- 8674(93)90529-Y,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cell Stem Cell 2011; 8:376- 88; PMID:21474102; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cell Stem Cell 2011; 8:633-8; PMID:21620789;  http://dx.doi.org/10.1016/j.stem.2011.05.001 55.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Curr Protein Pept Sci 2012;  13:372-9; PMID:22708488; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Genome Res 2010; 20:1010- 9; PMID:20508147; http://dx.doi.org/10.1101/ gr.103259.109 58.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
J Am Stat Assoc 1972; 67:687-90; http://dx.doi.org/10.1080/01621459.1972.1048127946.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Bioinformatics  2010; 26:223-7; PMID:19933167; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Genome Biol 2010; 11:R6;  PMID:20089154; http://dx.doi.org/10.1186/gb-2010- 11-1-r6 48.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cell  2007; 129:1401-14; PMID:17604727; http://dx.doi.org/10.1016/j.cell.2007.04.040 49.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cancer Res 2007; 67:2456-68;  PMID:17363563; http://dx.doi.org/10.1158/0008- 5472.CAN-06-2698 50.,Non-OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
RNA 2008; 14:35-42; PMID:18025253; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Methods Enzymol 2006; 411:352-69;  PMID:16939800; http://dx.doi.org/10.1016/S0076- 6879(06)11019-8 52.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Circ Res 2012; 110:1465- 73; PMID:22539765; http://dx.doi.org/10.1161/ CIRCRESAHA.112.26903538.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Cell 1993; 75:855-62; PMID:8252622; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nucleic Acids Res  2004; 32:6284-91; PMID:15585662; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Genes Dev 2003; 17:438- 42; PMID:12600936; http://dx.doi.org/10.1101/ gad.1064703 41.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
RNA 2011; 17:1858-69; PMID:21878547;  http://dx.doi.org/10.1261/rna.2778911 43.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Genes Dev  2004; 18:504-11; PMID:15014042; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
Nat Struct Mol Biol 2011; 18:1139- 46; PMID:21909094; http://dx.doi.org/10.1038/ nsmb.2115,OADS,/arxiv_data1/oa_pdf/ab/28/rna-10-1125.PMC3849160.pdf
"Do not distribute.RNA Biology 10:7, 1146–1159; July 2013; © 2013 Landes Bioscience Rese ARch  p A pe R 1146  RNA Biology  V olume 10 Issue 7*Correspondence to: Nikolaus Rajewsky; Email: rajewsky@mdc-berlin.de; Markus Landthaler; Email: markus.landthaler@mdc-berlin.de Submitted: 03/26/2013; Revised: 05/23/2013; Accepted: 05/28/2013http://dx.doi.org/10.4161/rna.25194Introduction Post-transcriptional gene regulation is elicited through a complex  network of RNA-binding proteins (RBPs) and miRNA-containing ribonucleoprotein complexes that target defined sequence elements within mRNAs and thereby regulate all aspects of RNA metabo - lism.",Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
"Supplemental Material Supplemental material may be found here:  http://www.landesbioscience.com/journals/rnabiology/article/25194or positions) were considered to counteract false-positive signals, such as SNPs.",Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Rev  Mol Cell Biol 2002; 3:195-205; PMID:11994740; http://dx.doi.org/10.1038/nrm760 2.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Rev Genet 2007; 8:533-43; PMID:17572691; http://dx.doi.org/10.1038/nrg2111 3.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2009; 136:719-30; PMID:19239891; http://dx.doi.org/10.1016/j.cell.2009.01.044 4.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2009; 136:731-45; PMID:19239892; http://dx.doi.org/10.1016/j.cell.2009.01.042 5.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2009; 136:688-700; PMID:19239889; http://dx.doi.org/10.1016/j.cell.2009.02.0016.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Trends Genet 2008; 24:416-25; PMID:18597886; http://dx.doi.org/10.1016/j.tig.2008.05.004 7.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Mol Cell 2012; 46:674-90; PMID:22681889; http://dx.doi.org/10.1016/j.mol-cel.2012.05.021 8.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2012; 149:1393-406; PMID:22658674; http://dx.doi.org/10.1016/j.cell.2012.04.031 9.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Science 1984; 226:409-16; PMID:6494891; http://dx.doi.org/10.1126/science.649489110.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Gene 2006; 384:51-61; PMID:16971064; http://dx.doi.org/10.1016/j.gene.2006.07.011 11.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Int J Biochem Cell Biol 2013; 45:973-8; PMID:23420006; http://dx.doi.org/10.1016/j.biocel.2013.02.006 12.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2011; 147:1066-79; PMID:22118463; http://dx.doi.org/10.1016/j.cell.2011.10.039 13.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Cell Biol 2008; 10:987-93;  PMID:18604195; http://dx.doi.org/10.1038/ncb1759,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nature 2008; 455:58-63; PMID:18668040; http://dx.doi.org/10.1038/nature07228 44.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Proteomics 2009; 9:205-9; PMID:19053139; http://dx.doi.org/10.1002/pmic.200800275 45.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Methods 2011; 8:559-64; PMID:21572407; http://dx.doi.org/10.1038/nmeth.1608 46.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Biotechnol 2011; 29:607-14; PMID:21633356; http://dx.doi.org/10.1038/nbt.1873 47.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nucleic Acids Res 2009; 37(Web Server issue):W202-8; PMID:19458158; http://dx.doi.org/10.1093/nar/gkp335 48.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nucleic Acids Res 2012; 40:3574-84; PMID:22210884; http://dx.doi.org/10.1093/nar/gkr1279 49.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Genet 2005; 37:495-500; PMID:15806104; http://dx.doi.org/10.1038/ng1536 50.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nucleic Acids Res 2012; 40(Database issue):D180-6; PMID:22086949; http://dx.doi.org/10.1093/nar/gkr1007 51.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Mol Syst Biol 2009; 5:288; PMID:19638969; http://dx.doi.org/10.1038/msb.2009.44 52.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Mol Cell Biol 2007; 27:6265-78; PMID:17620417; http://dx.doi.org/10.1128/MCB.00500-07 53.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Mol Cell Biol 2008; 28:4320-30; PMID:18443041; http://dx.doi.org/10.1128/MCB.00361-08 54.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Mol Cell Biol 2009; 29:1442-51; PMID:19124611; http://dx.doi.org/10.1128/MCB.01689-08 55.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Genes Dev 2007; 21:708-18; PMID:17369403; http://dx.doi.org/10.1101/gad.1525507 56.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
EMBO J 2001; 20:1785-96; PMID:11285241; http://dx.do i. org/10.1093/emboj/20.7.1785 57.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
RNA 2001; 7:819-32; PMID:11421360; http://dx.doi.org/10.1017/S135583820101021429.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
J Mol Biol 20 06; 360:702-14; PMID:16780871; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Protein Sci 2003; 12:112-23; PMID:12493834; http://dx.doi.org/10.1110/ps.0219703 31.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
RNA Biol 2007; 4:16-25; PMID:17617744; http://dx.doi.org/10.4161/rna.4.1.4364 32.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Genes Dev 2007; 21:1125-38 ; PMID:17473174; http://dx.doi.org/10.1101/ gad.415007 33.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Stem Cells 20 11; 29:496-504; PMID:21425412; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
RNA 2009; 15:357-61; PMID:19147696; http://dx.doi.org/10.1261/rna.1368009 35.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Carcinogenesis 2010; 31:1516-22; PMID:20525879; http://dx.doi.org/10.1093/carcin/bgq107 36.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nucleic Acids Res 2009; 37:4256-63; PMID:19443445; http://dx.doi.org/10.1093/nar/gkp372 37.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nucleic Acids Res 2010; 38:1240-8; PMID:19966271; http://dx.doi.org/10.1093/nar/gkp1071 38.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2012; 151:765-77; PMID:23102813; http://dx.doi.org/10.1016/j.cell.2012.10.019 39.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Mol Cell 2012; 48:195-206; PMID:22959275; http://dx.doi.org/10.1016/j.molcel.2012.08.004 40.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2010; 141:129-41; PMID:20371350; http://dx.doi.org/10.1016/j.cell.2010.03.009 41.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
RNA 2013; 19:613-26; PMID:23481595; http://dx.doi.org/10.1261/rna.036491.112 42.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Mol Cell 2011; 43:340-52; PMID:21723171; http://dx.doi.org/10.1016/j.molcel.2011.06.00814.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Gene Expr Patterns 2003; 3:719-26; PMID:14643679; http://dx.doi.org/10.1016/S1567-133X(03)00140-6 15.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Science 2007; 318:1917-20; PMID:18029452; http://dx.doi.org/10.1126/science.1151526 16.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Genet 2010; 42:626-30; PMID:20512147; http://dx.doi.org/10.1038/ng.593 17.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Trends Cell Biol 2 012; 22:474-82; PMID:22784697; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Genet 2009; 41:843-8; PMID:19483683; http://dx.doi.org/10.1038/ng.392 19.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nature 2000; 403:901-6; PMID:10706289; http://dx.doi.org/10.1038/35002607 20.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell Stem Cell 2010; 7:31-5; PMID:20621047; http://dx.doi.org/10.1016/j.stem.2010.06.011 21.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Struct Mol Biol 2009; 16:1016-20; PMID:19713957; http://dx.doi.org/10.1038/nsmb.1675 22.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Struct Mol Biol 2 009; 16:1021-5; PMID:19713958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2009; 138:696-708; PMID:19703396; http://dx.doi.org/10.1016/j.cell.2009.08.002 24.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nucleic Acids Res 2012; 40:7492-506; PMID:22570413; http://dx.doi.org/10.1093/nar/gks355 25.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2011; 147:1080-91; PMID:22078496; http://dx.doi.org/10.1016/j.cell.2011.10.020 26.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Struct Mol Biol 2012; 19:84-9; PMID:22157959; http://dx.doi.org/10.1038/nsmb.2202 27.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nucleic Acids Res 2012; 40:1767-77; PMID:22013165; http://dx.doi.org/10.1093/nar/gkr808 28.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Bioessays 2010; 32:109-18; P MID:20091748; http://dx.doi.org/10.1002/ bies.200900122,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Anal Chem 2003; 75:663-70; PMID:12585499; http://dx.doi.org/10.1021/ac026117i 68.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Bioinformatics 2009; 25:1754-60; PMID:19451168; http://dx.doi.org/10.1093/bioinformatics/btp324 69.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Biotechnol 2008; 26:1367-72; PMID:19029910; http://dx.doi.org/10.1038/nbt.151163.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nucleic Acids Res 2011; 39:3724-34; PMID:21247876; http://dx.doi.org/10.1093/nar/gkq1350 64.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
FEBS J 2010; 277:22-9;  PMID:19843173; http://dx.doi.org/10.1111/j.1742-4658.2009.07367.x 65.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Cell 2011; 147:81-94; PMID:21962509; http://dx.doi.org/10.1016/j.cell.2011.08.033 66.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Mol Cell Proteomics 2002; 1:376-86; PMID:12118079; http://dx.doi.org/10.1074/mcp.M200025-MCP20058.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nature 2007; 446:926-9; PMID:17361132; http://dx.doi.org/10.1038/nature05676 59.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
EMBO J 2011; 30:277-88; PMID:21131904; http://dx.doi.org/10.1038/emboj.2010.310 60.,Non-OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
Nat Struct  Mol Biol 2010; 17:306-12; PMID:20139984; http://dx.doi.org/10.1038/nsmb.1750 62.,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
FEBS Lett 2012; 586:3986-90; PMID:23063642; http://dx.doi.org/10.1016/j.febs - let.2012.09.034,OADS,/arxiv_data1/oa_pdf/4d/3a/rna-10-1146.PMC3849162.pdf
"*Correspondence to: Lars Barquist; Email: lb14@sanger.ac.uk Submitted: 02/13/13; Revised: 04/18/13; Accepted: 04/22/13http://dx.doi.org/10.4161/rna.24765In this review we discuss transposon-insertion sequencing,  variously known in the literature as TraDIS, Tn-seq, INSeq and HITS.",Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Proc Natl Acad Sci USA 2006; 103:425- 30; PMID:16407165; http://dx.doi.org/10.1073/ pnas.0510013103.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
PLoS One 2012; 7:e43012; PMID:22900082;  http://dx.doi.org/10.1371/journal.pone.0043012.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Bioinformatics 2013; 29:695-703;  PMID:23361328; http://dx.doi.org/10.1093/bioinfor-matics/btt043.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
PLoS Pathog 2006; 2:e81; PMID:16933988; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Science 2006; 313:236-8;  PMID:16763111; http://dx.doi.org/10.1126/sci- ence.1128794.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Appl Environ Microbiol  2012; 78:3098-107; PMID:22367088; http://dx.doi.org/10.1128/AEM.06865-11.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Mol Microbiol 2008; 68:600- 14; PMID:18373523; http://dx.doi.org/10.1111/ j.1365-2958.2008.06172.x.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
RNA  Biol 2012; 9:427-36; PMID:22546938; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Proc Natl Acad Sci USA  2012; 109:E1277-86; PMID:22538806; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Mob DNA 2012; 3:3; PMID:22313799;  http://dx.doi.org/10.1186/1759-8753-3-3.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nucleic Acids Res  2013; 41:4549-64; PMID:23470992; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Mol Syst Biol 2011;  7:528; PMID:21878915; http://dx.doi.org/10.1038/ msb.2011.58.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Proc Natl Acad Sci USA 1999; 96:1645- 50; PMID:9990078; http://dx.doi.org/10.1073/ pnas.96.4.1645.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Res Microbiol 2007; 158:767-78;  PMID:17997281; http://dx.doi.org/10.1016/j.res-mic.2007.09.004.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
J Biol Chem 1998; 273:7367-74; PMID:9516433;  http://dx.doi.org/10.1074/jbc.273.13.7367.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
PLoS Pathog 2012; 8:e1002946; PMID:23028335; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
J Bacteriol  2011; 193:1771-6; PMID:21278291; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Microbiology  2004; 150:3631-45; PMID:15528651; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Mol Microbiol 2003; 48:77-84; PMID:12657046;  http://dx.doi.org/10.1046/j.1365-2958.2003.03425.x.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
PLoS Pathog  2011; 7:e1002251; PMID:21980284; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Mol Syst Biol 2006; 2:0008; PMID:16738554;  http://dx.doi.org/10.1038/msb4100050.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
J Bacteriol 2010; 192:59- 67; PMID:19734312; http://dx.doi.org/10.1128/ JB.00873-09.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Science  1995; 269:400-3; PMID:7618105; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nat Rev Genet 2006; 7:929-39;  PMID:17139324; http://dx.doi.org/10.1038/nrg1984.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Science  1999; 286:2165-9; PMID:10591650; http://dx.doi.org/10.1126/science.286.5447.2165.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Genome Res 2009; 19:2308-16; PMID:19826075; http://dx.doi.org/10.1101/gr.097097.109.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Cell Host Microbe 2009; 6:279- 89; PMID:19748469; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nat Methods  2009; 6:767-72; PMID:19767758; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
MBio 2011; 2:e00315- 10; PMID:21253457; http://dx.doi.org/10.1128/ mBio.00315-10.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nat Protoc  2011; 6:1969-80; PMID:22094732; http://dx.doi.org/10.1038/nprot.2011.417.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Genome Biol 2010; 11:R119;  PMID:21143862; http://dx.doi.org/10.1186/gb-2010- 11-12-r119.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
FEMS Microbiol Rev 2009; 33:191-205;  PMID:19054113; http://dx.doi.org/10.1111/j.1574- 6976.2008.00149.x.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Mol Microbiol 2012; 86:273-83;  PMID:22925268; http://dx.doi.org/10.1111/j.1365- 2958.2012.08196.x.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
BMC Genomics 2012; 13:578; PMID:23114059;  http://dx.doi.org/10.1186/1471-2164-13-578.45.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nucleic Acids Res 2013;  41:3491-503; PMID:23396277; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
PLoS Pathog  2012; 8:e1002788; PMID:22807675; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nature 1999; 402:413-8; PMID:10586881;  http://dx.doi.org/10.1038/46558.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nature  2009; 462:1056-60; PMID:20033048; http://dx.doi.org/10.1038/nature08656.41.,Non-OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nucleic Acids Res 2013; 41(Database  issue):D226-32; PMID:23125362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Genome Res 2011; 21:1487-97; PMID:21665928;  http://dx.doi.org/10.1101/gr.119370.110.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
Nucleic Acids Res  2010; 38:5893-908; PMID:20460466; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
RNA Biol 2009; 6:266-75; PMID:19333007; http://dx.doi.org/10.4161/rna.6.3.8332.,OADS,/arxiv_data1/oa_pdf/2b/c1/rna-10-1161.PMC3849164.pdf
"10 Many eukaryotes make extensive use of RNA  *Correspondence to: Eric P. Nawrocki; Email: nawrockie@janelia.hhmi.org Submitted: 02/14/13; Revised: 05/13/13; Accepted: 05/14/13http://dx.doi.org/10.4161/rna.25038A key step toward understanding a metagenomics data set  is the identification of functional sequence elements within it, such as protein coding genes and structural r NAs.",Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Nat Rev Genet 2001;  2:919-29; PMID:11733745; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Genome Biol 2007; 8:210;  PMID:17472738; http://dx.doi.org/10.1186/gb-2007- 8-4-210 3.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Curr Opin Microbiol  2007; 10:279-85; PMID:17548241; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
PLoS Comput Biol 2007; 3:e65; PMID:17432929;  http://dx.doi.org/10.1371/journal.pcbi.00300657.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Trends Genet 2005; 21:399- 404; PMID:15913835; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Curr Opin Struct Biol 2005; 15:342- 8; PMID:15919195; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Bioinformatics  2008; 24:2281-7; PMID:18687694; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Trends Genet 1997; 13:497-8;  PMID:9433140; http://dx.doi.org/10.1016/S0168- 9525(97)01347-4 47.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Genome  Res 2007; 17:117-25; PMID:17151342; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
BMC Bioinformatics  2003; 4:44; PMID:14499004; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Nucleic Acids Res  2009; 37(Database issue):D141-5; PMID:19004872;  http://dx.doi.org/10.1093/nar/gkn879 50.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Nucleic Acids Res 2008; 36(Database issue):D281-8;  PMID:18039703; http://dx.doi.org/10.1093/nar/ gkm960 51.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Nucleic Acids Res 2013; 41(Database issue):D226-32;  PMID:23125362; http://dx.doi.org/10.1093/nar/gks1005 53.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Science 2005; 308:554-7; PMID:15845853; http://dx.doi.org/10.1126/sci- ence.1107851 54.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
J Comput Biol 1998; 5:479-91; PMID:9773344; http://dx.doi.org/10.1089/cmb.1998.5.479 55.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
BMC Genomics 2007; 8:347; PMID:17908319; http://dx.doi.org/10.1186/1471- 2164-8-347 56.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Parallel Comput  1996; 22:789-828; http://dx.doi.org/10.1016/0167- 8191(96)00024-5 57.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
2011; 7:e1002195; PMID:22039361;  http://dx.doi.org/10.1371/journal.pcbi.1002195 58.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
"[http://infernal.janelia.org/], 2009.",Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
J Mol Biol  1994; 235:1501-31; PMID:8107089; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Nucleic Acids Res 1994; 22:2079- 88; PMID:8029015; http://dx.doi.org/10.1093/ nar/22.11.2079 31.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
PLoS Comput Biol 2008; 4:e1000069; PMID:18516236; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Bioinformatics 2009; 25:1335-7; PMID:19307242; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
BMC Bioinformatics  2002; 3:18; PMID:12095421; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Inf Control 1967; 10:189-208;  http://dx.doi.org/10.1016/S0019-9958(67)80007-X 40.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Cold  Spring Harb Symp Quant Biol 2006; 71:117-28;  PMID:17381287; http://dx.doi.org/10.1101/sqb.2006.71.003 41.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
J Mol Biol 2001; 313:1003-11; PMID:11700055; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
2005; 2:366- 79; PMID:17044173 http://dx.doi.org/10.1109/ TCBB.2005.57 43.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
BMC Bioinformatics 2005; 6:89;  PMID:15817128; http://dx.doi.org/10.1186/1471- 2105-6-89 44.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Nucleic Acids  Res 2001; 29:4724-35; PMID:11713323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Biochimie 2002; 84:775-90;  PMID:12457565; http://dx.doi.org/10.1016/S0300- 9084(02)01402-5 11.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Cell 2004; 116:281-97;  PMID:14744438; http://dx.doi.org/10.1016/S0092- 8674(04)00045-5 13.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Cell 2002; 109:137-40; PMID:12007398;  http://dx.doi.org/10.1016/S0092-8674(02)00727-4 14.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Bioinformatics  2008; 24:2807-13; PMID:18974076; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Biol Chem 2005; 386:1219- 38; PMID:16336117; http://dx.doi.org/10.1515/ BC.2005.140 16.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
BMC Bioinformatics  2007; 8:33; PMID:17263882; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Brief Bioinform 2007; 8:396-414;  PMID:17483123; http://dx.doi.org/10.1093/bib/ bbm011 18.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Annu Rev Genomics Hum Genet 2007; 8:279-98;  PMID:17506659; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Mol Microbiol 2007; 66:1080-91; PMID:17971083; http://dx.doi.org/10.1111/j.1365-2958.2007.05978.x 20.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Nucleic Acids Res 1997; 25:3389- 402; PMID:9254694; http://dx.doi.org/10.1093/ nar/25.17.3389 21.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Science 2004; 304:1321- 5; PMID:15131266; http://dx.doi.org/10.1126/sci- ence.1098119 22.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Science 2000; 288:517-22; PMID:10775111;  http://dx.doi.org/10.1126/science.288.5465.517 24.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
Methods Enzymol 1996; 266:227-58; PMID:8743688;  http://dx.doi.org/10.1016/S0076-6879(96)66017-0 25.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
J Mol Biol  1990; 216:585-610; PMID:2258934; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/60/rna-10-1170.PMC3849165.pdf
"RNA Biology 10:7, 1180–1184; July 2013; © 2013 Landes Bioscience ReseAR ch p ApeR 1180 RNA Biology Volume 10 Issue 7*Correspondence to: Michelle M. Meyer; Email: m.meyer@bc.edu Submitted: 01/19/13; Revised: 02/19/13; Accepted: 02/28/13http://dx.doi.org/10.4161/rna.24151Introduction There are a wide variety of different bacterial regulatory RNAs  ranging from riboswitches that require complex secondary- and tertiary-structure motifs for function 1 to sRNAs that typi - cally act predominantly through base-pairing interactions.2,3  Some of the first regulatory RNAs to be described are those that autogenously regulate ribosomal protein biosynthesis in Escherichia coli .",Non-OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Supplemental Materials Supplemental material may be found here:  http://www.landesbioscience.com/journals/rnabiology/article/24151/Discussion Scientists have been aware of autogenous regulators of ribosomal protein synthesis since 1980.,Non-OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Curr Opin Struct Biol  2012; 22:279-86; PMID:22579413; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Mol Cell  2011; 43:880-91; PMID:21925377; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Trends Genet 2013; 29:92-8;  PMID:23141721; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Proc Natl Acad Sci  USA 1980; 77:7084-8; PMID:7012833; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Prog Nucleic Acid Res Mol Biol 1994; 47:331-70; PMID:7517053; http://dx.doi.org/10.1016/S0079- 6603(08)60256-1 6.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
RNA 2002; 8:878-89;  PMID:12166643; http://dx.doi.org/10.1017/ S13558382020290848.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Cell 2007; 130:1019-31; PMID:17889647;  http://dx.doi.org/10.1016/j.cell.2007.07.008 9.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
J  Biol Chem 2001; 276:38494-501; PMID:11504736;  http://dx.doi.org/10.1074/jbc.M106934200 10.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Nucleic Acids Res 2013;  41:3491-503; PMID:23396277; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
PLoS One  2012; 7:e36972; PMID:22615861; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
J Mol Biol  1989; 209:221-34; PMID:2685320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
EMBO J 2003; 22:1898-908;  PMID:12682022; http://dx.doi.org/10.1093/emboj/ cdg170 33.,Non-OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Genome Biol 2010; 11:R97;  PMID:20920266; http://dx.doi.org/10.1186/gb-2010- 11-9-r97 34.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
BMC Bioinformatics 2011; 12:3;  PMID:21205310; http://dx.doi.org/10.1186/1471-2105-12-320.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Bioinformatics  2009; 25:1335-7; PMID:19307242; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Bioinformatics  2013; 29:381-3; PMID:23172864; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Int J Syst Evol Microbiol  2004; 54:871-5; PMID:15143038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
J Mol Biol 2005; 351:280-90; PMID:16005889; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
FEMS Microbiol Lett 2005; 242:117- 26; PMID:15621428; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Biochemistry 2008; 47:2721-31;  PMID:18247578; http://dx.doi.org/10.1021/ bi701838y 14.,Non-OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
BMC Genomics  2009; 10:268; PMID:19531245; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
J Mol Biol 2001;  314:413-22; PMID:11846555; http://dx.doi.org/10.1006/jmbi.2001.5165 17.,Non-OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Nucleic Acids Res 2007; 35:1578-88;  PMID:17289755; http://dx.doi.org/10.1093/nar/ gkm011 18.,Non-OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
Nucleic Acids Res 2013; 41(Database  issue):D226-32; PMID:23125362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
PLoS Comput Biol 2007; 3:e126;  PMID:17616982; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/a8/70/rna-10-1180.PMC3849166.pdf
"www.landesbioscience.com RNA Biology 1185RNA Biology 10:7, 1185–1196; July 2013; © 2013 Landes Bioscience ReseAR ch p ApeR ReseAR ch p ApeR Correspondence to: Elena Rivas; Email: rivase@janelia.hhmi.org Submitted: 02/15/13; Revised: 05/06/13; Accepted: 05/08/13http://dx.doi.org/10.4161/rna.24971Introduction Methods for RNA secondary structure prediction based on  thermodynamic parameters were already introduced in the 1980s.",Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
SIAM J Appl Math  1978; 35:68-82; http://dx.doi.org/10.1137/0135006 2.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Math Biosci 1978; 42:257-66; http://dx.doi.org/10.1016/0025- 5564(78)90099-83.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 1981; 9:133-48; PMID:6163133; http://dx.doi.org/10.1093/ nar/9.1.133 4.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nature  1971; 230:362-7; PMID:4927725; http://dx.doi.org/10.1038/230362a0 6.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Inf Control 1959; 2:137-67; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
RNA 2001; 7:499-512; PMID:11345429; http://dx.doi.org/10.1017/ S1355838201002515 43.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics 2011; 27:i129-36;  PMID:21685061; http://dx.doi.org/10.1093/bioinfor- matics/btr220 47.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
J Comput Chem 2004; 25:1295- 304; PMID:15139042; http://dx.doi.org/10.1002/ jcc.20057 49.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
J Mol Biol 2005; 347:53- 69; PMID:15733917; http://dx.doi.org/10.1016/j.jmb.2004.12.012 54.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
"Signal Processing, IEEE 2004; 52:2165- 76; http://dx.doi.org/10.1109/TSP.2004.830991 55.",OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
BMC Bioinformatics 2002; 3:2;  PMID:11869452; http://dx.doi.org/10.1186/1471-2105-3-223.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics 2000; 16:583-605;  PMID:11038329; http://dx.doi.org/10.1093/bioinfor- matics/16.7.583 24.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 1994; 22:2079- 88; PMID:8029015; http://dx.doi.org/10.1093/ nar/22.11.2079 26.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res  1994; 22:5112-20; PMID:7800507; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 2003; 31:3423-8; PMID:12824339;  http://dx.doi.org/10.1093/nar/gkg614 28.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics  2009; 25:1335-7; PMID:19307242; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 2004; 24:4925-36; PMID:15448187  ;http://dx.doi.org/10.1093/nar/gkh839 30.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
BMC Bioinformatics 2004; 5:71;  PMID:15180907; http://dx.doi.org/10.1186/1471- 2105-5-71 31.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics 2006; 22:e90-8;  PMID:16873527; http://dx.doi.org/10.1093/bioinfor-matics/btl246 32.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics 2007; 23:i19-28; PMID:17646296; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
RNA 2010; 16:2304- 18; PMID:20940338; http://dx.doi.org/10.1261/ rna.1950510 35.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics 2009; 25:465- 73; PMID:19095700; http://dx.doi.org/10.1093/bio- informatics/btn601 37.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Theory Biosci 2011; 130:313-36; PMID:22135038;  http://dx.doi.org/10.1007/s12064-011-0139-7 39.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Cold Spring Harb Symp Quant  Biol 1987; 52:123-33; PMID:2456874; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Biochemistry 1996; 35:13753-61; PMID:8901517;  http://dx.doi.org/10.1021/bi960913z 9.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Biochemestry 1998; 37:14719-35;  PMID:9778347 http://dx.doi.org/10.1021/bi9809425 10.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
J Mol Biol 1999; 288:911- 40; PMID:10329189; http://dx.doi.org/10.1006/ jmbi.1999.2700 12.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Biochemistry 2011; 50:640-53; PMID:21133351;  http://dx.doi.org/10.1021/bi101470n 13.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res  2003; 31:3406-15; PMID:12824337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Monatsh Chem 1994; 125:167-88; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Algorithms Mol Biol 2011; 6:26;  PMID:22115189; http://dx.doi.org/10.1186/1748-7188-6-26 17.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
BMC Bioinformatics 2010; 11:129; PMID:20230624; http://dx.doi.org/10.1186/1471-2105-11-129 18.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
BMC Bioinformatics  2004; 5:105; PMID:15296519; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
BMC Bioinformatics 2004; 5:140; PMID:15458580;  http://dx.doi.org/10.1186/1471-2105-5-140 21.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics 1999; 15:446-54;  PMID:10383470; http://dx.doi.org/10.1093/bioinfor- matics/15.6.446,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
BMC Bioinformatics 2011; 12:103; PMID:21501497;  http://dx.doi.org/10.1186/1471-2105-12-103 89.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics  2012; 28:2691-2; PMID:22877864; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic  Acids Res 2009; 37:2294-312; PMID:19240142;  http://dx.doi.org/10.1093/nar/gkp011 91.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Curr Opin Struct Biol 2003; 13:300-8; PMID:12831880;  http://dx.doi.org/10.1016/S0959-440X(03)00076-9 92.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 2008; 36(Database issue):D392-7;  PMID:17947325; http://dx.doi.org/10.1093/nar/gkm842 94.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nat  Methods 2011; 8:513-21; PMID:21552257; http://dx.doi.org/10.1038/nmeth.1603 95.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res  2012; 40(Database issue):D439-44; PMID:22127861;  http://dx.doi.org/10.1093/nar/gkr943 97.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids  Res 2004; 32(suppl 2):W160-5; PMID:15215371;  http://dx.doi.org/10.1093/nar/gkh418 98.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
"RNA Biol 2009;  6:5-8; PMID:19106623; http://dx.doi.org/10.4161/ rna.6.1.7634 99. del Val C, Romero-Zaliz R, Torres-Quesada O, Peregrina A, Toro N, Jiménez-Zurdo JI.",OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
RNA Biol  2012; 9:119-29; PMID:22418845; http://dx.doi.org/10.4161/rna.1864374.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Comput Speech Lang 1990; 4:35-56; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Comput Speech Lang 1991; 5:237-57; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Biopolymers 1999; 49:145- 65; PMID:10070264; http://dx.doi.org/10.1002/ (SICI)1097-0282(199902)49:2<145::AID- BIP4>3.0.CO;2-G 77.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics 2008; 24:367-73; PMID:18056736;  http://dx.doi.org/10.1093/bioinformatics/btm591 79.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bull Math Biol 2005; 67:1031-47; PMID:15998494;  http://dx.doi.org/10.1016/j.bulm.2004.12.003 80.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Protein Eng 1995; 8:999-1009; PMID:8771180;  http://dx.doi.org/10.1093/protein/8.10.999 81.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
RNA 2005; 11:1157-66; PMID:16043502;  http://dx.doi.org/10.1261/rna.2500605 83.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
BMC Bioinformatics  2012; 13:78; PMID:22559985; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
J Bioinform Comput  Biol 2010; 8:727-42; http://dx.doi.org/10.1142/ S0219720010004926 85.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Proc Natl Acad Sci USA 2009; 6:97- 102; PMID:19109441; http://dx.doi.org/10.1073/ pnas.0806929106 86.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 2012; 40:4261-72; PMID:22287623; http://dx.doi.org/10.1093/nar/ gks009 87.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
J Comput Biol 2012; 19:1265-76; PMID:23210474;  http://dx.doi.org/10.1089/cmb.2012.021558.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids  Res 2005; 33:139-40; http://dx.doi.org/10.1093/nar/ gki012 59.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 2006; 34(Database  issue):D163-8; PMID:16381838; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 1999; 27:314; PMID:9847214; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Biophys J 1992;  63:751-9; PMID:1384741; http://dx.doi.org/10.1016/ S0006-3495(92)81649-1 62.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Nucleic Acids Res 2003; 31:489-91; PMID:12520059;  http://dx.doi.org/10.1093/nar/gkg068 63.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
RNA 2009; 15:1805-13; PMID:19703939;  http://dx.doi.org/10.1261/rna.1643609 64.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics 1999; 15:440-5; PMID:10383469;  http://dx.doi.org/10.1093/bioinformatics/15.6.440 65.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Bioinformatics  2013; 29:551-60; PMID:23355290; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Inf Control 1967; 10:189-208;  http://dx.doi.org/10.1016/S0019-9958(67)80007-X 72.,OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
Biopolymers 1990; 29:1105-19; PMID:1695107;  http://dx.doi.org/10.1002/bip.360290621,Non-OADS,/arxiv_data1/oa_pdf/31/38/rna-10-1185.PMC3849167.pdf
"www.landesbioscience.com RNA Biology 1197RNA Biology 10:7, 1197–1203; July 2013; © 2013 Landes Bioscience ReseAR ch p ApeR ReseAR ch p ApeR *Correspondence to: Dori Huertas; Email: dhuertas@idibell.cat; Manel Esteller; Email: mesteller@idibell.cat Submitted: 02/05/13; Revised: 03/07/13; Accepted: 03/13/13http://dx.doi.org/10.4161/rna.24286Introduction Epigenetic regulation, whose mechanisms involve chromatin  remodeling by many different enzymes/complexes/molecular scaffolds that targets DNA methylation and histone code modi - fications, 1 is also mediated by non-coding RNAs (ncRNAs).2-5  ncRNAs include the most studied member microRNAs, but also include long non-coding RNAs (lncRNAs).",Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Supplemental Material Supplemental material may be found here:  http://www.landesbioscience.com/journals/rnabiology/article/24286/TTC ACC GCG GAG AGC TGG-3'.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Prog Neurobiol 2009; 88:170- 83; PMID:19554713; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Genome Res 2008; 18:1433-45; PMID:18562676;  http://dx.doi.org/10.1101/gr.078378.108.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
PLoS Genet 2009; 5:e1000459; PMID:19390609;  http://dx.doi.org/10.1371/journal.pgen.1000459.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Nat Struct Mol Biol 2012; 19:1068- 75; PMID:23132386; http://dx.doi.org/10.1038/ nsmb.2428.7.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Cell 2010; 143:46-58; PMID:20887892; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Cell 2007; 129:1311- 23; PMID:17604720; http://dx.doi.org/10.1016/j.cell.2007.05.022.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Prog Mol Biol Transl Sci 2011; 101:351- 76; PMID:21507358; http://dx.doi.org/10.1016/B978-0-12-387685-0.00011-1.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Mol Cell 2011; 43:904-14;  PMID:21925379; http://dx.doi.org/10.1016/j.mol-cel.2011.08.018.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Behav Brain Res 2008; 192:70- 87; PMID:18353453; http://dx.doi.org/10.1016/j.bbr.2008.01.021.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Lancet Neurol 2009; 8:1056-72; PMID:19833297; http://dx.doi.org/10.1016/S1474- 4422(09)70262-5.13.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Ann Neurol 1983; 14:471-9; PMID:6638958; http://dx.doi.org/10.1002/ana.410140412.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Nat Genet 1999; 23:185-8;  PMID:10508514; http://dx.doi.org/10.1038/13810.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Neurology  2008; 70:1313-21; PMID:18337588; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Cell 1992; 69:905-14; PMID:1606614; http://dx.doi.org/10.1016/0092- 8674(92)90610-O.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Mol Cell 2005; 19:667-78;  PMID:16137622; http://dx.doi.org/10.1016/j.mol- cel.2005.07.021.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Nat Struct Mol Biol  2012; 19:664-70; PMID:22659877; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
PLoS One  2012; 7:e38907; PMID:22723905; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Neuron 2007; 56:58-65;  PMID:17920015; http://dx.doi.org/10.1016/j.neu-ron.2007.08.018.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Neurobiol Dis 2006; 21:217-27; PMID:16087343; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Nature 2010; 468:263-9; PMID:21068835;  http://dx.doi.org/10.1038/nature09582.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Exp Brain Res 2009; 199:245-52;  PMID:19198818; http://dx.doi.org/10.1007/s00221- 009-1918-y.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Cell Tissue Res 2007; 330:1-15; PMID:17610086;  http://dx.doi.org/10.1007/s00441-007-0446-y.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Exp Neurol  1999; 156:345-52; PMID:10328941; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
J Neurophysiol 2010; 103:2470-81;  PMID:20200124; http://dx.doi.org/10.1152/jn.00601.2009.29.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Epigenetics 2010; 5:656- 63; PMID:20716963; http://dx.doi.org/10.4161/ epi.5.7.13055.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Nat Genet  2001; 27:322-6; PMID:11242117; http://dx.doi.org/10.1038/85899.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Mol Cell 2010; 37:457-68; PMID:20188665;  http://dx.doi.org/10.1016/j.molcel.2010.01.030.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
J Neurosci 2009;  29:10488-98; PMID:19710302; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Mol Cell Neurosci 2012; 50:82-92; PMID:22521536;  http://dx.doi.org/10.1016/j.mcn.2012.03.008.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
J Neurophysiol  2008; 99:112-21; PMID:18032561; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Neurosci  Biobehav Rev 2012; 36:2044-55; PMID:22841562; http://dx.doi.org/10.1016/j.neubiorev.2012.07.005.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Hum Mol Genet 2007; 16:691-703; PMID:17339270;  http://dx.doi.org/10.1093/hmg/ddm014.19.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
EMBO J  2003; 22:6335-45; PMID:14633992; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Cancer Res 2006; 66:8342-6;  PMID:16951140; http://dx.doi.org/10.1158/0008- 5472.CAN-06-1932.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Oncogene 2008; 27:3556-66; PMID:18223687; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Cancer  Res 2007; 67:1424-9; PMID:17308079; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Hum Genet 2005; 116:91-104; PMID:15549394;  http://dx.doi.org/10.1007/s00439-004-1200-0.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Hum Mol Genet 2005; 14:483- 92; PMID:15615769; http://dx.doi.org/10.1093/hmg/ ddi045.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Hum Mol Genet 2005; 14:2247-56; PMID:16002417;  http://dx.doi.org/10.1093/hmg/ddi229.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Hum Mol Genet 2007; 16:640-50; PMID:17309881; http://dx.doi.org/10.1093/hmg/ ddm007.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
Science  2008; 320:1224-9; PMID:18511691; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/70/rna-10-1197.PMC3849168.pdf
"www.landesbioscience.com RNA Biology 1211RNA Biology 10:7, 1211–1220; July 2013; © 2013 Landes BioscienceReseAR ch p ApeR *Correspondence to: Daniel Gautheret; Email: daniel.gautheret@u-psud.fr Submitted: 05/05/13; Revised: 06/25/13; Accepted: 06/27/13http://dx.doi.org/10.4161/rna.25567Introduction Widespread or “pervasive” transcription of genomic regions out - side protein-coding genes is now well established in a wide range  of eukaryotic species.",Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
"All identified ncRNA sequences  were submitted to a BLASTN (version 2.2.15 with param - eters: -W 7 -r 2 -q -3 -G 5 -E 2 -e 10) search on a database of 76 archaeal genomes, selected based both on their “complete” status given by the Genomes OnLine Database (http://www.genomesonline.org) in March 2012, and their availability in the NCBI genome repository.",OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
RNA Biol 2012; 9:1039-44; PMID:22858676; http://dx.doi.org/10.4161/rna.21167 2.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Nucleic Acids Res 2002; 30:2076- 82; PMID:11972348; http://dx.doi.org/10.1093/nar/30.9.2076 5.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Nucleic Acids Res 2008; 36:2459- 75; PMID:18304947; http://dx.doi.org/10.1093/nar/ gkn0776.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
BMC  Genomics 2011; 12:312; PMID:21668986; http://dx.doi.org/10.1186/1471-2164-12-312 7.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
RNA 2012; 18:402-11; PMID:22282340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Genome Res 2010; 20:133- 41; PMID:19884261; http://dx.doi.org/10.1101/ gr.100396.109 9.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Nucleic Acids Res 2012; 40:3131-42;  PMID:22140119; http://dx.doi.org/10.1093/nar/ gkr1009 10.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Genome Biol 2012; 13:R63;  PMID:22809431; http://dx.doi.org/10.1186/gb-2012- 13-7-r6311.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Nucleic Acids Res 2012; 40:10964-79; PMID:22965121; http://dx.doi.org/10.1093/nar/ gks847 13.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
J Mol Evol 1997;  44:632-6; PMID:9169555; http://dx.doi.org/10.1007/ PL00006186 14.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Mol Microbiol 1998; 28:1043-9;  PMID:9680196; http://dx.doi.org/10.1046/j.1365- 2958.1998.00853.x 15.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Proc Biol  Sci 2001; 268:493-7; PMID:11296861; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
RNA 2012; 18:2201- 19; PMID:23097430; http://dx.doi.org/10.1261/ rna.033324.112 42.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Genome Biol 2009;  10:R25; PMID:19261174; http://dx.doi.org/10.1186/ gb-2009-10-3-r25 43.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
BMC  Bioinformatics 2003; 4:21; PMID:12783628; http://dx.doi.org/10.1186/1471-2105-4-21 45.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Bioinformatics 2011; 27:1017-8; PMID:21330290; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Nucleic Acids Res  2001; 29:4724-35; PMID:11713323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Nucleic Acids Res 2005;  33(Web Server issue):W540-3; PMID:15980530;  http://dx.doi.org/10.1093/nar/gki478 49.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Bioinformatics 2009; 25:1974-5; PMID:19398448;  http://dx.doi.org/10.1093/bioinformatics/btp25029.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Genome Biol 2010; 11:R31;  PMID:20230605; http://dx.doi.org/10.1186/gb-2010- 11-3-r31 30.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Biochemistry 1994; 33:7869-76; PMID:7516708; http://dx.doi.org/10.1021/bi00191a014 32.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Proc Jpn Acad Ser B Phys Biol Sci  2011; 87:587-602; PMID:22075760; http://dx.doi.org/10.2183/pjab.87.587 33.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Extremophiles 1998; 2:115-22; PMID:9672686; http://dx.doi.org/10.1007/ s007920050050 34.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Biochem Soc Trans 2013; 41:344- 9; PMID:23356309; http://dx.doi.org/10.1042/ BST20120280 36.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Genes Dev 2011; 25:1915- 27; PMID:21890647; http://dx.doi.org/10.1101/ gad.17446611 37.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Science  2009; 326:1268-71; PMID:19965477; http://dx.doi.org/10.1126/science.1176951 39.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Biochimie 2011; 93:1889- 96; PMID:21771634; http://dx.doi.org/10.1016/j.biochi.2011.07.001 40.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
J Bacteriol 2003; 185:210- 20; PMID:12486058; http://dx.doi.org/10.1128/ JB.185.1.210-220.200316.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Nucleic Acids  Res 1994; 22:1681-6; PMID:8202372; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Mol Microbiol 2003; 47:1495-512;  PMID:12622808; http://dx.doi.org/10.1046/j.1365- 2958.2003.03381.x 18.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Curr Microbiol 2012; 64:118-29;  PMID:22057919; http://dx.doi.org/10.1007/s00284- 011-0035-x 19.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Mol Microbiol  1999; 31:1589-92; PMID:10200975; http://dx.doi.org/10.1046/j.1365-2958.1999.01274.x 20.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Can J Microbiol 1989; 35:30-5; PMID:2497942;  http://dx.doi.org/10.1139/m89-005 21.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Proc Natl Acad Sci USA  2009; 106:21878-82; PMID:19996181; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
J Mol Biol 2000; 297:895-906; PMID:10736225;  http://dx.doi.org/10.1006/jmbi.2000.3593 25.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Mol Microbiol 2001; 40:509-19;  PMID:11359559; http://dx.doi.org/10.1046/j.1365- 2958.2001.02381.x 26.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Mol Microbiol 2005; 55:1812- 28; PMID:15752202; http://dx.doi.org/10.1111/j.1365-2958.2005.04505.x 27.,Non-OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
Methods Enzymol 2007; 425:355-87; PMID:17673091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d8/rna-10-1211.PMC3849170.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/f6/tcrm-9-483.PMC3849173.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 483–489Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  483Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5390 6Pseudobulbar affect: prevalence and management Aiesha Ahmed Zachary Simmons Department of Neurology,    Penn State Hershey Medical   Center, Hershey, PA, USA Correspondence: Zachary Simmons   Penn State Hershey Medical Center,   Department of Neurology – eC 037,   Hershey, PA 17033, USA   Tel +1 717 531 1377   Fax +1 717 531 0384   email zsimmons@hmc.psu.ed uAbstract:  Pseudobulbar affect (PBA) may occur in association with a variety of neurological  diseases, and so may be encountered in the setting of amyotrophic lateral sclerosis, extrapyra - midal and cerebellar disorders, multiple sclerosis, traumatic brain injury, Alzheimer’ s disease,  stroke, and brain tumors.",Non-OADS,/arxiv_data1/oa_pdf/5d/f6/tcrm-9-483.PMC3849173.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/5d/f6/tcrm-9-483.PMC3849173.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/f6/tcrm-9-483.PMC3849173.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.08.002 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/bc/ba/main.PMC3849240.pdf
conﬁrm these ﬁndings ( http://www.fungenes.org ).,Non-OADS,/arxiv_data1/oa_pdf/bc/ba/main.PMC3849240.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, and two movies and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/bc/ba/main.PMC3849240.pdf
"Stem Cell Reports Resource Identifying Division Symmetry of Mouse Embryonic Stem Cells: Negative Impact of DNA Methyltransferases on Symmetric Self-Renewal Lukasz Jasnos,1Fatma Betu ¨l Aksoy,1,2Hersi Mohamed Hersi,1Slawomir Wantuch,1and Tomoyuki Sawado1,* 1Haemato-Oncology Research Unit, Division of Molecular Pathology, Division of Cancer Biology, The Institute of Cancer Research, Sutton SM2 5NG, UK 2Present address: Department of Molecular Biology and Genetics, Bo /C21gazic ¸i University, Bebek 34342, Istanbul, Turkey *Correspondence: tomoyuki.sawado@icr.ac.uk http://dx.doi.org/10.1016/j.stemcr.2013.08.005 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/5f/4b/main.PMC3849243.pdf
"Stem Cell Reports Commentary iPSC-Based Cell Therapy: An Important Step Forward Mahendra Rao1,* 1Director, NIH Center for Regenerative Medicine, 50 South Drive, Bethesda, MD 20892 USA *Correspondence: mrao1234@verizon.net http://dx.doi.org/10.1016/j.stemcr.2013.10.002 Morizane et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/16/main.PMC3849244.pdf
"http://dx.doi.org/10.1038/nature11807 .Cave, A.",OADS,/arxiv_data1/oa_pdf/d9/16/main.PMC3849244.pdf
"The Telegraph, September 9, 2013. http://www.telegraph.co.uk/science/science-news/10295085/Stem-cell-banks-enable-wealthy-to-free-backup-version-of-their-adult-selves.html .",Non-OADS,/arxiv_data1/oa_pdf/d9/16/main.PMC3849244.pdf
"Published online Jan 24, 2013. http://dx.doi.org/10.1016/j.stem.2013.01.006 .",OADS,/arxiv_data1/oa_pdf/d9/16/main.PMC3849244.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d9/16/main.PMC3849244.pdf
http://dx.doi.org/10.1371/journal.pone.0023436 .,Non-OADS,/arxiv_data1/oa_pdf/d9/16/main.PMC3849244.pdf
http://dx.doi.org/10.1038/nature10135 .,Non-OADS,/arxiv_data1/oa_pdf/d9/16/main.PMC3849244.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.09.001 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/50/9c/main.PMC3849245.pdf
(C) Gene ontology (GO) analysis ( http://david.abcc.ncifcrf.gov ).,OADS,/arxiv_data1/oa_pdf/50/9c/main.PMC3849245.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, two tables, and three movies and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/50/9c/main.PMC3849245.pdf
"Stem Cell Reports Resource Analysis of Induced Pluripotent Stem Cells from a BRCA1 Mutant Family Abigail A. Soyombo,1,7Yipin Wu,1,7Lauren Kolski,1Jonathan J. Rios,4Dinesh Rakheja,2,3Alice Chen,5 James Kehler,5Heather Hampel,6Alanna Coughran,1and Theodora S. Ross1,* 1Department of Internal Medicine, High Risk Cancer Genetics Program 2Department of Pediatrics 3Department of Pathology University of Texas Southwestern Medical Center, Dallas, TX 75390, USA 4Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, TX 75390, USA 5Stemgent, Inc., San Diego, CA 92037, USA 6Division of Human Genetics, Ohio State University, Columbus, OH 43240, USA 7These authors contributed equally to this work *Correspondence: theo.ross@utsouthwestern.edu http://dx.doi.org/10.1016/j.stemcr.2013.08.004 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/1d/a2/main.PMC3849250.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and six tables and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2013.08.004 .,OADS,/arxiv_data1/oa_pdf/1d/a2/main.PMC3849250.pdf
"Stem Cell Reports Report Dissecting the Roles of miR-302/367 Cluster in Cellular Reprogramming Using TALE-based Repressor and TALEN Zhonghui Zhang,1,2Di Xiang,1Fransisca Heriyanto,1Yongxing Gao,3Zhijian Qian,4and Wen-Shu Wu1,2,4,* 1Jordan Family Center for Blood and Marrow Transplantation and Cellular Therapies, Children’s Hospital Oakland Research Institute, Oakland, CA 94609, USA 2Berkeley Stem Cell Center, University of California at Berkeley, Berkeley, CA 94720, USA 3Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA 4Section of Hematology/Oncology, Department of Medicine, and Cancer Research Center, University of Illinois at Chicago, Chicago, IL 60612, USA *Correspondence: wuwenshu1963@icloud.com http://dx.doi.org/10.1016/j.stemcr.2013.07.002 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6e/45/main.PMC3849252.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, one table, and six DNA sequences fortheTALE-KRAB and TALENs and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2013.07.002 .ACKNOWLEDGMENTS We thank members of the Wu laboratory for valuable discussions.This work was supported in part by an NICHD/NIH grant (R21 5R21HD061777) and by the Jordan Family’s endowment fund.",Non-OADS,/arxiv_data1/oa_pdf/6e/45/main.PMC3849252.pdf
"Stem Cell Reports Resource Long-T erm Self-Renewal of Human ES/iPS-Derived Hepatoblast-like Cells on Human Laminin 111-Coated Dishes Kazuo Takayama,1,2,3Yasuhito Nagamoto,1,2Natsumi Mimura,2Katsuhisa Tashiro,4Fuminori Sakurai,1 Masashi Tachibana,1Takao Hayakawa,5Kenji Kawabata,4and Hiroyuki Mizuguchi1,2,3,6,* 1Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan 2Laboratory of Hepatocyte Differentiation, National Institute of Biomedical Innovation, Osaka 567-0085, Japan 3iPS Cell-Based Research Project on Hepatic Toxicity and Metabolism, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan 4Laboratory of Stem Cell Regulation, National Institute of Biomedical Innovation, Osaka 567-0085, Japan 5Pharmaceutical Research and Technology Institute, Kinki University, Osaka 577-8502, Japan 6The Center for Advanced Medical Engineering and Informatics, Osaka University, Osaka 565-0871, Japan *Correspondence: mizuguch@phs.osaka-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2013.08.006 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/89/7e/main.PMC3849256.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and ﬁve tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2013.08.006 .,Non-OADS,/arxiv_data1/oa_pdf/89/7e/main.PMC3849256.pdf
"Ian Spencer,1Li Qian,1,2,3,4,7Yohei Hayashi,1 Paul Delgado-Olguin,1,8Sheng Ding,1,2,6Benoit G. Bruneau,1,2,3,5and Deepak Srivastava1,2,3,4,* 1Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA 2Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA 3Department of Pediatrics 4Department of Biochemistry and Biophysics 5Cardiovascular Research Institute 6Department of Pharmaceutical Chemistry University of California, San Francisco, San Francisco, CA 94158, USA 7Present address: McAllister Heart Institute, University of North Carolina, Chapel Hill, NC 27599-7126 8Present address: Program in Physiology and Experimental Medicine, The Hospital for Sick Children, Toronto, ON, Canada M5G 1X8 *Correspondence: dsrivastava@gladstone.ucsf.edu http://dx.doi.org/10.1016/j.stemcr.2013.07.005 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f8/33/main.PMC3849259.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six ﬁgures and two moviesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f8/33/main.PMC3849259.pdf
3. http://dx.doi.org/10.2202/1544- 6115.1027 .,Non-OADS,/arxiv_data1/oa_pdf/f8/33/main.PMC3849259.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):397-404 http://dx.doi.org/10.3341/kjo.2013.27.6.397 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.397 Original ArticlePrevalence and Risk Factors for Thyroid Eye Disease among Korean  Dysthyroid Patients Kyung In Woo1, Yoon-Duck Kim1, Sang Yeul Lee2 1Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 2The Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University College of Medicine, Seoul,  Korea Purpose:  To determine the prevalence of thyroid eye disease among dysthyroid Korean patients and to analyze  the relationship between demographic data, lifestyle risk factors, and status of thyroid disease and thyroid eye  disease.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/kjo-27-397.PMC3849301.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):405-408 http://dx.doi.org/10.3341/kjo.2013.27.6.405 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.405 Original ArticleThe Efficacy of the Combined Procedure in Involutional Entropion  Surgery: A Comparative Study Didem Serin1, Ibrahim Bulent Buttanri1, Safak Karslioglu2, Mehmet Sahin Sevim1, Bahtinur Buttanri3,   Muslime Akbaba2 1Eye Clinic, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey 2Oculoplastic Surgery and Ocular Oncology Center, Istanbul Okuloplasti, Istanbul, Turkey 3Eye Clinic, Sisli Etfal Education and Research Hospital, Istanbul, Turkey Purpose:  To evaluate the efficacy of the combined procedure in the management of involutional entropion.",Non-OADS,/arxiv_data1/oa_pdf/1a/05/kjo-27-405.PMC3849302.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):409-415 http://dx.doi.org/10.3341/kjo.2013.27.6.409 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.409 Original ArticleLong-term Evaluation of Endothelial Cell Changes in Fuchs  Corneal Dystrophy: The Influence of Phacoemulsification and  Penetrating Keratoplasty Yong Woo Kim1,2, Mee Kum Kim1,2, Won Ryang Wee1,2 1Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 2Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul, Korea Purpose:  To evaluate the natural course of the long-term endothelial cell changes in Fuchs corneal dystrophy  (FCD) patients and investigate the effects of phacoemulsification on the annual rate of change in endothelial  indices in FCD patients.",Non-OADS,/arxiv_data1/oa_pdf/0f/b4/kjo-27-409.PMC3849303.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):416-420 http://dx.doi.org/10.3341/kjo.2013.27.6.416 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.416 Original ArticleThe Pathologic Characteristics of Pingueculae on  Autofluorescence Images Tae Hyung Kim, Yeoun Sook Chun, Jae Chan Kim Department of Ophthalmology, Chung-Ang University Hospital, Seoul, Korea Purpose:  To analyze the autofluorescence (AF) properties of pinguecula using cobalt-blue and yellow filters  and to investigate the nature and pathogenesis of pingueculae using histochemical and immunohistochemical  staining.",Non-OADS,/arxiv_data1/oa_pdf/12/6b/kjo-27-416.PMC3849304.pdf
"Original ArticlepISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):421-424 http://dx.doi.org/10.3341/kjo.2013.27.6.421 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.421The Correlation between Angle Kappa and Ocular Biometry  in Koreans Se Rang Choi1, Ungsoo Samuel Kim1,2  1Department of Ophthalmology, Kim ’s Eye Hospital, Seoul, Korea 2Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea The angle kappa is defined as the angle between the vi - sual line and the pupillary axis.",Non-OADS,/arxiv_data1/oa_pdf/68/ee/kjo-27-421.PMC3849305.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):425-432 http://dx.doi.org/10.3341/kjo.2013.27.6.425 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.425 Original ArticleAnti-VEGF-refractory Exudative Age-related Macular Degeneration:  Differential Response According to Features  on Optical Coherence Tomography Joo Young Shin, Se Joon Woo, Jeeyun Ahn, Kyu Hyung Park Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea   Purpose:  To describe optical coherence tomography (OCT) characteristics of neovascular age-related macular  degeneration (AMD) patients refractory to intravitreal anti-vascular endothelial growth factor (VEGF) injections  (ranibizumab, bevacizumab) and their responses to alternative anti-VEGF agents or photodynamic therapy  (PDT).",Non-OADS,/arxiv_data1/oa_pdf/cc/3a/kjo-27-425.PMC3849306.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):433-439 http://dx.doi.org/10.3341/kjo.2013.27.6.433 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.433 Original ArticleComparison of Choroidal Thickness in Patients with Diabetes by  Spectral-domain Optical Coherence Tomography Hyo Kyung Lee1, Ji Won Lim2, Min Cheol Shin1 1Department of Ophthalmology, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Korea 2Department of Ophthalmology, Seoul Metropolitan Dongbu Hospital, Seoul, Korea Purpose:  To evaluate choroidal thickness in diabetes patients using spectral-domain optical coherence tomog - raphy.",Non-OADS,/arxiv_data1/oa_pdf/70/e4/kjo-27-433.PMC3849307.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):440-445 http://dx.doi.org/10.3341/kjo.2013.27.6.440 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.440 Original ArticleComparison between Glaucomatous and Non-glaucomatous Eyes with  Unilateral Retinal Vein Occlusion in the Fellow Eye Soa Kim, Kyung Rim Sung, Soo Geun Joe, Jee Taek Kim, Dong Hoon Lee, Joo Yong Lee, June-Gone Kim Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  To evaluate and compare the clinical and angiographic characteristics of retinal vein occlusion (RVO)  in glaucomatous and non-glaucomatous eyes with unilateral RVO in the fellow eye.",Non-OADS,/arxiv_data1/oa_pdf/2f/7f/kjo-27-440.PMC3849308.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):446-453 http://dx.doi.org/10.3341/kjo.2013.27.6.446 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article446In Vitro Effects of Preservative-free and Preserved Prostaglandin  Analogs on Primary Cultured Human Conjunctival Fibroblast Cells Eun Joo Kim1, Yeoun-Hee Kim1, Sun-Hee Kang2, Kyoo Won Lee1, Young Jeung Park1 1Cheil Eye Reserch Institute, Cheil Eye Hospital, Daegu, Korea 2Developmental Biology Laboratory, Department of Biology, College of Natural Sciences,  Kyungpook National University, Daegu, Korea Purpose:  Long-term use of topical medication is needed for glaucoma treatment.",Non-OADS,/arxiv_data1/oa_pdf/0d/1c/kjo-27-446.PMC3849309.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):454-458 http://dx.doi.org/10.3341/kjo.2013.27.6.454 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.454A Case of Korean Patient with Macular Corneal Dystrophy  Associated with Novel Mutation in the CHST6 Gene You Kyung Lee1, Dong-Jin Chang2, Sung Kun Chung1 1Department of Ophthalmology, The Catholic University of Korea College of Medicine, Seoul, Korea 2Medical and Scientific Affairs, Allergan Korea Ltd., Seoul, Korea Corneal dystrophies are hereditary diseases involving  corneal opacities at different layers of the cornea.",Non-OADS,/arxiv_data1/oa_pdf/db/fd/kjo-27-454.PMC3849310.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):459-462 http://dx.doi.org/10.3341/kjo.2013.27.6.459 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.459Self-inflicted Chronic Bacterial Keratoconjunctivitis  Using Self Semen Youngsub Eom1, Young-Ho Kim2, Seung-Hyun Kim1, Hyo Myung Kim1, Jong-Suk Song1 1Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea 2Paju Public Health Center, Paju, Korea Self-inflicted eye injuries are rare, but are important be - cause the diagnosis can be difficult.",Non-OADS,/arxiv_data1/oa_pdf/00/d5/kjo-27-459.PMC3849311.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):463-465 http://dx.doi.org/10.3341/kjo.2013.27.6.463 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.463Free-floating Vitreous Cyst in an Adult Male Yasin Tok lu1, Sabri Raza1, Hasan Basri Cakmak2, Nurullah Cagil2 1Ankara Ataturk Training and Research Hospital, Ankara, Turkey 2Ophthalmology Department, Yildirim Beyazit University, Ankara, Turkey Vitreous cysts are rare ocular curiosities.",Non-OADS,/arxiv_data1/oa_pdf/e2/ca/kjo-27-463.PMC3849312.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):466-469 http://dx.doi.org/10.3341/kjo.2013.27.6.466 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.466Frosted Branch Angiitis as Ocular Manifestation of Behçet’s Disease:  Unusual Case Report and Literature Review Soon Jae Kwon, Dong Ho Park, Jae Pil Shin Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea Behçet’s disease is a systemic immune-mediated vascu - litis of unclear origin [1].",Non-OADS,/arxiv_data1/oa_pdf/a5/62/kjo-27-466.PMC3849313.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):470-473 http://dx.doi.org/10.3341/kjo.2013.27.6.470 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.470Ophthalmic Artery Aneurysm: Potential Culprit of Central Retinal  Artery Occlusion Yong Woo K i m1, Se Joon Woo2, Jeeyun Ahn3, Kyu Hyung Park2, O-Ki Kwon4 1Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 3Department of Ophthalmology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center,  Seoul National University College of Medicine, Seoul, Korea 4Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea Central retinal artery occlusion (CRAO) is one of the  most devastating ophthalmic emergencies, causing acute  painless visual loss in the affected eye.",Non-OADS,/arxiv_data1/oa_pdf/78/04/kjo-27-470.PMC3849314.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(6):474-477 http://dx.doi.org/10.3341/kjo.2013.27.6.474 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.474Horner’s Syndrome and Contralateral Abducens Nerve Palsy  Associated with Zoster Meningitis Bum-Joo Cho1, Ji-Soo Kim2, Jeong-Min Hwang1,3 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea 2Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea 3Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea Horner’s syndrome, first described by Johann Friedrich  Horner in 1929, is characterized by the classic triad of mi - osis, ipsilateral blepharoptosis, and facial anhidrosis [1].",Non-OADS,/arxiv_data1/oa_pdf/2c/fe/kjo-27-474.PMC3849315.pdf
"Stem Cell Reports Resource Fast Quantitative Real-Time PCR-Based Screening for Common Chromosomal Aneuploidies in Mouse Embryonic Stem Cells Charlotte D’Hulst,1Irena Parvanova,1Delia Tomoiaga,1Maria L. Sapar,1and Paul Feinstein1,* 1Department of Biological Sciences, Hunter College and The Graduate Center Biochemistry, Biology and Biopsychology and Behavioral Neuroscience Programs, The City University of New York, New York, NY 10065, USA *Correspondence: feinstein@genectr.hunter.cuny.edu http://dx.doi.org/10.1016/j.stemcr.2013.08.003 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/be/5f/main.PMC3849352.pdf
"In the case that no such lines are readily availablein the lab, mESCs with a normal cytogenetic karyotypeare commercially available ( http://www.atcc.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/be/5f/main.PMC3849352.pdf
"Cut for 3 hr at 37/C14C (no heat inactivation) SYBR Green I Real-time ESC genomic DNA PCR Six PCR primer pairs were designed with Primer3 Software (http://bioinfo.ut.ee/primer3-0.4.0/ ), in silico validated by OligoAnalyzer 3.1 ( http://www.idtdna.com/analyzer/Applications/ OligoAnalyzer/ ), and synthesized by Integrated DNA Technologies with standard desalting puriﬁcation.",OADS,/arxiv_data1/oa_pdf/be/5f/main.PMC3849352.pdf
The BLAST program from theNCBI browser ( http://blast.ncbi.nlm.nih.gov/ ) was used for in silico speciﬁcity analysis and primer sequences were submittedto the RTPrimerDB ( http://medgen.ugent.be/rtprimerdb/ ).,OADS,/arxiv_data1/oa_pdf/be/5f/main.PMC3849352.pdf
The absence of secondary structures in the region in which the primers anneal was veriﬁed using MFOLD(http://mfold.rna.albany.edu/?q=mfold ).,OADS,/arxiv_data1/oa_pdf/be/5f/main.PMC3849352.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and six tables and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2013.08.003 .,Non-OADS,/arxiv_data1/oa_pdf/be/5f/main.PMC3849352.pdf
"Stem Cell Reports Article T ranscriptome Analysis Identiﬁes Regulators of Hematopoietic Stem and Progenitor Cells Roi Gazit,1,2,8,9Brian S. Garrison,1,2,9Tata Nageswara Rao,2,3Tal Shay,4James Costello,5Jeff Ericson,6 Francis Kim,2,3James J. Collins,5,7Aviv Regev,4,7Amy J. Wagers,2,3,7Derrick J. Rossi,1,2,* and The Immunological Genome Project Consortium 1Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA 02115, USA 2Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA 3Joslin Diabetes Center, Boston, MA 02215, USA 4Broad Institute, Cambridge, MA 02142, USA 5Department of Biomedical Engineering, Boston University, Boston, MA 02115, USA 6Department of Pathology, Harvard Medical School, Boston, MA 02215, USA 7Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA 8The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel 9These authors contributed equally to this work *Correspondence: derrick.rossi@childrens.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2013.07.004 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC3849420.pdf
"Togenerate transcriptome data from primitive subsets, we sorted HSCs, MPPs (MPP1 and MPP2), and oligopotent progenitors (common myeloid progenitor [CMP], granulo-cyte-macrophage progenitor [GMP], megakaryocyte-erythroid progenitor [MEP], and common lymphoid pro-genitor [CLP]) to a high degree of purity (for sorting details,seeTable S1 available online and http://www.immgen.org/ index_content.html ) and subjected them to ImmGen expression proﬁling and quality-control pipelines ( Heng and Painter, 2008 ).",Non-OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC3849420.pdf
"We next tested for functional enrichment in the Databasefor Annotation, Visualization and Integrated Discovery(DAVID) bioinformatics resource ( http://david.abcc.ncifcrf.",OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC3849420.pdf
"The fourth motif is predicted to bind STAT1, which is required for interferon-induced activation of HSCs ( Ess- ers et al., 2009 ).To further explore the potential regulatory network of HSCs, we utilized module analysis ( http://www.immgen.",Non-OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC3849420.pdf
Experimental cell-sorting and processing schemes are available at https://www.immgen.org/ index_content.html .,OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC3849420.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes seven ﬁgures and seven tablesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ce/e5/main.PMC3849420.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/SPA0355 prevents type 1 DM UJ Bae et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/8a/6b/emm2013109a.PMC3849566.pdf
48The images were quantiﬁed with the ImageJ software program (http://rsb.info.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/36/c0/emm2013111a.PMC3849567.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Experimen tal and Molecular Medicine website (http://www.nature.com/ emm)HER2 and VEGF dual blockade in gastric cancer RS i n g h et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/36/c0/emm2013111a.PMC3849567.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Experimen tal & Molecular Medicine website (http://www.nature.com/emm)Phosphoproteome in lapatinib-resistant cancer YY Lee et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/44/68/emm2013115a.PMC3849569.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/In situ tissue regeneration IK Ko et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/1b/e6/emm2013118a.PMC3849571.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Experimen tal & Molecular Medicine website (http://www.nature.com/emm)The therapeutic effects of hSGSCs on hyposalivation JJ e o n g et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/58/4b/emm2013121a.PMC3849572.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Relevance of cellular reprogramming for psychiatry BTD Tobe et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/07/95/emm2013124a.PMC3849573.pdf
"The viral titer was determinedas transducing units using ﬂow cytometry, guided by the protocol of the Trono lab (http://tronolab.epﬂ.ch/).",OADS,/arxiv_data1/oa_pdf/98/ce/emm2013125a.PMC3849574.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Experimen tal & Molecular Medicine website (http://www.nature.com/emm)Effects of amyloid- bon human neural stem cells I-S Lee et al 15 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/98/ce/emm2013125a.PMC3849574.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Human ESC-NPC in experimental stroke Chang, Oh et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/f4/6d/emm201393a.PMC3849578.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Developmental changes in HSCs MR Copley et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/f3/ca/emm201398a.PMC3849580.pdf
"Gene expression profile data are accessible as MIAME format on the NCBI Gene Expression Omnibus (GEO) website (http://www.ncbi.nlm.nih.gov/geo/), with accession number GSE50040.",OADS,/arxiv_data1/oa_pdf/20/d9/srep03416.PMC3849634.pdf
Additional information Accession codes: the GEO submission accession number is GSE50040 Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/d9/srep03416.PMC3849634.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3416 | DOI: 10.1038/srep03416 10",Non-OADS,/arxiv_data1/oa_pdf/20/d9/srep03416.PMC3849634.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/6f/srep03413.PMC3849635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3413 | DOI: 10.1038/srep03413 6",Non-OADS,/arxiv_data1/oa_pdf/56/6f/srep03413.PMC3849635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Table 2 |The surrounding layer thickness h and the corresponding Au concentration, both obtained from the minimum value of R2from Figure 7 Sample Surrounding layer thickness h (nm) Au concentration (at.%) 25 s 4.0 60.3 5.1 60.4 50 s 5.1 60.7 6.0 60.9www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3414 | DOI: 10.1038/srep03414 6",Non-OADS,/arxiv_data1/oa_pdf/98/b5/srep03414.PMC3849636.pdf
"Methods Data .Time series have been obtained from http://www.google.com/trends for Google Trends , http://stats.grok.se for Wikipedia and http://www.bitcoincharts.com for BitCoin .",OADS,/arxiv_data1/oa_pdf/66/d4/srep03415.PMC3849639.pdf
"http://bitcoin.org/ bitcoin.pdf, visited on 11 November 2013.",Non-OADS,/arxiv_data1/oa_pdf/66/d4/srep03415.PMC3849639.pdf
Additional information Data retrieval: Search volume data were retrieved by accessing the Google Trends website (http://www.google.com/trends) on 5 July 2013 and the Wikipedia article traffic statisticssite (http://stats.grok.se) on 21 August 2013.,OADS,/arxiv_data1/oa_pdf/66/d4/srep03415.PMC3849639.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3415 | DOI: 10.1038/srep03415 7",Non-OADS,/arxiv_data1/oa_pdf/66/d4/srep03415.PMC3849639.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3417 | DOI: 10.1038/srep03417 5",Non-OADS,/arxiv_data1/oa_pdf/0d/34/srep03417.PMC3849641.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Runx1 haploinsufﬁciency and lineage commitment KP Ng et al 5 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 5",Non-OADS,/arxiv_data1/oa_pdf/f9/a1/oncsis201341a.PMC3849692.pdf
METHODS  The angiotensin-converting enzyme was downloaded  from the Protein Data Bank (http://www.pdb.org/pdb/  home/home.do) with PDB ID 1UZE.,OADS,/arxiv_data1/oa_pdf/11/69/TOMCJ-7-30.PMC3849751.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/view/199 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
Recordings wereFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
Ocular Geste Antagoniste in Cervical Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"Mov Disord 1998;13:549–51, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"Mov Disord 2004;19:452–458, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"Mov Disord 1999;14:994–999, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"Ann NY Acad Sci 2003;1004:40–49, doi: http://dx.doi.org/10.1196/annals.1303.005.",Non-OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"Progress in Retinal and Eye Research 1999;18(3): 269–291, doi: http://dx.doi.org/ 10.1016/S1350-9462(98)00029-9.",Non-OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"2013 Jul 3;33:11281–95, doi: http://dx.doi.org/10.1523/ JNEUROSCI.3415-12.2013.",Non-OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"Mov Disord 2003; 18:231–240, doi: http://dx.doi.org/10.1002/mds.10327.16.Naumann M, Magyar-Lehmann S, Reiners K, Erbguth F, Leenders KL.",OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"Ann Neurol 2000;47:322–328, doi: http://dx.doi.org/10.1002/1531-8249(200003)47:3 ,322::AID-ANA7 .3.0.",OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
Ocular Geste Antagoniste in Cervical Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/93/fd/tre-03-199-4624-1.PMC3849767.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/High-risk pedigrees for suicide H Coon et al 8 Translational Psychiatry (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/fa/10/tp2013100a.PMC3849959.pdf
"BeadArray datawere analyzed with QuantiSNP (version 2.1, http://www.well.ox.ac.uk/QuantiSNP) 17and PennCNV (version 01 May 2010, http://www.",OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
"The transcription start and end position of each RefSeq gene was determined according to NCBIbuild 36, using the UCSC Genome Browser (http://genome.ucsc.edu/cgi-bin/hgGateway).",OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
"Technical veri ﬁcation of predicted CNVs All CNVs detected in the discovery sample were visually inspected in Genome- Studio (v2011.1, http://www.il lumina.com/softw are/genomestudio_software.ilmn).",OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
"Copy numbers were calculated using the ΔΔCt method implemented in CopyCaller Software (v1.0, http://www.appliedbiosystems.com/support/software/copycaller/).",OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
"The Database of Genomic Variants (beta version April, 2012, http://dgvbeta.tcag.ca/dgv/app/home?ref = NCBI36/hg18)21is a catalog of human genomic structural variation containing CNV data from 37 healthy control studies.",OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
"The Copy Number Variationproject at the Children's Hospital of Philadelphia lists CNVs from 2026 healthy children, all genotyped on Illumina BeadArrays HumanHap550v3 (http://cnv.chop.edu/).22Neither Database of Genomic Variants nor Children's Hospital of Philadelphia containedany duplications affecting RB1CC1 .",Non-OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
"In addition, we checked the interactive web-based database DECIPHER (Database of Chromosomal Imbalance and Phenotypein Humans Using Ensembl Resources; http://decipher.sanger.ac.uk/about) for CNVs in RB1CC1 .",OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
A full list of centers who contributed to thegeneration of the data is available from http://decipher.sanger.ac.uk and by emailfrom decipher@sanger.ac.uk.,OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp) APPENDIX Genetic Risk and Outcome in Psychosis (GROUP) Consortium Members: Rene´ S Kahn1, Don H Linszen2, Jim van Os3, Durk Wiersma4, Richard Bruggeman4, Wiepke Cahn1, Lieuwe de Haan2, Lydia Krabbendam3and Inez Myin-Germeys3 1Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, TheNetherlands;2Academic Medical Centre University of Amsterdam, Department of Psychiatry, Amsterdam, The Nether-lands;3Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, Maastricht, The Netherlands and4University Medical Center Groningen, Depart- ment of Psychiatry, University of Groningen, Groningen, TheNetherlands.Duplications in RB1CC1 and schizophrenia F Degenhardt et al 6 Translational Psychiatry (2013), 1 –6 © 2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3a/18/tp2013101a.PMC3849960.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Cross-species attentional testing JW Young et al 10 Translational Psychiatry (2013), 1 – 10 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/df/43/tp201382a.PMC3849961.pdf
"Data concerning an additional ACE polymorphism ( rs4291 ), as well as replicate data for rs4343 were also available, as these had been genotyped previously by the Lille Genopole(http://www.genopole-lille.fr/spip/) using DNA extracted from blood samples collected at baseline.",OADS,/arxiv_data1/oa_pdf/fb/b0/tp201395a.PMC3849962.pdf
"The importance of variation in or around the promoter regions has been suggested in a number ofcommon diseases41and functional consequences for ACE gene transcription regulation has been proposed for rs4291 .12 Furthermore, this SNP does appear to be functionally signiﬁcant as it has been associated with ACE level in two studies.42,43Whileno prior study has examined the functionality of the other variants examined in this study, we used a speciﬁc program RESCUE-ESE(http://genes.mit.edu/burgelab/rescue-ese/)44to help predict the effects of single-base changes on exonic splicing enhancer activity and thus their potential functionality.",Non-OADS,/arxiv_data1/oa_pdf/fb/b0/tp201395a.PMC3849962.pdf
"The other SNPs could also possibly be functionally important as they have been associated with other health-related outcomes in prior studies31,42,45(see also http://www.alzgene.org/geneoverview.asp?geneID=125), although this remains unknown.",Non-OADS,/arxiv_data1/oa_pdf/fb/b0/tp201395a.PMC3849962.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Angiotensin-converting enzyme and late-life depression M-L Ancelin et al 7 &2013 Macmillan Publishers Limited Translational Psychiatry (2013), 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/fb/b0/tp201395a.PMC3849962.pdf
"OncoImmunology 2013; 2:e25736; http://dx.doi.org/10.4161/onci.25736accumulation of cytotoxic T lymphocytes  (CTLs) within neoplastic lesions,3 (2) the  positive association between intratumoral CTL accumulation and increased patient survival (our unpublished data), and (3) the expression of tumor-associated antigens by malignant cells 4 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
Hematol Oncol Clin North Am 2002; 16:37- 52; PMID:12063828; http://dx.doi.org/10.1016/S0889-8588(01)00007-7 3.,Non-OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
Cancer Immunol Immunother 2010; 59:1389-400;  PMID:20514540; http://dx.doi.org/10.1007/s00262- 010-0870-95.,Non-OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
J Immunother 2007; 30:108-15;  PMID:17198089; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
J Clin Oncol 2012; 30:4077-83; PMID:23008325;  http://dx.doi.org/10.1200/JCO.2011.38.2960 7.,Non-OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
Int J Cancer 2013; 133:98-107; PMID:23233419; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
Cancer Lett 2008; 268:98-109; PMID:18486325;  http://dx.doi.org/10.1016/j.canlet.2008.03.056 9.,OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
Semin Immunopathol 2011; 33:369-83;  PMID:21611872; http://dx.doi.org/10.1007/s00281- 011-0245-0 10.,Non-OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
Proc Natl Acad Sci U S A 2011; 108:17111- 6; PMID:21969559; http://dx.doi.org/10.1073/ pnas.1108121108,OADS,/arxiv_data1/oa_pdf/af/47/onci-2-e25736.PMC3850017.pdf
"OncoImmunology 2013; 2:e25737;  http://dx.doi.org/10.4161/onci.25737(BLM).9 BLM is indeed known to stimu - late the production of reactive oxygen spe - cies (ROS), which may facilitate ICD via  the activation of the ER stress response.",Non-OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
Eur J Immunol  2004; 34:336-44; PMID:14768038; http://dx.doi.org/10.1002/eji.200324181 2.,Non-OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
Nat Med 2007; 13:1050-9;  PMID:17704786; http://dx.doi.org/10.1038/nm1622 3.,OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
Nat Med 2009; 15:1170-8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028 4.,Non-OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
J Invest  Dermatol 2013; 133:499-508; PMID:22951720;  http://dx.doi.org/10.1038/jid.2012.273 6.,Non-OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
Nat Med 2013; 19:57-64; PMID:23202296; http://dx.doi.org/10.1038/nm.2999 7.,OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
Cancer Res 2010; 70:3052-61; PMID:20388795; http://dx.doi.org/10.1158/0008- 5472.CAN-09-36908.,Non-OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347 9.,OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
PLoS  One 2013; 8:e65181; PMID:23762310; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/50/onci-2-e25737.PMC3850019.pdf
OncoImmunology 2013; 2:e25801; http://dx.doi.org/10.4161/onci.25801responses.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
PMID:23533029;  http://dx.doi.org/10.3389/fonc.2013.00063.,OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
Nat Rev Cancer 2008; 8:351-60;  PMID:18418403; http://dx.doi.org/10.1038/nrc2373 3.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
Br J Cancer 2011; 104:300-7; PMID:21179034; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
Clin Cancer Res 2008; 14:6487-95; PMID:18927288;  http://dx.doi.org/10.1158/1078-0432.CCR-08-10865.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
Int J Cancer 2008; 123:2616- 25; PMID:18770861; http://dx.doi.org/10.1002/ ijc.23823 6.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
J T ransl Med 2012; 10:141; PMID:22776426;  http://dx.doi.org/10.1186/1479-5876-10-141 7.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
Clin Cancer Res 2013; In press;  PMID:23714729; http://dx.doi.org/10.1158/1078- 0432.CCR-13-01978.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
Int J Cancer 2013 in press PMID: http://dx.doi.org/10.1002/ijc.28376 9.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
Cancer Res  2013; 73:19-29; PMID:23087058; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
Nat Rev Cancer 2012; 12:252- 64; PMID:22437870; http://dx.doi.org/10.1038/ nrc3239,Non-OADS,/arxiv_data1/oa_pdf/8f/f8/onci-2-e25801.PMC3850020.pdf
OncoImmunology 2013; 2:e25619; http://dx.doi.org/10.4161/Multiple myeloma (MM) patients exhibit consistent degrees of immune dysfunction.,Non-OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
Leukemia 2009; 23:3-9; PMID:18971951;  http://dx.doi.org/10.1038/leu.2008.291 2.,Non-OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
PLoS One  2012; 7:e47077; PMID:23071717; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
PLoS One  2012; 7:e35981; PMID:22666318; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
PLoS One 2012; 7:e49446; PMID:23152910;  http://dx.doi.org/10.1371/journal.pone.0049446 6.,Non-OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
Leuk Lymphoma 2012; 53:1406-8;  PMID:22200079; http://dx.doi.org/10.3109/1042819 4.2011.652106 7.,Non-OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
Cytometry Part B: Clinical Cytometry 2013;  Forthcoming; http://dx.doi.org/10.1002/cytob.211098.,Non-OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
Curr Cancer Drug Targets  2010; 10:155-67; PMID:20088798; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
Blood  2011; 117:1605-13; PMID:20978269; http://dx.doi.org/10.1182/blood-2010-04-278432,Non-OADS,/arxiv_data1/oa_pdf/24/4a/onci-2-e25619.PMC3850022.pdf
OncoImmunology 2013; 2:e25670; http://dx.doi.org/10.4161/onci.25670the MSP/ rON signaling pathway favors the conversion of micrometastatic lesions to overt metastases by suppressing  antitumor immune responses.,Non-OADS,/arxiv_data1/oa_pdf/95/74/onci-2-e25670.PMC3850023.pdf
Cell 2011; 144:646-74;  PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/74/onci-2-e25670.PMC3850023.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-101324 3.,Non-OADS,/arxiv_data1/oa_pdf/95/74/onci-2-e25670.PMC3850023.pdf
Curr Drug  Targets 2010; 11:1157-68; PMID:20545605; http://dx.doi.org/10.2174/138945010792006825 4.,Non-OADS,/arxiv_data1/oa_pdf/95/74/onci-2-e25670.PMC3850023.pdf
Proc Natl Acad Sci U S A  2007; 104:7570-5; PMID:17456594; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/74/onci-2-e25670.PMC3850023.pdf
Cancer Discov 2013; PMID:23612011; http://dx.doi.org/10.1158/2159- 8290.CD-12-04808.,Non-OADS,/arxiv_data1/oa_pdf/95/74/onci-2-e25670.PMC3850023.pdf
Nat Rev Immunol 2006; 6:715-27; PMID:16977338; http://dx.doi.org/10.1038/nri1936 9.,Non-OADS,/arxiv_data1/oa_pdf/95/74/onci-2-e25670.PMC3850023.pdf
Acta Pharmacol Sin 2010; 31:1181- 8; PMID:20694025; http://dx.doi.org/10.1038/ aps.2010.106,Non-OADS,/arxiv_data1/oa_pdf/95/74/onci-2-e25670.PMC3850023.pdf
"OncoImmunology 2013; 2:e25962;  http://dx.doi.org/10.4161/onci.25962Enhancing immunotherapy using  chemotherapy and radiation to modify  the tumor microenvironment Michael H Kershaw1,2,*, Christel Devaud1, Liza B John1, Jennifer a w estwood1, and Phillip K Darcy1,2 1Cancer Immunology r esearch Program; Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville, v IC australia  2Department of Immunology; Monash University; Prahran, v IC australia Keywords:  chemotherapy, immunotherapy, radiotherapy, tumor endothelium, tumor microenvironment The tumor microenvironment is a complex assortment of  cells that includes a variety of leukocytes.",Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Oncoimmunology  2013 ;  2:e22764 ; PMID:23525353 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Oncoimmunology  2013 ; 2:e23562 ;  PMID:23687622 ; http://dx.doi.org/10.4161/ onci.23562 4.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Oncoimmunology   2012 ; 1:1191-3; PMID:23170276 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Res 2007 ; 67:7477 -86;  PMID:17671218 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-46396.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Mol Ther  2010 ; 18:1947 -59; PMID:20683443 ;  http://dx.doi.org/10.1038/mt.2010.159 7.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Clin Cancer Res 2005 ; 11:6713 -21;  PMID:16166452 ; http://dx.doi.org/10.1158/1078- 0432.CCR-05-0883 8.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Immunity  2013 ; 38:729- 41; PMID:23562161 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Annu Rev Immunol 2013 ; 31:51-72;  PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008 11.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Oncoimmunology  2013 ; 2:e23510 ;  PMID:23687621 ; http://dx.doi.org/10.4161/ onci.2351012.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Oncogene   2010 ; 29:482-91; PMID :19881547 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
J Clin Invest 2011 ; 121:3100 -8; PMID:21765211 ;  http://dx.doi.org/10.1172/JCI43656 14.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Gut 2011 ; 60:341-9; PMID:20855451 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Nat Med  2013 ; 19:57-64; PMID:23202296 ;  http://dx.doi.org/10.1038/nm.2999 16.,OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Immunol  Immunother  2012 ; 61:275-82; PMID:22120757 ;  http://dx.doi.org/10.1007/s00262-011-1164-6 18.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Clin Cancer Res 2007 ; 13:5455 -62;  PMID:17875775 ; http://dx.doi.org/10.1158/1078- 0432.CCR-07-0517 20.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
J Immunol  2011 ; 186:807-15;  PMID:21148040 ; http://dx.doi.org/10.4049/ jimmunol.1001483 21.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Oncoimmunology  2012 ; 1:118- 20; PMID:22720230 ; http://dx.doi.org/10.4161/ onci.1.1.18049 22.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
J Exp Med 2009 ; 206:1103 - 16; PMID:19414558 ; http://dx.doi.org/10.1084/ jem.20082205 23.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Clin Cancer Res  2012 ; 18:5329 -40; PMID:22850568 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Clin  Cancer Res 2012 ; 18:1386 -94; PMID :22156613 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-2479 25.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Res  2010 ; 70:5213 -9; PMID:20551059 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Eur J Immunol 2013 ; PMID:23843024 ;  http://dx.doi.org/10.1002/eji.201242505 27.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Res 2012 ; 72:3928 -37;  PMID:22693252 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2837 28.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Oncoimmunology   2012 ; 1:358-60; PMID:22737614 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Oncologist   2008 ; 13:373-81; PMID:18448551 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Res 2004 ; 64:4328 -37;  PMID :15205348 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-0073 32.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Biother Radiopharm   2012 ; 27:12-22; PMID:22283603 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Immunol Immunother  2008 ; 57:1173 - 83;  PMID:18256832 ; http://dx.doi.org/10.1007/ s00262-008-0449-x 34.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
J Exp Med 2007 ; 204:49-55;  PMID:17210731 ; http://dx.doi.org/10.1084/ jem.20062056 35.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Clin Cancer Res  2009 ; 15:5379 -88; PMID:19706802 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Res 2012 ; 72:3163 -74; PMID:22570253 ;  http://dx.doi.org/10.1158/0008-5472.CAN-12-0210 37.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
J Clin Invest 2010 ; 120:694- 705; PMID:20179352 ; http://dx.doi.org/10.1172/ JCI40283 38.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cold  Spring Harb Perspect Med 2012 ; 2:a006429 ;  PMID :22315715 ; http://dx.doi.org/10.1101/cshper - spect.a006429 39.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Res 2010 ; 70:6171 -80;  PMID:20631075 ; http://dx.doi.org/10.1158/0008- 5472.CAN-10-015341.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Cancer Res 2011 ; 71:801-11; PMID:21266358 ;  http://dx.doi.org/10.1158/0008-5472.CAN-10-1733 42.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Clin Cancer Res 2006 ; 12:6808 -16;  PMID:17121902 ; http://dx.doi.org/10.1158/1078- 0432.CCR-06-1558 44.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Science  2010 ; 330:827-30; PMID:21051638 ;  http://dx.doi.org/10.1126/science.1195300 45.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
J Hematol Oncol 2008 ; 1:20; PMID:18959794 ;  http://dx.doi.org/10.1186/1756-8722-1-20 46.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Science  2011 ; 331:1612 - 6; PMID:21436454 ; http://dx.doi.org/10.1126/ science.1198443 47.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Expert Opin Biol Ther  2012 ; 12:1173 -90; PMID:22650606 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
J Immunother  2005 ; 28:129-35;  PMID:15725956 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Clin  Cancer Res 2008 ; 14:5284 -91; PMID:18698048 ;  http://dx.doi.org/10.1158/1078-0432.CCR-07-5162 50.,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
Ann Oncol   2013 ; 24:1813 -21; PMID:23535954 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
J Exp Med 2006 ; 203:1259 - 71; PMID:16636135 ; http://dx.doi.org/10.1084/ jem.20052494,Non-OADS,/arxiv_data1/oa_pdf/27/32/onci-2-e25962.PMC3850060.pdf
"http://dx.doi.org/10.1016/j.virol.2013.04.004i , this issue Schwartz C, Fang H, Huang L, Guo P. Sequential action of ATPase, ATP, ADP, Pi and dsDNA in  procapsid-free system to enlighten mechanism in viral dsDNA packaging.",OADS,/arxiv_data1/oa_pdf/53/f7/nihms526201.PMC3850062.pdf
http://dx.doi.org/10.1261/rna.037002.112 .,OADS,/arxiv_data1/oa_pdf/53/f7/nihms526201.PMC3850062.pdf
An animation is available at http://nanobio.uky.edu/movie.html .Schwartz et al.,Non-OADS,/arxiv_data1/oa_pdf/53/f7/nihms526201.PMC3850062.pdf
(Actual motion videos can be found in the  supplementary information and at http://nanobio.uky.edu/movie.html ).,Non-OADS,/arxiv_data1/oa_pdf/53/f7/nihms526201.PMC3850062.pdf
"As a result, tumorcells activate processes that allow them to adapt, tolerate, /C2112013 White This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/b9/98/2065.PMC3850091.pdf
[Keywords : Ras; macropinocytosis; autophagy; cancer metabolism; glu- tamine; scavenging] 1Correspondence E-mail eileenpwhite@gmail.com and epwhite@cinj.rutgers.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/b9/98/2065.PMC3850091.pdf
"(2012) found that deletion of dSir2 in the fat body abolished the extension of life span by a CR-like /C2112013 Guarente This article, published in Genes &Development ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/ by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/06/5c/2072.PMC3850092.pdf
[Keywords : CR mimetics; calorie restriction; sirtuins] 1Correspondence E-mail leng@mit.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.227439.113.,Non-OADS,/arxiv_data1/oa_pdf/06/5c/2072.PMC3850092.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/82/e7/2086.PMC3850093.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.8These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/82/e7/2086.PMC3850093.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.224899.113.,Non-OADS,/arxiv_data1/oa_pdf/82/e7/2086.PMC3850093.pdf
"2010; http://www.proteinatlas.org) we observed similar CtsC expression characteristics in human SCCs and breast carcinomas, with pronounced expression in tumor stroma and low expression levels inmost carcinoma cells (Supplemental Fig.",Non-OADS,/arxiv_data1/oa_pdf/82/e7/2086.PMC3850093.pdf
"Notably, while multiple data sets in Oncomine (http://www.oncomine.org; Rhodeset al.",OADS,/arxiv_data1/oa_pdf/82/e7/2086.PMC3850093.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/16/2a/2099.PMC3850094.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.1Present address: Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/16/2a/2099.PMC3850094.pdf
2Corresponding author E-mail joachim.lingner@epfl.ch Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/16/2a/2099.PMC3850094.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ea/78/2109.PMC3850095.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as desc ribed at http://creativecommons.org/ licenses/by-nc/3.0/.6These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/ea/78/2109.PMC3850095.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.222174.113.,Non-OADS,/arxiv_data1/oa_pdf/ea/78/2109.PMC3850095.pdf
"This article, published in Genes &Development ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.1Corresponding author E-mail elisa.izaurralde@tuebingen.mpg.de Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.226951.113.",Non-OADS,/arxiv_data1/oa_pdf/69/94/2125.PMC3850096.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/40/e5/2139.PMC3850097.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http:// creativecommons.org/licenses/by-nc/3.0/.3Corresponding author E-mail dawsond@omrf.org Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.227454.113.",Non-OADS,/arxiv_data1/oa_pdf/40/e5/2139.PMC3850097.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/85/8b/2147.PMC3850098.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.6Corresponding author E-mail angelika@mit.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.224253.113.",Non-OADS,/arxiv_data1/oa_pdf/85/8b/2147.PMC3850098.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/fc/6a/2164.PMC3850099.pdf
7Corresponding author E-mail kathy.gould@vanderbilt.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/fc/6a/2164.PMC3850099.pdf
"OncoImmunology 2013; 2:e25581; http://dx.doi.org/10.4161/onci.25581of TILs upon transfer, hence impacting  on their ability to exert antineoplastic effects.",Non-OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
Clin Cancer Res  2012; 18:6758-70; PMID:23032743; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0116 3.,Non-OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
J Immunother  2003; 26:332-42; PMID:12843795; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
Annu Rev Immunol 2005; 23:23-68; PMID:15771565; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
Cell Immunol 2009; 256:39-46;  PMID:19217084; http://dx.doi.org/10.1016/j.cel - limm.2009.01.003 7.,OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
J Immunol 2010; 184:452-65;  PMID:19949105; http://dx.doi.org/10.4049/jimmu- nol.09011018.,Non-OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
PLoS One  2013; 8:e60031; PMID:23560068; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
J Immunother 2011; 34:236-50; PMID:21389874;  http://dx.doi.org/10.1097/CJI.0b013e318209e7ec 10.,Non-OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
Clin Immunol  2010; 137:221-33; PMID:20708974; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/62/onci-2-e25581.PMC3850170.pdf
OncoImmunology 2013; 2:e25669; http://dx.doi.org/10.4161/onci.25669Inflammatory mediators can play a dual role in oncogenesis and tumor progression.,Non-OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
Cell 2011; 144:646-74;  PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
Anticancer Agents Med Chem 2012;  12:1045-57; PMID:22583417; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
Cell 1997; 91:521-30; PMID:9390561; http://dx.doi.org/10.1016/S0092-8674(00)80438-9 4.,OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
Blood 2011; 118:e156-67; PMID:21951685;  http://dx.doi.org/10.1182/blood-2011-04-3489465.,Non-OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
PLoS  One 2011; 6:e21546; PMID:21750716; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
Gene Ther 2007; 14:1226- 34; PMID:17597794; http://dx.doi.org/10.1038/ sj.gt.3302959 7.,OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
Cancer Res 2013; 73:4461-73;  PMID:23720051; http://dx.doi.org/10.1158/0008- 5472.CAN-12-38288.,Non-OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
EMBO Rep 2001; 2:151-6; PMID:11258708; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/b4/onci-2-e25669.PMC3850216.pdf
"OncoImmunology 2013; 2:e25563;  http://dx.doi.org/10.4161/onci.25563transcriptional program that stimulates  cancer cells to disengage from adhesive cell-to-cell interactions and achieve a mesenchymal motility, culminating in their escape from primary neoplastic lesions and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
Cancer Metastasis Rev 2012; 31:195-208;  PMID:22101652; http://dx.doi.org/10.1007/s10555- 011-9340-x 2.,Non-OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
Cancer Res  2012; 72:5130-40; PMID:22850421; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
Cancer Res 2010; 70:6945-56; PMID:20699369; http://dx.doi.org/10.1158/0008-5472.CAN-10-0785 4.,Non-OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
J Mol Med (Berl)  2013; 91:103-15; PMID:22903544; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
Oncogene  2013; In press; PMID:23728338; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
Cell Cycle  2013; 12:1791-801; PMID:23656776; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
EMBO Mol Med 2010; 2:211-30; PMID:20535745;  http://dx.doi.org/10.1002/emmm.201000073 9.,Non-OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
Antioxid  Redox Signal 2011; 14:2361-71; PMID:21235356;  http://dx.doi.org/10.1089/ars.2010.3727 10.,Non-OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
J Clin Invest 2012; 122:787- 95; PMID:22378047; http://dx.doi.org/10.1172/ JCI59643,Non-OADS,/arxiv_data1/oa_pdf/93/fe/onci-2-e25563.PMC3850271.pdf
"OncoImmunology 2013; 2:e26246; http://dx.doi.org/10.4161/onci.26246A CD38/CD203a/CD73 ectoenzymatic pathway  independent of CD39 drives a novel adenosinergic  loop in human T lymphocytes alberto L h orenstein1,2,3,*, antonella c hillemi1,4, Gianluca Zaccarello1,2, Santina Bruzzone5,   Valeria Quarona1,4, andrea Zito1,2, Sara Serra4,6, and Fabio Malavasi1,2,3,* 1Laboratory of Immunogenetics; Department of Medical Sciences; University of Torino; Torino, Italy;   2research c enter for e xperimental Medicine; University of Torino; Torino, Italy; 3Transplantation Immunology; ” città della Salute e della Scienza” h ospital; Torino, Italy;   4PhD Program on “Biomedical Science and h uman Oncology”; University of Torino; Torino, Italy; 5Department of e xperimental Medicine; Section of Biochemistry and ce Br;  University of Genova; Genova, Italy; 6human Genetics Foundation; University of Torino; Torino, Italy; Keywords:  adenosine, CD38, CD203a, ectonucleotidases, NAD+, PC-1 Abbreviations: ADA, adenosine deaminase; ADO, adenosine; ADP, adenosine 5 ′-diphosphate; ADPR, adenosine diphosphate ribose;  AMP, adenosine 5 ′-monophosphate; APCP, α ,β-methylene-ADP; ATP, adenosine 5 ′-triphosphate; cADPR, cyclic ADPR; cGDPR,  cyclic guanosine diphosphoribose; DCF, deoxycoformycin; Dyp, dipyridamole; EHNA, erythro-9-(2-hydroxy-3-nonyl)-adenine; Hxp,  hypoxanthine; HPLC, high-performance liquid chromatography; NAD+, nicotinamide adenine dinucleotide; NADase, nicotinamide  adenine dinucleotidase; NGD+, nicotinamide guanine dinucleotide; Nic, nicotinamide; NMN, nicotinamide mononucleotide; NPP,  nucleotide pyrophosphatase/phosphodiesterase; 5 ′-NT, 5′-nucleotidase; NTPDase, ectonucleoside triphosphate diphosphohydrolase;  PMA, phorbol 12-myristate 13-acetate; PPi, inorganic pyrophosphate; Rt, retention time; Treg, regulatory T cell The tumor microenvironment is characterized by of high levels of extracellular nucleotides that are metabolized  through the dynamic and sequential action of cell surface enzymes (ectoenzymes).",Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Nat Rev Immunol  2013; 13:73-4;  PMID:23469373 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Cell  2005; 121:503-4;  PMID :15907462 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Physiol Rev 2008; 88:841-86; PMID:18626062 ;  http://dx.doi.org/10.1152/physrev.00035.2007 4.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Purinergic Signal 2012; 8:437-502;  PMID:22555564 ; http://dx.doi.org/10.1007/ s11302-012-9309-4 5.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Innate Immun  2011; 17:212-33;  PMID:20388721 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
N Engl J Med 2012;  367:2322-33;  PMID:23234515 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Blood 2011; 118:6141-52; PMID:21998208 ;  http://dx.doi.org/10.1182/blood-2011-08-374728 11.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Purinergic Signal 2006; 2:343-50; PMID:18404474 ; http://dx.doi.org/10.1007/ s11302-006-9000-8 12.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
J Immunol Methods 2009; 346:55-63; PMID:19450601 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
PLoS Pathog 2011;  7:e1002110;  PMID:21750674 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Nat Rev Cancer 2012; 12:741-52; PMID:23018234 ;  http://dx.doi.org/10.1038/nrc334015.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Stem  Cells Dev 2011; 20:1183-98; PMID:20964598 ;  http://dx.doi.org/10.1089/scd.2010.0295 16.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
J Exp Med 2010; 207:2561-8; PMID:20975043 ;  http://dx.doi.org/10.1084/jem.20091154 20.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Cytometry B Clin Cytom 2013; 84:207- 17; PMID:23576305 ; http://dx.doi.org/10.1002/ cyto.b.21092 21.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Immunol Today  1994; 15:95-7;  PMID:8172650 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Immunol  Rev 1998; 161:11-26;  PMID:9553761 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Immunol Rev 1998; 161:95-109; PMID:9553767 ;  http://dx.doi.org/10.1111/j.1600-065X.1998.tb01574.x 25.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Front Immunol 2013;  4:212;  PMID:23898333 ; http://dx.doi.org/10.3389/ fimmu.2013.00212 26.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Oncoimmunology 2013; 2:e22448;  PMID:23483072 ; http://dx.doi.org/10.4161/ onci.22448 27.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Nat Rev Drug Discov 2008; 7:759- 70; PMID:18758473 ; http://dx.doi.org/10.1038/ nrd263828.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Nat Rev Immunol  2011; 11:201-12;  PMID:21331080 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Adv Pharmacol  2011; 61:263-99;  PMID :21586362 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Biochim Biophys Acta 2008; 1783:673-94;  PMID:18302942 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
J Biol Chem 2005; 280:5343-9;  PMID :15574424 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
FEBS Lett  2001; 492:4-8;  PMID:11248227 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Br J Pharmacol 2012; 167:238-55; PMID:22537142 ;  http://dx.doi.org/10.1111/j.1476-5381.2012.02008.x 37.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Biochem  J 2012; 441:131-41;  PMID:21933152 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
J Immunol Methods  2007; 319:1-5;  PMID:17174972 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Int Immunol 2009;  21:1105-11;  PMID:19737784 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Biochem Biophys  Res Commun 2006; 349:533-9; PMID:16956582 ;  http://dx.doi.org/10.1016/j.bbrc.2006.08.108Acknowledgments We thank Dr. L. Thompson for the Jurkat B-NT5.1/CD73+  cell line and Professor J. Goding for the anti-human PC-1 (3E8  clone).,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Structure 2005; 13:1331- 9; PMID:16154090 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Cell Biochem Funct 2002; 20:309-22;  PMID:12415565 ;  http://dx.doi.org/10.1002/cbf.978 44.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Biochim Biophys Acta 2003; 1638:1-19; PMID:12757929 ;  http://dx.doi.org/10.1016/S0925-4439(03)00058-9 45.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Trends Biochem Sci 2005; 30:542-50;  PMID:16125936 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Chem Immunol 2000; 75:60-78; PMID:10851779 ;  http://dx.doi.org/10.1159/000058762 47.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Pharmacol Ther 2006; 112:358- 404; PMID:16784779 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
J Biol Chem 2013; 288:25938-49;  PMID:23880765 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
N Engl J Med 2011; 364:432- 42; PMID:21288095 ; http://dx.doi.org/10.1056/ NEJMoa0912923 50.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Biochem J 2011; 435:701- 9; PMID:21306300 ; http://dx.doi.org/10.1042/ BJ2010174951.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Cancer Res 2012; 72:5441-7; PMID:23090120 ;  http://dx.doi.org/10.1158/0008-5472.CAN-12-1600 53.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
J Neurochem 1999;  72:826-34;  PMID:9930759 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Cytokine  2013; 62:232-43;  PMID:23538292 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Mol Med 2009; 15:76-84; PMID:19052657 ;  http://dx.doi.org/10.2119/molmed.2008.00108 56.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Nat Immunol 2003; 4:1057-64; PMID:14586424 ;  http://dx.doi.org/10.1038/ni1001 58.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Oncoimmunology 2012; 1:67-70;  PMID:22720214 ; http://dx.doi.org/10.4161/ onci.1.1.1806859.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Oncoimmunology 2013; 2:e24568;   PMID:23894718 ; http://dx.doi.org/10.4161/ onci.24568 60.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Immunity 2013; 39:74-88; PMID:23890065 ;  http://dx.doi.org/10.1016/j.immuni.2013.06.014 61.,OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
Tissue Antigens 2000; 56:539-47;  PMID:11169244 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/73/onci-2-e26246.PMC3850273.pdf
"OncoImmunology 2013; 2:e25595; http://dx.doi.org/10.4161/onci.25595radiotherapy has extensively been employed as a curative  or palliative intervention against cancer throughout the last  century, with a varying degree of success.",Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
"Thus, interrogating PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) with the string “cancer AND radiotherapy AND patients AND immunotherapy,” on",Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
"Cancer 2005; 104:1129- 37; PMID:16080176; http://dx.doi.org/10.1002/ cncr.21324cytostatic effects on malignant cells.1,2 Preclinical and clinical  evidence, however, indicates that the antineoplastic activity of  irradiation exceeds that of a merely cytotoxic/cytostatic inter - vention and rather involves the (re)activation of tumor-specific cellular immune responses.",Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
"Supplemental Material Supplemental materials may be found here: http://www.landesbioscience.com/journals/oncoimmunology/article/25595involving breast carcinoma patients is relatively heterogeneous, including the FDA-approved ERBB2-specific monoclonal anti - body trastuzumab, 240-243 the TLR7 agonist imiquimod,129,244,245  and ICD inducers such as cyclophosphamide and doxorubicin.",Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Cancer 2004; 4:737- 47; PMID:15343280; http://dx.doi.org/10.1038/ nrc14512.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Clin Oncol  2013; 10:52-60; PMID:23183635; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Semin Radiat Oncol 2007; 17:131-40;  PMID:17395043; http://dx.doi.org/10.1016/j.semra- donc.2006.11.009 34.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Lancet Oncol 2003; 4:529-36;  PMID:12965273; http://dx.doi.org/10.1016/S1470- 2045(03)01191-4 35.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Semin Radiat Oncol 2003; 13:176-81;  PMID:12903007; http://dx.doi.org/10.1016/S1053- 4296(03)00031-6 36.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat Oncol Biol  Phys 1991; 21:109-22; PMID:2032882; http://dx.doi.org/10.1016/0360-3016(91)90171-Y 37.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Crit Rev Oncol Hematol  2002; 41:317-25; PMID:11880207; http://dx.doi.org/10.1016/S1040-8428(01)00143-3 38.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Natl Cancer Inst 2012; 104:357-70; PMID:22312134;  http://dx.doi.org/10.1093/jnci/djr533 39.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
"Radiother Oncol 2009; 91:4-15, discussion  1-3; PMID:19201045; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Natl Cancer Inst  2010; 102:1083-95; PMID:20634481; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2009; 27:2356-62; PMID:19255307; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Clin Cancer Res 2011; 17:222-8;  PMID:21047979; http://dx.doi.org/10.1158/1078- 0432.CCR-10-1402 45.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int  J Radiat Oncol Biol Phys 2010; 76(Suppl):S10-9;  PMID:20171502; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Cancer 2009; 9:134-42;  PMID:19148183; http://dx.doi.org/10.1038/nrc2587 47.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Cancer  2011; 11:239-53; PMID:21430696; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Semin Radiat Oncol 2006; 16:199- 208; PMID:17010902; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Semin Thorac Cardiovasc Surg 2010; 22:59-66;  PMID:20813318; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Radiother Oncol 2008; 89:245- 53; PMID:18760852; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Semin Thorac Cardiovasc Surg 2008; 20:290-7; PMID:19251167; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Clin Oncol 2012; 9:654-65; PMID:23007273;  http://dx.doi.org/10.1038/nrclinonc.2012.166 24.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Am J Clin Oncol  2007; 30:156-62; PMID:17414465; http://dx.doi.org/10.1097/01.coc.0000251242.32763.35 27.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Radiother Oncol 2012; 103:5-7; PMID:22326572;  http://dx.doi.org/10.1016/j.radonc.2012.01.003 28.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Clin Oncol 2010; 7:37-43; PMID:19949433; http://dx.doi.org/10.1038/nrcli- nonc.2009.183 29.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Brachytherapy  2005; 4:130-6; PMID:15893266; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2002; 20:2453- 63; PMID:12011122; http://dx.doi.org/10.1200/JCO.2002.11.076 32.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
CA Cancer J Clin 2012; 62:220- 41; PMID:22700443; http://dx.doi.org/10.3322/ caac.21149 5.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
N  Engl J Med 2001; 345:1378-87; PMID:11794170; http://dx.doi.org/10.1056/NEJMoa010874 6.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Br J Ophthalmol 2010; 94:569- 74; PMID:19965816; http://dx.doi.org/10.1136/ bjo.2009.165423 10.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Ann N Y Acad  Sci 2008; 1138:15-8; PMID:18837877; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
CA Cancer J Clin 2005; 55:117-34;  PMID:15761080; http://dx.doi.org/10.3322/canj- clin.55.2.117 13.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Semin Radiat Oncol 1995; 5:86-99;  PMID:10717132; http://dx.doi.org/10.1016/S1053- 4296(95)80003-4 14.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat Oncol Biol Phys 2001; 51:880- 914; PMID:11704310; http://dx.doi.org/10.1016/ S0360-3016(01)01749-7 15.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Mutat Res 2010; 704:200-5; PMID:20178859; http://dx.doi.org/10.1016/j.mrrev.2010.02.003 16.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Clin Oncol  2012; 9:688-99; PMID:23165124; http://dx.doi.org/10.1038/nrclinonc.2012.194 17.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Advances in  image-guided radiation therapy--the role of PET-CT.  Med Dosim 2006; 31:3-11; PMID:16551524; http://dx.doi.org/10.1016/j.meddos.2005.12.006 18.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Radiother Oncol 2006; 78:119- 22; PMID:16413622; http://dx.doi.org/10.1016/j.radonc.2005.12.005,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J  Natl Cancer Inst 2007; 99:1441-54; PMID:17895480;  http://dx.doi.org/10.1093/jnci/djm135 78.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int  J Clin Oncol 2013; 18:364-70; PMID:23463521;  http://dx.doi.org/10.1007/s10147-013-0537-6 79.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2006; 24:106-14; PMID:16314619;  http://dx.doi.org/10.1200/JCO.2004.00.1768 81.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Radiother Oncol 1998; 46:135-46; PMID:9510041;  http://dx.doi.org/10.1016/S0167-8140(97)00220-X 83.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol  2010; 28:2989-95; PMID:20479425; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2009; 27:3014- 9; PMID:19364954; http://dx.doi.org/10.1200/ JCO.2008.21.3868 85.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell Death Differ 2012; 19:107-20; PMID:21760595;  http://dx.doi.org/10.1038/cdd.2011.96 86.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Physiol  Rev 2007; 87:99-163; PMID:17237344; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Invest  2013; 123:966-72; PMID:23454759; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cancer Metastasis Rev  2008; 27:471-80; PMID:18470482; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Mol Cell Biol 2007; 8:275-83; PMID:17380161;  http://dx.doi.org/10.1038/nrm214762.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Science 2008; 320:226- 30; PMID:18403709; http://dx.doi.org/10.1126/sci- ence.1154986 63.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology  2012; 1:1146-55; PMID:23170261; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2009; 27:127- 45; PMID:19018081; http://dx.doi.org/10.1200/JCO.2008.17.2627 65.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol  2002; 20:2895-903; PMID:12065567; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Cancer  2009; 9:351-60; PMID:19377507; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Cancer  2008; 8:967-75; PMID:18987634; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Theor Biol 2000; 207:405-14; PMID:11082309; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cancer Metastasis Rev 2007; 26:225-39; PMID:17440684; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2007; 25:4066-74; PMID:17827455; http://dx.doi.org/10.1200/ JCO.2007.12.7878 72.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Radiat Res 1997; 147:541-50;  PMID:9146699; http://dx.doi.org/10.2307/3579620 74.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Radiat Res 1997; 148:435-42; PMID:9355868; http://dx.doi.org/10.2307/357932048.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat Biol  2011; 87:889-901; PMID:21675818; http://dx.doi.org/10.3109/09553002.2011.583315 49.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Radiat Res  2009; 172:706-17; PMID:19929417; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Semin Radiat Oncol  2003; 13:62-72; PMID:12520465; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Biochim  Biophys Acta 2002; 1573:109-20; PMID:12399020;  http://dx.doi.org/10.1016/S0304-4165(02)00339-2 52.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Commun 2011; 2:497;  PMID:21988913; http://dx.doi.org/10.1038/ncom-ms1499 53.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat Biol 2009;  85:107-15; PMID:19280463; http://dx.doi.org/10.1080/09553000802662595 54.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat Biol 2002; 78:643-58; PMID:12194748; http://dx.doi.org/10.1080/09553000210137680 55.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2011; 29:2808- 14; PMID:21670453; http://dx.doi.org/10.1200/ JCO.2010.32.4095 57.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Gastroenterology 2000; 119:1286- 96; PMID:11054386; http://dx.doi.org/10.1053/gast.2000.19282 59.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Asian Pac J Cancer Prev 2012; 13:4763- 7; PMID:23167416; http://dx.doi.org/10.7314/ APJCP .2012.13.9.4763 60.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat  Oncol Biol Phys 2012; 83:228-34; PMID:22000579;  http://dx.doi.org/10.1016/j.ijrobp.2011.05.055 61.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012;  1:28-37; PMID:22720209; http://dx.doi.org/10.4161/ onci.1.1.17938 125.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:179-88; PMID:22720239;  http://dx.doi.org/10.4161/onci.1.2.19026 126.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology  2012; 1:306-15; PMID:22737606; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768; http://dx.doi.org/10.4161/ onci.20459 128.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:699-716; PMID:22934262; http://dx.doi.org/10.4161/ onci.20696 129.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:894-907; PMID:23162757;  http://dx.doi.org/10.4161/onci.20931 130.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:1111-34; PMID:23170259;  http://dx.doi.org/10.4161/onci.21494 131.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:1323- 43; PMID:23243596; http://dx.doi.org/10.4161/ onci.22009 132.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology  2012; 1:1557-76; PMID:23264902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology  2013; 2:e22789; PMID:23482847; http://dx.doi.org/10.4161/onci.22789 134.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2013; 2:e23082; PMID:23525565; http://dx.doi.org/10.4161/ onci.23082 135.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2013; 2:e23510; PMID:23687621;  http://dx.doi.org/10.4161/onci.23510 136.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology  2013; 2:e23803; PMID:23734328; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2013; 2:e24238; PMID:23762803;  http://dx.doi.org/10.4161/onci.24238 138.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
OncoImmunology 2013;  2:e24612; http://dx.doi.org/10.4161/onci.24612108.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Clin Cancer Res  2007; 13:851-7; PMID:17289877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Radiat Res 1999; 152:57-63;  PMID:10381841; http://dx.doi.org/10.2307/3580049 110.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Proc Natl Acad Sci U S A 2005; 102:14641- 6; PMID:16203985; http://dx.doi.org/10.1073/ pnas.0505473102 112.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:407- 8; PMID:22754758; http://dx.doi.org/10.4161/ onci.20074 113.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology  2012; 1:1610-1; PMID:23264910; http://dx.doi.org/10.4161/onci.21478 114.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cytokine Growth Factor Rev 2013; In press; PMID:23391812; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Annu Rev Immunol 2013; 31:51-72; PMID:23157435;  http://dx.doi.org/10.1146/annurev-immu- nol-032712-100008 116.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2013; 2:e22197; PMID:23482346;  http://dx.doi.org/10.4161/onci.22197 117.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:786- 8; PMID:22934283; http://dx.doi.org/10.4161/ onci.19750 118.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Mol Cell  Biol 2012; 13:780-8; PMID:23175281; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Cancer  2012; 12:860-75; PMID:23151605; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Science  2005; 307:58-62; PMID:15637262; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cancer Metastasis Rev 2011; 30:83-95; PMID:21249423;  http://dx.doi.org/10.1007/s10555-011-9281-4 123.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Exp Cell Res  1998; 238:148-54; PMID:9457067; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Mol Cell Biol 2011; 12:385- 92; PMID:21527953; http://dx.doi.org/10.1038/ nrm3115 94.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell Death Dis 2012; 3:e390; PMID:22972376;  http://dx.doi.org/10.1038/cddis.2012.120 96.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell Death Differ  2012; 19:245-56; PMID:21738214; http://dx.doi.org/10.1038/cdd.2011.91 97.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Sci  Signal 2011; 4:ra20; PMID:21467298; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Mol Cell Biol  2010; 11:700-14; PMID:20823910; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell 2008; 135:1161- 3; PMID:19109884; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int Rev Cell Mol Biol 2011; 289:1-35;  PMID:21749897; http://dx.doi.org/10.1016/B978-0- 12-386039-2.00001-8 101.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Prog Biophys Mol Biol 2007; 94:29-65; PMID:17507078; http://dx.doi.org/10.1016/j.pbio- molbio.2007.03.010 104.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Mol Cell Biol 2003; 4:285-94; PMID:12671651; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int  J Radiat Biol 2002; 78:837-44; PMID:12428924;  http://dx.doi.org/10.1080/09553000210149786 107.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Clin Genitourin Cancer 2009;  7:E7-9; PMID:19692326; http://dx.doi.org/10.3816/ CGC.2009.n.014 172.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Oncol 2010;  2010:689893; PMID:20224761; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2013; 2:e23036; PMID:23524369; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cancer Sci 2011; 102:1257-63;  PMID:21443690; http://dx.doi.org/10.1111/j.1349- 7006.2011.01940.x 176.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:1645- 7; PMID:23264923; http://dx.doi.org/10.4161/onci.21746 177.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Clin Cancer Res  2008; 14:1159-66; PMID:18281550; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2010; 28:4324- 32; PMID:20697067; http://dx.doi.org/10.1200/ JCO.2010.28.9793 179.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:227-8; PMID:22720251;  http://dx.doi.org/10.4161/onci.1.2.18169 180.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012;  1:943-5; PMID:23162765; http://dx.doi.org/10.4161/ onci.19789 181.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Clin Cancer Res 2009; 15:5379-88;  PMID:19706802; http://dx.doi.org/10.1158/1078- 0432.CCR-09-0265 182.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology  2012; 1:1223-5; PMID:23243584; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:544-6; PMID:22754781;  http://dx.doi.org/10.4161/onci.19442 184.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:1629- 31; PMID:23264917; http://dx.doi.org/10.4161/ onci.21652156.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Br J Radiol 1983; 56:63- 6; PMID:6185172; http://dx.doi.org/10.1259/0007- 1285-56-661-63 160.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Br J Radiol 1973; 46:220- 2; PMID:4706791; http://dx.doi.org/10.1259/0007- 1285-46-543-220 161.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Am J Gastroenterol  2008; 103:1320-1; PMID:18477367; http://dx.doi.org/10.1111/j.1572-0241.2007.01782_13.x 163.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Gut 1998; 43:575-7; PMID:9824589; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Arch Dermatol 2011; 147:870-2; PMID:21768497;  http://dx.doi.org/10.1001/archdermatol.2011.176 165.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Clin Genitourin  Cancer 2012; 10:196-8; PMID:22409865; http://dx.doi.org/10.1016/j.clgc.2012.01.004 166.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Front Oncol 2012; 2:95; PMID:22937524; http://dx.doi.org/10.3389/ fonc.2012.00095 168.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Curr Med Chem 2012; 19:1751-64; PMID:22414083;  http://dx.doi.org/10.2174/092986712800099811 169.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Front  Oncol 2012; 2:104; PMID:22973551; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Front Oncol 2012; 2:75; PMID:22848871;  http://dx.doi.org/10.3389/fonc.2012.00075139.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Immunotherapy 2009; 1:1025-37; PMID:20635917;  http://dx.doi.org/10.2217/imt.09.64 142.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Bone Marrow T ransplant 2011; 46:475- 84; PMID:21113184; http://dx.doi.org/10.1038/ bmt.2010.280 143.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Natl  Cancer Inst 2013; 105:256-65; PMID:23291374;  http://dx.doi.org/10.1093/jnci/djs629 144.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Radiol Prot 2009;  29(2A):A133-42; PMID:19454811; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Curr Mol Med 2012; 12:613-24; PMID:22452594;  http://dx.doi.org/10.2174/156652412800620011 146.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J  Radiat Oncol Biol Phys 1977; 2:141-7; PMID:403163;  http://dx.doi.org/10.1016/0360-3016(77)90020-7 149.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Med Pediatr Oncol 1981;  9:473-6; PMID:7029238; http://dx.doi.org/10.1002/ mpo.2950090510 150.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
"N Engl J Med 2012;  366:2035, author reply 2035-6; PMID:22621637;  http://dx.doi.org/10.1056/NEJMc1203984 152.",Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Br J Radiol  1975; 48:863-6; PMID:811297; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
N Engl J Med  2012; 366:925-31; PMID:22397654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat Oncol Biol  Phys 2013; 85:293-5; PMID:22560555; http://dx.doi.org/10.1016/j.ijrobp.2012.03.017 155.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Lancet Oncol 2012; 13:459-65;  PMID:22456429; http://dx.doi.org/10.1016/S1470- 2045(12)70090-6 216.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2012; 30:2046-54; PMID:22547592; http://dx.doi.org/10.1200/JCO.2011.38.4032 217.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:1167-8; PMID:23170267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
N Engl J Med 2010; 363:411-22;  PMID:20818862; http://dx.doi.org/10.1056/ NEJMoa1001294 220.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
"N  Engl J Med 2010; 363:1966, author reply 1967- 8; PMID:21067392; http://dx.doi.org/10.1056/ NEJMc1009982 221.",Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:1661-3; PMID:23264929;  http://dx.doi.org/10.4161/onci.22033 222.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2013; 2:e22246; PMID:23482454;  http://dx.doi.org/10.4161/onci.22246 223.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology  2012; 1:1546-56; PMID:23264901; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:1448- 50; PMID:23243625; http://dx.doi.org/10.4161/onci.21351 225.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:1417-9; PMID:23243613; http://dx.doi.org/10.4161/onci.21097 226.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:979-81; PMID:23162778; http://dx.doi.org/10.4161/ onci.20172 227.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Lancet 2008; 371:1695-709; PMID:18486742; http://dx.doi.org/10.1016/S0140- 6736(08)60728-X 228.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
J Clin Oncol 2006; 24:2612- 7; PMID:16763273; http://dx.doi.org/10.1200/ JCO.2005.05.2829 229.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat Oncol Biol Phys 2008; 71:1351- 5; PMID:18640496; http://dx.doi.org/10.1016/j.ijrobp.2008.04.006199.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nature 2010; 467:863- 7; PMID:20944749; http://dx.doi.org/10.1038/ nature09413 201.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nature 2009; 461:282-6; PMID:19741708;  http://dx.doi.org/10.1038/nature08296 202.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Med 2009; 15:1170-8;  PMID:19767732; http://dx.doi.org/10.1038/nm.2028 203.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Med 2007; 13:1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622 204.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell Death Differ 2013;  In press; PMID:23811849; http://dx.doi.org/10.1038/ cdd.2013.72.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nature 2002; 418:191-5; PMID:12110890;  http://dx.doi.org/10.1038/nature00858 206.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Autophagy 2010; 6:1181- 3; PMID:20861675; http://dx.doi.org/10.4161/ auto.6.8.13367 207.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012;  1:271-8; PMID:22737602; http://dx.doi.org/10.4161/ onci.18684 208.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Semin Nucl Med 2010; 40:122- 35; PMID:20113680; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
N Engl J Med  2005; 352:441-9; PMID:15689582; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Proc  Soc Exp Biol Med 1995; 208:51-9; PMID:7892295;  http://dx.doi.org/10.3181/00379727-208-43831 212.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Clin Oncol  2011; 8:720-34; PMID:22064461; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd3626 214.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Drug Discov 2005; (Suppl): S10-1; PMID:15962524; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cancer Biother Radiopharm  2012; 27:12-22; PMID:22283603; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Apoptosis 2006; 11:1709-26;  PMID:16951923; http://dx.doi.org/10.1007/s10495- 006-9527-8 187.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Methods 2008; 44:205- 21; PMID:18314051; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Ann  N Y Acad Sci 2010; 1209:77-82; PMID:20958319; http://dx.doi.org/10.1111/j.1749-6632.2010.05740.x 189.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
EMBO J  2012; 31:1062-79; PMID:22252128; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell Death Differ 2007; 14:1848- 50; PMID:17657249; http://dx.doi.org/10.1038/ sj.cdd.4402201 192.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
EMBO J 2009; 28:578-90; PMID:19165151;  http://dx.doi.org/10.1038/emboj.2009.1 193.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell Death Differ 2008; 15:1499-509; PMID:18464797; http://dx.doi.org/10.1038/ cdd.2008.67 194.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell Death Differ 2013; In press;  PMID:23787997; http://dx.doi.org/10.1038/ cdd.2013.73.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cancer Res 2010; 70:855-8;  PMID:20086177; http://dx.doi.org/10.1158/0008- 5472.CAN-09-3566 196.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cell Cycle 2009; 8:3723- 8; PMID:19855167; http://dx.doi.org/10.4161/cc.8.22.10026 197.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347 198.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:393- 5; PMID:22737627; http://dx.doi.org/10.4161/ onci.19070,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Clin Oncol 2011; 8:151-60; PMID:21364688;  http://dx.doi.org/10.1038/nrclinonc.2010.223 249.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:793-7; PMID:23162746;  http://dx.doi.org/10.4161/onci.20909 250.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Rev Drug Discov 2011; 10:591- 600; PMID:21804596; http://dx.doi.org/10.1038/ nrd3500 251.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cancer Immunol Immunother 2009; 58:317-24;  PMID:18704409; http://dx.doi.org/10.1007/s00262- 008-0576-4 253.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Blood 2012; 120:2417-27; PMID:22806892; http://dx.doi.org/10.1182/blood- 2012-02-411124 255.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Cancer Res 2012; 72:3439-44;  PMID:22761338; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3912238.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Gastroenterology 2010; 138:52-64; PMID:19766639;  http://dx.doi.org/10.1053/j.gastro.2009.09.006 239.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Am J Clin Oncol 2012; 35:91- 9; PMID:22363944; http://dx.doi.org/10.1097/ COC.0b013e3181f47583 240.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Lancet Oncol  2013; 14:678-9; PMID:23764182; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
N Engl J Med 2011; 365:1273- 83; PMID:21991949; http://dx.doi.org/10.1056/NEJMoa0910383 242.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
N Engl J Med  2001; 344:783-92; PMID:11248153; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:810-21; PMID:23162748;  http://dx.doi.org/10.4161/onci.20447 244.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Nat Immunol 2002; 3:196-200;  PMID:11812998; http://dx.doi.org/10.1038/ni758 246.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
OncoImmunology 2013; 2:e25396; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Int J Radiat Oncol Biol Phys 2009; 73:1088- 95; PMID:18707823; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncogene 2012; 31:1869-83; PMID:21892204;  http://dx.doi.org/10.1038/onc.2011.384 232.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
N Engl J Med  2006; 355:1114-23; PMID:16971718; http://dx.doi.org/10.1056/NEJMoa060829 233.,OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Ann Oncol 2012; 23:2479-516;  PMID:23012255; http://dx.doi.org/10.1093/annonc/ mds236 234.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Oncoimmunology 2012; 1:670-86; PMID:22934259;  http://dx.doi.org/10.4161/onci.20426 236.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
Clin Cancer Res 2011; 17:6847-57;  PMID:21918169; http://dx.doi.org/10.1158/1078- 0432.CCR-11-1385 237.,Non-OADS,/arxiv_data1/oa_pdf/f1/f1/onci-2-e25595.PMC3850274.pdf
"OncoImmunology 2013; 2:e25668; http://dx.doi.org/10.4161/onci.25668Despite its efficacy and widespread use, radiation therapy is often associated with local or distal tumor relapse.",Non-OADS,/arxiv_data1/oa_pdf/56/48/onci-2-e25668.PMC3850275.pdf
Lancet 2011; 378:1707-16;  PMID:22019144; http://dx.doi.org/10.1016/S0140-6736(11)61629-2 2.,Non-OADS,/arxiv_data1/oa_pdf/56/48/onci-2-e25668.PMC3850275.pdf
Int J Radiat Oncol Biol Phys 2005; 61:1285- 90; PMID:15817329; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/48/onci-2-e25668.PMC3850275.pdf
J Immunol 2013; 190:5874-81;  PMID: 23630355; http://dx.doi.org/10.4049/jimmu- nol.1202612 4.,Non-OADS,/arxiv_data1/oa_pdf/56/48/onci-2-e25668.PMC3850275.pdf
Blood 2009; 114:589-95;  PMID:19349616; http://dx.doi.org/10.1182/blood- 2009-02-206870 5.,Non-OADS,/arxiv_data1/oa_pdf/56/48/onci-2-e25668.PMC3850275.pdf
Cancer Res  2011; 71:2488-96; PMID:21300764; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/48/onci-2-e25668.PMC3850275.pdf
Nature 2007; 450:903- 7; PMID:18026089; http://dx.doi.org/10.1038/nature06309 8.,OADS,/arxiv_data1/oa_pdf/56/48/onci-2-e25668.PMC3850275.pdf
Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486,OADS,/arxiv_data1/oa_pdf/56/48/onci-2-e25668.PMC3850275.pdf
"OncoImmunology 2013; 2:e25773; http://dx.doi.org/10.4161/onci.25773N-terminus of wild-type SIRP α is an  ineffective CD47 antagonist and fails to  stimulate phagocytosis, presumably owing to its poor binding affinity (K d ~1 μ M).",Non-OADS,/arxiv_data1/oa_pdf/e9/86/onci-2-e25773.PMC3850276.pdf
Cell 2009; 138:286- 99; PMID:19632179; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/86/onci-2-e25773.PMC3850276.pdf
Cell 2010; 142:699- 713; PMID:20813259; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/86/onci-2-e25773.PMC3850276.pdf
Proc Natl Acad Sci U S A  2012; 109:6662-7; PMID:22451913; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/86/onci-2-e25773.PMC3850276.pdf
Proc Natl Acad Sci USA 2012; 109:6656-61;  PMID:22451919; http://dx.doi.org/10.1073/ pnas.11216291095.,OADS,/arxiv_data1/oa_pdf/e9/86/onci-2-e25773.PMC3850276.pdf
Mol Cell 2008; 31:266-77;  PMID:18657508; http://dx.doi.org/10.1016/j.mol- cel.2008.05.026,OADS,/arxiv_data1/oa_pdf/e9/86/onci-2-e25773.PMC3850276.pdf
"OncoImmunology 2013; 2:e25620; http://dx.doi.org/10.4161/onci.25620Over the last decade, cytomegalovirus (CMV) has been suggested to promote the development of glioblastoma  multiforme (GBM).",Non-OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
Clin Cancer Res  2011; 17:4619-21; PMID:21632859; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
Cancer Res 2013; 73:3441-50; PMID:23729642;  http://dx.doi.org/10.1158/0008-5472.CAN-12-38465.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
Cancer Res 2012; 72:5669-74; PMID:23002204;  http://dx.doi.org/10.1158/0008-5472.CAN-12-2425 6.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
Mol Cancer Res  2008; 6:675-84; PMID:18505913; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
Nature  2008; 455:1061-8; PMID:18772890; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
Sci Signal 2010;  3:ra58; PMID:20682912; http://dx.doi.org/10.1126/ scisignal.2001180 9.,OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
Cancer Res 2011; 71:6643-53;  PMID:21900396; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0744 10.,Non-OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
Nature  2008; 455:391-5; PMID:18701889; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/dc/onci-2-e25620.PMC3850294.pdf
"http://dx.doi.org/10.1016/j.lrr.2013.07.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permitsnon-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/1c/ab/main.PMC3850368.pdf
"http://dx.doi.org/10.1016/j.lrr.2013.06.004☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e6/dd/main.PMC3850374.pdf
"http://dx.doi.org/10.1016/j.lrr.2013.08.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permitsnon-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6c/90/main.PMC3850375.pdf
〈http://cgap.nci.nih.gov/Chromosomes/Mitelman 〉.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/main.PMC3850375.pdf
"http://dx.doi.org/10.1016/j.lrr.2013.09.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/1d/6b/main.PMC3850384.pdf
"http://dx.doi.org/10.1016/j.lrr.2013.09.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/3a/79/main.PMC3850385.pdf
"http://dx.doi.org/10.1016/j.lrr.2013.06.003☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/7b/eb/main.PMC3850389.pdf
"OncoImmunology 2013; 2:e26011; http://dx.doi.org/10.4161/onci.26011Monitoring NK cell activity in patients   with hematological malignancies Sébastien v iel1,2,3,4,5,6, emily Charrier1,2,3,4,5,6, antoine Marçais1,2,3,4,5, Paul r ouzaire,7 Jacques Bienvenu1,2,3,4,5,6, Lionel Karlin8,   Gilles Salles8, and Thierry w alzer1,2,3,4,5,* 1CIrI, International Center for Infectiology r esearch; Université de Lyon; Lyon, France; 2Inserm, U1111; Lyon, France; 3ecole Normale Supérieure de Lyon; Lyon, France;  4Université Lyon 1; Centre International de r echerche en Infectiologie; Lyon, France; 5CNrS, UM r5308; Lyon, France; 6Laboratoire d’Immunologie; Hospices Civils de Lyon;  Centre Hospitalier Lyon Sud; Lyon, France; 7Laboratoire d’Immunologie; CHU Clermont-Ferrand; Clermont-Ferrand, France; 8Hospices Civils de Lyon; Service d’Hématologie;  Centre Hospitalier Lyon Sud; Lyon, France Keywords:  natural killer cells, multiple myeloma, flow cytometry, cytotoxicity, Lenalidomide Natural killer (NK) cells are lymphocytes of the innate immune  system that can recognize and kill various types of malignant cells.",Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2009; 114:937-51;  PMID:19357394 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Cell 2000; 100:57-70;  PMID:10647931 ;  http://dx.doi.org/10.1016/S0092-8674(00)81683-9 3.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Cell 2011; 144:646-74;  PMID:21376230 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Nat Rev Immunol 2013; 13:145-9;  PMID:23348417 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Immunity 2012; 37:549-62; PMID:22940097 ;  http://dx.doi.org/10.1016/j.immuni.2012.05.029 6.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Immunity  2007; 26: 503-17;  PMID:17398124 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Nat Immunol  2008; 9:503-10;  PMID:18425107 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Cell 2012; 150 :1235-48 ;  PMID:22980983 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Immunol Rev 2001; 181:170-84;  PMID:11513138 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Annu Rev Immunol 2013; 31:413-41; PMID:23298206 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-095951 11.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
J Exp Med 2009; 206:1495-503; PMID:19528259 ; http://dx.doi.org/10.1084/ jem.20090681 12.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Curr Top Microbiol Immunol 2011;  350:105-25;  PMID:20680807 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Oncoimmunology 2012; 1:244-6; PMID:22720258 ; http://dx.doi.org/10.4161/ onci.1.2.18309 14.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Oncoimmunology  2012; 1:366-8;  PMID:22737617 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Oncoimmunology 2012; 1:974-5;  PMID:23162776 ;  http://dx.doi.org/10.4161/onci.20405 16.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Curr Opin Immunol 2013; 25:261-7;  PMID:23579076 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
J Clin Oncol 2009; 27:5944- 51; PMID:19858404 ; http://dx.doi.org/10.1200/ JCO.2008.19.614718.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Cell 2009; 138:30-50; PMID:19596234 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Nat Rev Immunol 2006; 6:715-27; PMID:16977338 ; http://dx.doi.org/10.1038/nri1936 20.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Lancet  2000; 356:1795-9;  PMID:11117911 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2009; 114:2667-77;  PMID:19553639 ; http://dx.doi.org/10.1182/ blood-2009-02-206532 22.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2012;  120:4324-33;  PMID:23033266 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2002; 99:754-8; PMID:11806974 ;  http://dx.doi.org/10.1182/blood.V99.3.754 24.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Clin Cancer Res 2011; 17:19-30; PMID:21208903 ;  http://dx.doi.org/10.1158/1078-0432.CCR-10-1292 25.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Front Immunol 2013;  4:46;  PMID:23450662 ; http://dx.doi.org/10.3389/ fimmu.2013.00046 27.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
J Immunol Methods 2004; 294:15- 22; PMID:15604012 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
J Clin Invest 2010; 120:907-23; PMID:20197626 ;  http://dx.doi.org/10.1172/JCI40645 31.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood  2008; 112:461-9;  PMID:18650461 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Eur J Immunol  2012; 42:447-57;  PMID:22105371 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
J Exp Med  2011; 208:13-21;  PMID:21173105 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Cancer Immunol Immunother 2011; 60:1-13; PMID:20697893 ;  http://dx.doi.org/10.1007/s00262-010-0898-x 35.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Cancer Microenviron 2013; 6:135-46; PMID:23242671 ; http://dx.doi.org/10.1007/ s12307-012-0125-8 36.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2010; 116: 1299 -307; PMID:20651077 ;  http://dx.doi.org/10.1182/blood-2009-11-253286 37.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2010; 116:3853-64;  PMID:20505160 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Methods Mol Biol 2010;  612:353-64;  PMID:20033653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2012; 119:4928-38; PMID:22490682 ;  http://dx.doi.org/10.1182/blood-2011-12-39518640.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
PLoS Med 2007;  4:e176;  PMID:17488182 ; http://dx.doi.org/10.1371/ journal.pmed.0040176 41.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Clin Dev Immunol 2012;  2012:196063;  PMID:22567028 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood  2005; 105:251-8;  PMID :15328155 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Cytometry 1996; 26:121-4;  PMID:8817087 ; http://dx.doi.org/10.1002/ (SICI)1097-0320(19960615)26:2<121::AID- CYTO4>3.0.CO;2-J 46.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Int J Clin Lab Res 1997; 27:48-54; PMID:9144027 ; http://dx.doi.org/10.1007/ BF02827242 47.,OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Acta Haematol  1997; 98:150-4;  PMID:9352746 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Leukemia  2006; 20:732-3;  PMID :16437151 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Med Oncol  2007; 24: 312 -7; PMID:17873307 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Cancer Immunol Immunother 2010; 59:829-39;  PMID:20024547 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Haematologica 2013; 98:79-86; PMID:22773604 ;  http://dx.doi.org/10.3324/haematol.2012.067272 53.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2010; 116:2286- 94; PMID:20460501 ; http://dx.doi.org/10.1182/ blood-2010-02-271874 54.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2001; 98: 210-6; PMID:11418482 ; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Br J Haematol 2005;  128:192-203;  PMID :15638853 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Am J Hematol 2009; 84:553- 9; PMID:19565649 ; http://dx.doi.org/10.1002/ ajh.21468 59.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Bone Marrow  Transplant 2010; 45: :349 -53; PMID:19584825 ;  http://dx.doi.org/10.1038/bmt.2009.155 60.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Curr Cancer  Drug Targets 2010; 10:155-67; PMID:20088798 ;  http://dx.doi.org/10.2174/156800910791054239 62.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
Blood 2011; 117:1605-13; PMID:20978269 ; http://dx.doi.org/10.1182/ blood-2010-04-278432,Non-OADS,/arxiv_data1/oa_pdf/a5/df/onci-2-e26011.PMC3850490.pdf
OncoImmunology 2013; 2:e25770; http://dx.doi.org/10.4161/onci.25770the mevalonate pathway is an attractive target for cancer therapy not only to override multidrug resistance but also to  promote the immunogenic demise of malignant cells.,Non-OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
J Control Release 2011; 149:196-205;  PMID:20946921; http://dx.doi.org/10.1016/j.jcon- rel.2010.10.003 2.,OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
Int J Cancer  2006; 119:17-27; PMID:16450390; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
PLoS One 2013; 8:e60975; PMID:23593363; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
Nat Rev Clin Oncol 2011; 8:151-60; PMID:21364688;  http://dx.doi.org/10.1038/nrclinonc.2010.223 6.,Non-OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
J Immunol 2011; 187:1578-90; PMID:21753152; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
Nat Rev Immunol  2010; 10:467-78; PMID:20539306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
Cell Mol Life Sci  2011; 68:2419-32; PMID:21584812; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
Cancer Res 2010; 70:9611-20;  PMID:20947520; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1968 10.,Non-OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
Blood 2010; 116:1726- 33; PMID:20519625; http://dx.doi.org/10.1182/ blood-2009-07-234211,Non-OADS,/arxiv_data1/oa_pdf/38/e4/onci-2-e25770.PMC3850498.pdf
"OncoImmunology 2013; 2:e25636;  http://dx.doi.org/10.4161/onci.25636the addition of zoledronate to tumor-associated antigen ( tAA)-loaded dendritic cells (DCs) promotes the activation  of interferon γ-secreting V γ9 γδ t cells, in turn eliciting tAA-specific CD8+ t-cell responses.",Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
J Immunol 2011; 186:1325- 31; PMID:21248270; http://dx.doi.org/10.4049/jim- munol.09025392.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
J Leukoc Biol  2008; 83:742-54; PMID:18156189; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
Br J Haematol  2011; 153:796-9; PMID:21477159; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
Cancer Immunol Immunother  2004; 53:315-22; PMID:14685778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
Blood 2005; 105:2465-72;  PMID:15546948; http://dx.doi.org/10.1182/blood- 2004-08-3105 6.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
Int Immunopharmacol  2013; 15:488-97; PMID:23474736; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
Int J Cancer  2002; 101:265-9; PMID:12209978; http://dx.doi.org/10.1002/ijc.105979.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
Nat Rev Immunol  2007; 7:964-74; PMID:18037898; http://dx.doi.org/10.1038/nri2214 10.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
Pancreas  2009; 38:e69-74; PMID:19276867; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/onci-2-e25636.PMC3850548.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/52/mder-6-203.PMC3850687.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2013:6 203–209Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  203ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S5290 3system for simultaneous measurements   of bilaterally symmetrical acupoints   multifrequency impedances Mi-Y ong su1 Y ong-hong Tan2 Zi-Min Wang3 cai-Jun gan3 shou-hong chen3 1school of Electronic Engineering,   Xidian University, Xi’an, shaanxi,   People’s Republic of china; 2college  of information, Mechanical and  Electronic Engineering, shanghai  normal University, shanghai,   People’s Republic of china; 3school  of Electronic Engineering and  automation, guilin University of  Electronic T echnology, guilin, guangxi,   People’s Republic of china correspondence: Mi-Yong su   school of Electronic Engineering,   Xidian University, no 2, south Taibai Road,   Xi’an city 710071, shaanxi Province,   People’s Republic of china   Email sum_yong@126.co mAbstract:  Devices which can obtain comparable bilaterally symmetrical acupoints (BSA)  multifrequency impedances (MFI) are often needed in the detection of the energy balance states  of acupoints in traditional Chinese medicine.",Non-OADS,/arxiv_data1/oa_pdf/e8/52/mder-6-203.PMC3850687.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2013:6submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 209Measurement of bilaterally symmetrical acupoints impedances References  1.,Non-OADS,/arxiv_data1/oa_pdf/e8/52/mder-6-203.PMC3850687.pdf
The current literature suggests that mMPT is mediated Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > Received 2 April 2013 | Accepted 26 November 2013 | Published 29 November 2013© 2013 Molecular Vision 2451Lenticular mitoprotection.,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2452via the opening of the mitochondrial permeability transition  pore [ 3-5].,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
"Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2453sodium phosphate dibasic), pH 7.4, before the monolayers  were lysed with hot lysis buffer (about 100 °C), subsequently  scraped into 1.7 ml micro centrifuge tubes, and immediately  sonicated.",Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
"Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2454RESULTS Switching HLE-B3 cell cultures from hypoxia to atmospheric  oxygen or, conversely, from atmospheric oxygen to hypoxia,  does not induce mitochondrial depolarization:  JC-1 analysis  of the DMSO mock-treated cells exposed to various cell  culture conditions was implemented to determine whether  environmental stress (i.e., hypoxia, atmospheric oxygen,  or reversal from one condition to the other) elicited mito - chondrial depolarization.",Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2455Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
"Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2456upper panel and Figure 5, upper panel).",Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2457The phosphorylation of c-Jun is a useful parameter for moni - toring JNK activity.,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2458 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
"Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  245920 µM), or DMSO vehicle (control).",Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
"Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2460Bcl-2, or pBcl-2 for cells treated with SP600125 or AS601245  versus cells treated with DMSO vehicle (Figure 6).",Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2461oxygen for 60 min.,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2462 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2463µM UO126 or DMSO and then placed under hypoxic condi - tions for 3 h. The cells were exposed to the JC-1 dye for 30  min in atmospheric oxygen.,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
"Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2464without the loss of Bcl-2, we conclude that pBcl-2 confers  anti-depolarization resistance in lens epithelial cells.",Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  24659).,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2466vascular endothelial growth factor (VEGF) but only upon  reintroduction from hypoxia to atmospheric oxygen (unpub - lished observation).,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
Molecular Vision  2013; 19:2451-2467 <http://www.molvis.org/molvis/v 19/2451 > © 2013 Molecular Vision  2467transduction by c-Jun NH(2)-terminal kinase.,Non-OADS,/arxiv_data1/oa_pdf/ea/e4/mv-v19-2451.PMC3850969.pdf
"Consequently, an Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > Received 24 September 2013 | Accepted 22 November 2013 | Published 22 November 2013© 2013 Molecular Vision 2426Two novel PRPF31 premessenger ribonucleic acid processing  factor 31 homolog mutations including a complex insertion- deletion identified in Chinese families with retinitis pigmentosa Bing Dong, Jieqiong Chen, Xiaohui Zhang, Zhe Pan, Fengge Bai, Yang Li (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  2427individual carrying a mutant allele and a high expressivity  wild-type PRPF31  allele would not display RP symptoms  [14-16].,Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
"Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  2428The breakpoint region was defined using long-range  PCR (Vigorous Biotechnology, Beijing, China) with primers  adjacent to the deleted regions and additional nested primers  91925F and PRPF31-3A2R (Table 1 and Table 2 ).",Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  2429Table  2.,Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  2430Genotyping results:  Two families were genotyped with 41  polymorphic markers around the known adRP loci.,Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  2431Table  3.,Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  2432 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  2433gene.,Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
"Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  2434penetrance observed in most adRP families linked to RP11,  no asymptomatic mutation/or obligate carriers were identified  in family RP24.",Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
Molecular Vision  2013; 19:2426-2435 <http://www.molvis.org/molvis/v 19/2426 > © 2013 Molecular Vision  24352.,Non-OADS,/arxiv_data1/oa_pdf/a2/d2/mv-v19-2426.PMC3850970.pdf
"Therefore, in this study, we used the multiplex bead  immunoassay to evaluate the concentrations of 27 cytokines  in the aqueous humor at the beginning of cataract surgery and  correlate their expression levels to the development of ME 4 Molecular Vision  2013; 19:2418-2425 <http://www.molvis.org/molvis/v 19/2418 > Received 3 August 2013 | Accepted 22 November 2013 | Published 24 November 2013© 2013 Molecular Vision 2418Aqueous cytokines as predictors of macular edema in non- diabetic patients following uncomplicated phacoemulsification  cataract surgery Liqun Chu, Bingsong Wang, Bing Xu, Ning Dong Department of Ophthalmology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’ s Republic of China Purpose:  To ascertain whether cytokines in the aqueous humor can predict macular edema (ME) in non-diabetic patients  following uncomplicated phacoemulsification cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/93/26/mv-v19-2418.PMC3850971.pdf
Molecular Vision  2013; 19:2418-2425 <http://www.molvis.org/molvis/v 19/2418 > © 2013 Molecular Vision  2419weeks after surgery.,Non-OADS,/arxiv_data1/oa_pdf/93/26/mv-v19-2418.PMC3850971.pdf
Molecular Vision  2013; 19:2418-2425 <http://www.molvis.org/molvis/v 19/2418 > © 2013 Molecular Vision  2420reference cytokine sample supplied in the kit and the Bio-Plex  200 System (software version 6.0; Bio-Rad Laboratories) and  were used to calculate the cytokine concentrations in aqueous  humor samples.,OADS,/arxiv_data1/oa_pdf/93/26/mv-v19-2418.PMC3850971.pdf
"Molecular Vision  2013; 19:2418-2425 <http://www.molvis.org/molvis/v 19/2418 > © 2013 Molecular Vision  2421units) compared to eyes without ME, which gained approxi - mately 1 line of vision (0.05 logMAR units).",Non-OADS,/arxiv_data1/oa_pdf/93/26/mv-v19-2418.PMC3850971.pdf
Molecular Vision  2013; 19:2418-2425 <http://www.molvis.org/molvis/v 19/2418 > © 2013 Molecular Vision  2422on the incidence of ME after uneventful cataract surgery  must continue.The pathophysiology of ME involves the accumulation  of transudate in the outer plexiform and the inner nuclear  layers of the retina; the microcysts coalesce into cysts [ 5].,Non-OADS,/arxiv_data1/oa_pdf/93/26/mv-v19-2418.PMC3850971.pdf
"Molecular Vision  2013; 19:2418-2425 <http://www.molvis.org/molvis/v 19/2418 > © 2013 Molecular Vision  2423The pathogenesis of ME is associated with the destruction  of the blood–retinal barrier and the blood–aqueous barrier  induced by prostaglandins or other inflammatory mediators  [3,6,7].",Non-OADS,/arxiv_data1/oa_pdf/93/26/mv-v19-2418.PMC3850971.pdf
Molecular Vision  2013; 19:2418-2425 <http://www.molvis.org/molvis/v 19/2418 > © 2013 Molecular Vision  2424cytokines were not included in the statistical analysis because  of the low detection rates in the current study.,Non-OADS,/arxiv_data1/oa_pdf/93/26/mv-v19-2418.PMC3850971.pdf
Molecular Vision  2013; 19:2418-2425 <http://www.molvis.org/molvis/v 19/2418 > © 2013 Molecular Vision  2425quantities of human aqueous humor.,Non-OADS,/arxiv_data1/oa_pdf/93/26/mv-v19-2418.PMC3850971.pdf
"The aim of our study was to  determine the relative contributions of mutations in congen - ital cataract cases in an Indian population with systematic  screening of 14 genes associated with cataract.Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > Received 7 February 2013 | Accepted 22 November 2013 | Published 24 November 2013© 2013 Molecular Vision 2436Molecular and structural analysis of genetic variations in  congenital cataract Manoj Kumar,1 Tushar Agarwal,2 Punit Kaur,3 Manoj Kumar,3 Sudarshan Khokhar,,2 Rima Dada1 1Laboratory for Molecular Reproduction and Genetics, Department of Anatomy, All India Institute of Medical Sciences, New  Delhi, India; 2Dr.",Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
"Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2437METHODS Patient ascertainment and clinical examination:  After  receiving ethical approval from the institutional review board  (IRB#00006862; All India Institute of Medical Sciences,  Delhi, India), 100 clinically diagnosed congenital cataract  cases from northern India who presented at the Dr. R. P.  Centre for Ophthalmic Sciences (AIIMS, New Delhi, India)  were enrolled in this study.",Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2438Table  1.,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2439Gene Name Primer Name Primer Sequence Anne Temp (°C) Product Size (bp) GAJ3Ex-1A-E 5′-TGCGGACCCGGCACTCAGC-3′62 °C 383Ex-1A-R 5′-TCCATGCGCACGATGTGCAGTCA-3′ Ex-1B-F 5′-CTGTTCATCTTCCGCATTTTGG-3′62 °C 603Ex-1B-R 5′-TCTTCTTCCAGCCCAGGTGGTA-3′ Ex-1C-F 5′-AAGCTCAAGCAGGGCGTGAC-3′62 °C 624Ex-1C-R 5′-CTAGATGGCCAAGTCCTCCGG-3′ BFSP1Ex-1-F 5′-GGGCCTCCGGTGTTTATTTA-3′58 °C 589Ex-1-R 5′-ATCGACAGGGGACCGAGAGAC-3′ Ex-2-F 5′-AAAGGAGAGGGCATCGTACC-3′58 °C 238Ex-2-R 5′-AACCTGCACTTCCACCATTC-3′ Ex-3-F 5′-CAGGTGGTCTGTGTGCACAT-3′58 °C 249Ex-3-R 5′-TCGGCTTACCTGATCAAACC-3′ Ex-4-F 5′-RGCCATTCCTGTTCTCATCT-3′58 °C 250Ex-4-R 5′-GCCCTTCCCTGGGAGTCT-3′ Ex-5-F 5′-ACCTTCTCTGCCCTTTTCCT-3′58 °C 227Ex-5-R 5′-CACCTCCATGAAACATGTGG-3′ Ex-6-F 5′-CCTTTTCCTGGGTGAGGTCTG-3′58 °C 366Ex-6-R 5′-GGCACACAATAGGCACTCAA-3′ Ex-7-F 5′-CTTGCCCCTGACCTCTGTT-3′58 °C 199Ex-7-R 5′-AAGAGAGCCGCTTGGTTTTT-3′ Ex-8-F 5′-TTCCAACCAGCGTATTTTCTTT-3′58 °C 699Ex-8-R 5′-TCAGGGCCTTCCAGCTCT-3′ In5-Ex-7-F 5′-CATCTTCCAGGGTGTCCAG-3′58 °C 316In5-Ex-7-R 5′-AAGAGAGCCGCTTGGTTTTT-3′,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2440Mutations in more than 40 genetic loci have been linked  to congenital cataracts.,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2441mediated by loop regions.,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
"Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2442Table  4. s ummar Y Of The muTaTiOns iden Tified  in crYba4, cr Ybb1, cr Ybb2 and gJa3 genes  wiTh differen T  cOngeni Tal caTarac T phen OTY pes bel Onging  TO differen T pOpula TiOns (caT-map).",Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
"Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2443GeneExon/  IntronDNA Change Coding ChangePattern of  InheritanceOrigin Cataract Phenotype GJA3Ex2 c.-39C>G Cx China Age-related nuclear Ex2 c.5G>A p.G2D AD China Nuclear pulverulent, Posterior polar Ex2 c.7G>T p.D3Y AD Honduras Zonular pulverulent Ex2 c.32T>C p.L11S AD Denmark “Ant-egg” Ex2 c.56C>T p.T19M AD India Posterior polar Ex2 c.82G>A p.V28M AD India Total, anterior capsular, cortical Ex2 c.96C>A p.F32L AD China Nuclear pulverulent Ex2 c.98G>T p.R33L AD India Granular embryonal Ex2 c.130G>A p.V4 4M AD China Central nuclear (punctate cortical) Ex2 c.130G>A p.V4 4M AD USA ?",Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
"Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2444movement of the loop, which imparts structural flexibility.",Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
"Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2445Aspartate (Asp) and Asn differ only in the side chain group,  with a carboxyl group in the former and an amide in the latter.",Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2446 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2447 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2448the non-synonymous changes were not possible due to the  lack of a suitable homolog model.,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  2449REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
Molecular Vision  2013; 19:2436-2450 <http://www.molvis.org/molvis/v 19/2436 > © 2013 Molecular Vision  245032.,Non-OADS,/arxiv_data1/oa_pdf/82/92/mv-v19-2436.PMC3850972.pdf
"The robust magnitude of protection in these  animal models implies that the epigenetic response is mecha - nistically pleiotropic, and involves gene expression changes in Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > Received 31 May 2013 | Accepted 21 November 2013 | Published 23 November 2013© 2013 Molecular Vision 2360Role of hypoxia-inducible factor-1α in preconditioning-induced  protection of retinal ganglion cells in glaucoma Yanli Zhu,1 Lihong Zhang,1 Jeffrey M. Gidday1,2,3 1Department of Neurosurgery, Washington University School of Medicine St. Louis, MO; 2Department of Ophthalmology & Visual  Sciences, Washington University School of Medicine St. Louis, MO; 3Department of and Cell Biology & Physiology, Washington  University School of Medicine St. Louis, MO Purpose:  We recently demonstrated in a mouse model of glaucoma that endogenous epigenetic mechanisms can be ac - tivated by a repetitive hypoxic preconditioning (RHP) stimulus to provide robust retinal ganglion cell (RGC) protection.",Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
"Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2361neuronal, glial, and vascular cells.",Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2362the fellow eye of each animal to serve as a non-glaucomatous  control.,Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
"Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2363overnight in 4% paraformaldehyde, thrice rinsed with PBS,  transferred to 10% formalin, and then paraffin-embedded.",Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
"Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2364As shown in Figure 2, HIF-1α immunohistochemistry on  retinal cross sections in WT mice revealed HIF-1α-positive  cells throughout the retinas even under normoxic control  conditions, including cells in the ganglion cell and inner  nuclear layers, as well as in photoreceptors (although much  of the signal in the photoreceptor layer was the result of  antibody autofluorescence; data not shown).",Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2365 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
"Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2366Intraocular pressure:  As shown previously by our group  [10,25], our episcleral vein ligation protocol resulted in consis - tent and sustained elevations in IOP in all four experimental  groups, starting 24 h after the initial surgery and lasting  for 3 weeks (when all endpoints were measured; Figure 5).",Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
"Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2367significant RGC soma loss in the WT mice; specifically,  30±2% (p=0.016; n=7) of NeuN-positive soma were lost in  non-preconditioned animals, relative to respective fellow  eyes.",Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2368 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2369of which may have contributed to the lack of phenotype we  observed in the HIF-1α  RGC-KO mice.,Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  2370in a single retinal cell type.,Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  237112.,Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
Molecular Vision  2013; 19:2360-2372 <http://www.molvis.org/molvis/v 19/2360 > © 2013 Molecular Vision  237237.,Non-OADS,/arxiv_data1/oa_pdf/f0/ab/mv-v19-2360.PMC3850973.pdf
"In  addition, we estimated the percentage of vitreous contraction Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > Received 28 November 2012 | Accepted 21 November 2013 | Published 23 November 2013© 2013 Molecular Vision 2374Cell-mediated contraction of vitreous explants from chicken  embryo: Possibility of screening for therapeutic agents against  proliferative vitreoretinal diseases Keitaro Oki,1 Yoshiki Miyata,1 Arata Shimada,1 Terumasa Nagase,2 Yoshiya Katsura,2 Hiroshi Kosano1 1Faculty of Pharma-Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo, Japan; 2The 5th Department of Internal  Medicine of Tokyo Medical College, Ibaraki, Japan Purpose:  We aimed to establish a novel screening system for identifying potential therapeutic agents for treating prolif - erative vitreoretinal diseases (PVDs).",Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
"Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  2375by measuring the wet weight as an index of contraction, after  cell adhesion.",Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  2376the cells in the high glucose condition since there is a report  that high glucose is actively involved in cell-matrix adhesion  in diabetic retinopathy [ 29].,Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
"Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  2377addition, contraction of vitreous explants after cell adhesion  was also confirmed by staining with CBB (Figure 2B).",Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  2378cell adhesion.,Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
"Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  2379preincubated with heparin, there was no significant effect on  cell-mediated vitreous contraction.",Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
"Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  2380study, Müller cells possessed the contractile activity against  vitreous explants from chicken embryos.",Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  2381 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  2382related to induction of tractional force on vitreous explants  from chicken embryos.,Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  238327.,Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
Molecular Vision  2013; 19:2374-2384 <http://www.molvis.org/molvis/v 19/2374 > © 2013 Molecular Vision  238452.,Non-OADS,/arxiv_data1/oa_pdf/01/40/mv-v19-2374.PMC3850974.pdf
"Although  the rate of progression of vision loss is variable, all patients Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > Received 11 September 2013 | Accepted 22 November 2013 | Published 24 November 2013© 2013 Molecular Vision 2393Whole-exome sequencing identifies a novel ALMS1  mutation  (p.Q2051X) in two Japanese brothers with Alström syndrome Satoshi Katagiri,1,2 Kazutoshi Yoshitake,3 Masakazu Akahori,1 Takaaki Hayashi,2 Masaaki Furuno,4 Jo  Nishino,3 Kazuho Ikeo,3 Hiroshi Tsuneoka,2 Takeshi Iwata1 1Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo  Medical Center, Tokyo, Japan; 2Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan;  3Laboratory of DNA Data Analysis, National Institute of Genetics, Shizuoka, Japan; 4RIKEN Center for Life Science  Technologies, Division of Genomic Technologies, Life Science Accelerator Technology Group, Transcriptome Technology Team,  Yokohama, Japan Purpose:  No mutations associated with Alström syndrome (AS), a rare autosomal recessive disease, have been reported  in the Japanese population.",Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
"Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2394show progressive retinal degeneration, with 90% becoming  totally blind by the age of 16 years [ 19] and all becoming  blind eventually [ 14,19].",Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2395Clinical Electrophysiology of Vision.,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
"Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2396RESULTS Ophthalmologic findings for patient II-1:  Patient II-1, the  elder of the two brothers, was referred to our hospital at the  age of 7 years and 4 months for the assessment of poor visual  acuity from infancy.",Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
"Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2397combined, photopic, or 30-Hz flicker responses in either eye  (Figure 2).",Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2398the age of 8 years showed retinal degeneration with attenu - ated vessels from the arcade artery to the periphery in both  eyes (Figure 4B).,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2399Systemic features except ocular findings:  Systemic exami - nations were performed for patient II-1 at the age of 29  and patient II-2 at the age of 23.,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2400progress known phenotype with syndromic disorders.,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2401Table  2. b io-informa Tion and bioChemi Cal assessmen T Bio-information and blood test results Normal range Patient II-1 Patient II-2 Bio-information     Weight (kg) 60 52     Height (m) 1.52 1.55     Body mass index (kg/m2) 18.5–25 25.96 21.6 Biochemical assessment     Fasting blood glucose (mg/dl) 65–109 247 77     Hemoglobin A1c (%) 4.6–6.2 12.5 6.0     Urea (mg/dl) 8–20 16 10     Creatinine (mg/dl) 0.50–1.10 0.99 0.63     Uric acid (mg/dl) 3.1–6.9 4.2 3.6     Sodium (mmol/l) 136–146 140 141     Potassium (mmol/l) 3.6–4.8 4.1 4.3     Chloride (mmol/l) 98–109 100 104     Calcium (mg/dl) 8.6–10.2 10.3 10.2     Aspartate aminotransferase (U/l) 10–33 76 81     Alanine aminotransferase (U/l) 6–35 99 241     Gamma glutamyl transpeptidase (U/l) 12–65 134 135     Alkaline phosphatase (U/l) 96–300 285 319     Low density lipoprotein-cholesterol (mg/dl) 70–139 120 282     Total cholesterol (mg/dl) 120–219 211 441     Triglycerides (mg/dl) 30–149 309 761     Albumin/globulin (g/dl) 3.5–5.2 5.0 5.1 Hemogram     White blood cells (103/ml) 3.3–8.6 4.7 6.4     Red blood cells (106/ml) 4.10–5.50 5.00 4.88     Hemoglobin (g/dl) 13.5–16.5 14.0 14.3     Hematocrit (%) 40.0–50.0 42.3 42.7     Mean corpuscular volume (fl) 83.0–101.0 84.6 87.5     Platelets (103/ml) 150–350 166 251     Erythrocyte sedimentation rate (mm/h) 2–10 21 19 Hormones and autoantibodies     Free T3 (pg/ml) 2.36–5.00 2.34 2.47     Free T4 (pmol/l) 0.88–1.67 1.33 0.79,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2402Bio-information and blood test results Normal range Patient II-1 Patient II-2     Thyroid stimulating hormone (mIU/l) 0.34–4.04 3.06 4.67     Anti-thyroid peroxidase antibody (U/ml) 0.0–15 10 10     Anti-thyroglobulin antibody (U/ml) 0.0–27 11 <10     Thyroglobulin (ng/ml) 0.0–32.7 6.1 29.4     Thyroid stimulating hormone receptor antibody (IU/ml) <1.0 0.9 <1.0     Parathyroid hormone (pg/ml) 10–65 26 20     Luteinizing hormone (mIU/ml) 1.7–8.6 13.2 9.1     Follicle stimulating hormone (mIU/ml) 1.5–12.4 30.7 20.3     Estradiol (pg/ml) 14.0–43.9 18.7 10.6     Total testosterone (ng/ml) 250.0–1100.0 90.7 53.5     Prolactin (ng/ml) 4.3–13.7 3.7 2.5     Cortisol (mg/dl) 4.0–18.3 8.1 10.6     Insulin (µU/ml) 0.0–13.0 9.2 63.6     Growth hormone (ng/ml) 0–2.47 0.3 0.27 Bold type indicates values outside the normal range,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
"Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2403or anatomic changes of the retina [ 14,18,21,40] have been  reported.",Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  2404roles in targeting ALMS1 to the centrosomes and ciliary  basal bodies [ 44].,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  240513.,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
Molecular Vision  2013; 19:2393-2406 <http://www.molvis.org/molvis/v 19/2393 > © 2013 Molecular Vision  240639.,Non-OADS,/arxiv_data1/oa_pdf/74/50/mv-v19-2393.PMC3850975.pdf
"When a mitochondrial disease as complex as LHON is  studied, it should be kept in mind that the penetrance, pheno - typic expression, and prognosis of this disorder may depend  on many factors, e.g., the mtDNA haplogroup-defining  polymorphisms (selectively neutral), the mutation type (e.g.,  patients with the 14,484 mutation have a better prognosis  and a greater chance of partial vision recovery than patients Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > Received 12 April 2013 | Accepted 19 November 2013 | Published 21 November 2013© 2013 Molecular Vision 2343Point mutations associated with Leber hereditary optic  neuropathy in a Latvian population Aleksandra Aitullina,1,2 Kristine Baumane,3 Solveiga Zalite,3 Renate Ranka,1,2 Egija Zole,2,4 Ilva Pole,2 Svetlana  Sepetiene,3 Guna Laganovska,1,3 Viesturs Baumanis,2,4 Liana Pliss2 1Riga Stradins University, Riga, Latvia; 2Latvian Biomedical Research and Study Centre, Riga, Latvia; 3Pauls Stradins Clinical  University Hospital, Riga, Latvia; 4Faculty of Biology, University of Latvia, Riga, Latvia Purpose:  To study mutations associated with Leber hereditary optic neuropathy (LHON) in patients suspected of having  this mitochondrial disorder in a Latvian population.",Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
"Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > © 2013 Molecular Vision  2344with the 11,778 mutation), hormonal factors, environmental  factors, and other factors.",Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
"Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > © 2013 Molecular Vision  2345PCR were as follows: one cycle at 95 °C for 5 min; 30 cycles  of 95  °C for 30 s, primer annealing for 30 s (temperatures are  given in Appendix 1) and 72 °C for 30 s (for long fragments,  13 and 15, the elongation time was 2 min); and a final elonga - tion at 72 °C for 5 min.",Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > © 2013 Molecular Vision  2346Table  2. s ummary  of mole Cular  daTa on analyzed  samples .,Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > © 2013 Molecular Vision  2347atrophy of the optic nerve.,Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > © 2013 Molecular Vision  2348T14484C) among individuals suspected of having LHON.,Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > © 2013 Molecular Vision  2349which is listed as associated with this polymorphism in the  PhyloTree  database.,Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > © 2013 Molecular Vision  235011.,Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
Molecular Vision  2013; 19:2343-2351 <http://www.molvis.org/molvis/v 19/2343 > © 2013 Molecular Vision  235132.,Non-OADS,/arxiv_data1/oa_pdf/7d/b0/mv-v19-2343.PMC3850976.pdf
"A recent study suggests  that the C-terminal of Prp8 is inserted into the RNA binding  tunnel of Brr2 thus inhibiting Brr2 RNA binding and U4/U6  unwinding activity [ 8].Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > Received 24 July 2013 | Accepted 22 November 2013 | Published 24 November 2013© 2013 Molecular Vision 2407Mutations in the small nuclear riboprotein 200 kDa gene  (SNRNP200)  cause 1.6% of autosomal dominant retinitis  pigmentosa Sara J. Bowne,1 Lori S. Sullivan,1 Cheryl E. Avery,1 Elizabeth M. Sasser,1 Austin Roorda,2 Jacque L. Duncan,3  Dianna H. Wheaton,4 David G. Birch,4 Kari E. Branham,5 John R. Heckenlively,5 Paul A. Sieving,6 Stephen P.  Daiger1 1Human Genetics Center, School of Public Health, The University of Texas Health Science Center Houston, TX; 2School of  Optometry and Vision Sciences Graduate Group, University of California, Berkeley, CA; 3Department of Ophthalmology,  University of California, San Francisco, CA; 4Retina Foundation of the Southwest, Dallas, TX; 5Kellogg Eye Center, University  of Michigan, Ann Arbor, MI; 6Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of  Health, Bethesda, MD Purpose:  The purpose of this project was to determine the spectrum and frequency of mutations in the small nuclear  riboprotein 200 kDa gene ( SNRNP200 ) that cause autosomal dominant retinitis pigmentosa (adRP).",Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
"Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2408The hBrr2 protein is composed of two DExD/H box  domains, two Sec63 domains, and a helicase superfamily  C-terminal domain [ 9].",Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2409Table  1.,Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2410Exon Forward Primer Sequence (5′-3′) Reverse Primer Sequence (5′-3′) 37 TGTAAAACGACGGCCAGTAGGTCTCACACAGGGACCAT CAGGAAACAGCTATGACCCTATGGAGGCGAGAGGTGAG 38 TGTAAAACGACGGCCAGTACGTGATCCTTTGGTGGTTC CAGGAAACAGCTATGACCCAGGCAGAGAAGGAGCAGAA 39 TGTAAAACGACGGCCAGTATGACACTGCAGGGGACAG CAGGAAACAGCTATGACCAGGGATGCCATGTGCTCT 40 TGTAAAACGACGGCCAGTCTTTGGCCTGAGCTGGTC CAGGAAACAGCTATGACCATAAAAGTGGGCGGAGTTGG 41 TGTAAAACGACGGCCAGTGAGGGGTCAGTGGTGCTCTA CAGGAAACAGCTATGACCCACCTTCGGAGGAACCATAA 42 TGTAAAACGACGGCCAGTTCTTTGCTGCCTGTGTCATT CAGGAAACAGCTATGACCTCAGTGATGGGGCAGTGG 43 TGTAAAACGACGGCCAGTCCTGTTGGGCACAGCATAAT CAGGAAACAGCTATGACCGCCCTTGTACCAAGCACCTA 44 TGTAAAACGACGGCCAGTCTGTACCATTTTCATGGTTGC CAGGAAACAGCTATGACCGCATGGACACAGGAAGCATT 45 TGTAAAACGACGGCCAGTAGCATTTGTTCTGGCATGG CAGGAAACAGCTATGACCGGACAGCACACCTAATGAGC,Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
"Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2411was performed using the “gold standard” for mutation  detection, traditional dideoxy sequencing.",Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
"Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2412Two novel SNRNP200  mutations were also detected  in this study and not observed in any unaffected family  members, controls, or databases.",Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2413SIFT scores strongly suggest that this is the cause of RP in  this family.,Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2414p.Pro682Ser mutation further increase the likelihood that this  is a pathogenic mutation (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2415Conclusions:  Our analyses identified five SNRNP200  muta - tions in seven families with adRP.,Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2416and S.P.D.,Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
Molecular Vision  2013; 19:2407-2417 <http://www.molvis.org/molvis/v 19/2407 > © 2013 Molecular Vision  2417degeneration.,Non-OADS,/arxiv_data1/oa_pdf/f2/6f/mv-v19-2407.PMC3850977.pdf
"In this study, 4×103  cells/well CVECs in complete media were seeded in 96-well  culture plates and maintained for 48–72 h to reach 60%–80% Molecular Vision  2013; 19:2385-2392 <http://www.molvis.org/molvis/v 19/2385 > Received 1 January 2013 | Accepted 21 November 2013 | Published 23 November 2013© 2013 Molecular Vision 2385Resveratrol inhibits proliferation of hypoxic choroidal vascular  endothelial cells Sankarathi Balaiya, Ravi K. Murthy, Kakarla V .",Non-OADS,/arxiv_data1/oa_pdf/96/ea/mv-v19-2385.PMC3850978.pdf
Molecular Vision  2013; 19:2385-2392 <http://www.molvis.org/molvis/v 19/2385 > © 2013 Molecular Vision  2386confluence.,Non-OADS,/arxiv_data1/oa_pdf/96/ea/mv-v19-2385.PMC3850978.pdf
Molecular Vision  2013; 19:2385-2392 <http://www.molvis.org/molvis/v 19/2385 > © 2013 Molecular Vision  2387post hoc Tukey test.,Non-OADS,/arxiv_data1/oa_pdf/96/ea/mv-v19-2385.PMC3850978.pdf
Molecular Vision  2013; 19:2385-2392 <http://www.molvis.org/molvis/v 19/2385 > © 2013 Molecular Vision  2388SAPK/JNK (0.097 ODU) in a dose-dependent manner and  were observed to be statistically significant.,OADS,/arxiv_data1/oa_pdf/96/ea/mv-v19-2385.PMC3850978.pdf
Molecular Vision  2013; 19:2385-2392 <http://www.molvis.org/molvis/v 19/2385 > © 2013 Molecular Vision  2389optimal hypoxic response in CVECs at 200 µM concentration  [12].,Non-OADS,/arxiv_data1/oa_pdf/96/ea/mv-v19-2385.PMC3850978.pdf
Molecular Vision  2013; 19:2385-2392 <http://www.molvis.org/molvis/v 19/2385 > © 2013 Molecular Vision  2390point to observe the maximal inhibitory effect of resveratrol  in CVECs.,Non-OADS,/arxiv_data1/oa_pdf/96/ea/mv-v19-2385.PMC3850978.pdf
Molecular Vision  2013; 19:2385-2392 <http://www.molvis.org/molvis/v 19/2385 > © 2013 Molecular Vision  2391upregulation of Bax expression and activation of caspase-9  in U251 glioma cells [ 37].,Non-OADS,/arxiv_data1/oa_pdf/96/ea/mv-v19-2385.PMC3850978.pdf
Molecular Vision  2013; 19:2385-2392 <http://www.molvis.org/molvis/v 19/2385 > © 2013 Molecular Vision  239222.,Non-OADS,/arxiv_data1/oa_pdf/96/ea/mv-v19-2385.PMC3850978.pdf
"Here the initial  analysis of the changes in the specimen dimensions and pres - ervation of internal cellular structure are reported.Molecular Vision 2013; 19:2352-2359 <http://www.molvis.org/molvis/v 19/2352 > Received 2 September 2013 | Accepted 19 November 2013 | Published 21 November 2013© 2013 Molecular Vision 2352Simple fixation and storage protocol for preserving the internal  structure of intact human donor lenses and extracted human nuclear cataract specimens Ashik Mohamed,1 Kurt O. Gilliland,2 Sangeetha Metlapally,2 Sönke Johnsen,3 M. Joseph Costello2 1Prof.",Non-OADS,/arxiv_data1/oa_pdf/44/7d/mv-v19-2352.PMC3850983.pdf
"Molecular Vision 2013; 19:2352-2359 <http://www.molvis.org/molvis/v 19/2352 > © 2013 Molecular Vision  2353METHODS Specimens:  Cataractous lens nuclei (n=19, ages 12 to 74 years)  were obtained, within 2 h of extracapsular cataract extrac - tion or small incision cataract surgery, from the operating  suites at L V Prasad Eye Institute (LVPEI), Hyderabad, India.",Non-OADS,/arxiv_data1/oa_pdf/44/7d/mv-v19-2352.PMC3850983.pdf
Molecular Vision 2013; 19:2352-2359 <http://www.molvis.org/molvis/v 19/2352 > © 2013 Molecular Vision  2354Figure 4 shows high-magnification images of fiber  cell interfaces from fetal and embryonic regions of nuclear  cataracts.,Non-OADS,/arxiv_data1/oa_pdf/44/7d/mv-v19-2352.PMC3850983.pdf
Molecular Vision 2013; 19:2352-2359 <http://www.molvis.org/molvis/v 19/2352 > © 2013 Molecular Vision  2355immediately fixed from fresh lenses [ 17].,Non-OADS,/arxiv_data1/oa_pdf/44/7d/mv-v19-2352.PMC3850983.pdf
"Molecular Vision 2013; 19:2352-2359 <http://www.molvis.org/molvis/v 19/2352 > © 2013 Molecular Vision  23566E,F) between elongating fiber cells.",Non-OADS,/arxiv_data1/oa_pdf/44/7d/mv-v19-2352.PMC3850983.pdf
"Molecular Vision 2013; 19:2352-2359 <http://www.molvis.org/molvis/v 19/2352 > © 2013 Molecular Vision  2357formalin followed by long fixation in glutaraldehyde [ 5], and  the TEM studies used the immediate fixation of Vibratome  sections from fresh lenses in a glutaraldehyde/paraformalde - hyde mixture [ 22,23].",Non-OADS,/arxiv_data1/oa_pdf/44/7d/mv-v19-2352.PMC3850983.pdf
Molecular Vision 2013; 19:2352-2359 <http://www.molvis.org/molvis/v 19/2352 > © 2013 Molecular Vision  2358provide preservation comparable to Vibratome sectioning of  fresh lenses.,Non-OADS,/arxiv_data1/oa_pdf/44/7d/mv-v19-2352.PMC3850983.pdf
Molecular Vision 2013; 19:2352-2359 <http://www.molvis.org/molvis/v 19/2352 > © 2013 Molecular Vision  23597.,Non-OADS,/arxiv_data1/oa_pdf/44/7d/mv-v19-2352.PMC3850983.pdf
http://dx.doi.org/10.1016/j.fob.2013.11.002,OADS,/arxiv_data1/oa_pdf/bd/0d/main.PMC3851183.pdf
http://dx.doi.org/10.1016/j.fob.2013.11.001,OADS,/arxiv_data1/oa_pdf/2e/74/main.PMC3851184.pdf
"Beck and r eichert are Associate Editor and Editor-in-Chief, respectively, of mAbs Correspondence to: Alain Beck and Janice M. Reichert; Email: alain.beck@pierre-fabre.com and reichert.biotechconsulting@gmail.com Submitted: 07/23/13; Accepted: 07/23/13http://dx.doi.org/10.4161/mabs.25864studies is estimated to be complete by the  end of 2013; thus, marketing applications for more biosimilar antibodies may be submitted in 2014.",Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
MAbs 2013; 5:339-57; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Nat Biotechnol 2011; 29:690-3;  PMID:21822237; http://dx.doi.org/10.1038/nbt.1936 3.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
BioDrugs 2013;  PMID:23649935; http://dx.doi.org/10.1007/s40259-013-0036-3 4.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Nat Rev Immunol 2010; 10:345-52;  PMID:20414207; http://dx.doi.org/10.1038/nri2747 5.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
MAbs 2011; 3:107- 10; PMID:21285536; http://dx.doi.org/10.4161/ mabs.3.2.14785 6.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Anal Chem  2012; 84:4637-46; PMID:22510259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
J Am Soc Mass Spectrom  2009; 20:2021-33; PMID:19744865; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Nat Biotechnol  2011; 29:310-2; PMID:21478841; http://dx.doi.org/10.1038/nbt.1839 28.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
MAbs 2011; 3:505-12; PMID:22123057;  http://dx.doi.org/10.4161/mabs.3.6.18090 29.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Methods Mol Biol  2013; 988:93-113; PMID:23475716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Anal Chem 2012; 84:9655- 62; PMID:23004563; http://dx.doi.org/10.1021/ac3023372 31.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Expert Rev Clin Pharmacol 2012; 5:597- 9; PMID:23234317; http://dx.doi.org/10.1586/ecp.12.60 32.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Clin Pharmacol Ther  2012; 91:405-17; PMID:22318617; http://dx.doi.org/10.1038/clpt.2011.343 33.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
MAbs 2011; 3:209- 17; PMID:21441787; http://dx.doi.org/10.4161/mabs.3.2.1500518.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
MAbs 2013; 5:479- 90; PMID:23563524; http://dx.doi.org/10.4161/ mabs.23995 20.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
J Pharm Biomed Anal 2013; 80:126-35; PMID:23563225; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
T rends Analyt Chem 2013; 48:81-95; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
MAbs 2013; 5:699-710; http://dx.doi.org/10.4161/ mabs.25423 24.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
GaBI J 2013; 2:26-9;  http://dx.doi.org/10.5639/gabij.2013.0201.008 25.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Clin Pharmacol  Ther 2013; 93:315-7; PMID:23443756; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Nat Biotechnol 2008; 26:985- 90; PMID:18779806; http://dx.doi.org/10.1038/ nbt0908-985 9.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Blood 2012; 120:5111-7; PMID:23093622;  http://dx.doi.org/10.1182/blood-2012-04-425744 10.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
MAbs 2009; 1:394- 416; PMID:20065643; http://dx.doi.org/10.4161/ mabs.1.5.9630 11.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
MAbs 2011; 3:415-6; PMID:21785279; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Nat Biotechnol  2012; 30:1179-85; PMID:23222783; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
J Pharm Biomed Anal 2012; 69:185-95; PMID:22633839;  http://dx.doi.org/10.1016/j.jpba.2012.04.037 16.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
Anal Chem  2013; 85:715-36; PMID:23134362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/bc/mabs-5-621.PMC3851211.pdf
"This long manufacturing  history has allowed Pfizer to develop a Characterization and comparison of commercially  available TNF receptor 2-Fc fusion protein  products Letter to the Editor Brian Hassett, Scott McMillen* and Brian Fitzpatrick Pfizer Biotech; Dublin, Ireland *Correspondence to: Scott McMillen; Email: Scott.Mcmillen@pfizer.com Submitted: 07/19/13; Accepted: 07/19/13 http://dx.doi.org/10.4161/mabs.25817comprehensive, detailed, and extensive set  of product quality data to ensure a consis - tent safety and efficacy profile for Enbrel®.",Non-OADS,/arxiv_data1/oa_pdf/bf/50/mabs-5-624.PMC3851212.pdf
Curr Med Res Opin 2012; 28:1053-8;  PMID:22519391; http://dx.doi.org/10.1185/030079 95.2012.686902 3.,Non-OADS,/arxiv_data1/oa_pdf/bf/50/mabs-5-624.PMC3851212.pdf
Available from: http://www.gene.com/about-us/ views-on-public-policy/biosimilars.,Non-OADS,/arxiv_data1/oa_pdf/bf/50/mabs-5-624.PMC3851212.pdf
"A satellite symposium to commemorate this event was held on the day before; a report of this symposium is also  *Correspondence to: Hervé Watier; Email: watier@med.univ-tours.fr Submitted: 06/06/13; Accepted: 06/06/13http://dx.doi.org/10.4161/mabs.25300the therapeutic Antibodies and infectious Diseases  international congress was held in tours, France on november  20–22, 2012. the first session was devoted to the development  of antibodies directed against bacterial toxins or viruses that  could be used in a potential bioterrorist threat situation.",Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Immunity 1999; 10:431-8; PMID:10229186;  http://dx.doi.org/10.1016/S1074-7613(00)80043-6 28.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Nature 2012; 492:118-22; PMID:23103874;  http://dx.doi.org/10.1038/nature11604 29.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Lancet Infect Dis 2012; 12:397-407; PMID:22541629; http://dx.doi.org/10.1016/S1473- 3099(11)70340-1 31.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Vaccine  2008; 26:5922-7; PMID:18804136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Hepatology  2013; 57:492-504; PMID:23081796; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Hepatology 2010; 51:1144-57; PMID:20069648;  http://dx.doi.org/10.1002/hep.23445 36.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
"Gastroenterology 2010;  139:953-64, e1-4; PMID:20685314; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Biotechnol Bioeng 2011; 108:2171- 81; PMID:21495017; http://dx.doi.org/10.1002/ bit.23166 38.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Clin Infect Dis 2012; 54:1588-94; PMID:22460976;  http://dx.doi.org/10.1093/cid/cis255 39.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
J  Infect Dis 2012; 205:1709-18; PMID:22448004;  http://dx.doi.org/10.1093/infdis/jis254 40.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
J Antimicrob Chemother 2011; 66:1110-6;  PMID:21398296; http://dx.doi.org/10.1093/jac/ dkr046 15.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Blood 2009; 113:3716-25; PMID:19018092; http://dx.doi.org/10.1182/ blood-2008-09-179754 16.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Blood 2012; 119:5640-9; PMID:22535666; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Blood 2012; 119:2533-44;  PMID:22138510; http://dx.doi.org/10.1182/blood- 2011-07-367334 18.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Blood 2013; 121:1563-73; PMID:23293080;  http://dx.doi.org/10.1182/blood-2012-07-442541 19.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Virol J 2009; 6:224;  PMID:20025741; http://dx.doi.org/10.1186/1743- 422X-6-224 20.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Eur J Immunol 2012; 42:863- 9; PMID:22531913; http://dx.doi.org/10.1002/ eji.201041225 22.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
PLoS Pathog 2010; 6:e1000948; PMID:20548955;  http://dx.doi.org/10.1371/journal.ppat.1000948 23.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
J Virol  2010; 84:10169-81; PMID:20610721; http://dx.doi.org/10.1128/JVI.00568-10 24.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Science 2009; 326:285-9; PMID:19729618;  http://dx.doi.org/10.1126/science.1178746 25.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Nature  2011; 477:466-70; PMID:21849977; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Available  at: http://taid.fr/?lang=en.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Available  at: http://mabimprove.univ-tours.fr/?lang=en.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Available at: http://www.infectiologie-regioncentre.fr/ Presentation/Le-cluster-de-recherche-en-infectiologie- de-la-region-Centre.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Antimicrob Agents  Chemother 2005; 49:3414-20; PMID:16048955;  http://dx.doi.org/10.1128/AAC.49.8.3414-3420.2005 5.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
J Mol Biol 2008; 378:1094- 103; PMID:18423488; http://dx.doi.org/10.1016/j.jmb.2008.03.045 6.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Infect  Immun 2001; 69:2390-5; PMID:11254598; http://dx.doi.org/10.1128/IAI.69.4.2390-2395.2001 8.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
PLoS  One 2012; 7:e41157; PMID:22815951; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
PLoS Pathog  2009; 5:e1000642; PMID:19888339; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Sci T ransl Med 2011;  3:ra103; PMID:22013123; http://dx.doi.org/10.1126/ scitranslmed.3002901 11.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Antimicrob Agents  Chemother 2010; 54:2338-44; PMID:20308370;  http://dx.doi.org/10.1128/AAC.01142-09,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
N Engl J Med  2005; 353:375-81; PMID:15947078; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Neurology 2011; 76:1697-704; PMID:21576685; http://dx.doi.org/10.1212/WNL.0b013e31821a446b 52.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Ann Neurol  2011; 70:742-50; PMID:22162056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Immunol Rev  2003; 196:85-108; PMID:14617200; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Am J T ransplant 2010; 10:535-46;  PMID:20415897; http://dx.doi.org/10.1111/j.1600- 6143.2009.03005.x46.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Blood  2010; 116:335-42; PMID:20308604; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Ann Rheum Dis 2010; 69:522-8; PMID:19854715;  http://dx.doi.org/10.1136/ard.2009.118935 48.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Ann Rheum Dis 2011; 70:616-23; PMID:21177290;  http://dx.doi.org/10.1136/ard.2010.137422 49.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Gastroenterology 2003; 124:1774-85;  PMID:12806611; http://dx.doi.org/10.1016/S0016-5085(03)00382-241.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Crit Care Med 2012; 40:2320- 6; PMID:22622405; http://dx.doi.org/10.1097/ CCM.0b013e31825334f6 42.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
BMJ 2012; 345:e4565; PMID:22815429; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Ann Rheum Dis 2008; 67:283- 7; PMID:17644544; http://dx.doi.org/10.1136/ ard.2006.065565 45.,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
Autoimmun Rev 2011; 10:714-9;  PMID:21570494; http://dx.doi.org/10.1016/j.aut- rev.2011.04.033,OADS,/arxiv_data1/oa_pdf/9c/b1/mabs-5-626.PMC3851213.pdf
"Marc de Ferrière le Vayer  (Université François-Rabelais de Tours, France)  then explained that this symposium was co-organized by the laboratory LÉA (Université François-Rabelais de Tours) 1 and the  Laboratory of Excellence (LabEx) MAbImprove coordinated by Hervé Watier  (Université François-Rabelais de Tours) 2 to close  *Correspondence to: Hervé Watier; Email: watier@med.univ-tours.fr Submitted: 06/25/13; Accepted: 06/25/13http://dx.doi.org/10.4161/mabs.25613Held on n ovember 19, 2012 in Saint-Cyr-sur-Loire, France, the  symposium “From Bretonneau to therapeutic antibodies,  from specificity to specific remedies” focused on the historical  development of antibodies as therapeutics, with an emphasis  on the seminal work of the French physician pierre-Fidèle  Bretonneau (1778–1862).",Non-OADS,/arxiv_data1/oa_pdf/24/3a/mabs-5-633.PMC3851214.pdf
Available  at: http://mabimprove.univ-tours.fr/?lang=en 3.,Non-OADS,/arxiv_data1/oa_pdf/24/3a/mabs-5-633.PMC3851214.pdf
Available  at: http://www.orhibio.org/joomla/index.php 4.,Non-OADS,/arxiv_data1/oa_pdf/24/3a/mabs-5-633.PMC3851214.pdf
Available at: http://taid.fr/?lang=eng 6.,Non-OADS,/arxiv_data1/oa_pdf/24/3a/mabs-5-633.PMC3851214.pdf
Dtsch Med Wochenschr 1890; 16:1113-45;  http://dx.doi.org/10.1055/s-0029-1207589 12.,Non-OADS,/arxiv_data1/oa_pdf/24/3a/mabs-5-633.PMC3851214.pdf
Int J Epidemiol 2011; PMID:22253300;  http://dx.doi.org/10.1093/ije/dyr162,OADS,/arxiv_data1/oa_pdf/24/3a/mabs-5-633.PMC3851214.pdf
"mAbs 5:4, 638–640; September/October 2013; © 2013 Landes Bioscience BOOK REVIEW 638 mAbs  Volume 5 Issue 5Keywords:  O-linked glycans, N-linked  glycans, orthogonal methods, epitope  characterization, immune complexes,  bio-assays Submitted: 07/03/13 Accepted: 07/03/13 http://dx.doi.org/10.4161/mabs.25631 Correspondence to: Roy Jefferis;   Email: r.jefferis@bham.ac.ukThe glycoform profile of a glycopro - tein is non-templated, i.e., is not  encoded within the genome or otherwise  predetermined; however, it is estimated  that ~50% of human genes having an  open reading frame encode a -N-X-S/T-  amino acid sequence, where X repre - sents any amino acid other than proline,  that comprises a potential site (sequon)  for N-linked glycosylation of the trans - lated protein.",Non-OADS,/arxiv_data1/oa_pdf/04/60/mabs-5-638.PMC3851215.pdf
"www.landesbioscience.com mAbs 699mAbs 5:5, 699–710; September/October 2013; © 2013 Landes Bioscience REPORT REPORT *Correspondence to: Daniel Ayoub, Wolfgang Jabs and Alain Beck; Email: dayoub@unistra.fr, wolfgang.jabs@bdal.de and alain.beck@pierre-fabre.com Submitted: 05/08/13; Revised: 06/13/13; Accepted: 06/15/13 http://dx.doi.org/10.4161/mabs.25423Introduction With more than 40 products currently approved and ~30 mol - ecules investigated in advanced clinical trials, monoclonal anti - bodies (mAbs) and derivatives constitute the most important  and the fastest growing class of human therapeutics.1 These large  proteins can be used for a variety of indications such as inflam - matory diseases and cancer.",Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Nat Rev Immunol 2010; 10:345-52;  PMID:20414207; http://dx.doi.org/10.1038/nri2747 2.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
MAbs 2011; 3:107- 10; PMID:21285536; http://dx.doi.org/10.4161/ mabs.3.2.14785 3.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Anal Chem  2012; 84:4637-46; PMID:22510259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
MAbs 2010; 2:613- 24; PMID:20818176; http://dx.doi.org/10.4161/ mabs.2.6.133335.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
MAbs 2011; 3:209- 17; PMID:21441787; http://dx.doi.org/10.4161/ mabs.3.2.15005 6.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
J Pharm  Biomed Anal 2012; 69:185-95; PMID:22633839;  http://dx.doi.org/10.1016/j.jpba.2012.04.037 7.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Nat Biotechnol 2008; 26:985- 90; PMID:18779806; http://dx.doi.org/10.1038/ nbt0908-985 8.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Blood 2012; 120:5111-7; PMID:23093622;  http://dx.doi.org/10.1182/blood-2012-04-425744 9.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
T rends Analyt Chem 2013; In press; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
MAbs 2010; 2:500- 7; PMID:20671426; http://dx.doi.org/10.4161/ mabs.2.5.12897 13.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Nat  Rev Drug Discov 2011; 10:101-11; PMID:21283105;  http://dx.doi.org/10.1038/nrd3365,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Pharm Res  2010; 27:1512-29; PMID:20422267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
J Chromatogr B Analyt Technol  Biomed Life Sci 2007; 849:115-28; PMID:17049937;  http://dx.doi.org/10.1016/j.jchromb.2006.09.041 32.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
J  Am Soc Mass Spectrom 1995; 6:229-33; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Anal Chem 2011; 83:8919- 27; PMID:22017162; http://dx.doi.org/10.1021/ ac201293m 35.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Nucleic Acids Res 2011; 39(Database  issue):D373-6; PMID:21045056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Anal Biochem 2007; 364:8- 18; PMID:17362871; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Mass  Spectrom Rev 2009; 28:147-76; PMID:18720354;  http://dx.doi.org/10.1002/mas.20190 25.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Anal  Chem 1993; 65:496-7; http://dx.doi.org/10.1021/ ac00052a030 27.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
J Am Soc Mass  Spectrom 2001; 12:1044-9; http://dx.doi.org/10.1016/ S1044-0305(01)00289-6 28.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Anal Chem  2007; 79:8678-85; PMID:17939742; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Anal Chem 2010; 82:3283-92; PMID:20329751;  http://dx.doi.org/10.1021/ac100051514.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Ann N Y Acad Sci 2012; 1253:170- 80; PMID:22288459; http://dx.doi.org/10.1111/ j.1749-6632.2011.06305.x 15.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Anal Chem  2013; 85:715-36; PMID:23134362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Cancer  Cell 2005; 7:301-11; PMID:15837620; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Anal Chem  2003; 75:5817-24; PMID:14588022; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Mass Spectrom Rev 2007; 26:672- 82; PMID:17492750; http://dx.doi.org/10.1002/ mas.20142 21.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
MAbs 2011; 3:505-12; PMID:22123057;  http://dx.doi.org/10.4161/mabs.3.6.18090 22.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
Methods Mol Biol  2013; 988:93-113; PMID:23475716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dd/mabs-5-699.PMC3851223.pdf
"www.landesbioscience.com mAbs 711mAbs 5:5, 711–722; September/October 2013; © 2013 Landes Bioscience RepOR t RepOR t *Correspondence to: Michael H. Xie and Surjit B. Dixit; Email: hxie@kbibiopharma.com and sdixit@zymeworks.com Submitted: 05/17/13; Revised: 06/18/13; Accepted: 06/20/13http://dx.doi.org/10.4161/mabs.25488Introduction Bispecific antibodies, which unlike conventional monoclonal  antibodies, can bind two different antigens and offer a novel therapeutic approach to the treatment of various malignant and autoimmune diseases.",Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
MAbs 2012; 4:182-97; PMID:22453100;  http://dx.doi.org/10.4161/mabs.4.2.19000 2.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
Nat Rev  Drug Discov 2011; 10:798-800; PMID:22037028; http://dx.doi.org/10.1038/nrd3581 3.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
BioDrugs 2010; 24:89-98; PMID:20199124; http://dx.doi.org/10.2165/11530960-000000000-00000 4.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
MAbs 2011; 3:338- 51; PMID:21697653; http://dx.doi.org/10.4161/ mabs.3.4.16615 5.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
Nat Rev Cancer 2001; 1:118-29; PMID:11905803; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
MAbs 2010; 2:129- 36; PMID:20190561; http://dx.doi.org/10.4161/ mabs.2.2.11221 7.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
MAbs  2009; 1:539-47; PMID:20073127; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
Nat Biotechnol 1998; 16:677-81; PMID:9661204; http://dx.doi.org/10.1038/nbt0798- 677 9.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
J Biol Chem 2010; 285:19637- 46; PMID:20400508; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
MAbs 2012; 4:653- 63; PMID:22925968; http://dx.doi.org/10.4161/ mabs.21379 11.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
Mass  Spectrom Rev 2009; 28:147-76; PMID:18720354;  http://dx.doi.org/10.1002/mas.20190 12.,OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
MAbs 2010; 2:379- 94; PMID:20458189; http://dx.doi.org/10.4161.,OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
J Biol Chem  2010; 285:20850-9; PMID:20444694; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
Anal Chem  2009; 81:5699-708; PMID:19518054; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
Anal Biochem 2007; 360:75- 83; PMID:17113563; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
MAbs 2012; 4:24-44; PMID:22327428;  http://dx.doi.org/10.4161/mabs.4.1.18748 20.,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
Biotechnol Bioeng 2008; 100:1132- 43; PMID:18553400; http://dx.doi.org/10.1002/ bit.21855,Non-OADS,/arxiv_data1/oa_pdf/58/09/mabs-5-711.PMC3851224.pdf
"mAbs 5:5, 736–747; September/October 2013; © 2013 Landes Bioscience RepOR t 736 mAbs Volume 5 Issue 5*Correspondence to: Hélène Haegel; Email: haegel@transgene.fr Submitted: 04/24/13; Revised: 07/02/13; Accepted: 07/03/13http://dx.doi.org/10.4161/mabs.25743Introduction CD115 (macrophage colony-stimulating factor receptor, or CSF-1  receptor) is the sole cell-surface receptor identified for CSF-1, the predominant growth factor regulating the survival, growth and differentiation of myeloid lineage cells comprising monocytes, macrophages, DCs and osteoclasts.",Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
"MAbs H27K15, 1.2SM and rituximab ( http://www.drugbank.ca/drugs/DB00073)  were produced in CHO cells and purified as described in the Supplemental Methods .",Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Nat Rev Immunol 2007; 7:292-304; PMID:17380158;  http://dx.doi.org/10.1038/nri2062 3.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Blood 2002; 99:111-20;  PMID:11756160; http://dx.doi.org/10.1182/blood.V99.1.111 4.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
T rends  Immunol 2013; 34:81-9; PMID:23000011; http://dx.doi.org/10.1016/j.it.2012.08.006 5.,OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Future Oncol 2009; 5:1429- 40; PMID:19903070; http://dx.doi.org/10.2217/fon.09.103 9.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Gynecol Oncol 2008; 110:445-51; PMID:18565574;  http://dx.doi.org/10.1016/j.ygyno.2008.04.038 10.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Breast Cancer Res T reat 1996; 39:275- 83; PMID:8877007; http://dx.doi.org/10.1007/ BF01806155 11.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Nat Immunol 2000; 1:510-4;  PMID:11101873; http://dx.doi.org/10.1038/8276313.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
J Exp Med 2001; 193:727- 40; PMID:11257139; http://dx.doi.org/10.1084/ jem.193.6.727 15.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Eur J Cancer  2006; 42:717-27; PMID:16520032; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Cancer Res  2006; 66:11238-46; PMID:17114237; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
PLoS One 2009; 4:e6562; PMID:19668347; http://dx.doi.org/10.1371/journal.pone.0006562 19.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Cancer Res 2004; 64:7022-9;  PMID:15466195; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1449 20.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Eur J Immunol 1998; 28:2498-507;  PMID:9710227; http://dx.doi.org/10.1002/ (SICI)1521-4141(199808)28:08<2498::AID- IMMU2498>3.0.CO;2-Q 21.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Blood 2007; 110:4319-30; PMID:17848619; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
J Leukoc Biol 2006; 79:285- 93; PMID:16330536; http://dx.doi.org/10.1189/ jlb.0105015 24.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Nat Rev Immunol  2008; 8:533-44; PMID:18551128; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Cancer Res  2009; 69:9395-403; PMID:19951991; http://dx.doi.org/10.1158/0008-5472.CAN-09-2050 27.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Clin Cancer  Res 2009; 15:778-87; PMID:19188147; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
J Leukoc Biol  2009; 86:1065-73; PMID:19741157; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
J Immunol 2009; 182:4415-22;  PMID:19299742; http://dx.doi.org/10.4049/jimmu- nol.0713732 31.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Proc Natl Acad Sci U S A 2004; 101:4560-5; PMID:15070757; http://dx.doi.org/10.1073/ pnas.0400983101 32.,OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Semin  Cancer Biol 2012; 22:289-97; PMID:22349514;  http://dx.doi.org/10.1016/j.semcancer.2012.02.002,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
MAbs 2012; 4:291- 3; PMID:22531437; http://dx.doi.org/10.4161/ mabs.20100 52.,OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Nat Rev Drug Discov 2012; 11:311-31;  PMID:22460124; http://dx.doi.org/10.1038/nrd2909 54.,OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
J Immunol  2009; 183:2349-55; PMID:19635920; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Cytokine 2010; 52:215-20; PMID:20829061;  http://dx.doi.org/10.1016/j.cyto.2010.08.005 57.,OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Eur J Immunol 1987; 17:1453- 9; PMID:3500057; http://dx.doi.org/10.1002/ eji.183017101142.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
J Bone Miner Metab 2009; 27:105-9;  PMID:19018457; http://dx.doi.org/10.1007/s00774- 008-0002-1 43.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Int J Hematol 2002; 76:27- 34; PMID:12138892; http://dx.doi.org/10.1007/ BF02982715 44.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Arthritis Res  Ther 2010; 12:R32; PMID:20181277; http://dx.doi.org/10.1186/ar2940 45.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Proc Natl Acad Sci U S  A 1987; 84:6179-83; PMID:2819867; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Expert Rev Clin  Immunol 2009; 5:735-47; PMID:20477693; http://dx.doi.org/10.1586/eci.09.5733.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
J Exp Med 1999; 190:1741- 54; PMID:10601350; http://dx.doi.org/10.1084/ jem.190.12.1741 34.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
PLoS One 2011; 6:e21462; PMID:21738673;  http://dx.doi.org/10.1371/journal.pone.0021462 35.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Exp Cell Res  2009; 315:2442-52; PMID:19427849; http://dx.doi.org/10.1016/j.yexcr.2009.05.002 36.,OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Cell Death Differ  2010; 17:1917-27; PMID:20489731; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
Blood  2009; 114:3633-41; PMID:19721010; http://dx.doi.org/10.1182/blood-2009-03-208843 41.,Non-OADS,/arxiv_data1/oa_pdf/fb/c2/mabs-5-736.PMC3851226.pdf
"www.landesbioscience.com mAbs 787mAbs 5:5, 787–794; September/October 2013; © 2013 Landes Bioscience REPORT REPORT *Correspondence to: Alexandre Ambrogelly; Email: alexandre.ambrogelly@merck.com Submitted: 04/28/13; Revised: 05/31/13; Accepted: 06/03/13 http://dx.doi.org/10.4161/mabs.25269Introduction Development of a therapeutic protein is a long and costly process  that can take over a decade from discovery to commercialization.",Non-OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
MAbs 2010; 2:695-700; PMID:20930555;  http://dx.doi.org/10.4161/mabs.2.6.13603 2.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
Nat Biotechnol 2009; 27:26- 34; PMID:19131992; http://dx.doi.org/10.1038/ nbt0109-26 3.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
J Pharm Sci 2012; 101:895- 913; PMID:22083792; http://dx.doi.org/10.1002/ jps.228124.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
J Chromatogr A 2007; 1164:153-61;  PMID:17640657; http://dx.doi.org/10.1016/j.chro - ma.2007.06.063 5.,OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
Anal Biochem  1996; 236:56-62; PMID:8619496; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
http://www.ich.org/fileadmin/Public_Web_Site/ ICH_Products/Guidelines/Quality/Q1B/Step4/Q1B_ Guideline.pdf7.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
MAbs  2012; 4:578-85; PMID:22820257; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
J Biol Chem 2008;  283:16194-205; PMID:18339624; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/e7/mabs-5-787.PMC3851230.pdf
"www.landesbioscience.com mAbs 795mAbs 5:5, 795–800; September/October 2013; © 2013 Landes Bioscience RepOR t RepOR t *Correspondence to: Sanchayita Ghose; Email: Sanchayita.ghose@biogenidec.com Submitted: 05/21/13; Revised: 06/25/13; Accepted: 06/25/13http://dx.doi.org/10.4161/mabs.25552Introduction Hydrophobic interaction chromatography (HIC) occupies a  unique niche as a polishing step in many monoclonal antibody (mAb) purification processes.",Non-OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
T rends Biotechnol 2010; 28:253- 61; PMID:20304511; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
Curr Opin  Chem Eng 2011; 1:27-37; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
Bioprocess Biosyst Eng 2008; 31:261-75;  PMID:18205016; http://dx.doi.org/10.1007/s00449- 008-0200-14.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2007; 848:28- 39; PMID:17046339; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
Curr Pharm Biotechnol  2009; 10:427-33; PMID:19519419; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
J Chromatogr A 2011;  1218:1219-26; PMID:21255785; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
J Chromatogr 1984; 317:67-85;  PMID:6530455; http://dx.doi.org/10.1016/S0021- 9673(01)91648-6,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
MAbs 2010; 2:480-99; PMID:20647768;  http://dx.doi.org/10.4161/mabs.2.5.12645 10.,Non-OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
Biotechnol Bioeng 2009; 103:930-5; PMID:19382248;  http://dx.doi.org/10.1002/bit.22313 11.,Non-OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
Biotechnol J 2013; Apr  26. http://dx.doi.org/10.1002/biot.201300123.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
J Chromatogr A 2008; 1177:272- 81; PMID:17709111; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
Protein Expr Purif 2007; 54:110-6; PMID:17408966;  http://dx.doi.org/10.1016/j.pep.2007.02.010 17.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
J Chromatogr A 2007; 1154:81-6;  PMID:17449045; http://dx.doi.org/10.1016/j.chro- ma.2007.02.06118.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
J Chromatogr A 2012; 1221:57-70; PMID:22071423;  http://dx.doi.org/10.1016/j.chroma.2011.10.034 19.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
J Chromatogr A 2004; 1036:45-50;  PMID:15139412; http://dx.doi.org/10.1016/j.chro- ma.2004.02.009 20.,OADS,/arxiv_data1/oa_pdf/91/74/mabs-5-795.PMC3851231.pdf
reprints and permissions information is available online at http://www.nature.,Non-OADS,/arxiv_data1/oa_pdf/37/ab/41592_2013_Article_BFnmeth2714.PMC3851240.pdf
"To view a copy of   this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/37/ab/41592_2013_Article_BFnmeth2714.PMC3851240.pdf
"H. sapiens  RNA-seq data correspond to ENCODE 33 HepG2  whole-cell long poly(A)+ RNA CALTECH replicate 2, avail - able from http://www.encodeproject.org/.",OADS,/arxiv_data1/oa_pdf/37/ab/41592_2013_Article_BFnmeth2714.PMC3851240.pdf
All of the data used in this  study have been consolidated as a single experimental record in the ArrayExpress repository ( http://www.ebi.ac.uk/arrayexpress/)  under accession E-MTAB-1730.,OADS,/arxiv_data1/oa_pdf/37/ab/41592_2013_Article_BFnmeth2714.PMC3851240.pdf
Source code for the evaluations performed  in this study can be obtained from https://github.com/RGASP- consortium/.,Non-OADS,/arxiv_data1/oa_pdf/37/ab/41592_2013_Article_BFnmeth2714.PMC3851240.pdf
http://dx.doi.org/10.1016/j.fob.2013.11.004,OADS,/arxiv_data1/oa_pdf/85/13/main.PMC3851254.pdf
"This has caused the Swedish Orthopae-dic Society, in association with the patient insurance orga-nization LÖF, to take action in a national program covering all clinics with the aim of cutting down PJI by half (http://www.patientforsakring.se/PRISS.html).",Non-OADS,/arxiv_data1/oa_pdf/4f/71/ORT-84-507.PMC3851661.pdf
"After the meeting, the document was again edited and is  now available at http://www.msis-na.org/international-con-sensus/.",Non-OADS,/arxiv_data1/oa_pdf/4f/71/ORT-84-507.PMC3851661.pdf
Our advice to all orthopedic surgeons working with joint  implants is to start reading the over 300-page document that is available at http://www.msis-na.org/international-consensus/.,Non-OADS,/arxiv_data1/oa_pdf/4f/71/ORT-84-507.PMC3851661.pdf
Swedish Hip Arthroplasty Register: Annual report 2011 [http://www.shpr.se/ sv/default.aspx].,Non-OADS,/arxiv_data1/oa_pdf/4f/71/ORT-84-507.PMC3851661.pdf
"Swedish Knee Arthroplasty Register: Annual report 2013 Skane University  Hospital, Lund; 2013 [http://www.knee.se/].",Non-OADS,/arxiv_data1/oa_pdf/4f/71/ORT-84-507.PMC3851661.pdf
"Annual Report 2012. http://www.dmac.adelaide.edu.au/aoanjrr/docu- ments/aoanjrrreport_2012.pdf Biomet: M2a-Magnum large metal articulation: design rationale,2009.http:// www.biomet.com/campaign/trueAlternativeBearings/BO103400Magnum - DesignRationale.pdf Bosker B H, Ettema H B, Boomsma M F, Kollen B J, Maas M, Verheyen C  C P M. High incidence of pseudotumour formation after large-diameter metal-on-metal total hip replacement.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ORT-84-549.PMC3851668.pdf
http://www.suomenartro- plastiayhdistys.fi  Food and drug administration: Metal-on-metal hip implants.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/ORT-84-549.PMC3851668.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/ORT-84-549.PMC3851668.pdf
"http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/con079162.pdf  Mokka J, Mäkelä KT, Virolainen P, Remes V, Pulkkinen P, Eskelinen A.  Cementless total hip arthroplasty with large diameter metal-on-metal heads – short term survivorship of 8,059 hips from the Finnish Arthroplasty Reg-ister.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ORT-84-549.PMC3851668.pdf
Ethical Principles for Medical Research Involving Human Subjects http://www.wma.net/en/30publications/10policies/b3/.,Non-OADS,/arxiv_data1/oa_pdf/9f/ed/ORT-84-555.PMC3851669.pdf
US Department of Health and Human Services; 2008. http://www.nimh.nih.gov/health/ publications/attention-deﬁcit-hyperactivity-disorder/adhd_booklet_cl508.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c4/7b/40268_2013_Article_34.PMC3851698.pdf
http://www.nice.org.uk/nicemedia/ pdf/cg72niceguidelinev3.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/c4/7b/40268_2013_Article_34.PMC3851698.pdf
2009. http://www.sign.ac.,Non-OADS,/arxiv_data1/oa_pdf/c4/7b/40268_2013_Article_34.PMC3851698.pdf
Available at http://www.unaids.org/en/media/unaids/contentassets/ documents/epidemiology/ 2012/gr2012/20121120_UNAIDS_ Global_Report_2012_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/39/b3/11904_2013_Article_176.PMC3851699.pdf
2Corresponding author E-mail irmtraud.meyer@cantab.net Article and publication date are at http://www.rnajournal.org/cgi/doi/ 10.1261/rna.037390.112.,Non-OADS,/arxiv_data1/oa_pdf/8d/39/1461.PMC3851714.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported),as described at http://creativecommons.org/licenses/by-nc/3.0/.REVIEW RNA 19:1461 –1473; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1461",Non-OADS,/arxiv_data1/oa_pdf/8d/39/1461.PMC3851714.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039610.113.© 2013 Hudson et al.,OADS,/arxiv_data1/oa_pdf/d3/6b/1474.PMC3851715.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/1474.PMC3851715.pdf
"After 12 months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d3/6b/1474.PMC3851715.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.037945.112.© 2013 Nolze et al.,OADS,/arxiv_data1/oa_pdf/44/4f/1483.PMC3851716.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/44/4f/1483.PMC3851716.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/44/4f/1483.PMC3851716.pdf
2006) (http://bioinformatics.ramapo.edu/QGRS/analyze.php).,OADS,/arxiv_data1/oa_pdf/44/4f/1483.PMC3851716.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039073.113.© 2013 Contreras et al.,OADS,/arxiv_data1/oa_pdf/dd/84/1497.PMC3851717.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/dd/84/1497.PMC3851717.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/dd/84/1497.PMC3851717.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038919.113.© 2013 Garcia et al.,OADS,/arxiv_data1/oa_pdf/ea/61/1510.PMC3851718.pdf
"After 12 months, it is available under aCreative Commons License (Attribution-NonCommercial 3.0 Unported), asdescribed at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ea/61/1510.PMC3851718.pdf
"We used RStudio (http://www.rstudio.org/) to inter- face with the R statistical suite (http://www.r-project.org), and the R-based cummeRbund package (http://compbio.mit.edu/cummeRbund/) was used as a graphical interface with the Cufflink ’s Cuffdiff output.",OADS,/arxiv_data1/oa_pdf/ea/61/1510.PMC3851718.pdf
(2011) (http://www.modencode.org/) from L2 to L3 puff stage7–9 were downloaded from the NCBI Sequence Read Archive(SRA) and converted to fastq format with the SRA toolkit.,OADS,/arxiv_data1/oa_pdf/ea/61/1510.PMC3851718.pdf
The heatmap was generated with the Heatplus R package from biocon-ductor (http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/ea/61/1510.PMC3851718.pdf
2002) and are acces- sible through GEO Series accession number GSE49587 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49587).,OADS,/arxiv_data1/oa_pdf/ea/61/1510.PMC3851718.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040709.113.,OADS,/arxiv_data1/oa_pdf/0a/dd/1537.PMC3851721.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), asdescribed at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0a/dd/1537.PMC3851721.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038414.113.© 2013 Chavali et al.,OADS,/arxiv_data1/oa_pdf/b8/6e/1552.PMC3851722.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b8/6e/1552.PMC3851722.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/b8/6e/1552.PMC3851722.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038612.113.© 2013 Smekalova et al.,OADS,/arxiv_data1/oa_pdf/2c/2b/1563.PMC3851723.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/2c/2b/1563.PMC3851723.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041665.113.© 2013 Zhang et al.,OADS,/arxiv_data1/oa_pdf/e4/76/1575.PMC3851724.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e4/76/1575.PMC3851724.pdf
"After 12 months, it isavailable under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/e4/76/1575.PMC3851724.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040790.113.© 2013 Martinez et al.,OADS,/arxiv_data1/oa_pdf/06/dc/1583.PMC3851725.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/06/dc/1583.PMC3851725.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/06/dc/1583.PMC3851725.pdf
http://www.actelion.com .,Non-OADS,/arxiv_data1/oa_pdf/41/21/40268_2013_Article_31.PMC3851755.pdf
http://www.actelion.com .,Non-OADS,/arxiv_data1/oa_pdf/41/21/40268_2013_Article_31.PMC3851755.pdf
Availability: CaBLASTP is available under the GNU Public License at http://cablastp.csail.mit.edu/ Contact: bab@mit.edu 1 INTRODUCTION Identification of homologous sequences is of fundamental im- portance in computational biology.,OADS,/arxiv_data1/oa_pdf/90/27/btt214.PMC3851851.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/27/btt214.PMC3851851.pdf
"http://golang.org/ (3 June 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/90/27/btt214.PMC3851851.pdf
"http://github.org/kortschak/biogo (3 June 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/90/27/btt214.PMC3851851.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/d8/srep03420.PMC3851880.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3420 | DOI: 10.1038/srep03420 9",Non-OADS,/arxiv_data1/oa_pdf/fc/d8/srep03420.PMC3851880.pdf
"Thehuman disease gene set was generated on May 2012 from the Genetic Association Database (GAD, http://geneticassociationdb.nih.gov/), which includes 2831 disease genes corresponding to 18 disease classes.",OADS,/arxiv_data1/oa_pdf/9d/ef/srep03426.PMC3851881.pdf
"The human PPI network (http://www.hprd.org)57, which involves 9028 proteins with 35865 high-confidence interactions, is then used to construct DIN.",OADS,/arxiv_data1/oa_pdf/9d/ef/srep03426.PMC3851881.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9d/ef/srep03426.PMC3851881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3426 | DOI: 10.1038/srep03426 11",Non-OADS,/arxiv_data1/oa_pdf/9d/ef/srep03426.PMC3851881.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/c3/srep03422.PMC3851883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3422 | DOI: 10.1038/srep03422 5",Non-OADS,/arxiv_data1/oa_pdf/ad/c3/srep03422.PMC3851883.pdf
wrote the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/55/srep03432.PMC3851884.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3432 | DOI: 10.1038/srep03432 10",Non-OADS,/arxiv_data1/oa_pdf/57/55/srep03432.PMC3851884.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/The microcirculation after SAH L Østergaard et al 1837 &2013 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2013), 1825 – 1837",Non-OADS,/arxiv_data1/oa_pdf/3e/c5/jcbfm2013173a.PMC3851911.pdf
Additional information Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/srep03425.PMC3851917.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3425 | DOI: 10.1038/srep03425 6",Non-OADS,/arxiv_data1/oa_pdf/d3/6b/srep03425.PMC3851917.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3419 | DOI: 10.1038/srep03419 6",Non-OADS,/arxiv_data1/oa_pdf/36/30/srep03419.PMC3851919.pdf
(date of access: 12/15/2012; available website link: http://ntrs.nasa.gov/archive/nasa/casi.ntrs.nasa.gov/19710020300_ 1971020300.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/6b/srep03428.PMC3851920.pdf
Additional information Reprints and permissions information is available online at http://npg.nature.com/ reprintsandpermissions.,Non-OADS,/arxiv_data1/oa_pdf/47/6b/srep03428.PMC3851920.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/47/6b/srep03428.PMC3851920.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3428 | DOI: 10.1038/srep03428 8",Non-OADS,/arxiv_data1/oa_pdf/47/6b/srep03428.PMC3851920.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial.,Non-OADS,/arxiv_data1/oa_pdf/8e/c6/srep03434.PMC3852139.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3434 | DOI: 10.1038/srep03434 6",Non-OADS,/arxiv_data1/oa_pdf/8e/c6/srep03434.PMC3852139.pdf
"All procedures for probe preparation, hybridization, washing, staining, and scanning of the GeneChip Htomato arrays, as well as data collection, were performed by the Affymetrix custom service (CapitalBio, Beijing, China) according to standard protocols (http://www.affymetrix.com/support/technical/ manual/expression-manual.affx).",OADS,/arxiv_data1/oa_pdf/d8/5c/srep03433.PMC3852141.pdf
The peptide mass fingerprints were searched against the NCBInr (http://www.ncbi.nlm.nih.gov/) protein databases using MASCOT Version 2.1.,OADS,/arxiv_data1/oa_pdf/d8/5c/srep03433.PMC3852141.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d8/5c/srep03433.PMC3852141.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3433 | DOI: 10.1038/srep03433 8",Non-OADS,/arxiv_data1/oa_pdf/d8/5c/srep03433.PMC3852141.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5c/37/srep03430.PMC3852150.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3430 | DOI: 10.1038/srep03430 8",Non-OADS,/arxiv_data1/oa_pdf/5c/37/srep03430.PMC3852150.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Figure 4 |Retention with respect to repeated learning15.The blue lines and green lines are the fresh stage and working stage of learning, respectively.",Non-OADS,/arxiv_data1/oa_pdf/a0/b6/srep03431.PMC3852151.pdf
The Depart- ment of Clinical Pharmacology is participating in the World Wide Antimalarial Resistance Network quality control and  assurance proficiency testing program (http://www.wwarn.,Non-OADS,/arxiv_data1/oa_pdf/6c/cd/psp201359a.PMC3852159.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/6c/cd/psp201359a.PMC3852159.pdf
<http://www.page-meeting.org/?abstract=2859> (2013).,Non-OADS,/arxiv_data1/oa_pdf/06/57/psp201361a.PMC3852160.pdf
<http://www.asco.org> (2005).,Non-OADS,/arxiv_data1/oa_pdf/06/57/psp201361a.PMC3852160.pdf
"To view a copy of   this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/06/57/psp201361a.PMC3852160.pdf
"Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Role of EPHX2 gene variants in AN AA Scott-Van Zeeland et al 732 Molecular Psychiatry (2014), 724 – 732 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/70/fa/mp201391a.PMC3852189.pdf
"http://informahealthcare.com/bij ISSN: 0269-9052 (print), 1362-301X (electronic) Brain Inj, 2013; 27(13–14): 1500–1507 !2013 Informa UK Ltd. DOI: 10.3109/02699052.2013.830332 REVIEW The clinical and cost-benefits of investing in neurobehavioural rehabilitation: A multi-centre study Michael Oddy, & Sara da Silva Ramos Brain Injury Rehabilitation Trust, Horsham, West Sussex, UK Abstract Primary objective : The aim of this study was to investigate the cost-benefits of a residential post- acute neurobehavioural rehabilitation programme and its effects on care needs and socialparticipation of adults with acquired brain injury.",Non-OADS,/arxiv_data1/oa_pdf/55/80/BIJ-27-1500.PMC3852231.pdf
[cited 2012 Dec 4]; Available from http://www.ons.gov.uk/ons/rel/lifetables/period- and-cohort-life- expectancy-tables/ 2010-based/p-and-c-le.html 29.,OADS,/arxiv_data1/oa_pdf/55/80/BIJ-27-1500.PMC3852231.pdf
"London, UK: Bank of England 2012 [cited 2013 Jul 3] Availablefrom: http://www.bankofengland.co.uk/publications/Documents/inflationreport/ir12feb.pdf.",Non-OADS,/arxiv_data1/oa_pdf/55/80/BIJ-27-1500.PMC3852231.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3421 | DOI: 10.1038/srep03421 5",Non-OADS,/arxiv_data1/oa_pdf/b4/6f/srep03421.PMC3852363.pdf
Available at:  http://www.seco.admin .,Non-OADS,/arxiv_data1/oa_pdf/5b/ee/GEN-19-244.PMC3852497.pdf
"http://informahealthcare.com/bmg ISSN: 1040-9238 (print), 1549-7798 (electronic) Editor: Michael M. Cox Crit Rev Biochem Mol Biol, 2013; 48(6): 575–608 !2013 Informa Healthcare USA, Inc. DOI: 10.3109/10409238.2013.840259 REVIEW ARTICLE The Mediator complex and transcription regulation Zachary C. Poss *, Christopher C. Ebmeier *, and Dylan J. Taatjes Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO, USA Abstract The Mediator complex is a multi-subunit assembly that appears to be required for regulating expression of most RNA polymerase II (pol II) transcripts, which include protein-coding andmost non-coding RNA genes.",Non-OADS,/arxiv_data1/oa_pdf/13/86/BMG-48-575.PMC3852498.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/69/rjs003.PMC3852629.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/61/rjt075.PMC3852630.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/e7/rjt079.PMC3852632.pdf
"Accessed 5 June  2013 from:  http://www.en.federa.org.pl/dokumenty_ pdf/podrzednegora/abortion-report.pdf         Kessler   R ,  Sonnega   A ,  Bromet   E ,  7. et   al  .",Non-OADS,/arxiv_data1/oa_pdf/90/62/EJC-18-480.PMC3852718.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijwh-5-803.PMC3852763.pdf
Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 803–810International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  803OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5386 5Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijwh-5-803.PMC3852763.pdf
"Or use: http://dvpr.es/18QkRd 3Maternal and neonatal outcomes of placenta   previa and placenta accreta: three years   of experience with a two-consultant approach gamal a Kassem1 ali K alzahrani2 1Department of Obstetrics and  gynecology, 2neonatal Intensive  care Unit, King abdul-aziz specialist  Hospital, Taif, Kingdom of saudi arabia correspondence: gamal a Kassem   Borg al seleem 3, Fourth Floor, Flat 6,   alqumia street, Zagazig, egypt   Tel +205 5235 3828   email gamal-1960@hotmail.co mObjective:  The aim of this retrospective cohort study was to evaluate maternal and neonatal  outcomes in patients with placenta previa (PP) and placenta accreta (PA).",Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijwh-5-803.PMC3852763.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijwh-5-803.PMC3852763.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijwh-5-803.PMC3852763.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/63/rjt073.PMC3852797.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/13/rjt094.PMC3852857.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/36/rjs005.PMC3852952.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/23/rjt091.PMC3853028.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/13/rjt092.PMC3853105.pdf
http://dx.doi.org/10.1016/j.nicl.2013.11.001 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/8f/74/main.PMC3853114.pdf
"In-house image process- ing software (diffusional kurtosis estimator, DKE; Tabesh et al., 2011 ; http://www.nitrc.org/projects/dke ) was used for checking image quality, motion correction, and for estimating the diffusion tensorand diffusional kurtosis tensors.",OADS,/arxiv_data1/oa_pdf/8f/74/main.PMC3853114.pdf
http://dx.doi.org/10.3174/ajnr.A3553 .,Non-OADS,/arxiv_data1/oa_pdf/8f/74/main.PMC3853114.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/8a/rjs017.PMC3853150.pdf
http://www.ilo.org/wcmsp5/groups/public/ — ed_norm/ —declaration/documents/publication/wcms_182004.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/a0/11524_2013_Article_9837.PMC3853176.pdf
"Protocol to prevent, suppress and punish trafﬁcking in persons, especially women and children, supplementing the United Nations Convention Against Transnational Organized Crime, 2000. http://www.uncjin.org .",Non-OADS,/arxiv_data1/oa_pdf/e2/a0/11524_2013_Article_9837.PMC3853176.pdf
"Fact sheet No 239, November 2009. http://www.who.int/mediacentre/factsheets/fs239/en .",Non-OADS,/arxiv_data1/oa_pdf/e2/a0/11524_2013_Article_9837.PMC3853176.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/rjt090.PMC3853234.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/d7/rjt074.PMC3853346.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.016 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
"Acoustic speech analyses Non-dysﬂ uent speech recordings of overt reading were analyzed re- garding speech intensity, intensity variation, spectral range, spectral change, fundamental frequency variation, and reading time ( Rosen et al., 2006) using PRAAT (http://www.fon.hum.uva.nl/praat/ )(Boersma and Weenik, 1996).",OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
"Perceptual speech analyses Two independent experienced speech language pathologists, who were otherwise not involved in this study, judged the recordings of overt reading for pitch, loudness, voice quality, comprehensibility and speech tempo with a standardized Speech Characteristics Rating Scale (http://www.speech-language-therapy.com/~speech/pdf/scr.pdf ) (Skinder-Meredith, 2009 ) and were asked to categorize speech samples as belonging to patients (ON or OFF) or controls.",Non-OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
Inline Supplementary Table S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
Inline Supplementary Table S2 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
Inline Supplementary Table S3 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
Inline Supplementary Table S4 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
Inline Supplementary Table S5 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
http://dx.doi.org/10.1155/2012/ 391946 .,Non-OADS,/arxiv_data1/oa_pdf/e6/4b/main.PMC3853351.pdf
SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2013; 108:1877–1888;  doi: 10.1038/ajg.2013.335; published online 22 October 2013           INTRODUCTION   Anemia is a frequent complication often seen in conjunc- tion with acute exacerbation of inflammatory bowel diseases (IBDs) with known negative impact on quality of life (QoL) ( 1 – 10 ).,Non-OADS,/arxiv_data1/oa_pdf/51/9f/ajg2013335a.PMC3853365.pdf
http://www.who.int/nutrition/ topics/ida/en/index.html   .,Non-OADS,/arxiv_data1/oa_pdf/51/9f/ajg2013335a.PMC3853365.pdf
Available from: http://www.who.int/tb/ laboratory/egmreport_microscopymethods_nov09.pdf.,OADS,/arxiv_data1/oa_pdf/2e/c7/IJO-61-603.PMC3853464.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/35/rjt088.PMC3853481.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ APPENDIX Steering Committee: H Makino, S Ito, M Haneda, E Imai, JCN Chan.",Non-OADS,/arxiv_data1/oa_pdf/54/60/hr201386a.PMC3853587.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs117/en/.,Non-OADS,/arxiv_data1/oa_pdf/6f/f1/AMHSR-3-16.PMC3853597.pdf
Available from: http://www.ispub.,Non-OADS,/arxiv_data1/oa_pdf/ce/3e/AMHSR-3-18.PMC3853598.pdf
New Delhi: Available from:  http://www.nicd.nic.in/ab_policy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c3/a8/AMHSR-3-55.PMC3853613.pdf
Available from: http://www.apothecurry.wordpress.,Non-OADS,/arxiv_data1/oa_pdf/c3/a8/AMHSR-3-55.PMC3853613.pdf
New Delhi: Available from:  http://www.nicd.nic.in/ab_policy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1d/51/AMHSR-3-56.PMC3853614.pdf
Available from: http://www.apothecurry.wordpress.,Non-OADS,/arxiv_data1/oa_pdf/1d/51/AMHSR-3-56.PMC3853614.pdf
Available  from: http://www.plagiat.htw berlin.de/start‑en/.,Non-OADS,/arxiv_data1/oa_pdf/1d/51/AMHSR-3-56.PMC3853614.pdf
Available from: http://www.plagiarismadvice.org/ research‑papers.,Non-OADS,/arxiv_data1/oa_pdf/1d/51/AMHSR-3-56.PMC3853614.pdf
Available from: http://www.ippheae.eu/.,Non-OADS,/arxiv_data1/oa_pdf/1d/51/AMHSR-3-56.PMC3853614.pdf
Available from: http://www.cse.msu.edu/~alexliu/ plagiarism.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1d/51/AMHSR-3-56.PMC3853614.pdf
Available from: http://www.plagiarismadvice.org/ research‑papers.,Non-OADS,/arxiv_data1/oa_pdf/30/8a/AMHSR-3-58.PMC3853615.pdf
Available from: http://www.ippheae.eu/.,Non-OADS,/arxiv_data1/oa_pdf/30/8a/AMHSR-3-58.PMC3853615.pdf
Available from: http://www.cse.msu.edu/~alexliu/ plagiarism.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/8a/AMHSR-3-58.PMC3853615.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/3f/rjs012.PMC3853626.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5c/e1/srep03443.PMC3853657.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3443 | DOI: 10.1038/srep03443 6",Non-OADS,/arxiv_data1/oa_pdf/5c/e1/srep03443.PMC3853657.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/fe/srep03442.PMC3853658.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3442 | DOI: 10.1038/srep03442 7",Non-OADS,/arxiv_data1/oa_pdf/70/fe/srep03442.PMC3853658.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/srep03391.PMC3853659.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3391 | DOI: 10.1038/srep03391 5",Non-OADS,/arxiv_data1/oa_pdf/a4/35/srep03391.PMC3853659.pdf
Available from: http://www.who-umc.org/.,Non-OADS,/arxiv_data1/oa_pdf/3d/77/JPP-4-1.PMC3853660.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/3d/77/JPP-4-1.PMC3853660.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/3d/77/JPP-4-1.PMC3853660.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/26/71/JPP-4-104.PMC3853661.pdf
Available from: http://www.who-umc.org.,Non-OADS,/arxiv_data1/oa_pdf/4f/54/JPP-4-20.PMC3853663.pdf
Available from: http://www.agenziafarmaco.gov.it.,Non-OADS,/arxiv_data1/oa_pdf/4f/54/JPP-4-20.PMC3853663.pdf
Available from: http://eudravigilance.ema.europa.eu/human/index.asp [Last  accessed on 2013 Jun 2].,Non-OADS,/arxiv_data1/oa_pdf/4f/54/JPP-4-20.PMC3853663.pdf
26. http://www.ema.europa.eu/ema/ [Last accessed on 2013 Jun 2].,Non-OADS,/arxiv_data1/oa_pdf/4f/54/JPP-4-20.PMC3853663.pdf
Available from: http://www.agenziafarmaco.gov.it/en/content/post- marketing-surveillance.,Non-OADS,/arxiv_data1/oa_pdf/4f/54/JPP-4-20.PMC3853663.pdf
Available from: http://www.who-umc.org/graphics/24965.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/54/JPP-4-20.PMC3853663.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/94/f9/JPP-4-33.PMC3853665.pdf
Available from: http://www.agenziafarmaco.gov.it/.,Non-OADS,/arxiv_data1/oa_pdf/94/f9/JPP-4-33.PMC3853665.pdf
Available from:  http://www.ema.europa.eu/ema/.,Non-OADS,/arxiv_data1/oa_pdf/94/f9/JPP-4-33.PMC3853665.pdf
"(Official Journal L 348, 31.12.2010,  p. 1-16) Available from: http://www.eur -lex.europa.eu/LexUriServ/LexUri  Serv.do?uri=OJ: L: 2010:348:0001:0016:EN: PDF [Last accessed on  2013 Sep 10].",Non-OADS,/arxiv_data1/oa_pdf/b0/c5/JPP-4-4.PMC3853667.pdf
Available from:  http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/ news/2012/02/news_detail_001451.jsp and mid=WC0b01ac058004d5c1  [Last accessed on 2013 Sep 10].,OADS,/arxiv_data1/oa_pdf/b0/c5/JPP-4-4.PMC3853667.pdf
Measures for the stabilization of public  finance (Official Journal of the Italian Republic 30/12/1997) Available from:  http://www.parlamento.it/parlam/leggi/97449l.htm [Last accessed date on  2013 Sep 10].,Non-OADS,/arxiv_data1/oa_pdf/b0/c5/JPP-4-4.PMC3853667.pdf
Available from: http://www.parlamento.it/parlam/leggi/06296l.htm [Last  accessed date on 2013 Sep 10].,Non-OADS,/arxiv_data1/oa_pdf/b0/c5/JPP-4-4.PMC3853667.pdf
Available from: http://www.agenziafarmaco.gov.it/sites/default/files/ tipo_filecb84.pdf [Last accessed on 2013 Jul 15].6.,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/JPP-4-43.PMC3853668.pdf
Available from: http://www.agenziafarmaco.gov.it/sites/default/files/ tipo_file07d6.pdf [Last accessed on 2013 Jul 15].,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/JPP-4-43.PMC3853668.pdf
Available from: http://www.agenziafarmaco.gov.it/sites/default/files/scheda_ aifa_operatore_sanitario16.07.2012.doc [Last accessed on 2013 Jul 15].,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/JPP-4-43.PMC3853668.pdf
Available from: http://www.agenziafarmaco.gov.it/sites/default/files/scheda_ aifa_cittadino_16.07.2012.doc [Last accessed on 2013 Jul 15].,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/JPP-4-43.PMC3853668.pdf
Available from: http://www.drugcite.com/indi/?q=Tizanidineandi=CYSTITIS   [Last accessed on 2013 Jul 15].,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/JPP-4-43.PMC3853668.pdf
Available from: http://www.druginformer.com/search/side_effect/metformin+   hydrochloride [Last accessed on 2013 Jul 15].,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/JPP-4-43.PMC3853668.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/02/70/JPP-4-47.PMC3853669.pdf
Available from: http://www.priomedchild.eu/[Last  accessed on 2013 Jun 13].,OADS,/arxiv_data1/oa_pdf/72/10/JPP-4-51.PMC3853670.pdf
Available from: http://www.apps.who.int/medicinedocs/pdf/s4893e/ s4893e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/08/JPP-4-55.PMC3853671.pdf
Available from: http://www.salute.gov.it/ imgs/C_17_pubblicazioni_1721_allegato.pdf) [Last accessed on 2013 Jul 31].,Non-OADS,/arxiv_data1/oa_pdf/58/96/JPP-4-61.PMC3853672.pdf
Available from:  http://www.imshealthasia.com.,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
http://www.dav.gov.vn/ [Last accessed on  2013 August 20] .,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Available from: http://cdsco.nic.in/pharmacovigilance.htm.,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Available from: http://thomsonreuters.com/ business-unit/science/pdf/ls/newport-japanese-generics.pdf.,OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Available from: http://www.pmda.go.jp/ regulatory/file/english_presentation/safety/S-E2hori.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Available from: http://www.apec-ahc.org/.../Joungwon_Oh_28_April_ Plenary_Session_1030a  DIA 2011.,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Available from: http://www.pmda.go.jp/...indonesian.../5_Bu_Ratna_Revised_12_Feb_13_Pres [Last accessed on  2013 August 20].,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Available from:  http://www.portal.bpfk.gov.my.,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Available from: http://www.hsa.,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b7/29/JPP-4-7.PMC3853674.pdf
Available from:  http://www.who.int/medicines/areas/quality_safety/safety_efficacy/ Pharmacovigilance_B.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/05/JPP-4-73.PMC3853675.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/29/05/JPP-4-73.PMC3853675.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/23/25/JPP-4-78.PMC3853676.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8a/44/srep03436.PMC3853681.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3436 | DOI: 10.1038/srep03436 5",Non-OADS,/arxiv_data1/oa_pdf/8a/44/srep03436.PMC3853681.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3440 | DOI: 10.1038/srep03440 5",Non-OADS,/arxiv_data1/oa_pdf/28/23/srep03440.PMC3853684.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors are employees of Nippon Telegraph and Telephone Communication Science Laboratories, which is a basic-science research section of Nippon Telegraph and Telecommunication.",Non-OADS,/arxiv_data1/oa_pdf/40/44/srep03437.PMC3853685.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3437 | DOI: 10.1038/srep03437 5",Non-OADS,/arxiv_data1/oa_pdf/40/44/srep03437.PMC3853685.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/9d/srep03439.PMC3853688.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3439 | DOI: 10.1038/srep03439 6",Non-OADS,/arxiv_data1/oa_pdf/70/9d/srep03439.PMC3853688.pdf
Available  from: http://news.bbc.co.uk/1/hi/england/2496527.htm.,Non-OADS,/arxiv_data1/oa_pdf/37/5c/JAPTR-4-173.PMC3853692.pdf
Available from: http://www.who.int/medicines/areas/ quality_safety/4.1GHBcritical_review.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/37/5c/JAPTR-4-173.PMC3853692.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/00/a4/JAPTR-4-179.PMC3853693.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/39/95/JAPTR-4-206.PMC3853697.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/39/95/JAPTR-4-206.PMC3853697.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/5c/25/JAPTR-4-210.PMC3853698.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/3a/srep03444.PMC3853707.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3444 | DOI: 10.1038/srep03444 9",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/srep03444.PMC3853707.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/c1/58/IJPI-3-188.PMC3853758.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/c1/58/IJPI-3-188.PMC3853758.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/8d/11/IJPI-3-203.PMC3853760.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/bc/f5/IJPI-3-212.PMC3853761.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/df/rjs008.PMC3853771.pdf
"19 Ongoing or recently completed clinical  trials (http://clinicaltrials.gov) report on the potential efficacy of other biologic response  modifiers such as adalimumab (anti TNF-a  antibody), anakinra (IL-1 receptor antagonist), tocilizumab (IL-6 blocker), secukinumab (anti IL- 17 antibody), daclizumab (anti T-cell activated  antigen monoclonal antibody), and rituximab (anti CD20 antibody).",Non-OADS,/arxiv_data1/oa_pdf/0d/f4/JOVR-08-291.PMC3853784.pdf
"BIDMC, 330 Brookline Avenue, Shapiro 5th Floor, Boston, MA 02215,  USA; Tel: +1 617 667 3391, Fax: +1 617 6675025; e-mail: jarroyo@bidmc.harvard.edu; The endoscopic view video blog:  http://bit.ly/17GWcYA Received: May 13, 2013 Accepted: July 10, 2013 INTRODUCTION Dating back as early as 1934, the ophthalmic  application of endoscopy was first described by Thorpe, when he designed an instrument for removal of nonmagnetic intraocular foreign bodies (IOFB).",Non-OADS,/arxiv_data1/oa_pdf/81/75/JOVR-08-283.PMC3853791.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/61/rjs006.PMC3853803.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/34/rjs009.PMC3853804.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/75/e9/JHRS-6-168.PMC3853872.pdf
Available from:  http://www.cdc.gov.,OADS,/arxiv_data1/oa_pdf/d7/fe/JHRS-6-176.PMC3853873.pdf
Available from: http://www.righdiagnosis.com/i/infertility/ stats‑country.htm.,Non-OADS,/arxiv_data1/oa_pdf/d7/fe/JHRS-6-176.PMC3853873.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/d7/fe/JHRS-6-176.PMC3853873.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/d7/fe/JHRS-6-176.PMC3853873.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/46/de/JHRS-6-183.PMC3853874.pdf
"The list  of the names of the cytokines, chemokines and growth  factors estimated in the Bio‑Rad multiplex microbead  assays and their assay characteristics is available at  http://www.bio‑rad.com/webroot/web/pdf/lsr/literature/ Bulletin_5828A.pdf.",OADS,/arxiv_data1/oa_pdf/d6/ee/JHRS-6-205.PMC3853878.pdf
"The immunoassay data were expressed  in terms of mg protein estimated from Bradford protein  concentration in respective follicular fluid samples using  Bio‑Rad microtiter microassay kit (Bio‑Rad Laboratory,  Hercules, CA, USA) and human serum albumin (Sigma  Chemical, St. Louis, MO, USA) according to the procedure  provided by the manufacturer (http://labs.fhcrc.org/fero/ Protocols/BioRad_Bradford.pdf).Enzyme immunoassys Standard enzyme immunoassays for serum concentrations  of FSH, inhibin B and LH and concentrations of estradiol  17β and progesterone in follicular fluid were done in  duplicates using immunoassay kits purchased from DRG  International Inc. (New Jersey, NJ, USA).",OADS,/arxiv_data1/oa_pdf/d6/ee/JHRS-6-205.PMC3853878.pdf
Available from: http://www.who.int/wer/2010/ wer8535.pdf [Last accessed on 2012 Mar 01].2.,OADS,/arxiv_data1/oa_pdf/96/6a/IDOJ-4-273.PMC3853889.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/rjt089.PMC3853974.pdf
The statistical analyses were performed  with the help of the GRAPHPAD PRISM software version  5.00 for Windows (http://www.graphpad.com).,OADS,/arxiv_data1/oa_pdf/82/7e/0100-879X-bjmbr-45-11-1017.PMC3854147.pdf
"The visual  stimulus consisted of a black-white radial checkerboard  pattern covering the entire visual field and flickering at 8  Hz, which was programmed using the E-Prime software  (Psychology Software Tools, USA, http://www.pstnet.com/),  and was shown to the subjects on a monitor inside the MR  scanner using the Eloquence system ( InVivo , USA, http:// www.invivocorp.com/fmri/eloquence.php).",Non-OADS,/arxiv_data1/oa_pdf/a1/41/0100-879X-bjmbr-45-11-1031.PMC3854159.pdf
http://tabnet.datasus.,OADS,/arxiv_data1/oa_pdf/4a/e0/0100-879X-bjmbr-45-11-1080.PMC3854161.pdf
http://www.sjc.sp.gov.br/acidade/populacao.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/0100-879X-bjmbr-45-11-1080.PMC3854161.pdf
http://mtc-m19.sid.inpe.br/ col/sid.inpe.br/mtc-m19/2011/05.26.18.34/doc/publicacao.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/0100-879X-bjmbr-45-11-1080.PMC3854161.pdf
http://www.der.sp.gov.br/malha/estat_malha/frotaVeicu - los2006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/e0/0100-879X-bjmbr-45-11-1080.PMC3854161.pdf
http://www.mma.gov.br/port/conama/legipesq.cfm ?tipo=3&numero=03&ano=1990&texto=.,OADS,/arxiv_data1/oa_pdf/4a/e0/0100-879X-bjmbr-45-11-1080.PMC3854161.pdf
The program and  activities developed by INeC can be found in its website (http://www.inec-usp.org/).,Non-OADS,/arxiv_data1/oa_pdf/43/66/0100-879X-bjmbr-45-04-291.PMC3854163.pdf
Neuroscience  2011; [http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/06/0100-879X-bjmbr-45-04-357.PMC3854170.pdf
http://www.inca.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/a1/9a/0100-879X-bjmbr-45-10-891.PMC3854186.pdf
"The two different types of alleles of the gene repre - sent 76 (http://hla.alleles.org/nomenclature/stats.html)  sequence alleles in the mature protein-coding region  (MICA*001 to *064N, http://www.ebi.ac.uk/imgt/hla/   allele.html) and seven microsatellite alleles.",Non-OADS,/arxiv_data1/oa_pdf/13/04/0100-879X-bjmbr-45-03-222.PMC3854198.pdf
"Since the structure of most MICA-STR alleles can be  obtained from the Anthony Nolan Trust (HLA Informatics  Group website: http://www.ebi.ac.uk/imgt/hla/allele.html),  the sequences of the alleles genotyped above were used  to determine the corresponding STR genotypes.",Non-OADS,/arxiv_data1/oa_pdf/13/04/0100-879X-bjmbr-45-03-222.PMC3854198.pdf
http://www.ncbi.nlm.nih.gov/pubmed/22483201.,Non-OADS,/arxiv_data1/oa_pdf/0b/fa/0100-879X-bjmbr-45-12-1102.PMC3854212.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/0b/fa/0100-879X-bjmbr-45-12-1102.PMC3854212.pdf
http://biology.ucsd.,Non-OADS,/arxiv_data1/oa_pdf/b7/21/0100-879X-bjmbr-45-12-1221.PMC3854215.pdf
"Strasbourg, Council of  Europe, November 2001. http://www.coe.int/T/E/Social_Co - hesion/socp/Defproceedingshospitals.pdf2008.",Non-OADS,/arxiv_data1/oa_pdf/63/15/0100-879X-bjmbr-45-12-1301.PMC3854217.pdf
http://e-legis.anvisa.gov.br/leisref/public/showAct.,Non-OADS,/arxiv_data1/oa_pdf/63/15/0100-879X-bjmbr-45-12-1301.PMC3854217.pdf
"Measurement of cell size  Cardiomyocytes were seeded on 24-well plates and  cultured for 48 h. After treatment with HGF (10 ng/mL),  Ang II (1 µM), or HGF (10 ng/mL) plus Ang II (1 µM) for 12  h, the cells were digested with EDTA-trypsin (0.25%) for 5  min, 10% FBS was used to terminate the reaction and the  average cell size was determined using the Image J soft - ware (http://rsb.info.nih.gov/ij/download.html) as previously  described (26).",OADS,/arxiv_data1/oa_pdf/9d/bb/0100-879X-bjmbr-45-12-1150.PMC3854218.pdf
"6.x software (Statistical Analysis for Genetic  Epidemiology, Release 6.3, http://darwin.cwru.edu/, Case  Western Reserve University, USA).",Non-OADS,/arxiv_data1/oa_pdf/8e/de/0100-879X-bjmbr-45-12-1269.PMC3854221.pdf
"Blood pressure and physical activity: genetic/environment 1271 www.bjournal.com.br Braz J Med Biol Res 45(12) 2012were computed using the SOLAR 4.0 software (Sequential  Oligogenic Linkage Analysis Routines, http://www.sfbr.org,  Southwest Foundation for Biomedical Research, USA).",OADS,/arxiv_data1/oa_pdf/8e/de/0100-879X-bjmbr-45-12-1269.PMC3854221.pdf
The miRNA-specific forward primer sequences were  designed based on the mature miRNA sequence ob - tained from the miRBase database (http://www.mirbase.,OADS,/arxiv_data1/oa_pdf/81/f0/0100-879X-bjmbr-45-12-1308.PMC3854222.pdf
http://www.childkindinternational.org/ChildKind_ International/Resources.html.,Non-OADS,/arxiv_data1/oa_pdf/09/69/0100-879X-bjmbr-45-12-1287.PMC3854228.pdf
"Of the  23 groups of dust mite allergens listed in the International  Union of Immunological Societies (IUIS) nomenclature  dataset (http://www.allergen.org/), 21 have been identified from Dermatophagoides spp.",Non-OADS,/arxiv_data1/oa_pdf/6b/62/0100-879X-bjmbr-45-08-746.PMC3854237.pdf
Alignment between Der f 5 and its homologous amino acid sequence of other mite spe- cies by ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/).,OADS,/arxiv_data1/oa_pdf/6b/62/0100-879X-bjmbr-45-08-746.PMC3854237.pdf
Result of the prediction of protein subcellular localization for Der f  5 by CELLO v.2.5 (http://cello.life.nctu.edu.tw/).,OADS,/arxiv_data1/oa_pdf/6b/62/0100-879X-bjmbr-45-08-746.PMC3854237.pdf
The Harvard Classics [In - ternet] Bartleby com  http://www.bartleby.com/38/4/; 2010.,Non-OADS,/arxiv_data1/oa_pdf/8a/de/0100-879X-bjmbr-45-08-681.PMC3854239.pdf
Available at  [http://www.ocpi.cu/boletines/boletin_244_ago_2008.pdf].,Non-OADS,/arxiv_data1/oa_pdf/8a/de/0100-879X-bjmbr-45-08-681.PMC3854239.pdf
http://journals.lww.,Non-OADS,/arxiv_data1/oa_pdf/8a/de/0100-879X-bjmbr-45-08-681.PMC3854239.pdf
http://www.senasa.gov.ar/ contenido.php?to=n&iN = 858&io=15899.,Non-OADS,/arxiv_data1/oa_pdf/a0/c3/0100-879X-bjmbr-45-02-139.PMC3854252.pdf
"The  combined list is dominated by vicilins and  vicilin-like proteins (e.g., gis 160332746   and 145207915), which were extracted  from the nr database, clustered using  blastclust and aligned [data shown at   (http://dl.dropbox.com/u/7886304/supple - ments/BJMBR-Souza2012/BJMBR-Souza- MSA.pdf)].",OADS,/arxiv_data1/oa_pdf/e0/6e/0100-879X-bjmbr-45-02-118.PMC3854254.pdf
"We extracted taxonomic informa - tion for all the hits and found that all the detected  homologs were from the Tracheophyta clade  (vascular plants), encompassing homologs in  the basal vascular plant Selaginella moellen - dorffii (Lycopodiophyta), the fern Matteuccia  struthiopteris , conifers, various monocots (e.g.,  Oryza sativa  and Zea mays ) and eudicots  (e.g., Vitis vinifera , Phaseolus vulgaris and  Glycine max ) [data shown at (http://dl.dropbox.com/u/7886304/supplements/BJMBR-Souza2012/BJMBR- Souza-MSA.pdf)].",OADS,/arxiv_data1/oa_pdf/e0/6e/0100-879X-bjmbr-45-02-118.PMC3854254.pdf
"After retrieving  the 3’UTR of human, mouse, rat, chicken, and lizard from  the TargetScan (http://www.targetscan.org), the alignments  with miR-17-5p, miR-19a, miR-19b, miR-20a, and miR-92-1  are illustrated in Figure 1B.",Non-OADS,/arxiv_data1/oa_pdf/18/f2/0100-879X-bjmbr-45-02-131.PMC3854259.pdf
Bootscanning was performed with alignment (available  at http://lasp.cpqgm.fiocruz.br/retrovirusHIV.html).,OADS,/arxiv_data1/oa_pdf/67/7b/0100-879X-bjmbr-45-02-104.PMC3854261.pdf
http://www.hiv.lanl.gov/content/sequence/HIV/ CRFs/CRFs.html.,Non-OADS,/arxiv_data1/oa_pdf/67/7b/0100-879X-bjmbr-45-02-104.PMC3854261.pdf
http://data.unaids.org/ pub/Report/2008/jc1530_epibriefs_latinamerica_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/7b/0100-879X-bjmbr-45-02-104.PMC3854261.pdf
http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/67/7b/0100-879X-bjmbr-45-02-104.PMC3854261.pdf
DNA data analysis The sequences obtained were analyzed using the BLAST  program (http://www.ncbi.nlm.nih.gov/BLAST/) (32) and com - pared to each other with the MULTALIN program (http://prodes.,OADS,/arxiv_data1/oa_pdf/06/5a/0100-879X-bjmbr-45-07-644.PMC3854270.pdf
Available at [http://www.who.in/en].,Non-OADS,/arxiv_data1/oa_pdf/06/5a/0100-879X-bjmbr-45-07-644.PMC3854270.pdf
Available  at [http://tabnet.datasus.gov.br/cgi/tabcgi.exe?idb2006/c04.,OADS,/arxiv_data1/oa_pdf/fa/b3/0100-879X-bjmbr-45-07-625.PMC3854275.pdf
"Currently, eleven major variants of SCC mec  (type I to XI) have been characterized (http://www.sccmec.",Non-OADS,/arxiv_data1/oa_pdf/f5/63/0100-879X-bjmbr-45-07-637.PMC3854277.pdf
Research supported in part by the  National Natural Science Foundation of China (#30570738;  http://www.nsfc.gov.cn/Portal0/default124.htm).,Non-OADS,/arxiv_data1/oa_pdf/97/ff/0100-879X-bjmbr-45-07-591.PMC3854278.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/21815811.,Non-OADS,/arxiv_data1/oa_pdf/27/a6/0100-879X-bjmbr-45-05-376.PMC3854287.pdf
http://www.ncbi.nlm.nih.gov/pubmed/21478889.,Non-OADS,/arxiv_data1/oa_pdf/27/a6/0100-879X-bjmbr-45-05-376.PMC3854287.pdf
"Data on linearity, functional sensitiv - ity, reproducibility, recovery, interference, carryover, and drift  for the mass spectrometry method used in this study were  presented by the manufacturer to the Food and Drug Ad - ministration (FDA), and are available at the agency website  [http://www.fda.gov/ohrms/dockets/dockets/04n0482/04n- 0482-bkg00001-vol1.pdf].",OADS,/arxiv_data1/oa_pdf/6c/36/0100-879X-bjmbr-45-06-546.PMC3854303.pdf
"First published online October 2, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 839-843, http://dx.doi.org/10.1590/1414-431X20133140 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(10) 2013",Non-OADS,/arxiv_data1/oa_pdf/56/77/1414-431X-bjmbr-46-10-839.PMC3854305.pdf
"First published online October 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 868-880, http://dx.doi.org/10.1590/1414-431X20132834 ISSN 1414-431X Braz J Med Biol Res 46(10) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/cf/e8/1414-431X-bjmbr-46-10-868.PMC3854306.pdf
"First published online September 24, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 861-867, http://dx.doi.org/10.1590/1414-431X20133036 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(10) 2013",Non-OADS,/arxiv_data1/oa_pdf/c7/59/1414-431X-bjmbr-46-10-861.PMC3854307.pdf
"First published online September 18, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 904-908, http://dx.doi.org/10.1590/1414-431X20133178 ISSN 1414-431X Braz J Med Biol Res 46(10) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/80/45/1414-431X-bjmbr-46-10-904.PMC3854308.pdf
"First published online October 2, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 815-823, http://dx.doi.org/10.1590/1414-431X20133115 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(10) 2013",Non-OADS,/arxiv_data1/oa_pdf/4d/44/1414-431X-bjmbr-46-10-815.PMC3854309.pdf
"First published online October 18, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 831-838, http://dx.doi.org/10.1590/1414-431X20133092 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(10) 2013",Non-OADS,/arxiv_data1/oa_pdf/7e/8a/1414-431X-bjmbr-46-10-831.PMC3854310.pdf
"First published online October 2, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 824-830, http://dx.doi.org/10.1590/1414-431X20132964 ISSN 1414-431X Review Braz J Med Biol Res 46(10) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/54/61/1414-431X-bjmbr-46-10-824.PMC3854311.pdf
"First published online October 2, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 855-860, http://dx.doi.org/10.1590/1414-431X20133117 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(10) 2013",Non-OADS,/arxiv_data1/oa_pdf/cc/39/1414-431X-bjmbr-46-10-855.PMC3854312.pdf
"First published online October 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 892-896, http://dx.doi.org/10.1590/1414-431X20132849 ISSN 1414-431X Braz J Med Biol Res 46(10) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/bf/ee/1414-431X-bjmbr-46-10-892.PMC3854313.pdf
http://www2.datasus.gov.br/DATASUS/index.php.12.,OADS,/arxiv_data1/oa_pdf/bf/ee/1414-431X-bjmbr-46-10-892.PMC3854313.pdf
"First published online October 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 844-854, http://dx.doi.org/10.1590/1414-431X20133102 ISSN 1414-431X Braz J Med Biol Res 46(10) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/18/b6/1414-431X-bjmbr-46-10-844.PMC3854314.pdf
"First published online October 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 881-891, http://dx.doi.org/10.1590/1414-431X20133061 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(10) 2013",Non-OADS,/arxiv_data1/oa_pdf/e2/d2/1414-431X-bjmbr-46-10-881.PMC3854315.pdf
"First published online September 24, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 897-903, http://dx.doi.org/10.1590/1414-431X20133139 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(10) 2013",Non-OADS,/arxiv_data1/oa_pdf/48/48/1414-431X-bjmbr-46-10-897.PMC3854316.pdf
Bethesda: American Society for Photogrammetry and Remote Sensing [cited 21/12/2007]  [http://www.asprs.org/a/society/about.html].Table 1.,Non-OADS,/arxiv_data1/oa_pdf/95/8e/0100-879X-bjmbr-45-09-806.PMC3854328.pdf
"First published online November 18, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 993-999, http://dx.doi.org/10.1590/1414-431X20132948 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(11) 2013",Non-OADS,/arxiv_data1/oa_pdf/7c/9d/1414-431X-bjmbr-46-11-0993.PMC3854329.pdf
"According to the United Nations Office on Drugs and Crime (UNODC, 2011 ,http://www.unodc.org/documents/ data-and-analysis/WDR2011/World_Drug_Report_2011_ ebook.pdf .",Non-OADS,/arxiv_data1/oa_pdf/53/e3/1414-431X-bjmbr-46-11-0909.PMC3854330.pdf
"First published online October 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 909-915, http://dx.doi.org/10.1590/1414-431X20133379 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(11) 2013",Non-OADS,/arxiv_data1/oa_pdf/53/e3/1414-431X-bjmbr-46-11-0909.PMC3854330.pdf
"It is estimated that approximately 30,000- 160,000 newborns are exposed to cocaine in utero per year (Mathias, 1995 ,http://archives.drugabuse.gov/ NIDA_Notes/NNVol10N1/NIDASurvey.html .",Non-OADS,/arxiv_data1/oa_pdf/53/e3/1414-431X-bjmbr-46-11-0909.PMC3854330.pdf
"First published online November 6, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 929-935, http://dx.doi.org/10.1590/1414-431X20132863 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(11) 2013",Non-OADS,/arxiv_data1/oa_pdf/69/52/1414-431X-bjmbr-46-11-0929.PMC3854331.pdf
"First published online October 22, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 920-928, http://dx.doi.org/10.1590/1414-431X20132873 ISSN 1414-431X Braz J Med Biol Res 46(11) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/27/e1/1414-431X-bjmbr-46-11-0920.PMC3854333.pdf
"First published online November 18, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 985-992, http://dx.doi.org/10.1590/1414-431X20132885 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(11) 2013",Non-OADS,/arxiv_data1/oa_pdf/51/c6/1414-431X-bjmbr-46-11-0985.PMC3854334.pdf
"First published online November 18, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 956-967, http://dx.doi.org/10.1590/1414-431X20133138 ISSN 1414-431X Braz J Med Biol Res 46(11) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/26/e1/1414-431X-bjmbr-46-11-0956.PMC3854335.pdf
"First published online November 6, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 943-948, http://dx.doi.org/10.1590/1414-431X20133179 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(11) 2013",Non-OADS,/arxiv_data1/oa_pdf/32/f4/1414-431X-bjmbr-46-11-0943.PMC3854336.pdf
"First published online November 6, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 936-942, http://dx.doi.org/10.1590/1414-431X20132764 ISSN 1414-431X Braz J Med Biol Res 46(11) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/d8/15/1414-431X-bjmbr-46-11-0936.PMC3854337.pdf
"First published online November 18, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 949-955, http://dx.doi.org/10.1590/1414-431X20133163 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(11) 2013",Non-OADS,/arxiv_data1/oa_pdf/c2/7c/1414-431X-bjmbr-46-11-0949.PMC3854338.pdf
"First published online October 22, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 916-919, http://dx.doi.org/10.1590/1414-431X20133035 ISSN 1414-431X Short Communication Braz J Med Biol Res 46(11) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/04/ec/1414-431X-bjmbr-46-11-0916.PMC3854339.pdf
"First published online October 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 968-973, http://dx.doi.org/10.1590/1414-431X20133184 ISSN 1414-431X Short Communication Braz J Med Biol Res 46(11) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/51/b8/1414-431X-bjmbr-46-11-0968.PMC3854340.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 14-20, http://dx.doi.org/10.1590/1414-431X20121956 ISSN 1414-431X Braz J Med Biol Res 46(1) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/63/9a/1414-431X-bjmbr-46-01-014.PMC3854341.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 91-97, http://dx.doi.org/10.1590/1414-431X20122453 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(1) 2013",Non-OADS,/arxiv_data1/oa_pdf/8f/bd/1414-431X-bjmbr-46-01-091.PMC3854342.pdf
"First published online September 25, 2012.Brazilian Journal of Medical and Biological Research (2013) 46: 39-51, http://dx.doi.org/10.1590/S0100-879X2012007500157 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(1) 2013",Non-OADS,/arxiv_data1/oa_pdf/02/ec/1414-431X-bjmbr-46-01-039.PMC3854343.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 79-84, http://dx.doi.org/10.1590/1414-431X20122451 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(1) 2013",Non-OADS,/arxiv_data1/oa_pdf/2b/37/1414-431X-bjmbr-46-01-079.PMC3854344.pdf
The SNP database (http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/2b/37/1414-431X-bjmbr-46-01-079.PMC3854344.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 21-31, http://dx.doi.org/10.1590/1414-431X20122263 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(1) 2013",Non-OADS,/arxiv_data1/oa_pdf/b1/9e/1414-431X-bjmbr-46-01-021.PMC3854345.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 85-90, http://dx.doi.org/10.1590/1414-431X20122449 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(1) 2013",Non-OADS,/arxiv_data1/oa_pdf/b2/9f/1414-431X-bjmbr-46-01-085.PMC3854346.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 52-57, http://dx.doi.org/10.1590/1414-431X20122434 ISSN 1414-431X Braz J Med Biol Res 46(1) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/bc/58/1414-431X-bjmbr-46-01-052.PMC3854347.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 71-78, http://dx.doi.org/10.1590/1414-431X20121423 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(1) 2013",Non-OADS,/arxiv_data1/oa_pdf/4c/e4/1414-431X-bjmbr-46-01-071.PMC3854348.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 1-13, http://dx.doi.org/10.1590/1414-431X20122388 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(1) 2013",Non-OADS,/arxiv_data1/oa_pdf/e3/6b/1414-431X-bjmbr-46-01-001.PMC3854349.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 98-102, http://dx.doi.org/10.1590/1414-431X20122477 ISSN 1414-431X Braz J Med Biol Res 46(1) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/69/93/1414-431X-bjmbr-46-01-098.PMC3854350.pdf
"First published online September 28, 2012.Brazilian Journal of Medical and Biological Research (2013) 46: 32-38, http://dx.doi.org/10.1590/S0100-879X2012007500155 ISSN 1414-431X Braz J Med Biol Res 46(1) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/bc/38/1414-431X-bjmbr-46-01-032.PMC3854351.pdf
"First published online January 11, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 58-64, http://dx.doi.org/10.1590/1414-431X20122409 ISSN 1414-431X Braz J Med Biol Res 46(1) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/a7/cc/1414-431X-bjmbr-46-01-058.PMC3854352.pdf
"First published online October 23, 2012.Brazilian Journal of Medical and Biological Research (2013) 46: 65-70, http://dx.doi.org/10.1590/S0100-879X2012007500167 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(1) 2013",Non-OADS,/arxiv_data1/oa_pdf/9b/83/1414-431X-bjmbr-46-01-065.PMC3854353.pdf
"[Master’s thesis]: Instituto de Cieˆncias Biome ´dicas, Universidade de Sa ˜o Paulo; 2009. http://www.teses.",Non-OADS,/arxiv_data1/oa_pdf/9b/83/1414-431X-bjmbr-46-01-065.PMC3854353.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 109-116, http://dx.doi.org/10.1590/1414-431X20122460 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(2) 2013",Non-OADS,/arxiv_data1/oa_pdf/07/30/1414-431X-bjmbr-46-02-109.PMC3854354.pdf
"Accepted December 3, 2012.Brazilian Journal of Medical and Biological Research (2013) 46: 164-170, http://dx.doi.org/10.1590/1414-431X20122627 ISSN 1414-431X Braz J Med Biol Res 46(2) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/fd/25/1414-431X-bjmbr-46-02-164.PMC3854355.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 138-147, http://dx.doi.org/10.1590/1414-431X20122378 ISSN 1414-431X Braz J Med Biol Res 46(2) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/f7/a7/1414-431X-bjmbr-46-02-138.PMC3854356.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 178-185, http://dx.doi.org/10.1590/1414-431X20122190 ISSN 1414-431X Braz J Med Biol Res 46(2) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/39/d4/1414-431X-bjmbr-46-02-178.PMC3854357.pdf
"Accepted January 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 103-108, http://dx.doi.org/10.1590/1414-431X20131873 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(2) 2013",Non-OADS,/arxiv_data1/oa_pdf/3c/45/1414-431X-bjmbr-46-02-103.PMC3854358.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 128-137, http://dx.doi.org/10.1590/1414-431X20122515 ISSN 1414-431X Braz J Med Biol Res 46(2) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/14/af/1414-431X-bjmbr-46-02-128.PMC3854359.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 194-199, http://dx.doi.org/10.1590/1414-431X20122376 ISSN 1414-431X Braz J Med Biol Res 46(2) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/8e/e1/1414-431X-bjmbr-46-02-194.PMC3854360.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 171-177, http://dx.doi.org/10.1590/1414-431X20122472 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(2) 2013",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/1414-431X-bjmbr-46-02-171.PMC3854361.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 117-120, http://dx.doi.org/10.1590/1414-431X20122266 ISSN 1414-431X Concepts and Comments www.bjournal.com.br Braz J Med Biol Res 46(2) 2013",Non-OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
http://www.cgee.org.br/ atividades/redirect.php?idProduto=6401.,OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
http://gestao2010.mec.gov.br/download/ sinopse_acoes_mec.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
http://www.cnpq.br/documents/10157/ 66956/11_Total_Invest_9610.xls.,Non-OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
http://www.ibge.gov.br/seculoxx/.,Non-OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
http://www.fapesp.br/estatisticas/receitas/.,Non-OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
http://www.fapemig.br/institucional/ relatorio-de-atividades/.,Non-OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
Workshops at the Twenty-Fifth AAAI Conference on Artificial Intelligence 2011. http://atlas.media.mit.edu/country/bra/.,Non-OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
http://atlas.media.mit.edu/book/.,Non-OADS,/arxiv_data1/oa_pdf/e8/eb/1414-431X-bjmbr-46-02-117.PMC3854362.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 121-127, http://dx.doi.org/10.1590/1414-431X20122148 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(2) 2013",Non-OADS,/arxiv_data1/oa_pdf/f3/2d/1414-431X-bjmbr-46-02-121.PMC3854363.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 148-153, http://dx.doi.org/10.1590/1414-431X20122556 ISSN 1414-431X Short Communication Braz J Med Biol Res 46(2) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/20/ee/1414-431X-bjmbr-46-02-148.PMC3854364.pdf
http://portal.saude.gov.br/portal/arquivos/ pdf/livro_cries_3ed.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/ee/1414-431X-bjmbr-46-02-148.PMC3854364.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 200-206, http://dx.doi.org/10.1590/1414-431X20122397 ISSN 1414-431X Braz J Med Biol Res 46(2) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/21/6b/1414-431X-bjmbr-46-02-200.PMC3854365.pdf
"First published online February 1, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 186-193, http://dx.doi.org/10.1590/1414-431X20122308 ISSN 1414-431X Braz J Med Biol Res 46(2) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/53/75/1414-431X-bjmbr-46-02-186.PMC3854366.pdf
"First published online March 20, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 257-262, http://dx.doi.org/10.1590/1414-431X20122769 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/62/e9/1414-431X-bjmbr-46-03-257.PMC3854367.pdf
"First published online March 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 270-277, http://dx.doi.org/10.1590/1414-431X20122551 ISSN 1414-431X Braz J Med Biol Res 46(3) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/99/36/1414-431X-bjmbr-46-03-270.PMC3854368.pdf
"First published online March 20, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 306-310, http://dx.doi.org/10.1590/1414-431X20122559 ISSN 1414-431X Braz J Med Biol Res 46(3) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/be/5e/1414-431X-bjmbr-46-03-306.PMC3854369.pdf
"First published online March 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 235-244, http://dx.doi.org/10.1590/1414-431X20122429 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/80/ff/1414-431X-bjmbr-46-03-235.PMC3854370.pdf
"B, Using digitized radiographs, measure- ments including the proximal (PV) and distal (DV) vertebral body height and intervertebral disc height (DH) were analyzed using the public domain image analysis program developed by the U.S. National Institutes of Health - ImageJ (http://imagej.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/80/ff/1414-431X-bjmbr-46-03-235.PMC3854370.pdf
"First published online March 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 217-226, http://dx.doi.org/10.1590/1414-431X20132703 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/eb/8a/1414-431X-bjmbr-46-03-217.PMC3854371.pdf
"First published online March 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 253-256, http://dx.doi.org/10.1590/1414-431X20122462 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/2a/7d/1414-431X-bjmbr-46-03-253.PMC3854372.pdf
"First published online March 20, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 245-252, http://dx.doi.org/10.1590/1414-431X20122702 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/69/3e/1414-431X-bjmbr-46-03-245.PMC3854373.pdf
"First published online March 20, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 207-216, http://dx.doi.org/10.1590/1414-431X20122483 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/cd/ff/1414-431X-bjmbr-46-03-207.PMC3854374.pdf
CISH in comparison with other methodologies Using the PubMed database (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/cd/ff/1414-431X-bjmbr-46-03-207.PMC3854374.pdf
"First published online March 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 293-298, http://dx.doi.org/10.1590/1414-431X20132448 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/b5/32/1414-431X-bjmbr-46-03-293.PMC3854375.pdf
"First published online March 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 311-317, http://dx.doi.org/10.1590/1414-431X20132774 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/a7/8d/1414-431X-bjmbr-46-03-311.PMC3854376.pdf
"First published online March 8, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 278-286, http://dx.doi.org/10.1590/1414-431X20122230 ISSN 1414-431X Braz J Med Biol Res 46(3) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/55/d0/1414-431X-bjmbr-46-03-278.PMC3854377.pdf
"First published online March 20, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 263-269, http://dx.doi.org/10.1590/1414-431X20122085 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/ce/3b/1414-431X-bjmbr-46-03-263.PMC3854378.pdf
"First published online March 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 287-292, http://dx.doi.org/10.1590/1414-431X20122561 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/bb/64/1414-431X-bjmbr-46-03-287.PMC3854379.pdf
"First published online March 20, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 227-234, http://dx.doi.org/10.1590/1414-431X20122616 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/dd/ce/1414-431X-bjmbr-46-03-227.PMC3854380.pdf
"First published online March 20, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 318-326, http://dx.doi.org/10.1590/1414-431X20122658 ISSN 1414-431X Braz J Med Biol Res 46(3) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/8b/fa/1414-431X-bjmbr-46-03-318.PMC3854381.pdf
"First published online March 15, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 299-305, http://dx.doi.org/10.1590/1414-431X20122379 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(3) 2013",Non-OADS,/arxiv_data1/oa_pdf/33/eb/1414-431X-bjmbr-46-03-299.PMC3854382.pdf
"First published online May 10, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 433-439, http://dx.doi.org/10.1590/1414-431X20132665 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(5) 2013",Non-OADS,/arxiv_data1/oa_pdf/a5/8e/1414-431X-bjmbr-00-00-20132665.PMC3854395.pdf
"First published online.Brazilian Journal of Medical and Biological Research (2013) 00: 1-6, http://dx.doi.org/10.1590/1414-431X20132595 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 00(00) 2013",Non-OADS,/arxiv_data1/oa_pdf/a8/21/1414-431X-bjmbr-00-00-20132595.PMC3854396.pdf
"First published online May 31, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 405-416, http://dx.doi.org/10.1590/1414-431X20132893 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(5) 2013",Non-OADS,/arxiv_data1/oa_pdf/98/d4/1414-431X-bjmbr-46-5-405.PMC3854397.pdf
"First published online April 19, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 440-446, http://dx.doi.org/10.1590/1414-431X20132770 ISSN 1414-431X Braz J Med Biol Res 46(5) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/53/5a/1414-431X-bjmbr-00-00-20132770.PMC3854398.pdf
"First published online April 12, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 417-425, http://dx.doi.org/10.1590/1414-431X20132663 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(5) 2013",Non-OADS,/arxiv_data1/oa_pdf/a3/f1/1414-431X-bjmbr-00-00-20132663.PMC3854399.pdf
"First published online May 24, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 426-432, http://dx.doi.org/10.1590/1414-431X20132784 ISSN 1414-431X Braz J Med Biol Res 46(5) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/22/f8/1414-431X-bjmbr-20132784.PMC3854400.pdf
"First published online May 24, 2012.Brazilian Journal of Medical and Biological Research (2013) 46: 447-453, http://dx.doi.org/10.1590/1414-431X20122111 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(5) 2013",Non-OADS,/arxiv_data1/oa_pdf/aa/c6/1414-431X-bjmbr-20122111.PMC3854401.pdf
"First published online September 21, 2012.Brazilian Journal of Medical and Biological Research (2013) 46: 460-464, http://dx.doi.org/10.1590/S0100-879X2012007500152 ISSN 1414-431X Braz J Med Biol Res 46(5) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/97/75/1414-431X-bjmbr-46-5-460.PMC3854402.pdf
"First published online April 12, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 382-393, http://dx.doi.org/10.1590/1414-431X20132677 ISSN 1414-431X Braz J Med Biol Res 46(4) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/c0/b2/1414-431X-bjmbr-46-04-00382.PMC3854403.pdf
"First published online April 5, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 339-342, http://dx.doi.org/10.1590/1414-431X20132609 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(4) 2013",Non-OADS,/arxiv_data1/oa_pdf/bb/1a/1414-431X-bjmbr-46-04-00339.PMC3854404.pdf
http://www.idf.org/ webdata/docs/IDF_Metasybdrome_definition.pdf.,OADS,/arxiv_data1/oa_pdf/bb/1a/1414-431X-bjmbr-46-04-00339.PMC3854404.pdf
"First published online April 5, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 394-404, http://dx.doi.org/10.1590/1414-431X20122211 ISSN 1414-431X Braz J Med Biol Res 46(4) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/77/25/1414-431X-bjmbr-46-04-00394.PMC3854405.pdf
"First published online April 12, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 348-358, http://dx.doi.org/10.1590/1414-431X20132322 ISSN 1414-431X Braz J Med Biol Res 46(4) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/29/04/0100-879X-bjmbr-46-04-00348.PMC3854406.pdf
"First published online April 12, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 327-338, http://dx.doi.org/10.1590/1414-431X20132788 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(4) 2013",Non-OADS,/arxiv_data1/oa_pdf/ae/73/0100-879X-bjmbr-46-04-00327.PMC3854407.pdf
"First published online April 19, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 368-374, http://dx.doi.org/10.1590/1414-431X20132830 ISSN 1414-431X Braz J Med Biol Res 46(4) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/e8/ff/0100-879X-bjmbr-46-04-00368.PMC3854408.pdf
"First published online April 5, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 375-381, http://dx.doi.org/10.1590/1414-431X20122603 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(4) 2013",Non-OADS,/arxiv_data1/oa_pdf/e2/1e/1414-431X-bjmbr-46-04-00375.PMC3854409.pdf
"First published online April 19, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 343-347, http://dx.doi.org/10.1590/1414-431X20132557 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(4) 2013",Non-OADS,/arxiv_data1/oa_pdf/b1/45/0100-879X-bjmbr-46-04-00343.PMC3854410.pdf
"First published online April 12, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 359-367, http://dx.doi.org/10.1590/1414-431X20132799 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(4) 2013",Non-OADS,/arxiv_data1/oa_pdf/37/bd/0100-879X-bjmbr-46-04-00359.PMC3854411.pdf
"First published online August 26, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 659-669, http://dx.doi.org/10.1590/1414-431X20132903 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(8) 2013",Non-OADS,/arxiv_data1/oa_pdf/b3/1a/1414-431X-bjmbr-46-08-0659.PMC3854412.pdf
"First published online August 13, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 722-727, http://dx.doi.org/10.1590/1414-431X20132332 ISSN 1414-431X Braz J Med Biol Res 46(8) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/1b/84/1414-431X-bjmbr-46-08-0722.PMC3854413.pdf
http://s-provencher.com/pages/lcmodel.shtml; 2008.,Non-OADS,/arxiv_data1/oa_pdf/1b/84/1414-431X-bjmbr-46-08-0722.PMC3854413.pdf
"First published online July 30, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 643-649, http://dx.doi.org/10.1590/1414-431X20132979 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(8) 2013",Non-OADS,/arxiv_data1/oa_pdf/d9/f1/1414-431X-bjmbr-46-08-0643.PMC3854414.pdf
"First published online August 26, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 696-699, http://dx.doi.org/10.1590/1414-431X20132970 ISSN 1414-431X Short Communication Braz J Med Biol Res 46(8) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/e6/31/1414-431X-bjmbr-46-08-0696.PMC3854415.pdf
"First published online August 19, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 708-714, http://dx.doi.org/10.1590/1414-431X20133030 ISSN 1414-431X Braz J Med Biol Res 46(8) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/18/a7/1414-431X-bjmbr-46-08-0708.PMC3854416.pdf
"First published online August 19, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 715-721, http://dx.doi.org/10.1590/1414-431X20132626 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(8) 2013",Non-OADS,/arxiv_data1/oa_pdf/9a/cb/1414-431X-bjmbr-46-08-0715.PMC3854417.pdf
"All animals were maintained in compliance with the Guide for Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (NIH publication 27-89, revised 1996; http://www.nap.edu) to minimize suffering.",Non-OADS,/arxiv_data1/oa_pdf/9a/cb/1414-431X-bjmbr-46-08-0715.PMC3854417.pdf
"First published online August 26, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 676-680, http://dx.doi.org/10.1590/1414-431X20132896 ISSN 1414-431X Short Communication Braz J Med Biol Res 46(8) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/03/24/1414-431X-bjmbr-46-08-0676.PMC3854418.pdf
"First published online August 13, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 689-695, http://dx.doi.org/10.1590/1414-431X20132796 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(8) 2013",Non-OADS,/arxiv_data1/oa_pdf/0d/d9/1414-431X-bjmbr-46-08-0689.PMC3854419.pdf
"First published online July 30, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 681-688, http://dx.doi.org/10.1590/1414-431X20132620 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(8) 2013",Non-OADS,/arxiv_data1/oa_pdf/fb/fb/1414-431X-bjmbr-46-08-0681.PMC3854420.pdf
"First published online August 19, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 700-707, http://dx.doi.org/10.1590/1414-431X20133024 ISSN 1414-431X Braz J Med Biol Res 46(8) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/5a/85/1414-431X-bjmbr-46-08-0700.PMC3854421.pdf
"First published online August 13, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 650-658, http://dx.doi.org/10.1590/1414-431X20133003 ISSN 1414-431X Braz J Med Biol Res 46(8) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/64/14/1414-431X-bjmbr-46-08-0650.PMC3854422.pdf
"First published online August 13, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 670-675, http://dx.doi.org/10.1590/1414-431X20133050 ISSN 1414-431X Braz J Med Biol Res 46(8) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/72/06/1414-431X-bjmbr-46-08-0670.PMC3854423.pdf
"First published online September 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 780-788, http://dx.doi.org/10.1590/1414-431X20132940 ISSN 1414-431X Braz J Med Biol Res 46(9) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/6d/93/1414-431X-bjmbr-46-09-00780.PMC3854424.pdf
"First published online September 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 765-770, http://dx.doi.org/10.1590/1414-431X20132733 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(9) 2013",Non-OADS,/arxiv_data1/oa_pdf/8f/39/1414-431X-bjmbr-46-09-00765.PMC3854425.pdf
"First published online September 6, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 746-751, http://dx.doi.org/10.1590/1414-431X20132936 ISSN 1414-431X Braz J Med Biol Res 46(9) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/75/2a/1414-431X-bjmbr-46-09-00746.PMC3854426.pdf
"Protein bands were visualized by electrochemi- luminescence reagents (Pierce, USA), and films were evaluated densitometrically with the Gel-Pro Analyzer 4.0 software (http://gel-pro-analyzer.software.informer.com).",OADS,/arxiv_data1/oa_pdf/75/2a/1414-431X-bjmbr-46-09-00746.PMC3854426.pdf
"First published online August 30, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 803-808, http://dx.doi.org/10.1590/1414-431X20132902 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(9) 2013",Non-OADS,/arxiv_data1/oa_pdf/58/65/1414-431X-bjmbr-46-09-00803.PMC3854427.pdf
"First published online September 23, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 735-738, http://dx.doi.org/10.1590/1414-431X20132975 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(9) 2013",Non-OADS,/arxiv_data1/oa_pdf/3e/1f/1414-431X-bjmbr-46-09-00735.PMC3854428.pdf
"First published online September 6, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 797-802, http://dx.doi.org/10.1590/1414-431X20132694 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(9) 2013",Non-OADS,/arxiv_data1/oa_pdf/b5/5d/1414-431X-bjmbr-46-09-00797.PMC3854429.pdf
"First published online September 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 771-779, http://dx.doi.org/10.1590/1414-431X20133013 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(9) 2013",Non-OADS,/arxiv_data1/oa_pdf/11/13/1414-431X-bjmbr-46-09-00771.PMC3854430.pdf
http://riodb01.ibase.aist.go.jp/sdbs/.,Non-OADS,/arxiv_data1/oa_pdf/11/13/1414-431X-bjmbr-46-09-00771.PMC3854430.pdf
"First published online September 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 739-745, http://dx.doi.org/10.1590/1414-431X20132843 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(9) 2013",Non-OADS,/arxiv_data1/oa_pdf/91/77/1414-431X-bjmbr-46-09-00739.PMC3854431.pdf
"First published online September 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 809-814, http://dx.doi.org/10.1590/1414-431X20132929 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(9) 2013",Non-OADS,/arxiv_data1/oa_pdf/0f/25/1414-431X-bjmbr-46-09-00809.PMC3854432.pdf
"First published online August 23, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 789-796, http://dx.doi.org/10.1590/1414-431X20132856 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(9) 2013",Non-OADS,/arxiv_data1/oa_pdf/7c/e6/1414-431X-bjmbr-46-09-00789.PMC3854433.pdf
"First published online September 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 728-734, http://dx.doi.org/10.1590/1414-431X20133202 ISSN 1414-431X Review Braz J Med Biol Res 46(9) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/67/a2/1414-431X-bjmbr-46-09-00728.PMC3854434.pdf
"First published online September 23, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 758-764, http://dx.doi.org/10.1590/1414-431X20132907 ISSN 1414-431X Braz J Med Biol Res 46(9) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/61/23/1414-431X-bjmbr-46-09-00758.PMC3854435.pdf
"First published online September 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 752-757, http://dx.doi.org/10.1590/1414-431X20133232 ISSN 1414-431X Short Communication Braz J Med Biol Res 46(9) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/d3/07/1414-431X-bjmbr-46-09-00752.PMC3854436.pdf
"First published online May 24, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 513-520, http://dx.doi.org/10.1590/1414-431X20132853 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(6) 2013",Non-OADS,/arxiv_data1/oa_pdf/94/cb/0100-879X-bjmbr-46-06-513.PMC3854437.pdf
"First published online July 12, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 546-554, http://dx.doi.org/10.1590/1414-431X20131662 ISSN 1414-431X Braz J Med Biol Res 46(6) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/eb/47/1414-431X-bjmbr-46-06-546.PMC3854438.pdf
"First published online June 6, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 507-512, http://dx.doi.org/10.1590/1414-431X20132785 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(6) 2013",Non-OADS,/arxiv_data1/oa_pdf/23/5c/0100-879X-bjmbr-46-06-507.PMC3854439.pdf
"First published online May 28, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 486-501, http://dx.doi.org/10.1590/1414-431X20132643 ISSN 1414-431X Review Braz J Med Biol Res 46(6) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/46/0e/0100-879X-bjmbr-46-06-486.PMC3854440.pdf
"First published online June 25, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 539-545, http://dx.doi.org/10.1590/1414-431X20132757 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(6) 2013",Non-OADS,/arxiv_data1/oa_pdf/95/03/0100-879X-bjmbr-46-06-539.PMC3854441.pdf
CANCER Mondial Statistical Information S ystem (http://www-dep.iarc.fr/).,Non-OADS,/arxiv_data1/oa_pdf/95/03/0100-879X-bjmbr-46-06-539.PMC3854441.pdf
"First published online June 25, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 528-532, http://dx.doi.org/10.1590/1414-431X20132818 ISSN 1414-431X Braz J Med Biol Res 46(6) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/a7/8e/0100-879X-bjmbr-46-06-528.PMC3854442.pdf
http://en.wikipedia.org/wiki/Malondialdehyde.,Non-OADS,/arxiv_data1/oa_pdf/a7/8e/0100-879X-bjmbr-46-06-528.PMC3854442.pdf
"First published online May 24, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 502-506, http://dx.doi.org/10.1590/1414-431X20132850 ISSN 1414-431X Braz J Med Biol Res 46(6) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/ca/7c/0100-879X-bjmbr-46-06-502.PMC3854443.pdf
"First published online May 24, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 533-538, http://dx.doi.org/10.1590/1414-431X20132519 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(6) 2013",Non-OADS,/arxiv_data1/oa_pdf/03/71/1414-431X-bjmbr-46-06-533.PMC3854444.pdf
"First published online July 3, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 521-527, http://dx.doi.org/10.1590/1414-431X20132666 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(6) 2013",Non-OADS,/arxiv_data1/oa_pdf/79/9c/1414-431X-bjmbr-46-06-521.PMC3854445.pdf
"First published online July 3, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 465-485, http://dx.doi.org/10.1590/1414-431X20133086 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 46(6) 2013",Non-OADS,/arxiv_data1/oa_pdf/1d/2e/1414-431X-bjmbr-46-06-465.PMC3854446.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/88/rjs022.PMC3854482.pdf
"Keywords Tobacco smoke pollution, secondhand smoke, public policy, policy compliance, developing countriesThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/czs118.PMC3854491.pdf
"Keywords Obesity, Africa, policy, policy makers, decision making, stakeholdersThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/c1/czs125.PMC3854492.pdf
"https://apps.who.int/ infobase/Indicators.aspx, accessed 30 September 2012.",OADS,/arxiv_data1/oa_pdf/d8/c1/czs125.PMC3854492.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d8/c1/czs125.PMC3854492.pdf
"http://www.who.int/dietphysicalactivity/PA-promo- tionguide-2007.pdf, accessed 30 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/d8/c1/czs125.PMC3854492.pdf
"http://www.who.int/dietphysicalactiv- ity/childhood/child-obesity-eng.pdf, accessed 30 September 2012.870 HEALTH POLICY AND PLANNING",Non-OADS,/arxiv_data1/oa_pdf/d8/c1/czs125.PMC3854492.pdf
"Based on the MSA, amino acid sequence logos were generatedusing WebLogo (http://weblogo.berkeley.edu/logo.cgi) 61.T M hitanalysis (L/2 threshold) was performed online (http://bio-cluster.iis.sinica.edu.tw/TMhit/)28, with topological restraints introduced based on the published TMS boundaries for the Wzy Patopology map4.",OADS,/arxiv_data1/oa_pdf/ad/fc/srep03441.PMC3854497.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/fc/srep03441.PMC3854497.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3441 | DOI: 10.1038/srep03441 9",Non-OADS,/arxiv_data1/oa_pdf/ad/fc/srep03441.PMC3854497.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/d2/cwt083.PMC3854501.pdf
"Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, Ava i l ab l e f rom http://www.ncbi.nlm.nih.gov/books/NBK1908/ .",Non-OADS,/arxiv_data1/oa_pdf/7e/d2/cwt083.PMC3854501.pdf
"Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, A vailable from http://www.ncbi.nlm.nih.gov/books/ NBK1908/ .",Non-OADS,/arxiv_data1/oa_pdf/7e/d2/cwt083.PMC3854501.pdf
"Athens, GA: Complex Carbohydrate Research Center, University of Georgia ( http://www.glycam.com ).",Non-OADS,/arxiv_data1/oa_pdf/7e/d2/cwt083.PMC3854501.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/9e/cwt094.PMC3854502.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.037531.112.BIOINFORMATICS RNA 19:1317 –1326; © 2013; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1317,Non-OADS,/arxiv_data1/oa_pdf/e8/04/1317.PMC3854522.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038828.113.REPORT RNA 19:1349 –1354; © 2013; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1349,OADS,/arxiv_data1/oa_pdf/70/d8/1349.PMC3854525.pdf
( A) The individual RNA residues defining the pores as seen in Table 1 are high- lighted in red on a secondary structure diagram obtained from the Ribovision site (http://apollo.chemistry.gatech.edu/RiboVision).,OADS,/arxiv_data1/oa_pdf/70/d8/1349.PMC3854525.pdf
"Crystal structures were obtained from the Protein Data Bank (PDB, http://www.pdb.org).",OADS,/arxiv_data1/oa_pdf/70/d8/1349.PMC3854525.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039917.113.REPORT RNA 19:1355 –1362; © 2013; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1355,OADS,/arxiv_data1/oa_pdf/36/b9/1355.PMC3854526.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040048.113.REPORT RNA 19:1363 –1371; © 2013; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1363,OADS,/arxiv_data1/oa_pdf/8f/20/1363.PMC3854527.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038497.113.,OADS,/arxiv_data1/oa_pdf/05/85/1384.PMC3854529.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038653.113.,OADS,/arxiv_data1/oa_pdf/82/e5/1394.PMC3854530.pdf
miRNA-specific primers sme-miR-2169-5p RT primer: CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTG AGATCAGATC FR primer: ACACTCCAGCTGGGAACTTTGAAATTC sme-miR-2152 RT primer: CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTG AGAAAGAGAG FR primer: ACACTCCAGCTGGGGGGTTCGAAGTATG sme-miR-124c RT primer: CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTG AGTGGCATTC FR primer: ACACTCCAGCTGGGTAAGGCACGCGGTUniversal Reverse primer: TGGTGTTCGTGGAGTCGGCAATTC AGTTG Solexa RT primer: CTCAACTGGTGTCGTGGAGTCGGCAATTC AGTTGAGGATCGTCG Solexa FR primer: ACACTCCAGCTGGGGTTCAGAGTTCTACAGSolexa RNA adaptor sequence: GUUCAGAGUUCUACAGCGAC GAUC DATA DEPOSITION The small RNA sequencing data have been deposited at the NCBI Sequence Read Archive (SRA) at http://www.ncbi.nlm.nih.gov/sra(accession number SRA065477).,Non-OADS,/arxiv_data1/oa_pdf/82/e5/1394.PMC3854530.pdf
"SUPPLEMENTAL MATERIAL Supplemental material is available for this article, and codes ofLS-RSMR are available at http://sse.tongji.edu.cn/yingshen/RSMR/LS_RSMR.html.ACKNOWLEDGMENTS We thank Dr. Yashoda Ghanekar and Palakodeti lab members forproofreading and helpful comments.",Non-OADS,/arxiv_data1/oa_pdf/82/e5/1394.PMC3854530.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040428.113.,OADS,/arxiv_data1/oa_pdf/3c/a1/1405.PMC3854531.pdf
2011) by using the tblastn algorithmin SilkBase (http://silkbase.ab.a.u-tokyo.ac.jp/cgi-bin/index.,OADS,/arxiv_data1/oa_pdf/3c/a1/1405.PMC3854531.pdf
"Determination of full-length cDNA sequence of BmPAPI by RACE From SilkBase (http://silkbase.ab.a.u-tokyo.ac.jp/cgi-bin/index.cgi), we retrieved the BGIBMGA007473 GeneModel sequence as a signif-icant homolog to Drosophila PAPI; this gene was named BmPAPI .",OADS,/arxiv_data1/oa_pdf/3c/a1/1405.PMC3854531.pdf
The structureof the BmPAPI gene was determined by comparing the identified BmPAPI sequence with the B. mori genome sequence obtained from SilkDB (http://www.silkdb.org/silkdb/).,OADS,/arxiv_data1/oa_pdf/3c/a1/1405.PMC3854531.pdf
Remaining reads were aligned to the B. mori (bm0) genome (downloaded from SilkDB; http://www.silkdb.org/silkdb/) usingthe BWA alignment program (Li and Durbin 2009) with default pro-gram parameters allowing for 0.04 fraction of missing alignmentsgiven a 2% uniform base error rate.,OADS,/arxiv_data1/oa_pdf/3c/a1/1405.PMC3854531.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038547.113.,OADS,/arxiv_data1/oa_pdf/9e/de/1419.PMC3854532.pdf
5 ′→3′exoribonucleases derive from the pfam XRN_N protein family (http://pfam.sanger.ac.uk/).,Non-OADS,/arxiv_data1/oa_pdf/9e/de/1419.PMC3854532.pdf
"Consistent with a role in this process, XRNE is predicted by Nuc- Pred (http://www.sbc.su.se/~maccallr/nucpred/cgi-bin/single.cgi) to have 85% probability of nuclear localization and is predicted by motifscan (http:// myhits.isb-sib.ch/cgi-bin/motif_scan) to con- tain a bipartite nuclear localization signal (NLS).",OADS,/arxiv_data1/oa_pdf/9e/de/1419.PMC3854532.pdf
"2006) and searched using the X!Tandem search engine (Craig and Beavis 2004) against T. brucei protein database v. 4.0 (ftp://ftp.sanger.ac.uk/pub/databases/T.bru-cei_sequences/T.brucei_genome_v4/), which included additional TABLE 2.",OADS,/arxiv_data1/oa_pdf/9e/de/1419.PMC3854532.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038893.113.,OADS,/arxiv_data1/oa_pdf/74/62/1432.PMC3854533.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.038117.113.METHOD RNA 19:1449 –1459; © 2013; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1449,Non-OADS,/arxiv_data1/oa_pdf/ce/40/1449.PMC3854534.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/2c/rjs014.PMC3854545.pdf
Available at: http://www.alz.co.uk/ research/world-report; last accessed 23 October 2013.American Psychiatric Association .,Non-OADS,/arxiv_data1/oa_pdf/70/d9/S1041610213001804a.PMC3854552.pdf
© Cambridge University Press 2013 doi:10.1017/S0033291713000561ORIGINAL ARTICLE The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.The written permission of Cambridge University Press must be obtained for commercial re-use.,Non-OADS,/arxiv_data1/oa_pdf/ac/e4/S0033291713000561a.PMC3854554.pdf
Stat- istical inferences were made at p<0.05 after family- wise error (FWE) correction for multiple comparisons.Regions reported in Tables S1 –S9 of the Supple- mentary material were identi ﬁed using the Automated Anatomical Labeling atlas as implemented inPickAtlas software (http://fmri.wfubmc.edu/software/ PickAtlas).,OADS,/arxiv_data1/oa_pdf/ac/e4/S0033291713000561a.PMC3854554.pdf
Supplementary material For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0033291713000561.,Non-OADS,/arxiv_data1/oa_pdf/ac/e4/S0033291713000561a.PMC3854554.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/d9/rjt102.PMC3854653.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/85/CCGTM-7-9.PMC3854659.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License  (http://creativecommons.org/licenses/by -nc/3.0/) which permits unrestricted, non -commercial  use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/2e/CCGTM-7-21.PMC3854661.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/86/CCGTM-7-16.PMC3854662.pdf
"This is an open access article licensed under the terms of the Creati ve Commons Attribution Non -Commercial License  (http://creativecommons.org/licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/ab/CCGTM-7-1.PMC3854663.pdf
"http://informahealthcare.com/bij ISSN: 0269-9052 (print), 1362-301X (electronic) Brain Inj, 2013; 27(13–14): 1685–1691 !2013 Informa UK Ltd. DOI: 10.3109/02699052.2013.831128 ORIGINAL ARTICLE Modulation of cortical vestibular processing by somatosensory inputs in the posterior insula Teruo Hashimoto1, Miki Taoka1, Shigeru Obayashi2, Yukihiro Hara2, Michio Tanaka1, & Atsushi Iriki1 1Laboratory for Symbolic Cognitive Development, RIKEN Brain Science Institute, Wako, Japan and2Department of Rehabilitation Medicine, Nippon Medical School Chiba-Hokusoh Hospital, Inzai, Japan Abstract Primary objective : To study the mechanism of somatosensory-vestibular interactions, this study examined the effects of somatosensory inputs on body sway induced by galvanic vestibular stimulation (GVS) in healthy participants and persons with brain injury in the posterior insula, a region constituting a part of the parietoinsular vestibular cortex.Research design : This study adopted an experimental, controlled, repeated measures design.",Non-OADS,/arxiv_data1/oa_pdf/5e/2b/BIJ-27-1685.PMC3854664.pdf
"London: University College London; 2010; [Accessed March 2013]; Available:  http://discovery.ucl.ac.uk/64-5676/1/645676.pdf  [15] Zhang JH, Chung TD, Oldenburg KR.",Non-OADS,/arxiv_data1/oa_pdf/9e/e7/CCGTM-7-30.PMC3854666.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/e7/CCGTM-7-30.PMC3854666.pdf
"The NHS Information Centre, Leeds, UK, 2009. http://www.ic.nhs.uk/pubs/hse08physicalactivity (accessed Jun 2010).",Non-OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
http://www.nice.org.uk/aboutnice/qof/Indicators.jsp (accessed Jun 2010).,OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/AnnualReports/Browsable/DH_5330236 (accessed Jun 2010).,OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
"Batt M. London 2012: Legacy A Position Paper from the Faculty of Sport and Exercise Medicine, 2009. http://www.fsem.co.uk/DesktopModules/Documents/DocumentsView.aspx?tabID=0&ItemID=114641&MId=5288&wversion=Staging.",Non-OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
"London, 2009. http://www.london.nhs.uk/webﬁ  les/Independent%20inquiries/Developing%20physical%20activity%20and%20health%20legacy%20-%20full%20report.pdf (accessed Jun 2010).",Non-OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
"Sport England, press release, 11 March 2009. http://www.sportengland.org/media_centre/press_releases/building_partnerships.aspx (accessed Jun 2010).",Non-OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
"Gibson O, Higgins C. The Guardian, 25 May 2010. http://www.guardian.co.uk/politics/2010/may/25/arts-sport-facing-budget-cuts (accessed Jun 2010).",Non-OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
"The Boorman Review, 2009. http://www.nhshealthandwellbeing.org/pdfs/NHS%20HWB%20Review%20Interim%20Report%20190809.pdf (accessed Jun 2010).",Non-OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
"Four Commonly Used Methods to Increase Physical Activity: Brief Interventions in Primary Care, Exercise Referral Schemes, Pedometers and Community-based Exercise Programmes for Walking and Cycling, 2006.  http://guidance.nice.org.uk/PH2  (accessed  Jun 2010).",Non-OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
"Department of Health, 2009:28 http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_105944.pdf (accessed Jun 2010).",OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_101579.pdf (accessed Jun 2010).,OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/terms, provided the original work is properly cited and the use iswork non-commercially, and license their derivative works on different license, which permits others to distribute, remix, adapt, build upon thisCreative Commons Attribution Non Commercial (CC BY-NC 3.0) This is an Open Access article distributed in accordance with the serviceEmail alerting the box at the top right corner of the online article.Receive free email alerts when new articles cite this article.",Non-OADS,/arxiv_data1/oa_pdf/c7/be/bjsports73726.PMC3854667.pdf
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_114012.pdf (accessed 26 May 2011) .,OADS,/arxiv_data1/oa_pdf/af/e5/bjsports-2011-084186.PMC3854668.pdf
http://www.health.gov/paguidelines/pdf/paguide.pdf (accessed 26 May 2011) .,Non-OADS,/arxiv_data1/oa_pdf/af/e5/bjsports-2011-084186.PMC3854668.pdf
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4080981.pdf (accessed 26 May 2011) .,OADS,/arxiv_data1/oa_pdf/af/e5/bjsports-2011-084186.PMC3854668.pdf
http://www.gmc-uk.org/static/documents/content/GMP_0910.pdf (accessed 26 May 2011)  .,Non-OADS,/arxiv_data1/oa_pdf/af/e5/bjsports-2011-084186.PMC3854668.pdf
"Department of Health  ,   2009  :  28     http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_105944.pdf .",OADS,/arxiv_data1/oa_pdf/af/e5/bjsports-2011-084186.PMC3854668.pdf
"Health Survey for England –  2008: Physical Activity and Fitness , 2009.  http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles-related-surveys/health-survey-for-england/health-survey-for-england--2008-physical-activity-and-ﬁ  tness .",Non-OADS,/arxiv_data1/oa_pdf/af/e5/bjsports-2011-084186.PMC3854668.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/terms, provided the original work is properly cited and the use iswork non-commercially, and license their derivative works on different license, which permits others to distribute, remix, adapt, build upon thisCreative Commons Attribution Non Commercial (CC BY-NC 3.0) This is an Open Access article distributed in accordance with the serviceEmail alerting the box at the top right corner of the online article.Receive free email alerts when new articles cite this article.",Non-OADS,/arxiv_data1/oa_pdf/af/e5/bjsports-2011-084186.PMC3854668.pdf
"Recent advances in treatment of acute coronary syndromes Bhuvnesh Aggarwal 1 and Venu Menon 2 * Addresses: 1 Departments of Internal Medicine, 9500 Euclid Avenue, Cleveland, Ohio 44114, USA; 2 Cardiovascular Medicine Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44114, USA * Corresponding author: Venu Menon (menonv@ccf.org) F1000Prime Reports 2013, 5:56 (doi:10.12703/P5-56) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/56 Abstract In this manuscript we highlight recent advances in the management of acute coronary syndromes.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"For prasugrel, the recommen- dations state that it should be utilized only in patients Page 2 of 10 (page number not for citation purposes) F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"Thisstudy randomized 3,229 patients with NSTE –ACSandaplanned Page 3of10 (page number notforcitation purposes) F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"Although there were no improvements in ejection fraction at 12 months, Page 4 of 10 (page number not for citation purposes) F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"The investigators reported an 80% reduction in 30 –day bleeding and access site complication Page 5 of 10 (page number not for citation purposes) F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"Page 6 of 10 (page number not for citation purposes) F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"Roe MT, Armstrong PW, Fox KAA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng C, Merkely B, Page 7 of 10 (page number not for citation purposes) F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"Mega JL, Braunwald E, Murphy SA, Plotnikov AN, Burton P, Kiss RG, Parkhomenko A, Tendera M, Widimsky P, Gibson CM: Rivaroxaban in patients stabilized after a ST-segment elevation myocar-dial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addi- tion to Standard Therapy in Subjects with Acute Coronary Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
[http://www.prnewswire.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
[http://press.healthcare.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"Vlaar PJ, Svilaas T, van der Horst IC, Diercks GFH, Fokkema ML, Smet BJGL de, van den Heuvel AFM, Anthonio RL, Jessurun GA, Tan E, Suurmeijer AJH, Zijlstra F: Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:56 http://f1000.com/prime/reports/m/5/56",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/medrep-05-56.PMC3854689.pdf
"Acute pain medicine in anesthesiology André P. Boezaart1,2*, Anastacia P. Munro2and Patrick J. Tighe2 Addresses:1Department of Orthopaedic Surgery, University of Florida College of Medicine, 1600 SW Archer Road, PO Box 100254, Gainesville, FL 32610, USA;2Department of Anesthesiology, Division of Acute and Perioperative Pain Medicine, University of Florida College of Medicine, 1600 SW Archer Road, PO Box 100254, Gainesville, FL 32610, USA * Corresponding author: André P. Boezaart (aboezaart@anest.ufl.edu) F1000Prime Reports 2013, 5:54 (doi:10.12703/P5-54) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/54 Abstract The American Academy of Pain Medicine and the American Society for Regional Anesthesia have recently focused on the evolving practice of acute pain medicine.,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
"Complementary supplementation The current reliance on pharmacological modalities,specifically opioids, as the primary method of pain controlhas led to their misuse, to increased incidences of toleranceand addiction, as well as to increased adverse side effectssuch as hyperalgesia, pruritus, and postoperative nausea.A dedicated APS focuses on multimodal analgesia while minimizing the use of opioids and promotes alternative Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:54 http://f1000.com/prime/reports/m/5/54",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
"Expanding on the 2010 guidelines forfellowship training [24], several changes were proposedthat suggest a more holistic and multimodal approachmust take place, including placing more emphasis on the APM physician as a consultant who is able to integrate Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:54 http://f1000.com/prime/reports/m/5/54",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
"treating acute pain in all surgical phases in the hopes of preventing chronic pain and debilitation),future research can center on the patient as a whole and on Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:54 http://f1000.com/prime/reports/m/5/54",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
[http://www.nhmrc.gov.au/_files_nhmrc/ publications/attachments/cp135_emergency_acute_pain_management_ manual.pdf] 3.,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
"Royal College of Surgeons of England, The College of Anesthetists: Pain after surgery; 1990 [http://www.rcoa.ac.uk/system/files/FPM- Pain-After-Surgery.pdf] 4.",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
[http://mpog.med.,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
"pressganey.com/Documents_secure/Pulse%20Reports/Hospital_Pulse_Report_2009.pdf?viewFile] Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:54 http://f1000.com/prime/reports/m/5/54",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:54 http://f1000.com/prime/reports/m/5/54",Non-OADS,/arxiv_data1/oa_pdf/a7/1a/medrep-05-54.PMC3854690.pdf
"The rise of the Type VI secretion system Alain Filloux Address: Imperial College London, Department of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, South Kensington Campus, Flowers Building, London SW7 2AZ, UK Email: a.filloux@imperial.ac.uk F1000Prime Reports 2013, 5:52 (doi:10.12703/P5-52) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/52 Abstract Bacterial cells have developed multiple strategies to communicate with their surrounding environment.,Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
"The function of the phage gp27/gp5 puncturing device is to create a hole in the outer membrane of the target cell Page 2 of 8 (page number not for citation purposes) F1000Prime Reports 2013, 5:52 http://f1000.com/prime/reports/b/5/52",Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
"Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:52 http://f1000.com/prime/reports/b/5/52",Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
"Page 4 of 8 (page number not for citation purposes) F1000Prime Reports 2013, 5:52 http://f1000.com/prime/reports/b/5/52",Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
"Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:52 http://f1000.com/prime/reports/b/5/52",Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
"Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:52 http://f1000.com/prime/reports/b/5/52",Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
"Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:52 http://f1000.com/prime/reports/b/5/52",Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:52 http://f1000.com/prime/reports/b/5/52",Non-OADS,/arxiv_data1/oa_pdf/69/18/biolrep-05-52.PMC3854691.pdf
"Nicolette Theriault New and alternative approaches to tackling antibiotic resistance Address: TranScrip Partners LLC, 2941 Honeymead Road, Downington, PA 19335, USA * Corresponding author: Glenn S. Tillotson (glenn.tillotson@transcrip-partners.com) F1000Prime Reports 2013, 5:51 (doi:10.12703/P5-51) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/51 Abstract Multidrug-resistant bacteria are becoming more common and due to their multiplicity of mechanisms, they are frequently resistant to many if not all of the current antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"Page 2 of 9 (page number not for citation purposes) F1000Prime Reports 2013, 5:51 http://f1000.com/prime/reports/b/5/51",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
POL7080 has completed Phase I studies in healthy volunteers (please see http://www.polyphor.com/ products/pol7080).,Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"Clinical response of brilacidin (PMX-30063) and daptomycin in acute bacterial skin and skin structure infections: a Phase II study Clinical response Low dose Medium dose High dose Daptomycin N=5 2 N=5 4 N=5 4 N=5 5 Day 3 94.4% 90.7% 81.5% 90.6% Day 7 87.0% 92.6% 83.3% 96.2% Sustained response Day 10 90.2% 91.8% 95.5% 97.9% Day 28 95.7% 89.6% 95.6% 98.0% Page 3 of 9 (page number not for citation purposes) F1000Prime Reports 2013, 5:51 http://f1000.com/prime/reports/b/5/51",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"Bacterial cells are typically in the micrometer range in size with cell wall peptido- Page 4 of 9 (page number not for citation purposes) F1000Prime Reports 2013, 5:51 http://f1000.com/prime/reports/b/5/51 E. coli Mutations in these residues disrupt mannose",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"Thus QS could be a Page 5 of 9 (page number not for citation purposes) F1000Prime Reports 2013, 5:51 http://f1000.com/prime/reports/b/5/51",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"Comparison of developmental Beta-lactam/Beta-lactamase inhibitor combinations Beta-lactam Beta-lactamase inhibitor Ratio Company Comment Ceftolozane tazobactam 2:1 Cubist Active vs Pseudomonas aeruginosa Ceftazidime avibactam 4:1 A-Z Active vs ESBLs Ceftaroline avibactam 1:1 Forest/Cerexa Active vs ESBLs Imipenem-cilastatin MK 7655 2:2:1 Merck Active vs carbapenemase Imipenem-cilastatin MK 7655 4:4:1 Merck Active vs carbapenemase Meropenem RPX7009 1:1 Rempex Active vs class A serine carbapenemases, + Pseudomonas sp ecies Page 6 of 9 (page number not for citation purposes) F1000Prime Reports 2013, 5:51 http://f1000.com/prime/reports/b/5/51",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"shareholder.com/downloads/ABEA-4ITCYZ/1997024712x0x611205/ FEA66C67-D02F-4FF2-B230-AA711F46ED7F/PMX-30063_Antibiotic_ Fact_Sheet_Nov_2012_.pdf] Page 7 of 9 (page number not for citation purposes) F1000Prime Reports 2013, 5:51 http://f1000.com/prime/reports/b/5/51 aureus factor regulation; QS, quorum sensing; UPEC, uropathogenic infection; ZnO, Zinc Oxide.",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"Page 8 of 9 (page number not for citation purposes) F1000Prime Reports 2013, 5:51 http://f1000.com/prime/reports/b/5/51 20.",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
[http://tphase.com/pipeline/ overview/eravacycline/default.cfm.],OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"Page 9 of 9 (page number not for citation purposes) F1000Prime Reports 2013, 5:51 http://f1000.com/prime/reports/b/5/51",Non-OADS,/arxiv_data1/oa_pdf/ed/a2/biolrep-05-51.PMC3854692.pdf
"Microglia –the brain ’s busy bees James C. Cronk and Jonathan Kipnis* Address: Center for Brain Immunology and Glia, Department of Neuroscience and Graduate Program in Neuroscience, Medical Scientist Training Program, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA * Corresponding author: Jonathan Kipnis (kipnis@virginia.edu) F1000Prime Reports 2013, 5:53 (doi:10.12703/P5-53) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/53 Abstract Recent years have seen significant changes in the way scientists view microglia and their role in health and disease.,Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"IL-34 LacZ reporter mice, in which the IL-34 locus has been replaced with a LacZ reporter gene and are therefore functional IL-34 knockouts, revealed that IL-34 is expressed in a tissue-specific manner, and is particu- larly important in certain regions of the CNS and in the Page 3 of 10 (page number not for citation purposes) F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"Gautier EL, Shay T, Miller J, Greter M, Jakubzick C, Ivanov S, Helft J, Chow A, Elpek KG, Gordonov S, Mazloom AR, Ma'ayan A, Chua W, Hansen TH, Turley SJ, Merad M, Randolph GJ: Gene-expression profiles and transcriptional regulatory pathways that Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:53 http://f1000.com/prime/reports/b/5/53",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/biolrep-05-53.PMC3854698.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/terms, provided the original work is properly cited and the use iswork non-commercially, and license their derivative works on different license, which permits others to distribute, remix, adapt, build upon thisCreative Commons Attribution Non Commercial (CC BY-NC 3.0) This is an Open Access article distributed in accordance with the serviceEmail alerting the box at the top right corner of the online article.Receive free email alerts when new articles cite this article.",Non-OADS,/arxiv_data1/oa_pdf/b5/8c/heart186593.PMC3854700.pdf
This approach has several advan-tages 16 17: post-traumatic stress can easily be measured  in larger samples by means of the PDS; post-traumatic stress can be detected in patients who may benefit from therapeutic interventions despite not having full PTSD; and ongoing revision of the diagnostic crite-ria of PTSD cannot affect the validity of the results (http://pn.psychiatryonline.org/content/45/10/8.full; last accessed 14 June 2010).,Non-OADS,/arxiv_data1/oa_pdf/87/95/flgastro-2010-002733.PMC3854716.pdf
See: http://creativecommons.org/licenses/by- nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/87/95/flgastro-2010-002733.PMC3854716.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/c8/rjs019.PMC3854785.pdf
Published by Elsevier B.V.  http://dx.doi.org/10.1016/j.virusres.2013.09.034Open access under CC BY-NC-SA license.,OADS,/arxiv_data1/oa_pdf/0f/4e/main.PMC3854842.pdf
Densitometry  was  carried  out  using  the  image  J  system (http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/0f/4e/main.PMC3854842.pdf
Reagent  Action  Minimumconcentration EGTA  Open  cores  in  Ca2+and  Mg2+free  solution  200  /H9262M Ca2+Stabilise cores  in  EGTA  buffered  solution  50  /H9262M Mg2+Stabilise  cores  in  EGTA  buffered  solution  300  /H9262M Spermidine3+Stabilise  cores  in  buffered  solution  50  /H9262M Cobalthexamine3+Stabilise  cores  in  buffered  solution  40  /H9262M Differences  in  the  slopes  and  intercepts  were  assessed  by  the ANCOVA  test  (http://ude1.edu/ ∼mcdonald/statancova.html ).,OADS,/arxiv_data1/oa_pdf/0f/4e/main.PMC3854842.pdf
*  Determined  by  densito- metric  analysis  of  scanned  autoradiograph  using  the  Image  J  programme  ‘Image  J’ (http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/0f/4e/main.PMC3854842.pdf
Cold  Slope  Intercept  N  R  P  Slope RNA RNA  ratio RV  RV  y  =  0.384 x  +  3.422  16  0.853  <0.001 RV  HIV  y  =  0.341 x  +  6.009  12  0.783  <0.003  0.89 HIV  HIV  y  =  0.276 x  +  8.226  16  0.732  <0.001 HIV RV  y  =  0.239 x  +  11.453  28  0.730  <0.001  0.87 RV  hom HIV hom 0.72 RV het HIV het  0.70 The  slopes  and  intercepts  were  found  not  to  differ  signiﬁcantly  by  the  ANCOVA  test (http://ude1.edu/ ∼mcdonald/statancova.html ).,OADS,/arxiv_data1/oa_pdf/0f/4e/main.PMC3854842.pdf
"Supplementary  data Supplementary  material  related  to  this  article  can  be  found, in  the  online  version,  at  http://dx.doi.org/10.1016/j.virusres.2013.",OADS,/arxiv_data1/oa_pdf/0f/4e/main.PMC3854842.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/e6/rjt080.PMC3854853.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/rjs011.PMC3854914.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/cc/btt-7-259.PMC3854916.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2013:7 259–264Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  259Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BTT .S5200 3effects of 6 months of abatacept   treatment on aortic stiffness in patients   with rheumatoid arthritis sylvain Mathieu1,2 Marion couderc1,2 Baptiste glace1,2 Bruno Pereira2,3 anne T ournadre1,2 Jean-Jacques Dubost1,2 Martin soubrier1,2 1Department of rheumatology,   gabriel-Montpied hospital, 2Faculty  of Medicine, University clermont 1,   3Délégation de la recherche clinique,   gabriel-Montpied hospital,    clermont-Ferrand, France correspondence: sylvain Mathieu   hôpital gabriel-Montpied, service   de rhumatologie, Place h Dunant,   63000 clermont-Ferrand, France   Tel +33 4 73 75 14 88   Fax +33 4 73 75 14 89   email smathieu@chu-clermontferrand.f rBackground:  Systemic inflammation plays an important role in the increased cardiac risk  observed in rheumatoid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/39/cc/btt-7-259.PMC3854916.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/39/cc/btt-7-259.PMC3854916.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/39/cc/btt-7-259.PMC3854916.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/000955/WC500054890.,Non-OADS,/arxiv_data1/oa_pdf/39/cc/btt-7-259.PMC3854916.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/idr-6-225.PMC3854917.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2013:6 225–233Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  225ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S4600 2antibiotic sensitivity pattern of uropathogens   from pregnant women with urinary tract   infection in abakaliki, nigeria Rc Onoh1 OUJ Umeora1 Ve egwuatu2 PO ezeonu1 TJP Onoh3 1Department of Obstetrics and  gynecology, Federal T eaching hospital  abakaliki, ebonyi state, n igeria;   2Department of Obstetrics and  gynecology, enugu state University  T eaching hospital, enugu state,   nigeria; 3Department of Pathology,   Federal T eaching hospital abakaliki,   ebonyi state, nigeria correspondence: Rc Onoh   Department of Obstetrics and   gynecology, Federal Teaching hospital  abakaliki, ebonyi state, PMB 102,   480001, nigeria   Tel +234 803 700 7519   email dronohrc@gmail.co mBackground:  Urinary tract infection (UTI) is a common bacterial infection during  pregnancy and a significant cause of perinatal and maternal morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/7a/bb/idr-6-225.PMC3854917.pdf
Available from: http://emedicine.medscape.com/article/452604- overview.,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/idr-6-225.PMC3854917.pdf
Available from: http://www.Onlinenigeria.com/links/ebonyiadv.,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/idr-6-225.PMC3854917.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/7a/bb/idr-6-225.PMC3854917.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/idr-6-225.PMC3854917.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/e5/ijn-8-4613.PMC3854918.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4613–4622International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4613OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5414 2effect of Peg-PDlla polymeric nanovesicles  loaded with doxorubicin and hematoporphyrin  monomethyl ether on human hepatocellular  carcinoma hepg2 cells in vitro guang-hua Xiang1,2,* guo-Bin hong2,3,* Y ong Wang2 Du cheng2 Jing-Xing Zhou1 Xin-Tao shuai2 1Department of radiology, sun  Yat-sen Memorial hospital, sun  Yat-sen University, guangzhou,  People’s republic of china; 2PcFM  laboratory of Ministry of education,  school of chemistry and chemical  engineering, sun Yat- sen University,  guangzhou, People’s republic of  china; 3Department of radiology,  Fifth affiliated hospital, sun Yat- sen  University, Zhuhai, People’s republic  of china *These two authors contributed  equally to this work correspondence: Du cheng   PcFM laboratory of Ministry of  education, school of chemistry and  chemical, engineering, sun Yat-sen  University, guangzhou 510275,   People’s republic of china   email chengdu@mail.sysu.edu.c n    Jing-Xing Zhou   Department of radiology, sun Yat- sen Memorial hospital, sun Yat-sen  University, guangzhou 510120,   People’s republic of china   email gdzhoujx@163.co mObjective:  To evaluate the cytotoxicity of poly(ethylene glycol)-block-poly(D,L-lactic acid)  (PEG-PDLLA) nanovesicles loaded with doxorubicin (DOX) and the photosensitizer hemato - porphyrin monomethyl ether (HMME) on human hepatocellular carcinoma HepG2 cells and  to investigate potential apoptotic mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/d0/e5/ijn-8-4613.PMC3854918.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d0/e5/ijn-8-4613.PMC3854918.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d0/e5/ijn-8-4613.PMC3854918.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/e5/ijn-8-4613.PMC3854918.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/79/cia-8-1611.PMC3854920.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1611–1616Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1611OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5277 8relation between the ankle-brachial index   and the complexity of coronary artery   disease in older patients Felipe José de Andrade  Falcão1 Cláudia Maria rodrigues  Alves1 Adriano Caixeta1 leonardo de Freitas  guimarães1 Juscélio Trajano de sousa  Filho2 Juliana A soares2 Izo helber2 Antônio C Carvalho1 1Department of Interventional  Cardiology, 2Department of Cardiology,  Federal University of são Paulo,  são Paulo, Brazil Correspondence: Felipe José de Andrade  Falcão   rua Isaac salazar 102/902, recife,  Pernambuco, Brazil   Tel +55 87 9921 6886   email felipejaf@gmail.co mBackground:  In the elderly, the ankle-brachial index (ABI) has greater than 90% sensitivity  and specificity for peripheral artery disease identification.",Non-OADS,/arxiv_data1/oa_pdf/e7/79/cia-8-1611.PMC3854920.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e7/79/cia-8-1611.PMC3854920.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/79/cia-8-1611.PMC3854920.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/3d/cia-8-1591.PMC3854921.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1591–1601Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1591OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4461 4effectiveness of a lifestyle exercise program for  older people receiving a restorative home care  service: a pragmatic randomized controlled trial elissa Burton1,2 gill lewin1,2 lindy Clemson3 Duncan Boldy4 1Faculty of health sciences, Curtin  University, Perth, WA, Australia;   2research Department, silver Chain,   Perth, WA, Australia; 3health and  Work research Unit, The University  of sydney, sydney, nsW, Australia;   4school of n ursing and Midwifery,   Curtin University, Perth, WA, Australia Correspondence: elissa Burton   Faculty of health sciences, Curtin  University, gPO Box U1987, Perth,  WA 6845, Australia   Tel +61 8 9266 7993   email e .burton@curtin.edu.a uBackground:  Restorative home care services are short-term and aimed at maximizing a person’ s  ability to live independently.",Non-OADS,/arxiv_data1/oa_pdf/d8/3d/cia-8-1591.PMC3854921.pdf
Available from: http://www.abs.gov.au/Ausstats/abs@.,Non-OADS,/arxiv_data1/oa_pdf/d8/3d/cia-8-1591.PMC3854921.pdf
Available from: http://www.pc.gov.,Non-OADS,/arxiv_data1/oa_pdf/d8/3d/cia-8-1591.PMC3854921.pdf
Available from: http://www.acc.,Non-OADS,/arxiv_data1/oa_pdf/d8/3d/cia-8-1591.PMC3854921.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d8/3d/cia-8-1591.PMC3854921.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/3d/cia-8-1591.PMC3854921.pdf
Available from: https://www.anzctr.org.au/ Trial/Registration/TrialReview.aspx?id=335813&showOriginal=true.,Non-OADS,/arxiv_data1/oa_pdf/d8/3d/cia-8-1591.PMC3854921.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/d6/ijn-8-4623.PMC3854922.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4623–4629International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4623OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5106 5evaluation of glycophenotype in breast cancer   by quantum dot-lectin histochemistry camila g andrade1 Paulo e cabral Filho2 Denise P l T enório3 Beate s santos4 eduardo Ic Beltrão1 adriana Fontes2 luiz B carvalho Jr1 1Keizo asami Immunopathology  laboratory, 2Biophysics and  radiobiology Department,   3Fundamental chemistry Department,   4Pharmaceutical science Department,   Federal University of Pernambuco,   recife, Pernambuco, Brazil correspondence: adriana Fontes   av Prof Moraes rego, s/N, Departamento   de Biofísica e radiobiologia, ccB, UFPe,   50670-901, recife, Pernambuco, Brazil   Tel +55 81 2126 7819   Fax +55 81 2126 8560   email adriana.fontes@pesquisador.cnpq.b rAbstract:  Cell surface glycoconjugates play an important role in differentiation/dedifferentia - tion processes and lectins are employed to evaluate them by several methodologies.",Non-OADS,/arxiv_data1/oa_pdf/d5/d6/ijn-8-4623.PMC3854922.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d5/d6/ijn-8-4623.PMC3854922.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/d6/ijn-8-4623.PMC3854922.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/c1/btt-7-247.PMC3854923.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2013:7 247–258Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  247Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5300 7Optimizing therapeutics in the management   of patients with multiple sclerosis: a review   of drug efficacy, dosing, and mechanisms of action Kavitha Damal emily Stoker John F Foley Rocky Mountain Multiple Sclerosis  Research Group, Salt Lake City,    UT, USA Correspondence: John F Foley   Rocky Mountain Multiple Sclerosis  Research Group, 370 East   9th Avenue – Suite 106, Salt Lake City,   UT 84103, USA   Tel +1 801 408 5700   email jfoley@rockymountainmsclinic.co mAbstract:  Multiple sclerosis (MS) is a debilitating neurological disorder that affects nearly  2 million adults, mostly in the prime of their youth.",Non-OADS,/arxiv_data1/oa_pdf/98/c1/btt-7-247.PMC3854923.pdf
"Over 95%  of this adhesion was significantly inhibited by antibodies  against the integrin molecule α4β1 (very late-activation  antigen 4 [VLA-4]), a glycoprotein surface molecule found  on all leukocytes except neutrophils.57 Administration of the  antibodies reduced the progression of inflammatory disease  severity in MS patients (MRI lesions),59,60 and prevented the  development of paralysis in animal studies.61 Hence, it was  hypothesized that monoclonal antibodies against VLA-4  could help with treating autoimmune inflammatory diseases  such as MS by blocking the VCAM-1/VLA-4 interaction,  and preventing infiltration of leukocytes across the BBB.57,58  In early 2000, natalizumab (Antegren; Elan, Dublin, Ireland,  and Biogen Idec Inc.), an α4-integrin humanized monoclonal  antibody to VLA-4, was developed.62 Natalizumab specifically  targets the T cells63 and inhibits the α4-integrin-mediated firm  adhesion of T cells to the inflamed BBB by 70%, but does  not interfere with the initial contact of T cells with the BBB,  suggesting that the central mechanism of natalizumab action  is prevention of T cell entry into the CNS.64 After establishment of the relative safety profile in  a Phase I clinical trial,65 Phase II and Phase III double- blind placebo-controlled trials demonstrated its efficacy in  reducing ARR, especially in patients with higher disease  activity.60,66 The FDA subsequently approved natalizumab  (Tysabri; Biogen Idec Inc.) as an MS monotherapy in 2004  (http://www.accessdata.fda.gov/drugsatfda_docs/applet - ter/2004/125104_0000_ltr.pd f).",Non-OADS,/arxiv_data1/oa_pdf/98/c1/btt-7-247.PMC3854923.pdf
Available from: http://www.slideshare.net/  gavingiovannoni/natalizuman .,Non-OADS,/arxiv_data1/oa_pdf/98/c1/btt-7-247.PMC3854923.pdf
Avail - able from:  http://clinicaltrials.gov/show/NCT00622700.,Non-OADS,/arxiv_data1/oa_pdf/98/c1/btt-7-247.PMC3854923.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/98/c1/btt-7-247.PMC3854923.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/98/c1/btt-7-247.PMC3854923.pdf
Available from: http://journals.lww.com/neurotodayonline/blog/ breakingnews/pages/post.aspx?PostID =240.,Non-OADS,/arxiv_data1/oa_pdf/98/c1/btt-7-247.PMC3854923.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/cb/dddt-7-1409.PMC3854924.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1409–1420Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1409Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5086 1estrogen receptor modulatory effects   of germinated brown rice bioactives   in the uterus of rats through the regulation   of estrogen-induced genes sani ismaila Muhammad1,2 ismail Maznah1,3 rozi Bint Mahmud4 Mohammed ibrahim saeed1 Mustapha Umar imam1 aminu ishaka1 1laboratory of Molecular Biomedicine,   institute of Bioscience, Universiti  Putra Malaysia, selangor, Malaysia;   2Department of Pharmacology and  T oxicology, Faculty of Veterinary  Medicine Usmanu, Danfodiyo  University sokoto, sokoto, nigeria;   3Department of nutrition and  Dietetics, 4Department of radiology,   Faculty of Medicine and health  sciences, Universiti Putra Malaysia,   selangor, Malaysia correspondence: ismail Maznah   laboratory of Molecular Biomedicine,   institute of Bioscience, Universiti Putra   Malaysia, 43400 UPM serdang,   selangor, Malaysia   Tel +60 389 472 115   Fax +60 389 472 116   email maznah@medic.upm.edu.m y;  myhome.e@gmail.co mPurpose:  The expression of genes regulated by estrogen in the uterus was studied in ovariec - tomized (OVX) rats treated with germinated brown rice (GBR) bioactives, and compared to  Remifemin or estrogen at different doses to identify the regulation of these genes in the uterus  and their molecular mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/eb/cb/dddt-7-1409.PMC3854924.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/eb/cb/dddt-7-1409.PMC3854924.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/cb/dddt-7-1409.PMC3854924.pdf
"Official title Sponsor Collaborators Identifier Purpose Primary outcome measures Secondary outcome measures Estimated enrollment Study start date Estimated study completion date Ages eligible for study   Inclusion criteria Health authority country WebsiteProgesterone for traumatic brain injury:  experi mental clinical treatment Emory University 31 Center of United States NCT00822900 Intravenous (IV) progesterone; within 4 h of  injury; a total of 96 h; moderate to severe TBI GOS-E  DRS; Mortality 1140 March 2010 June 2015 18 years and older Moderate to severe TBI (GCS 12–4);  blunt,  closed head injury;  arrival <4 h from injury  http://clinicaltrials.gov/ct2/show/record/ NCT00822900.A randomized, double-blind, placebo-controlled phase 3  study to investigate the efficacy and safety of progesterone  in patients with severe traumatic brain injury BHR pharma, LLC PRA international and INC research NCT01143064 Intravenous (IV) progesterone; within 8 h of injury; a total of  120 h; severe TBI GOS SF-36; Mortality 1180 June 2010 August 2013 16 years to 70 years Severe TBI (GCS 8–3);  at least one reactive pupil; arrival  <8 h from injury USA; Argentina; Austria; Belgium; China; Czech Republic;  Germany; Hungary; Israel; Italy; Netherlands; Romania;  Singapore; Spain; China Taiwan; United Kingdom and so on.",Non-OADS,/arxiv_data1/oa_pdf/7a/d8/aps2013160a.PMC3854945.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/7a/d8/aps2013160a.PMC3854945.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/rjt093.PMC3854963.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/8d/rjs023.PMC3854980.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/c4/rjs010.PMC3854998.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/3a/rjs025.PMC3855010.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/8c/jmdh-6-441.PMC3855011.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2013:6 441–450Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  441Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5325 2Quality improvement in clinical documentation:  does clinical governance work?,Non-OADS,/arxiv_data1/oa_pdf/3d/8c/jmdh-6-441.PMC3855011.pdf
"Available from:  http://journals.tums.ac.ir/upload_files/pdf/_/587.pd f.  Accessed October  31, 2013.",Non-OADS,/arxiv_data1/oa_pdf/3d/8c/jmdh-6-441.PMC3855011.pdf
"Available from: http://www.sid.ir/fa/ VEWSSID/J_pdf/72913885902.pd f. Accessed on October 31, 2013.",OADS,/arxiv_data1/oa_pdf/3d/8c/jmdh-6-441.PMC3855011.pdf
Available from: http://www.goums.,Non-OADS,/arxiv_data1/oa_pdf/3d/8c/jmdh-6-441.PMC3855011.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/3d/8c/jmdh-6-441.PMC3855011.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3d/8c/jmdh-6-441.PMC3855011.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2013:6 423–434Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  423Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S5018 5Role, implementation, and effectiveness   of advanced allied health assistants:   a systematic review Jessica Stanhope1 Claire Pearce2 1international Centre for Allied  Health evidence, University of South  Australia, Adelaide, SA, Australia;   2ACT (Australian Capital Territory)  Government Health Directorate,   Canberra, ACT, Australia Correspondence: Claire Pearce   ACT Government Health Directorate,  GPO Box 825, Canberra City,   ACT 2601, Australia   Tel +61 26205 0893   Fax +61 26205 2037   email c laire.pearce@act.gov.a uBackground:  The purpose of this systematic review was to determine the effectiveness and  implementation of advanced allied health assistant roles.",Non-OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
"6	What are the workforce issues for A/AHAs?Materials and methods Systematic search A systematic search of key library da tabases (Embase  [OvidSP], Medline [OvidSP], Scopus, Web of Science, Nurs - ing and Allied Health Source [ProQuest], Health and Medi - cal Complete [ProQuest], and Cumulative Index to Nursing  and Allied Health Literature [CINAHL], EbscoHost) was  conducted in February 2013, using a comprehensive list of  search terms (see http://www.unisa.edu.au/PageFiles/68220/ AAHA%20paper%20appendix%20pdf%20(2).pd f).",OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
"Available from http://www.health.sa.gov.au/DesktopModules/ SSSA_Documents/LinkClick.aspx?tabid=46&table=SSSA_Docume nts&field=ItemID&id=874&link=T%3A%5C_Online+Services%5C Web+Admin%5CIndividual_site_correspondence%5CProject+Corre spondence%5CAllied+Health%5CA s. Accessed September 30, 2013.",OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
Available from: http://www.nhmrc.,Non-OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
Available from: http://www.cebm.net/index.,Non-OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
Available from: http://www.pedro.org.au/ english/downloads/pedro-scale /.,Non-OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c2/38/jmdh-6-423.PMC3855013.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/d1/jmdh-6-435.PMC3855014.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2013:6 435–439Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  435Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S4955 8Vaccination against human papillomavirus   among 865 female students from the health   professions in central greece: a questionnaire-   based cross-sectional study Dimitrios Papagiannis1 george rachiotis1 emmanouil K symvoulakis2 alexandros Daponte3 ioanna n grivea4 george a  syrogiannopoulos4 christos  Hadjichristodoulou1 1Department of Hygiene and  epidemiology, Faculty of Medicine,   school of Health sciences, University  of Thessaly, Thessalia, 2Private  Family Practice Unit, Heraklion,   crete, 3Department of Obstetrics  and gynaecology, University of  Thessalia Medical school, Thessalia,   4Department of Paediatrics, University  of Thessaly, school of Medicine,   general University Hospital of larissa,   Thessalia, greece correspondence: george rachiotis   Department of Hygiene and  epidemiology, Medical Faculty, school of  sciences, University of Thessaly (greece),  22 Papakyriazi str, larissa,   Thessalia, greece   Tel +30 241 056007   Fax +30 241 056 5051   email g.rachiotis@gmail.co mBackground:  There are still sparse data on vaccination coverage against human papillomavirus  (HPV) among students in the health professions.",Non-OADS,/arxiv_data1/oa_pdf/cc/d1/jmdh-6-435.PMC3855014.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/cc/d1/jmdh-6-435.PMC3855014.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/cc/d1/jmdh-6-435.PMC3855014.pdf
Available from: http://www.ecca.info/fileadmin/user_upload/ HPV_Vaccination/ECCA_HPV_Vaccination_April_2009.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cc/d1/jmdh-6-435.PMC3855014.pdf
Available from: http://www.who.int/wer/2009/ wer8432/en/index.html .,OADS,/arxiv_data1/oa_pdf/cc/d1/jmdh-6-435.PMC3855014.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/39/rjs026.PMC3855058.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/38/ccid-6-289.PMC3855059.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2013:6 289–294Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  289OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S5522 3epidemiology of “fragile skin”: results   from a survey of different skin types Marek haftek1 Christine Coutanceau2 Charles Taïeb3 1Université lyon 1, laboratoire de  recherche Dermatologique, Faculté  de Médecine et de Pharmacie, lyon,   2Département Médical, laboratoires  Dermatologiques a-Derma, lavaur,   3Public health, Pierre Fabre sa, Paris,   France Correspondence: Charles Taïeb   Pierre Fabre sa, 12 avenue hoche,  75008, Paris, France   email charles.taieb@pierre-fabre.co mBackground:  Epidemiologic information regarding the prevalence of “fragile skin” in different  adult populations is currently limited.",Non-OADS,/arxiv_data1/oa_pdf/21/38/ccid-6-289.PMC3855059.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/21/38/ccid-6-289.PMC3855059.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/38/ccid-6-289.PMC3855059.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/bd/rjs007.PMC3855067.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/34/rjt084.PMC3855073.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/d3/rjs030.PMC3855092.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/f7/mder-6-211.PMC3855100.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2013:6 211–218Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  211REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S4952 2Capsular contracture by silicone breast implants:  possible causes, biocompatibility, and prophylactic  strategies Andreas E Steiert Maria Boyce Heiko Sorg Department of Plastic, Hand and  Reconstructive Surgery, Hannover  Medical School, Hannover, Germany Correspondence: Andreas E Steiert   Department of Plastic, Hand and  Reconstructive Surgery, Hannover  Medical School, Carl-Neuberg-Str 1,  30625 Hannover, Germany   Tel +49 511 532 0   Fax +49 511 532 8890   Email steiert.andreas@mh-hannover.d eAbstract:  The most common implanted material in the human body consists of silicone.",Non-OADS,/arxiv_data1/oa_pdf/ab/f7/mder-6-211.PMC3855100.pdf
"Available from: http://ec.europa.eu/ health/medical-devices/files/meddev/2_5-7_07-1998_en.pd f. Accessed  October 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ab/f7/mder-6-211.PMC3855100.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/ab/f7/mder-6-211.PMC3855100.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/d8/ndt-9-1859.PMC3855101.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1859–1865Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1859Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S3234 2Current clinical application of deep-brain  stimulation for essential tremor Amit Chopra Bryan T Klassen Matt Stead Department of Neurology,    Mayo Clinic, Rochester, MN, USA Correspondence: Matt Stead   Department of Neurology,   Mayo Clinic, 200 1st Street Southwest,  Rochester, MN 55905, USA   email squire.stead@mayo.ed uBackground:  Deep-brain stimulation (DBS) is an established treatment for medically refractory  essential tremor (ET).",Non-OADS,/arxiv_data1/oa_pdf/87/d8/ndt-9-1859.PMC3855101.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/87/d8/ndt-9-1859.PMC3855101.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/d8/ndt-9-1859.PMC3855101.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/b2/ott-6-1751.PMC3855102.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1751–1760OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1751Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5264 3sam68 is a novel marker for aggressive  neuroblastoma Xiaohong Zhao1,* Zuoqing li2,* Benfu he3 Juncheng liu2 suisheng li2 li Zhou2 cuiling Pan2 Zhe Yu4 Zhe Xu2 1state Key laboratory of Oncology  in southern china, Department  of experimental research, cancer  center, sun Yat-sen University,   2Department of Pediatric surgery,   First affiliated hospital of sun Yat-sen  University, 3Oncology Department,   Pla421 hospital, 4laura Biotech co,   ltd, guangzhou, People’s republic of  china *These authors contributed equally to  this work correspondence: Zhe Xu   First Affiliated Hospital of Sun Yat-sen  University and Department of Pediatric  surgery, guangzhou 510080, People’s  republic of china   Tel +86 13 8029 71546   Fax +86 20 8775 0632   email Drzhexu@163.co mBackground:  Neuroblastoma (NB) is the most common solid extracranial tumor in children.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/ott-6-1751.PMC3855102.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/ott-6-1751.PMC3855102.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/b2/ott-6-1751.PMC3855102.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/31/ott-6-1779.PMC3855103.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1779–1787OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1779Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5390 1Optical imaging of head and neck squamous   cell carcinoma in vivo using arginine-glycine-   aspartic acid peptide conjugated near-infrared   quantum dots hao huang Yun-long Bai Kai Yang hong Tang Y ou-Wei Wang Department of Oral and Maxillofacial  surgery, The First affiliated hospital  of chongqing Medical University,   chongqing, People’s republic of china correspondence: Kai Yang   Department of Oral and Maxillofacial  Surgery, The First Affiliated   hospital of chongqing Medical   University, no 1, Youyi road,   Yuzhong District, chongqing 400016,   People’s republic of china   Tel +86 23 8901 2569   Fax +86 23 8901 2569   email cqfyyk@hotmail.co mAbstract:  Molecular imaging plays a key role in personalized medicine and tumor diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/8a/31/ott-6-1779.PMC3855103.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8a/31/ott-6-1779.PMC3855103.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/31/ott-6-1779.PMC3855103.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/fa/rjs024.PMC3855163.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/c7/ijgm-6-855.PMC3855164.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 855–861International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  855 ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S5100 4S100 calcium binding protein B as a biomarker   of delirium duration in the intensive care   unit – an exploratory analysis Babar A Khan1–3 Mark O Farber1 Noll Campbell2–5 Anthony Perkins2,3 Nagendra K Prasad6 Siu L Hui1–3 Douglas K Miller1–3 Enrique Calvo-Ayala1 John D Buckley1 Ruxandra Ionescu1 Anantha Shekhar1 E Wesley Ely7,8 Malaz A Boustani1–3 1Indiana University School of  Medicine, 2Indiana University Center  for Aging Research, 3Regenstrief  Institute, Inc., 4Wishard Health  Services, Indianapolis, 5Department of  Pharmacy Practice, Purdue University  College of Pharmacy, West Lafayette,   6Indiana University Melvin and Bren  Simon Cancer Center, Indianapolis,   IN, 7Vanderbilt University School  of Medicine, 8VA Tennessee Valley  Geriatric Research Education Clinical  Center (GRECC), Nashville, TN, USA Correspondence: Babar A Khan   Indiana University Center for Aging  Research, 410 West 10th Street,   Suite 2000, Indianapolis, IN 46202, USA   Tel +1 317 423 5633   Fax +1 317 423 5695   Email bakhan@iupui.ed uBackground:  Currently, there are no valid and reliable biomarkers to identify delirious  patients predisposed to longer delirium duration.",Non-OADS,/arxiv_data1/oa_pdf/20/c7/ijgm-6-855.PMC3855164.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/20/c7/ijgm-6-855.PMC3855164.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c7/ijgm-6-855.PMC3855164.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/cd/rjt069.PMC3855167.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/ea/rjt100.PMC3855171.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/2f/rjs016.PMC3855188.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/a8/rjs020.PMC3855215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/ec/rjs034.PMC3855217.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/3e/rjs013.PMC3855220.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/ba/rjt081.PMC3855244.pdf
http://www.ctsne t.org/sections/c linicalresources/ clinicalcases/article-23.html.,Non-OADS,/arxiv_data1/oa_pdf/06/ba/rjt081.PMC3855244.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/be/rjs004.PMC3855273.pdf
Released March 2012. http://www.abs.gov.au/ausstats/abs@.nsf/Products/3303.0~2010~Chapter~Leading+Causes+of+Death?OpenDocument.,Non-OADS,/arxiv_data1/oa_pdf/09/be/rjs004.PMC3855273.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/0f/rjt097.PMC3855276.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/a3/rjs015.PMC3855280.pdf
Image analysis was performed using ImageJ v.1.43m ( http://rsbweb.nih.gov/ij/download.,OADS,/arxiv_data1/oa_pdf/be/ea/125_2013_Article_3089.PMC3855472.pdf
"85-23, revised 1985, http://grants1.nih.gov/grants/olaw/ references/phspol.htm ).",Non-OADS,/arxiv_data1/oa_pdf/45/1e/125_2013_Article_3070.PMC3855476.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004074).,Non-OADS,/arxiv_data1/oa_pdf/a0/b3/bmjopen-2013-004074.PMC3855491.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003952).,Non-OADS,/arxiv_data1/oa_pdf/ee/1b/bmjopen-2013-003952.PMC3855494.pdf
2013. http://www.epi.ucdavis.edu/diagnostictests/betabuster.html(accessed 21 Nov 2013).,OADS,/arxiv_data1/oa_pdf/ee/1b/bmjopen-2013-003952.PMC3855494.pdf
Available from http://www.epidata.dk).,Non-OADS,/arxiv_data1/oa_pdf/9e/26/bmjopen-2013-004157.PMC3855495.pdf
2010.http://www.uroweb.org/ 11.,Non-OADS,/arxiv_data1/oa_pdf/9e/26/bmjopen-2013-004157.PMC3855495.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003879).,Non-OADS,/arxiv_data1/oa_pdf/b8/db/bmjopen-2013-003879.PMC3855496.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003612).,Non-OADS,/arxiv_data1/oa_pdf/3c/70/bmjopen-2013-003612.PMC3855530.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003801).,Non-OADS,/arxiv_data1/oa_pdf/45/63/bmjopen-2013-003801.PMC3855532.pdf
"This is an Open Access article distributed unde r the terms of the Creative CommonsAttribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ),which permits non-commercial re-use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/65/eht290.PMC3855551.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003732).,Non-OADS,/arxiv_data1/oa_pdf/09/4f/bmjopen-2013-003732.PMC3855557.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004025).,Non-OADS,/arxiv_data1/oa_pdf/22/2a/bmjopen-2013-004025.PMC3855563.pdf
2012. http://www.cprd.com 12.,Non-OADS,/arxiv_data1/oa_pdf/22/2a/bmjopen-2013-004025.PMC3855563.pdf
"Brussels, Belgium: International Diabetes Federation, 2011. http://www.idf.org/diabetesatlas 6 Morgan CL, Owens DR, Aubonnet P, et al.BMJ Open 2013; 3:e004025.",Non-OADS,/arxiv_data1/oa_pdf/22/2a/bmjopen-2013-004025.PMC3855563.pdf
"Step 4: Poststratification weight (w ps)—data on population of the region of Murcia by sex, age and healthcare area were pro-vided by the CREM ( Centro Regional de Estadística de Murcia; Padrón 2010; http://www.carm.es/econet/sicrem/PU_padron/).",Non-OADS,/arxiv_data1/oa_pdf/ee/38/bmjopen-2013-004035.PMC3855565.pdf
A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/.,Non-OADS,/arxiv_data1/oa_pdf/ee/38/bmjopen-2013-004035.PMC3855565.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003650).,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/bmjopen-2013-003650.PMC3855566.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/bmjopen-2013-003650.PMC3855566.pdf
http://www.nrls.npsa.nhs.uk/EasySiteWeb/getresource.axd?AssetID=61392 (accessed Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/bmjopen-2013-003650.PMC3855566.pdf
http://www.health.org.uk/publications/reducing-prescribing-errors/ (accessed Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/bmjopen-2013-003650.PMC3855566.pdf
http://www.nrls.npsa.nhs.uk/alerts/?entryid45=66271(accessed Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/bmjopen-2013-003650.PMC3855566.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004068).,Non-OADS,/arxiv_data1/oa_pdf/2e/23/bmjopen-2013-004068.PMC3855567.pdf
http://www.idf.org/worlddiabetesday/dka (accessed 13 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/2e/23/bmjopen-2013-004068.PMC3855567.pdf
http://www.diabetes.org.uk/Get_ involved/Campaigning/4Ts-campaign/ (accessed 13 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/2e/23/bmjopen-2013-004068.PMC3855567.pdf
http://www.msdiabetes.org/article.php?article_id=71(accessed 13 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/2e/23/bmjopen-2013-004068.PMC3855567.pdf
http://www.youthhealthtalk.org/Diabetes_type_ 1_in_young_people/Topic/1510.,Non-OADS,/arxiv_data1/oa_pdf/2e/23/bmjopen-2013-004068.PMC3855567.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004060).,Non-OADS,/arxiv_data1/oa_pdf/57/ab/bmjopen-2013-004060.PMC3855570.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003707).,Non-OADS,/arxiv_data1/oa_pdf/e8/9a/bmjopen-2013-003707.PMC3855572.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003754).,Non-OADS,/arxiv_data1/oa_pdf/f5/d5/bmjopen-2013-003754.PMC3855588.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-002941).,Non-OADS,/arxiv_data1/oa_pdf/2d/87/bmjopen-2013-002941.PMC3855592.pdf
Detailsof the survey are available at http://www.measuredhs.,OADS,/arxiv_data1/oa_pdf/2d/87/bmjopen-2013-002941.PMC3855592.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/2d/87/bmjopen-2013-002941.PMC3855592.pdf
The Nobel Peace Prize for 2006. http://nobelprize.org/nobel_prizes/ peace/laureates/2006/press.html (accessed 10 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/2d/87/bmjopen-2013-002941.PMC3855592.pdf
http://www.strobe-statement.org/ (accessed 13 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/2d/87/bmjopen-2013-002941.PMC3855592.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004277).,Non-OADS,/arxiv_data1/oa_pdf/7a/87/bmjopen-2013-004277.PMC3855594.pdf
"’Statistical Software Components S457234: Boston College Department of Economics, 2011. http://ideas.repec.org/c/boc/bocode/s457234.html (accessed 5 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/7a/87/bmjopen-2013-004277.PMC3855594.pdf
": Global Development and Environment Institute,Tufts University, February 2009. http://www.ase.tu s.edu/gdae/Pubs/rp/PB09-01SweeteningPotFeb09.pdf 31.",Non-OADS,/arxiv_data1/oa_pdf/7a/87/bmjopen-2013-004277.PMC3855594.pdf
The Office of the Actuary in the Centers for Medicare & Medicaid Services.http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Proj2012.pdf (accessed 15 Oct 2013).,OADS,/arxiv_data1/oa_pdf/7a/87/bmjopen-2013-004277.PMC3855594.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004176).,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://www.nap.edu/catalog/12815.html 2.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/20946001 10 Barolia RI, Clark AM, Higginbottom GMA.",Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://www.ncbi.nlm.nih.gov/pubmed/16042163 22.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://www.sasnet.lu.se/EASASpapers/ PHDZulfiqarBhutta.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
October 2007.http://www.jica.go.jp/activities/issues/poverty/profile/pdf/pakistan_e.pdf 39.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://www.ncbi.nlm.nih.gov/pubmed/17361677 43.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 15493211 52.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
March 2010. http://www.un.org/esa/population 57.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://www.nicvd.edu.pk/Patient.htm 60.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://www.nicvd.edu.pk/Rehabilitation.htm 61.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
http://hospitals.aku.edu/ karachi/aboutus/Pages/home.aspx 62.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
2010. http://www.who.int/healthsystems/topics/research/55Heartfile_HEF_POC.pdf 63.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
ATLAS.ti: Home http://www.atlasti.com/index.html66.,Non-OADS,/arxiv_data1/oa_pdf/1e/54/bmjopen-2013-004176.PMC3855597.pdf
Further details on the sampling design can be found athttp://www.who.int/tobacco/surveillance/en_t ﬁ_gats_ 2010_brazil.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/9c/bmjopen-2013-003538.PMC3855598.pdf
http://www.who.int/tobacco/surveillance/en_tfi_gats_2010_ brazil.pdf (accessed 20 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/29/9c/bmjopen-2013-003538.PMC3855598.pdf
"—Rio de Janeiro: INCA, 2010, 208 p. http://www.who.int/tobacco/surveillance/en_tfi_gats_2010_brazil.pdf 6.",Non-OADS,/arxiv_data1/oa_pdf/29/9c/bmjopen-2013-003538.PMC3855598.pdf
http://www.ipea.gov.br/portal/index.php?option=com_ content&view=article&id=15818&catid=159&Itemid=75 (accessed15 Feb 2013).29.,OADS,/arxiv_data1/oa_pdf/29/9c/bmjopen-2013-003538.PMC3855598.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/af/e1/bmjopen-2013-003850.PMC3855601.pdf
http://www.emcreg.org/publications/ monographs/acep/2009/ACEP2009_dbd.pdf (accessed 30 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/af/e1/bmjopen-2013-003850.PMC3855601.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003458).,Non-OADS,/arxiv_data1/oa_pdf/69/05/bmjopen-2013-003458.PMC3855607.pdf
2008. http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Population+Estimates+by+Ethnic+Group 25.,OADS,/arxiv_data1/oa_pdf/69/05/bmjopen-2013-003458.PMC3855607.pdf
Secondary National Institute for Health and Clinical Excellence: CG73: Chronic Kidney Disease 2008. http://www.nice.org.uk/CG73 26.,Non-OADS,/arxiv_data1/oa_pdf/69/05/bmjopen-2013-003458.PMC3855607.pdf
http://www.hscic.gov.uk/qof 27.,Non-OADS,/arxiv_data1/oa_pdf/69/05/bmjopen-2013-003458.PMC3855607.pdf
Secondary Index of Multiple Deprivation (IMD) 2007 26/1/2013 2007. http://data.gov.uk/ dataset/index_of_multiple_deprivation_imd_2007 30.,Non-OADS,/arxiv_data1/oa_pdf/69/05/bmjopen-2013-003458.PMC3855607.pdf
http://www.hscic.gov.uk/pcmdatabase 33.,Non-OADS,/arxiv_data1/oa_pdf/69/05/bmjopen-2013-003458.PMC3855607.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003633).,Non-OADS,/arxiv_data1/oa_pdf/e8/2c/bmjopen-2013-003633.PMC3855609.pdf
2013 Data (after dissemination of current PA guidelines) The 2013 survey was developed using an online survey soft- ware and questionnaire tool (http://www.surveymonkey.,OADS,/arxiv_data1/oa_pdf/e8/2c/bmjopen-2013-003633.PMC3855609.pdf
"Data sharing statement HSE 2007 data are available open-access from the ESDS website at http://www.esds.ac.uk/findingData/hseTitles.asp Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/e8/2c/bmjopen-2013-003633.PMC3855609.pdf
http://www.getalifegetactive.com/11.,Non-OADS,/arxiv_data1/oa_pdf/e8/2c/bmjopen-2013-003633.PMC3855609.pdf
http://www.nhs.uk/change4life12.,Non-OADS,/arxiv_data1/oa_pdf/e8/2c/bmjopen-2013-003633.PMC3855609.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004115).,Non-OADS,/arxiv_data1/oa_pdf/18/d1/bmjopen-2013-004115.PMC3855707.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2013 |  78  | e50564 | Page 1 of 12Video Article The Generation of Higher-order Laguerre-Gauss Optical Beams for High- precision Interferometry Ludovico Carbone1, Paul Fulda1, Charlotte Bond1, Frank Brueckner1, Daniel Brown1, Mengyao Wang1, Deepali Lodhia1, Rebecca Palmer1, Andreas Freise1 1School of Physics and Astronomy, University of Birmingham Correspondence to: Ludovico Carbone at lc@star.sr.bham.ac.uk URL: http://www.jove.com/video/50564 DOI: doi:10.3791/50564 Keywords: Physics, Issue 78, Optics, Astronomy, Astrophysics, Gravitational waves, Laser interferometry, Metrology, Thermal noise, Laguerre- Gauss modes, interferometry Date Published: 8/12/2013 Citation: Carbone, L., Fulda, P., Bond, C., Brueckner, F., Brown, D., Wang, M., Lodhia, D., Palmer, R., Freise, A.",Non-OADS,/arxiv_data1/oa_pdf/66/f4/jove-78-50564.PMC3855912.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50564/ Introduction During the past decades high-precision interferometric experiments were pushed towards an ultimate sensitivity regime where quantum effects are starting to play a decisive role.,Non-OADS,/arxiv_data1/oa_pdf/66/f4/jove-78-50564.PMC3855912.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2013 |  78  | e50311 | Page 1 of 5Video Article Cell Population Analyses During Skin Carcinogenesis Dongsheng Gu1, Qipeng Fan1, Jingwu Xie1 1Department of Pediatrics, Wells Center for Pediatric Research, IU Simon Cancer Center, Indiana University Correspondence to: Jingwu Xie at jinxie@iupui.edu URL: http://www.jove.com/video/50311 DOI: doi:10.3791/50311 Keywords: Cancer Biology, Issue 78, Medicine, Cellular Biology, Molecular Biology, Biomedical Engineering, Genetics, Anatomy, Physiology, Oncology, Cocarcinogenesis, animal models, Skin cancer, basal cell carcinoma, hedgehog, smoothened, keratinocyte, cancer, carcinogenesis, cells, cell culture, animal model Date Published: 8/21/2013 Citation: Gu, D., Fan, Q., Xie, J.",Non-OADS,/arxiv_data1/oa_pdf/a0/94/jove-78-50311.PMC3855927.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50311/ Introduction As the most common type of human cancer, basal cell carcinoma (BCC) affects about 2 million Americans per year 1.",Non-OADS,/arxiv_data1/oa_pdf/a0/94/jove-78-50311.PMC3855927.pdf
"For in-stance, besides the second generation of VCE for the esopha-gus and colon, the next generation of VCEs such as those with Open Access Received: October 11, 2013    Accepted:  October 15, 2013 Correspondence: Ki Baik Hahm Digestive Disease Center, CHA Bundang Medical Center, CHA University, 59 Y atap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5005, Fax: +82-31-780-5219, E-mail: hahmkb@cha.ac.kr  cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.599 Perfecting Video Capsule Endoscopy: Is There Need for Training?",Non-OADS,/arxiv_data1/oa_pdf/89/b5/ce-46-599.PMC3856258.pdf
"After a median follow-up of 6.7 years in a previous study, the overall biliary complication rate was 10.1% in the Open Access Received: October 17, 2013    Revised: October 21, 2013 Accepted:  October 22, 2013 Correspondence: Chang-Il KwonDigestive Disease Center, CHA Bundang Medical Center, CHA University, 59  Y atap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5641, Fax: +82-31-780-5219, E-mail: endoscopy@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.601 Long-Term Outcome of Endoscopic Papillary Large Balloon   Dilatation Chang-Il Kwon Digestive Disease Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea See “Late Complications and Stone Recurrence Rates after Bile Duct Stone Removal by Endoscopic Sphincterotomy and  Large Balloon Dilation Are Similar to Those after Endoscopic Sphincterotomy Alone” by Ka Y oung Kim, Jimin Han, Ho Gak Kim, et al., on page 637-642COMMENTARY",Non-OADS,/arxiv_data1/oa_pdf/60/70/ce-46-601.PMC3856259.pdf
"Key Words :  Gastrointestinal neoplasms; Technology; Molecular imagingOpen Access Received: September 15, 2013    Revised: September 30, 2013 Accepted:  September 30, 2013 Correspondence: Naoki MugurumaDepartment of Gastroenterology and Oncology, Institute of Health Biosci- ences, The University of Tokushima Graduate School, 3-18-15, Kuramoto-cho,  Tokushima 770-8503, JapanTel: +81-88-633-7124, Fax: +81-88-633-9235 E-mail: muguruma.clin.med@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.603 INTRODUCTION Gastrointestinal endoscopy has been widely used for detec - tion, differentiation, and staging of neoplasia in the digestive  tract and has made great progress during the last decade.1 Di- agnostic accuracy can be enhanced by better training, more efficient techniques, and the development of new image-pro-cessing technologies; 2 however, diagnosis using conventional  endoscopy with optical characteristics is essentially limited because it is based on morphological changes and/or discol-oration.",Non-OADS,/arxiv_data1/oa_pdf/6e/fa/ce-46-603.PMC3856260.pdf
"Key Words :  Spectrometry, mass, matrix-assisted laser desorption-ionization; Imaging mass spectrometer; Biological markers;    Premalignant gastrointestinal lesions; ChemopreventionOpen Access Received: October 4, 2013    Accepted:  October 11, 2013 Correspondence: Ki Baik Hahm Digestive Disease Center, CHA Bundang Medical Center, CHA University, 59 Y atap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5218, Fax: +82-31-780-5219, E-mail: hahmkb@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.611FOCUSED REVIEW SERIES:  Endoscopic and Molecular Imaging of Premalignant GI Lesions, Part I",Non-OADS,/arxiv_data1/oa_pdf/75/29/ce-46-611.PMC3856261.pdf
"Key Words :  Molecular imaging; Endoscopy; Fluorescence probe; Intestinal diseasesOpen Access Received: October 10, 2013    Revised: October 12, 2013 Accepted:  October 17, 2013 Correspondence: Seung-Jae MyungDepartment of Gastroenterology, Asan Medical Center, University of Ulsan  College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3917, Fax: +82-2-476-0824, E-mail: sjmyung@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.620 INTRODUCTION Gastrointestinal (GI) endoscopy for the diagnosis of neo- plasia in the digestive tract has evolved over the last decade.",Non-OADS,/arxiv_data1/oa_pdf/9d/62/ce-46-620.PMC3856262.pdf
"Key Words :  Accuracy; Endoscopic ultrasound-guided fine needle aspiration; Extraintestinal mass; Intramural mass; YieldOpen Access Received: July 24, 2012    Revised: October 9, 2012 Accepted:  October 13, 2012 Correspondence: Yu Kyung ChoDivision of Gastroenterology, Department of Internal Medicine, The Catholic  University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul  137-701, KoreaTel: +82-2-2258-2044, Fax: +82-2-2258-2055, E-mail: ykcho@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.627 INTRODUCTION Endoscopic ultrasound (EUS) plays an important role in  the characterization of subepithelial lesions by providing in- formation regarding their layer of origin, echogenicity, size, and local invasion.",Non-OADS,/arxiv_data1/oa_pdf/99/87/ce-46-627.PMC3856263.pdf
"Key Words :  Capsule endoscopy; Learning curveOpen Access Received: April 21, 2013    Revised: June 12, 2013 Accepted:  June 16, 2013 Correspondence: Myung-Gyu ChoiDepartment of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic  University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul  137-701, KoreaTel: +82-2-2258-2083, Fax: +82-2-2258-2089, E-mail: choim@catholic.ac.kr  cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.633 See commentary on page 599-600",Non-OADS,/arxiv_data1/oa_pdf/28/3f/ce-46-633.PMC3856264.pdf
"Key Words :  Common bile duct stone; Sphincterotomy, endoscopic; Endoscopic large balloon dilation; Stone recurrence; Late complicationOpen Access Received: October 22, 2012    Revised: December 5, 2012 Accepted:  January 9, 2013 Correspondence: Jimin HanDepartment of Internal Medicine, Catholic University of Daegu School of  Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-3042, Fax: +82-53-624-3281, E-mail: jmhan@cu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.637 See commentary on page 601-602",Non-OADS,/arxiv_data1/oa_pdf/8c/34/ce-46-637.PMC3856265.pdf
"Key Words :  Injections, intralesional; Esophageal stenosis; Endoscopic submucosal dissection; Esophageal neoplasmsOpen Access Received: October 10, 2012    Revised: November 18, 2012 Accepted:  November 22, 2012 Correspondence: Hwoon-Y ong JungDepartment of Gastroenterology, Asan Medical Center, University of Ulsan  College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3180, Fax: +82-2-476-0824, E-mail: hyjung@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.643",Non-OADS,/arxiv_data1/oa_pdf/8c/3a/ce-46-643.PMC3856266.pdf
"Key Words :  Gastric mucosa-associated lymphoid tissue lymphoma; Polypectomy; HelicobacterOpen Access Received: October 12, 2012    Revised: October 30, 2012 Accepted:  November 1, 2012 Correspondence: Jun Haeng LeeDepartment of Medicine, Samsung Medical Center, Sungkyunkwan Universi- ty School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-3409, Fax: +82-2-3410-6983 E-mail: stomachlee@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.647",Non-OADS,/arxiv_data1/oa_pdf/7f/60/ce-46-647.PMC3856267.pdf
"Key Words :  Gastrointestinal amyloidosis; Spondylitis, ankylosing; Linitis plasticaOpen Access Received: October 29, 2012    Revised: November 30, 2012 Accepted:  February 12, 2013 Correspondence: Y oung Sook ParkDepartment of Internal Medicine, Eulji General Hospital, Eulji University School  of Medicine, 68 Hangeulbiseong-ro, Nowon-gu, Seoul 139-711, Korea Tel: +82-2-970-8207, Fax: +82-2-970-8621, E-mail: pys1109@eulji.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.651 INTRODUCTION Secondary (AA) amyloidosis is a systemic disease caused  by the deposition of amyloid in various tissues and organs  leading to impaired function.1 It occurs most frequently in pa - tients with poorly controlled chronic inflammatory disease, mainly rheumatoid arthritis, and ankylosing spondylitis.",Non-OADS,/arxiv_data1/oa_pdf/7b/03/ce-46-651.PMC3856268.pdf
"Key Words :  Neuroendocrine tumors; Endoscopic mucosal resection; DuodenumOpen Access Received:  November 7, 2012    Revised:  February 5, 2013 Accepted:  February 13, 2013 Correspondence:  Chang Hwan Park Division of Gastroenterology, Department of Internal Medicine, Chonnam  National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 501- 757, Korea Tel: +82-62-220-6296, Fax: +82-62-225-8578, E-mail:  p1052ccy@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443  http://dx.doi.org/10.5946/ce.2013.46.6.656",Non-OADS,/arxiv_data1/oa_pdf/92/c6/ce-46-656.PMC3856269.pdf
"Key Words :  Situs inversus totalis; Percutaneous endoscopic gastrostomy; Anatomic variationOpen Access Received: December 14, 2012    Revised: February 13, 2013 Accepted:  April 18, 2013 Correspondence: Kwang Bum ChoDepartment of Internal Medicine, Keimyung University School of Medicine,  56 Dalseong-ro, Jung-gu, Daegu 700-712, Korea Tel: +82-53-250-7088, Fax: +82-53-250-7088, E-mail: chokb@dsmc.or.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.662 INTRODUCTION Situs inversus is a congenital condition in which the major  organs within the abdomen or the thoracic cavities are re- versed from their normal positions.",Non-OADS,/arxiv_data1/oa_pdf/1f/73/ce-46-662.PMC3856270.pdf
"Key Words :  Neoplasm metastasis; Stomach neoplasms; Pleura; Lymphatic metastasisOpen Access Received: December 27, 2012    Revised: January 17, 2013 Accepted:  February 1, 2013 Correspondence: Jae Y oung JangDepartment of Internal Medicine, Kyung Hee University School of Medicine,  26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Korea Tel: +82-2-958-8200, Fax: +82-2-968-1848, E-mail: jyjang@khu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.666",Non-OADS,/arxiv_data1/oa_pdf/2b/34/ce-46-666.PMC3856271.pdf
"Key Words :  Irritable bowel syndrome; Parasitic infection; Ancylostoma duodenale ; AncylostomatoideaOpen Access Received: February 12, 2013    Revised: April 9, 2013 Accepted:  April 13, 2013 Correspondence: Sang Wook KimDepartment of Internal Medicine, Research Institute for Medical Science,  Chonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju  561-712, KoreaTel: +82-63-250-2302, Fax: +82-63-254-1609, E-mail: clickm@jbnu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.671 INTRODUCTION Irritable bowel syndrome (IBS) is defined as a gastrointesti - nal disorder characterized by chronic abdominal pain and al - tered bowel habits in the absence of any organic cause.",Non-OADS,/arxiv_data1/oa_pdf/89/13/ce-46-671.PMC3856272.pdf
"1, Supplementary Video 1 [available online at http://www.e-ce.org/]).",Non-OADS,/arxiv_data1/oa_pdf/89/13/ce-46-671.PMC3856272.pdf
"cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.675 INTRODUCTION Parasitic diseases in Korea have remarkably decreased in  prevalence since the 1980s, partly owing to the introduction  of several national health care programs.1 However, many  new parasitic infections have hence emerged, and >35 para-sitic species have emerged and re-emerged since 1980.",Non-OADS,/arxiv_data1/oa_pdf/1d/27/ce-46-675.PMC3856273.pdf
"Key Words :  Afferent loop syndrome; Anastomosis, Roux-en-Y; LithotripsyOpen Access Received: January 31, 2013    Revised: May 20, 2013 Accepted:  May 24, 2013 Correspondence: Seok JeongDivision of Gastroenterology, Department of Internal Medicine, Inha Universi - ty Hospital, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon 400-711, KoreaTel: +82-32-890-2548, Fax: +82-32-890-2549, E-mail: inos@inha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.679 INTRODUCTION Afferent loop obstruction is a potentially life-threatening  complication of Billroth II gastrectomy or Roux-en-Y hepati- cojejunostomy (RYHJ).",Non-OADS,/arxiv_data1/oa_pdf/00/34/ce-46-679.PMC3856274.pdf
"1  Hence, the most probable reason for the detachable snare not BRIEF REPORT A Second Assisting Endoscope for the Removal of an Accidentally  Unreleased Detachable Snare during Colon Polypectomy Ju Wan Kim, Hyoung-Chul Oh, Chang Hwan Choi, Beom Jin Kim, Jeong Wook Kim and Jae Gyu Kim Division of Gastroenterology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, KoreaOpen Access Received: March 7, 2013    Revised: April 26, 2013 Accepted:  April 26, 2013 Correspondence: Hyoung-Chul OhDivision of Gastroenterology, Department of Internal Medicine, Chung-Ang  University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755,  KoreaTel: +82-2-6299-3149, Fax: +82-2-6299-1530, E-mail: ohcgi@cau.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.6.683 Fig.",Non-OADS,/arxiv_data1/oa_pdf/10/06/ce-46-683.PMC3856275.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.6.371 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/1b/d0/kjfm-34-371.PMC3856277.pdf
Available from: http://ori.dhhs.gov/ori-policy-plagiarism.,Non-OADS,/arxiv_data1/oa_pdf/1b/d0/kjfm-34-371.PMC3856277.pdf
"CrossCheck (http://www.crossref.org/crosscheck/index.html), a unique web-service for detecting plagiarism in scientific publication s, is an excellent service for  detecting plagiarism, which de tected almost all plagiarized  manuscripts.",Non-OADS,/arxiv_data1/oa_pdf/1b/d0/kjfm-34-371.PMC3856277.pdf
"eTBLAST (http://etest.vbi.vt.edu/etblast3/), a text-similarity based search engine, is also very useful resource.",OADS,/arxiv_data1/oa_pdf/1b/d0/kjfm-34-371.PMC3856277.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.6.372 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/7b/3b/kjfm-34-372.PMC3856278.pdf
"Keywords:  Review; Peer Review; Manuscript; Medical Journal Received: October 29, 2013,  Accepted: November 6, 2013 *Corresponding Author: Hyun Ah Park T el: +82-2-2270-0097, Fax: +82-2-2267-2030E-mail: drparkhyunah@gmail.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.techniques of peer reviewing can be nurtured and developed.",Non-OADS,/arxiv_data1/oa_pdf/7b/3b/kjfm-34-372.PMC3856278.pdf
Available from: http://www.icmje.org/index.html.,Non-OADS,/arxiv_data1/oa_pdf/7b/3b/kjfm-34-372.PMC3856278.pdf
  http://dx.doi.org/10.4082/kjfm.2013.34.6.377 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/7f/df/kjfm-34-377.PMC3856279.pdf
"Keywords:  Fathers; Students; Alcohol; Depression; Anxiety Received: August 30, 2010,  Accepted: August 22, 2013 *Corresponding Author: Jong Sung Kim T el: +82-42-280-8172, Fax: +82-42-280-7879E-mail: jskim@cnuh.co.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The prevalence of lifetime alcohol abuse disorder has been  reported to be 13.3% in Korea.1) However, it is expected that  the real number of alcoholics is much higher than the reported number because Korean culture is tolerant of alcohol consumption and Korean society tends not to consider drinking problems to be a disorder.",Non-OADS,/arxiv_data1/oa_pdf/7f/df/kjfm-34-377.PMC3856279.pdf
Available from: http://stat.mw.go.kr/front/statData/publicationView.jsp?menuId=47&bbsSeq=13&nttSeq=18458&searchKey=&searchWord=&nPage=1.,OADS,/arxiv_data1/oa_pdf/7f/df/kjfm-34-377.PMC3856279.pdf
Available from: http://pubs.niaaa.nih.gov/publications/practitioner/PocketGuide/pocket.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7f/df/kjfm-34-377.PMC3856279.pdf
  http://dx.doi.org/10.4082/kjfm.2013.34.6.385 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/00/a5/kjfm-34-385.PMC3856280.pdf
"Keywords:  Underweight; Sex; Social Characteristics; Demographic Factors Received: June 27, 2013,  Accepted: September 23, 2013 *Corresponding Author: Y oung Gyu Cho T el: +82-2-2270-0097, Fax: +82-2-2270-0560E-mail: jacobel@hanmail.net Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Healthy weight refers to a range of weight that is optimal  for health, which is defined as a body mass index (BMI) of 18.5 to 24.9 kg/m 2.1) Individuals whose weights are below or above  this range are considered to have unhealthy weights because of increased health risks.",Non-OADS,/arxiv_data1/oa_pdf/00/a5/kjfm-34-385.PMC3856280.pdf
Available from: http://www.statcan.gc.ca/pub/11-008-x/2002003/article/6394-eng.pdf.,OADS,/arxiv_data1/oa_pdf/00/a5/kjfm-34-385.PMC3856280.pdf
  http://dx.doi.org/10.4082/kjfm.2013.34.6.393 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/20/87/kjfm-34-393.PMC3856281.pdf
"Keywords:  Underweight; Body Image; Body Weight; Weight Reduction; Social Class Received: August 31, 2012,  Accepted: October 21, 2013 *Corresponding Author: Y oung Gyu Cho T el: +82-2-2270-0097, Fax: +82-2-2267-2030E-mail: jacobel@hanmail.net Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Underweight refers to the weight range in which health  risk can increase since the weight is lower than a healthy weight, 1) which is the weight range corresponding to lower risk  of mortality and morbidity, better physical fitness and better quality of life.",Non-OADS,/arxiv_data1/oa_pdf/20/87/kjfm-34-393.PMC3856281.pdf
  http://dx.doi.org/10.4082/kjfm.2013.34.6.403 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/kjfm-34-403.PMC3856282.pdf
"Keywords:  Cardiovascular Health Metrics; Korean National Health and Nutrition Examination Surveys; Trends Received: August 31, 2012,  Accepted: October 21, 2013 *Corresponding Author: Dong Wook Shin T el: +82-2-2072-0847, Fax: +82-2-766-3276E-mail: dwshin.snuh@gmail.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.rate of population with risk factors of CVD (i.e., hypertension,  diabetes mellitus, obesity, etc.)",Non-OADS,/arxiv_data1/oa_pdf/d5/89/kjfm-34-403.PMC3856282.pdf
Available from: http://kosis.kr.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/kjfm-34-403.PMC3856282.pdf
Available from: http://health.mw.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/kjfm-34-403.PMC3856282.pdf
Available from: http://health.mw.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/kjfm-34-403.PMC3856282.pdf
Available from: http://www.mcst.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/kjfm-34-403.PMC3856282.pdf
  http://dx.doi.org/10.4082/kjfm.2013.34.6.413 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/2b/d4/kjfm-34-413.PMC3856283.pdf
"Keywords:  Carcinoembryonic Antigen; Tumor Marker; Insulin Resistance; Cardiovascular Diseases Received: August 24, 2012,  Accepted: November 1, 2013 *Corresponding Author: Hee-Jeong Choi T el: +82-42-611-3230, Fax: +82-42-611-3776E-mail: ohinia@daum.net Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.adenocarcinomas, particularly color ectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/2b/d4/kjfm-34-413.PMC3856283.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.6.420 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/2a/9f/kjfm-34-420.PMC3856284.pdf
"Keywords:  Metabolic Syndrome; Reactive Oxygen Species; Oxidative Stress; High-Sensitivity C-reactive Protein Received: August 24, 2012,  Accepted: October 25, 2013 *Corresponding Author: Sang-Wook Song T el: +82-31-249-8230, Fax: +82-31-248-7404E-mail: sswkoj@unitel.co.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.men and 25.6% in Korean women.1) Metabolic syndrome is  associated with the development of cardiovascular disease, thus, the cardiovascular mortality in metabolic syndrome patients is 2 to 3 times higher than  that of the general population.",Non-OADS,/arxiv_data1/oa_pdf/2a/9f/kjfm-34-420.PMC3856284.pdf
  http://dx.doi.org/10.4082/kjfm.2013.34.6.429 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/c5/5e/kjfm-34-429.PMC3856285.pdf
"Keywords:  Aortic Dissection; Acute Coronary Syndrome; Chest Pain; Diagnosis; Symptom Received: May 8, 2013,  Accepted: October 21, 2013 *Corresponding Author: Belong Cho T el: +82-2-2072-2195, Fax: +82-2-766-3276E-mail: belong@snu.ac.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.2% per hour without any treatment.3) Therefore, fast and accurate  diagnosis of aortic dissection is crucial and one must maintain a  high index of suspicion.",Non-OADS,/arxiv_data1/oa_pdf/c5/5e/kjfm-34-429.PMC3856285.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.6.434 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/04/bc/kjfm-34-434.PMC3856286.pdf
  http://dx.doi.org/10.4082/kjfm.2013.34.6.437 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/bb/11/kjfm-34-437.PMC3856287.pdf
"Korean J Fam Med 2013;34 :  334-346. http://dx.doi.org/10.4082/kjfm.2013.34.5.334 To the Editor: In the articles titled “Relationships between Dietary Habits and Allosta tic Load Index in Metabolic Syndrome Patients ” that  appeared in the September 2013 issue of Korean Journal of Family Medicine (Korean J Fam Med 2013;34:334-346), we found that the   names and the institutional affiliation of the authors were published incorrectly.",Non-OADS,/arxiv_data1/oa_pdf/bb/11/kjfm-34-437.PMC3856287.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2013 |  78  | e50689 | Page 1 of 13Video Article A Guided Materials Screening Approach for Developing Quantitative Sol-gel Derived Protein Microarrays Blake-Joseph Helka1, John D. Brennan1 1Department of Chemistry and Chemical Biology, McMaster University Correspondence to: John D. Brennan at brennanj@mcmaster.ca URL: http://www.jove.com/video/50689 DOI: doi:10.3791/50689 Keywords: Chemistry, Issue 78, Biochemistry, Chemical Engineering, Molecular Biology, Genetics, Bioengineering, Biomedical Engineering, Chemical Biology, Biocompatible Materials, Siloxanes, Enzymes, Immobilized, chemical analysis techniques, chemistry (general), materials (general), spectroscopic analysis (chemistry), polymer matrix composites, testing of materials (composite materials), Sol-gel, microarray, high- throughput screening, acetylcholinesterase, kinase, drug discovery, assay Date Published: 8/26/2013 Citation: Helka, B.J., Brennan, J.D.",Non-OADS,/arxiv_data1/oa_pdf/51/0a/jove-78-50689.PMC3856314.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50689/ Introduction Microarrays have gained popularity within the scientific community as a method for increasing assay throughput.,Non-OADS,/arxiv_data1/oa_pdf/51/0a/jove-78-50689.PMC3856314.pdf
"10       http://www.medsci.org  1805  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1805 -1816.  doi: 10.7150/ ijms.6530   Research Paper   Insights into the Hallmarks of Human Nucleus Pulposus  Cells with Particular Reference to Cell Viability,     Phagocytic Potential and Long Process Formation   Yu-Fei Chen1, †, Yong -Zhao Zhang1, †, Wei- Lin Zhang1, †, Guan -Nan Luan2, †, Zhi-Heng Liu1, †, Yang Gao1,  Zhong -Yuan Wa n1, Zhen Sun1, Shu Zhu1, Dino Samartzis3, Chun -Mei Wang1, Hai -Qiang Wang1,  Zhuo -Jing Luo1  1.",Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
Thi s is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
"10    http://www.medsci.org  1806  proteoglycans, the nucleus pulposus (NP).",Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10    http://www.medsci.org  1807  added and incubated for 15 min at 4°C.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10       http://www.medsci.org  1808    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10       http://www.medsci.org  1809    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10    http://www.medsci.org  1810    Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10       http://www.medsci.org  1811  Human NP consists of mainly viable cells.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10    http://www.medsci.org  1812    Fig 7.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10    http://www.medsci.org  1813    Fig 9.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10    http://www.medsci.org  1814  displayed morphologic hallmarks of both NP cells  and macrophages indicates that the cells belong to histiocytes.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
"10    http://www.medsci.org  1815  human NP cells have phagocytic potential to possibly  clear  apoptotic /necrotic cells and ruptured ECM,  and  ultimately contribute to the maintenance  of immune  privilege  [51].",Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
10    http://www.medsci.org  1816  nucleus pulposus cells and their responsiveness to mechanical loading.,Non-OADS,/arxiv_data1/oa_pdf/22/a5/ijmsv10p1805.PMC3856371.pdf
"10       http://www.medsci.org  1817  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1817 -1829.  doi: 10.7150/ ijms.6902  Research Paper   Evaluation of Antiviral Activities of  Four Local Malaysian  Phyllanthus Species against Herpes Simplex Viruses and  Possible Antiviral Target   Wee Chee Tan1, Indu Bala Jaganath2, Rishya Manikam3 and Shamala Devi Sekaran1  1.",Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
10     http://www.medsci.org  1818  the treatment of ailments [13] .,Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
"10     http://www.medsci.org  1819  added into each designated well at 3 hours before  infect ion (pre -treatment), 0 hours after infection  (simultaneous treatment) and 3 hours after infection (post -treatment) to reach a final concentration of  100µg/mL.",Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
"10     http://www.medsci.org  1820  kept at - 80°C until use or was equilibrated in equil i- bration solution (6M urea, 75mM  Tris-HCl (pH8.8),  29.3% glycerol, 2% SDS and 0.002% bromophenol  blue) containing 100mg DTT per 10mL for 15 minutes and 250mg iodoacetamide per 10mL for 15 minutes.",Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
10     http://www.medsci.org  1821  and HSV -2 were confirmed by conventional plaque  reduction assay (Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
"10       http://www.medsci.org  1822  In order to study at which stage the ex tracts e x- erting their effect against the viruses, the antiviral  activity of the four Phyllanthus species against HSV -1  and HSV -2 were also determined at pre- treatment,  simultaneous treatment and post- treatment respec- tively by using quantitative real time P CR approach.",Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
"10       http://www.medsci.org  1823  Two dimensional gel electrophoresis and mass  spectrometry   In order to understand how the HSV infection  and the extract treatment affected the proteome of the  host cells, two dimensional gel electrophoresis fo l- lowed by mass spectrometry protein identification was carried out (Figure 3 and 4).",OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
10     http://www.medsci.org  1824    Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
10     http://www.medsci.org  1825  [38kDa] which played important role in determining  efficient viral attachment and entry into the cells were identified based on their respective molecular weight.,OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
10     http://www.medsci.org  1826  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
10     http://www.medsci.org  1827  sential for facilitating efficien t virus entry via the i n- teraction with the host heparan sulphate receptors  and associated co- receptors.,Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
"10     http://www.medsci.org  1828  pha-actinin -1 was shown to be lowered to normal  expression level when P. urinaria  was added to the  HSV -2 infected cells, but did not exhibit any lowering  effect on the expression level of alpha -actinin -1 in  HSV -1 infected cells.",Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
10     http://www.medsci.org  1829  25.,Non-OADS,/arxiv_data1/oa_pdf/13/20/ijmsv10p1817.PMC3856372.pdf
"10       http://www.medsci.org  1830  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1830 -1836.  doi: 10.7150/ ijms.6184  Research Paper   Spontaneous Weight Change during Chronic Hepatitis  C Treatment: Association with Virologic  Response  Rates   Hany R. Alwakeel1, Hasan E. Zaghla1, Nabeel A. Omar1, Hasan A. Alashinnawy1, Eman A. Rewisha1,  Laura E. Matarese2, Azza A. Taha3, and Hossam M. Kandil2  1.",Non-OADS,/arxiv_data1/oa_pdf/3b/1d/ijmsv10p1830.PMC3856373.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/ijmsv10p1830.PMC3856373.pdf
10     http://www.medsci.org  1831  with higher treatment response 13-15.,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/ijmsv10p1830.PMC3856373.pdf
10     http://www.medsci.org  1832  purposes (Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/ijmsv10p1830.PMC3856373.pdf
10     http://www.medsci.org  1833  associated with EVR.,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/ijmsv10p1830.PMC3856373.pdf
10     http://www.medsci.org  1834  Table 4: Effect of pre treatment BMI on virological responses.,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/ijmsv10p1830.PMC3856373.pdf
10       http://www.medsci.org  1835  Discussion   Several studies have demonstrated that weight  loss observed during hepatitis C Interferon based  therapy is associated with response to therapy 13-15.,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/ijmsv10p1830.PMC3856373.pdf
10     http://www.medsci.org  1836  7.,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/ijmsv10p1830.PMC3856373.pdf
"10       http://www.medsci.org  1837  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1837 -1845.  doi: 10.7150/ ijms.6786  Research Paper   Extracellular Matrix of M echanically Stretched Cardiac  Fibroblasts I mproves V iability and Metabolic Activity of  Ventricular Cells  Yong Guo1, Qiang -cheng Zeng  2, Chun -qiu Zhang 3, Xi-zheng Zhang 1, Rui-xin Li 2, Ji-min Wu 1, Jing  Guan 1, Lu Liu 4, Xin -chang Zhang1, Jian-yu Li1, Zong -ming Wan1   1.",Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
This is an open- access article distributed u nder the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
"10     http://www.medsci.org  1838  for mammalian cells  in vitro  and in vivo (2, 3).",Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
10       http://www.medsci.org  1839    Fig 1.,Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
10     http://www.medsci.org  1840  showed  as the inorganic phosphorous (Pi) production  from the decomposition per mg protein per hour  (μmolPi/mg∙h).,OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
10     http://www.medsci.org  1841  stretched cells enhanced  metabolic  activity.,Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
10     http://www.medsci.org  1842    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
10     http://www.medsci.org  1843    Fig 5.,Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
"10     http://www.medsci.org  1844  heart, it regulates  the Ca2+ loading of the sar- co(endo)plasmic reticulum  and therefore the Ca2+  released and card iac muscle contractility  (27-28).",Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
10     http://www.medsci.org  1845  8.,Non-OADS,/arxiv_data1/oa_pdf/92/e3/ijmsv10p1837.PMC3856374.pdf
"10       http://www.medsci.org  1846  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1846 -1859.  doi: 10.7150/ ijms.6908  Research Paper   Distinct E ffects of RGD -glycoproteins on  Integrin -Mediated Adhesion and Osteogenic  Differentiation of Human Mesenchymal Stem Cells   Elisabeth H. Schwab1 *, Maria Halbig1 *, Kristina Glenske2, Alena -Svenja Wagner2, Sabine Wenisch2,    Elisabetta A. Cavalcanti- Adam1  1.",Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10     http://www.medsci.org  1847  origin (1).,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
"10     http://www.medsci.org  1848  Adhesion assay   For analysis of cell adhesion, 4.5  x 103 cells/cm2  were seeded in single wells of a 48 -well plate and a l- lowed to attach  for 2 or 4  h, respectively.",Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
Actively proliferating cells  (Alexa Fluor 647 -positive cell nuclei) were counted  using the particle analyzer plugin of ImageJ software (http://rsb.info.nih.gov/ij/; version 1.47n) and nor-malize d to total cell number (DAPI stained cell n u- clei).,OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
"10     http://www.medsci.org  1849  total protein concentration of the supernatant was  determined using a BCA protein assay kit (Pierce Bi-otechnology, Inc., Rockford, USA).",OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10     http://www.medsci.org  1850  when compared to the control (p  > 0.01) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10     http://www.medsci.org  1851  (27-29).,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10     http://www.medsci.org  1852    Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
"10       http://www.medsci.org  1853  α5-integrin expression is increased on FN and  under osteogenic conditions   Most integrins bind to several ECM molecules  and conversely, most ECM bind to more than one  integrin heterodimer.",Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10     http://www.medsci.org  1854    Fig 5.,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
"10       http://www.medsci.org  1855  Osteogenic differentiation and mineral depo- sition are elevated in MSCs cultured on FN and  OPN   The expression of cell differentiation markers  was examined by quantitative RT -PCR at 1, 5 and 10  days after cell seeding onto ECM coatings.",OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10     http://www.medsci.org  1856    Fig 7.,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10       http://www.medsci.org  1857  In contrast to Ode et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10     http://www.medsci.org  1858  tiation.,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
10     http://www.medsci.org  1859  13.,Non-OADS,/arxiv_data1/oa_pdf/aa/a0/ijmsv10p1846.PMC3856375.pdf
"10       http://www.medsci.org  1860  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1860 -1867.  doi: 10.7150/ ijms.6460  Research Paper   Identification of Hypermethylation in Hepatocyte Cell  Adhesion Molecule  Gene Promoter Region in Bladder  Carcinoma   Jia Tao1#, Qi Liu1#, Xiaohou Wu2, Xin Xu1, Yanyi Zhang1, Qiuju Wang1, Chunli Luo1  1.",Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
10     http://www.medsci.org  1861  cancer is unknown.,Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
Promoter CpG islands prediction of hepaCAM   Promoter prediction of hepaCAM gene was  performed by FirstEF software[13] (http://rulai.cshl.org/tools/FirstEF/).,OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
"Then, CpG  islands was predicted and methprimers for MSP was designed through the bioinformatics program[14]   (http://www.urogene.org/cgi -bin/methprimer/met hprimer.cgi ).",OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
10     http://www.medsci.org  1862  sodium dodecylbenzene sul fonate (SDS) loading  buffer at 100 ℃ for 5min .,Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
10     http://www.medsci.org  1863    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
10       http://www.medsci.org  1864    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
"10       http://www.medsci.org  1865  The methylation status of hepaCAM g ene  promoter and its expression of protein in  paired tissues   In vitro, h ypermethylation of hepaCAM  gene  promoter was discovered  in cell lines.",Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
"10     http://www.medsci.org  1866  sine pyrimidine ring of DNA under the action of DNA  methyltransferase (DNMT), forming 5-methylcytosine .",Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
We found a CpG island in hepaCAM pr o- moter through Interne t software  (http://rulai.cshl.org/tools/FirstEF/ and http://ww w.urogene.org/methprimer/index1.html).,OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
10     http://www.medsci.org  1867  3.,Non-OADS,/arxiv_data1/oa_pdf/7c/15/ijmsv10p1860.PMC3856376.pdf
"10       http://www.medsci.org  1868  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1868 -1875.  doi: 10.7150/ ijms.6868  Research Paper   FGFR4 and TGF -β1 Expression in Hepatocellular    Carcinoma : Correlation with Clinicopathological    Features and Prognosis   Zhixin Chen*1, Bao Xie*1, 2, Qinhua Zhu*1, Qinghai Xia*1, Songmin Jiang*3, Ruoyu  Cao*4, Lihua Shi1, Dansi  Qi2, Xiaokun Li1, Lin Cai1  1.",Non-OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
This is an open- access articl e distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
10     http://www.medsci.org  1869  the damage to liver function.,Non-OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
10     http://www.medsci.org  1870  except that the primary antibody was replaced by  PBS.,Non-OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
10       http://www.medsci.org  1871  Immunohistochemical analysis   TGF -β1 and FGFR4 were localized mainly in the  cytoplasm of tumor cells or hepatocytes.,Non-OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
10     http://www.medsci.org  1872    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
10     http://www.medsci.org  1873  Multivariate analysis of clinicopathological  paramaters and prognosis    The factors with possible prognostic effects in  hepatocarcinoma were analyzed by Cox regression  analysis.,OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
10       http://www.medsci.org  1874  Discussion   HCC has the worst prognosis among all major  cancers.,Non-OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
10     http://www.medsci.org  1875  sues.,Non-OADS,/arxiv_data1/oa_pdf/a9/c1/ijmsv10p1868.PMC3856377.pdf
"10       http://www.medsci.org  1876  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1876 -1879.  doi: 10.7150/ ijms.6613  Research Paper   Changes in Left Ventricular Filling in Patients with  Persistent Atrial Fibrillation  Franjo Naji, Mihael Pagliaruzzi, Meta Penko,  Vojko Kanic , Damijan Vokac  Department of Cardiology and Angiology, University Clinical Centre, Maribor, Slovenia .",Non-OADS,/arxiv_data1/oa_pdf/92/25/ijmsv10p1876.PMC3856378.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/25/ijmsv10p1876.PMC3856378.pdf
10     http://www.medsci.org  1877  filling.,Non-OADS,/arxiv_data1/oa_pdf/92/25/ijmsv10p1876.PMC3856378.pdf
10     http://www.medsci.org  1878    Fig 1.,Non-OADS,/arxiv_data1/oa_pdf/92/25/ijmsv10p1876.PMC3856378.pdf
10     http://www.medsci.org  1879  part be the cause rather than consequence of impaired  diastolic function.,Non-OADS,/arxiv_data1/oa_pdf/92/25/ijmsv10p1876.PMC3856378.pdf
"10       http://www.medsci.org  1880  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1880 -1887.  doi: 10.7150/ ijms.5359  Research Paper   Impact of the Training on the Compliance and Persis- tence of Weekly Bisphosphonate Treatment in Pos t- menopausal Osteoporosis: A Randomized Controlled  Study   Şansın Tüzün1, Gülseren Akyüz2, Nurten Eskiyurt3, Asuman Memiş4, Banu Kuran5, Afitap İçağasıoğlu6,  Tunay Sarpel7, Ferda Özdemir8, Neşe Özgirgin9, Rezzan Günaydın10, Aytül Çakçı11, Merih Yurtkuran12   1.",Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
This is an open- access article distributed under  the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
"10     http://www.medsci.org  1881  Key words: Bisphosphonates, osteoporosis, patient education, medication adherence.",Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
10     http://www.medsci.org  1882  formed of the t opic to be covered in the next educa- tional meeting and invited to the meeting.,Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
"10     http://www.medsci.org  1883  Osteoporosis Awareness Questionnaire  In to tal, 444 patients at visit 1 and 299 patients at  visit 2 answered the Osteoporosis Awareness Que s- tionnaire.",Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
10     http://www.medsci.org  1884  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
10     http://www.medsci.org  1885  Table 5.,Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
10     http://www.medsci.org  1886  has symptoms.,Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
10     http://www.medsci.org  1887  4.,Non-OADS,/arxiv_data1/oa_pdf/34/9b/ijmsv10p1880.PMC3856379.pdf
"10       http://www.medsci.org  1888  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1888 -1898.  doi: 10.7150/ ijms.6019  Research Paper   Modulation  of β-Catenin Signaling by the Inhibitors of  MAP Kinase, Tyrosine Kinase, and PI3 -Kinase Pathways   Wenwen Zhang1,2,3, Hongyu Zhang1,2, Ning Wang2,4, Chen Zhao2,4, Hongmei Zhang1,2, Fang Deng1,4,  Ningning Wu1,2, Yunfeng He1,2, Xian Chen1,2, Junhui Zhang1,2, Sheng Wen1,2, Zhan Liao2, Qian Zhang1,2,  Zhonglin Zhang2, Wei Liu1,2, Zhengjian Yan1,2, Hue H. Luu2, Rex C. Haydon2, Lan Zhou1, and Tong -Chuan  He1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
10     http://www.medsci.org  1889  volved in the Wingles s pathway in Drosophilla [1-7] .,Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
"10     http://www.medsci.org  1890  phorbol 13 -acetate), suramin sodium, wortmannin,  HDBA (2 -hyroxyl -5-(2,5-dihydroxybenzylamino)  benzoic acid), DRB (5,6 -dichloro -1-β-D-  ribofuranosylbenzimidazole), PD -98059, and  genistein (4’,5,7 -trihydroxyisoflavone) were pu r- chased from BIOMOL (Plymouth Meeting, PA).",Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
"10     http://www.medsci.org  1891  electrophoresis, proteins were transferred to an I m- mobilon- P membrane (Millipore) via electroblotting.",Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
"10     http://www.medsci.org  1892  tested, we observed a more complex effect on lith i- um-stimulated β-catenin activity ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
"10     http://www.medsci.org  1893  β-Catenin -Regulated Transcription Is Antag o- nized by Tyrosine Kinase and PI3 Kinase I n- hibitors   To test possible involvement of tyrosine phos- phorylation in regulating β-catenin signaling, we  examined genistein, a tyrosine kinase  inhibitor, for its  effect on lithium -stimulated β-catenin activity.",Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
10     http://www.medsci.org  1894  solvent control ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
10       http://www.medsci.org  1895  EGF Signaling Activates TCF4/ β-Catenin  Transcriptional Activity and Induces Tyrosine  Phosphorylation of the β-Catenin Protein   We next sought to determine if EGF stimulation  activates β-catenin signaling pathway and induces  tyrosine phosphorylation.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
"10     http://www.medsci.org  1896    Furthermore, we found that tyrosine phospho r- ylated β-catenin was immunoprecipitated by using  4G10 antibody in the EGF -stimulated HEK -293 and  HOS cells (but not in the unstimulated cells) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
10     http://www.medsci.org  1897  ways may also play an important role in modulating  β-catenin activity in the presence or absence of Wnt  signals ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
10     http://www.medsci.org  1898  41.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/ijmsv10p1888.PMC3856380.pdf
"10       http://www.medsci.org  1899  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1899 -1906.  doi: 10.7150/ ijms.6774  Research Paper   Recombinant Human Adiponectin as a Potential Protein  for Treating Diabetic Tendinopathy Promotes Tenocyte  Progenitor Cells Proliferation a nd Tenogenic  Differentiation In Vitro   Hussin A. Rothan1, Abdulrazzaq Mahmod Suhaeb2, Tunku Kamarul2,3  1.",Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
"10     http://www.medsci.org  1900  many literatures, and is commonly known as diabetic  tendinopathy [2].",Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
10     http://www.medsci.org  1901  measured using a glucometer hourly for four hours.,Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
10     http://www.medsci.org  1902  glucose tolerant test.,Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
10     http://www.medsci.org  1903    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
10     http://www.medsci.org  1904  observed in most diabetic patients.,Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
10     http://www.medsci.org  1905    Figure 6: Evaluation of tenogenic differentiation in adiponectin -treated cells by Western blot.,Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
10     http://www.medsci.org  1906  have better metabolism rate hence resulting in the  tenogenic ge nes being upregulated.,Non-OADS,/arxiv_data1/oa_pdf/41/a9/ijmsv10p1899.PMC3856381.pdf
"10       http://www.medsci.org  1907  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1907 -1913.  doi: 10.7150/ ijms.6776  Research Paper   Glucose- 6-Phosphate Dehydrogenase Deficiency and  Diabetes Mellitus with Severe Retinal Complications in a  Sardinian Population, Italy   Antonio Pinna1, Emma Luigia Contini1, Ciriaco  Carru2, Giuliana Solinas3   1.",Non-OADS,/arxiv_data1/oa_pdf/df/46/ijmsv10p1907.PMC3856382.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/df/46/ijmsv10p1907.PMC3856382.pdf
"10     http://www.medsci.org  1908  G6PD activity, which is the only source of NAPDH.1  The gene encoding G6PD is located in the telomeric  region of the long arm of the X chromosome (band  Xq28).",Non-OADS,/arxiv_data1/oa_pdf/df/46/ijmsv10p1907.PMC3856382.pdf
"10     http://www.medsci.org  1909  medical conditions, including systemic hypertension,  hypercholesterolemia, and cardio - and cerebrovasc u- lar status were recorded.",Non-OADS,/arxiv_data1/oa_pdf/df/46/ijmsv10p1907.PMC3856382.pdf
10     http://www.medsci.org  1910  drug -induced hemolysis in the two years before their  enrolment in this study.,Non-OADS,/arxiv_data1/oa_pdf/df/46/ijmsv10p1907.PMC3856382.pdf
"10     http://www.medsci.org  1911  capillary occlusion and retinal nonperfusion, as well  as decompensation of the endothelial bar rier function,  which allows serum leakage and retinal edema to occur.",Non-OADS,/arxiv_data1/oa_pdf/df/46/ijmsv10p1907.PMC3856382.pdf
"10     http://www.medsci.org  1912  probably by interfering with the synthesis of NO.28 A  large body of experimental evidence linking G6PD  activity, cholesterol synthesis, and cell growth has  accumulated in recent years.5,31 Interestingly, Batetta  et al.5 have shown that the Mediterranean va riant of  G6PD deficiency is characterized by peculiar alter a- tions in plasma and intracellular cholesterol metab o- lism, such as reduced synthesis and esterification.",Non-OADS,/arxiv_data1/oa_pdf/df/46/ijmsv10p1907.PMC3856382.pdf
10     http://www.medsci.org  1913  nopathy when age at diagnosis is 30 or more years.,Non-OADS,/arxiv_data1/oa_pdf/df/46/ijmsv10p1907.PMC3856382.pdf
"10       http://www.medsci.org  1914  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(13): 1914 -1920.  doi: 10.7150/ ijms.7117  Research Paper   Higher Dosage of HIFU Treatment May Lead to Higher  and Longer Efficacy f or Moderate t o Severe Perennial  Allergic Rhinitis   Hongqua n Wei 1, Yong  Zhang 2, Lei Shi1, Jingru Zhang1, Yan Xia1, Jian Zang1, Aihui Yan1, Wei Li1 and  Xuejun Jiang1   1.",Non-OADS,/arxiv_data1/oa_pdf/34/49/ijmsv10p1914.PMC3856383.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/49/ijmsv10p1914.PMC3856383.pdf
10     http://www.medsci.org  1915  often used in biological work.,Non-OADS,/arxiv_data1/oa_pdf/34/49/ijmsv10p1914.PMC3856383.pdf
10     http://www.medsci.org  1916  time on lateral wall was 200 seconds and 50 seconds  on nasal septum.,Non-OADS,/arxiv_data1/oa_pdf/34/49/ijmsv10p1914.PMC3856383.pdf
10     http://www.medsci.org  1917  relieved within 5  months.,Non-OADS,/arxiv_data1/oa_pdf/34/49/ijmsv10p1914.PMC3856383.pdf
10     http://www.medsci.org  1918    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/34/49/ijmsv10p1914.PMC3856383.pdf
10       http://www.medsci.org  1919    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/34/49/ijmsv10p1914.PMC3856383.pdf
10     http://www.medsci.org  1920  the treatment of the innervation area of the anterior  ethmoidal nerve.,Non-OADS,/arxiv_data1/oa_pdf/34/49/ijmsv10p1914.PMC3856383.pdf
Programs of  virtual scene setting and force-feedback effect came from the  open source programs of the Swiss Force Dimension Com-pany (http://www.chai3d.org /download.html).,OADS,/arxiv_data1/oa_pdf/f5/e6/TOBEJ-7-116.PMC3856390.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licen- ses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution a nd reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/e6/TOBEJ-7-116.PMC3856390.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3447 | DOI: 10.1038/srep03447 7,Non-OADS,/arxiv_data1/oa_pdf/fd/d9/srep03447.PMC3856402.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3447 | DOI: 10.1038/srep03447 8",Non-OADS,/arxiv_data1/oa_pdf/fd/d9/srep03447.PMC3856402.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Drs Bonnefoy, Bensussan, Alberici and Eliaou are cofounders and shareholders of OREGA Biotech.",Non-OADS,/arxiv_data1/oa_pdf/b9/85/srep03456.PMC3856404.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3456 | DOI: 10.1038/srep03456 10",Non-OADS,/arxiv_data1/oa_pdf/b9/85/srep03456.PMC3856404.pdf
"As conducted in previous  research, [25, 34, 35] non-informative prior distributions  were used for all the treatment effects; see program code for  more details (Program 1 (d): http://www.nicedsu.org.uk/TS  D2%20General%20meta%20analysis%20corrected%20Mar2  013.pdf).",Non-OADS,/arxiv_data1/oa_pdf/18/99/CDS-8-236.PMC3856428.pdf
"Available from: http://www.esicm.org/flashConference/  2011/Berlin/10438/swf/player.swf  [15] Guidet B, Martinet O, Boulain T, et al .",Non-OADS,/arxiv_data1/oa_pdf/18/99/CDS-8-236.PMC3856428.pdf
"Available from:  http://www.nicedsu.org.uk/TSD2%20General%20meta%20analysi s%20corrected%20Mar2013.pdf  [30] Zarychanski R, Turgeon AF, Fergusson DA, et al.",Non-OADS,/arxiv_data1/oa_pdf/18/99/CDS-8-236.PMC3856428.pdf
"http://www.openbugs.info/w/  [34] Lu G, Ades AE.",Non-OADS,/arxiv_data1/oa_pdf/18/99/CDS-8-236.PMC3856428.pdf
"http://www.mtm.uoi.gr/PLE  NARY.pdf  [51] Dundar Y, Dodd S, Williamson P, Dickson R, Walley T. Case  study of the comparison of data from conference abstracts and full- text articles in health technology assessment of rapidly evolving  technologies: does it make a diffe rence?",Non-OADS,/arxiv_data1/oa_pdf/18/99/CDS-8-236.PMC3856428.pdf
2009 Sep  [cited 2012 Dec 13]; http://www.homebybaxter.us/downloads/healt  hcare_professionals/products/Buminate_25_PI.pdf  [64] US Food and Drug Administration.,OADS,/arxiv_data1/oa_pdf/18/99/CDS-8-236.PMC3856428.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3246 | DOI: 10.1038/srep03246 6",Non-OADS,/arxiv_data1/oa_pdf/51/0e/srep03246.PMC3856482.pdf
"BJR doi: 10.1259/bjr.20130492 Received: 5 August 2013Revised:2 October 2013 Accepted:3 October 2013© 2013The Authors.Publishedby the BritishInstituteof Radiology underthe terms of the Creative Commons Attribution-NonCommercial 3.0 Unported License http://creativecommons.org/licenses/by-nc/3.0/ , which permits unrestricted non-commercial reuse, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d8/2d/bjr-86-1032-D13492.PMC3856543.pdf
The Alliance for MRI ( http://www.myesr.,Non-OADS,/arxiv_data1/oa_pdf/d8/2d/bjr-86-1032-D13492.PMC3856543.pdf
Available from: http://new.eur-lex.,Non-OADS,/arxiv_data1/oa_pdf/d8/2d/bjr-86-1032-D13492.PMC3856543.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004190).,Non-OADS,/arxiv_data1/oa_pdf/6d/ee/bmjopen-2013-004190.PMC3856615.pdf
Data sharing statement The MCS data are available at http://www.esds.ac.uk/ findingData/mcs.asp.,OADS,/arxiv_data1/oa_pdf/6d/ee/bmjopen-2013-004190.PMC3856615.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/ee/bmjopen-2013-004190.PMC3856615.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003710).,Non-OADS,/arxiv_data1/oa_pdf/54/e8/bmjopen-2013-003710.PMC3856616.pdf
September 2010. http://epc2010.princeton.edu/papers/100690 9.,Non-OADS,/arxiv_data1/oa_pdf/54/e8/bmjopen-2013-003710.PMC3856616.pdf
April 2010. http://www.unece.org/fileadmin/DAM/stats/documents/ece/ces/ge.11/2010/wp.10.e.pdf 10.,OADS,/arxiv_data1/oa_pdf/54/e8/bmjopen-2013-003710.PMC3856616.pdf
doi:10.1136/ bmjopen-2013-003591 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003591).,Non-OADS,/arxiv_data1/oa_pdf/79/16/bmjopen-2013-003591.PMC3856617.pdf
This project was designed for young people with juvenile idiopathic arthritis (JIA) (http://www.kuleuven.be/switch2/rheuma.html) andaimed to provide a proof of concept for a transition pro- gramme devised as a brief intervention.,Non-OADS,/arxiv_data1/oa_pdf/79/16/bmjopen-2013-003591.PMC3856617.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003861).,Non-OADS,/arxiv_data1/oa_pdf/13/fd/bmjopen-2013-003861.PMC3856618.pdf
See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/df/bjsports-2012-091380.PMC3856633.pdf
"Department of Health, England, 2009. http://www.dh.gov.uk/ prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_105944.pdf.",OADS,/arxiv_data1/oa_pdf/7b/df/bjsports-2012-091380.PMC3856633.pdf
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001037.,OADS,/arxiv_data1/oa_pdf/7b/df/bjsports-2012-091380.PMC3856633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/11/cia-8-1603.PMC3857009.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1603–1609Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1603OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5359 1effect of 6 months of whole body vibration   on lumbar spine bone density in postmenopausal  women: a randomized controlled trial Chung-liang lai1,2 shiuan-Yu Tseng1,2 Chung-n an Chen3 Wan-Chun liao2 Chun-hou Wang4 Meng-Chih lee1,5,* Pi-shan hsu5,* 1Institute of Medicine, Chung shan  Medical University, Taichung, Taiwan;   2Department of Physical Medicine  and rehabilitation, Taichung hospital,   Ministry of health and Welfare,   Taichung, Taiwan; 3Department of  radiology, Taichung hospital, Ministry  of health and Welfare, Taichung,   Taiwan; 4school of Physical Therapy,   Chung shan Medical University,   Taichung, Taiwan; 5Department of  Family Medicine, Taichung hospital,   Ministry of health and Welfare,   Taichung, Taiwan *These authors contributed equally to  this work Correspondence: Meng-Chih lee   Institute of Medicine, Chung shan   Medical University, 110 section 1,  Jianguo n road, Taichung, Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/fe/11/cia-8-1603.PMC3857009.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/fe/11/cia-8-1603.PMC3857009.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/11/cia-8-1603.PMC3857009.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/b0/clep-5-493.PMC3857010.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 493–499Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  493Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S4935 4lifestyle factors among proton pump inhibitor  users and nonusers: a cross-sectional study   in a population-based setting Frederik hvid-Jensen1 rikke B nielsen2 lars Pedersen2 Peter Funch-Jensen3 asbjørn Mohr Drewes4 Finn B larsen5 reimar W Thomsen2 1Department of surgical  gastroenterology l, aarhus University  hospital, aarhus, 2Department of  Clinical Epidemiology, institute of  Clinical Medicine, aarhus University  hospital, aarhus, 3institute of  Clinical Medicine, aarhus University  hospital, aarhus, 4Mech-sense Centre,   Department of gastroenterology,   aarhus University hospital,   aalborg, 5Public health and Quality  improvement, Central Denmark  region, Denmark Correspondence: Frederik hvid-Jensen   Department of surgical  gastroenterology, aarhus   University hospital, nørrebrogade   44 DK-8000 aarhus C, Denmark   Email frederikhvid@gmail.co mPurpose:  Lifestyle factors may influence observed associations between proton pump  inhibitor (PPI) usage and health outcomes.",Non-OADS,/arxiv_data1/oa_pdf/3a/b0/clep-5-493.PMC3857010.pdf
Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/ Content/StaticFile/Top_Line_Data/Top_20_Global_Therapy_Classes.,OADS,/arxiv_data1/oa_pdf/3a/b0/clep-5-493.PMC3857010.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/3a/b0/clep-5-493.PMC3857010.pdf
"Available at:  http://www.sst.dk/Sundhed%20og%20forebyggelse/Alkohol.asp x.  Accessed October 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/3a/b0/clep-5-493.PMC3857010.pdf
Available from: http://www.whocc.no/ atc_ddd_index/.,OADS,/arxiv_data1/oa_pdf/3a/b0/clep-5-493.PMC3857010.pdf
Available from: http://www.whocc.no/ atc_ddd_index /.,OADS,/arxiv_data1/oa_pdf/3a/b0/clep-5-493.PMC3857010.pdf
"Available from:  http://apps.who.int/classifications/icd10/browse/2010/e n. Accessed  October 10, 2013.",OADS,/arxiv_data1/oa_pdf/3a/b0/clep-5-493.PMC3857010.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2013:5 611–621ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  611ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S5206 3C-QU aliTY: cost and quality-of-life  pharmacoeconomic analysis of antidepressants  used in major depressive disorder in the regional  italian settings of Veneto and sardinia Claudio Mencacci1 Eugenio aguglia2 giovanni Biggio3 lodovico Cappellari4 guido Di sciascio5 andrea Fagiolini6 giuseppe Maina7 alfonso T ortorella8 Pablo Katz9 Claudio Ripellino9 1Department of Mental health,   Fatebenefratelli hospital, Milan,   2Department of Clinical and  Molecular Biomedicine, University  of Catania, Catania, 3Department of  Experimental Biology and Center  of Excellence for the neurobiology   of Drug Dependence, University of  Cagliari, Calgiari, 4Department of  Mental health, Camposampiero  hospital, Padova, 5Department of  Psychiatry, Policlinico hospital, Bari,   6Department of Molecular Medicine,   University of siena and Department  of Mental health, University of siena  Medical Center, siena, 7Department of  neurosciences, University of T orino,   T orino, 8Department of Mental health,   University of naples sUn, naples,   9CsD Medical Research srl, Milan, italyBackground:  Major depression is a commonly occurring, seriously impairing, and often  recurrent mental disorder.",Non-OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
"Available from: http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pd f. Accessed September 25, 2013.",OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
"Available from: http://www.tlv.se/Upload/genomgangen/review- antidepressants.pd f. Accessed September 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
Available from: http://www.agenziafarmaco.gov.it /.,Non-OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
Available from:  http://www.whocc.no /.,Non-OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
Available from: http://guideline.gov/content.aspx?i d=15521.,Non-OADS,/arxiv_data1/oa_pdf/d2/8c/ceor-5-611.PMC3857011.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/a2/dddt-7-1427.PMC3857067.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1427–1431Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1427Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5097 2combined letrozole and clomiphene versus   letrozole and clomiphene alone in infertile   patients with polycystic ovary syndrome Masomeh hajishafiha1 Meisam Dehghan2 nazila Kiarang1 nahideh sadegh-asadi1 seyed n avid shayegh3 Mohammad ghasemi-rad2 1Department of gynecology,   reproductive health research center,   Urmia University of Medical sciences,   2Urmia University of Medical sciences,   3gulf Medical University, ajman,   United arab emirates correspondence: Mohammad   ghasemi-rad   Department of Medicine,   Brigham and Women’s hospital,   harvard-MiT Division of health   sciences and Technology, harvard   Medical school, Boston, Ma, Usa   email medman11@gmail.co mBackground:  Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in  women of childbearing age (6.8%–18%), is among the most common causes of infertility due to  ovulation factors, and accounts for 55%–70% of infertility cases caused by chronic anovulation.",Non-OADS,/arxiv_data1/oa_pdf/8a/a2/dddt-7-1427.PMC3857067.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8a/a2/dddt-7-1427.PMC3857067.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/a2/dddt-7-1427.PMC3857067.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/92/clep-5-501.PMC3857068.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 501–512Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  501Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S5162 5Patterns of 6-mercaptopurine and azathioprine  maintenance therapy among a cohort   of commercially insured individuals diagnosed   with Crohn’s disease in the United states Jennifer l lund1 suzanne F Cook2 Jeffery K allen2 Charlotte F Carroll2 Michael D Kappelman3 1Department of Clinical   Epidemiology, aarhus University,  aarhus, Denmark; 2Worldwide  Epidemiology, glaxosmithKline,  research Triangle Park, nC, Usa;  3Department of Pediatrics, University  of north Carolina at Chapel hill,  Chapel hill, nC, Usa Correspondence: Jennifer l lund   Department of Epidemiology, gillings  school of global Public health, University  of north Carolina at Chapel hill, 2102-D  Mcgavran-greenberg hall, 135 Dauer  DriveCampus Box 7435 Chapel hill  27599-7435, nC, Usa   Tel +1 919 966 7440   Email Jennifer.lund@unc.ed uBackground and aims:  Thiopurines, including 6-mercaptopurine (6-MP) and azathioprine  (AZA), are the mainstay of maintenance therapy for Crohn’ s disease (CD).",Non-OADS,/arxiv_data1/oa_pdf/ae/92/clep-5-501.PMC3857068.pdf
Available from: http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/UCM07082 9.,Non-OADS,/arxiv_data1/oa_pdf/ae/92/clep-5-501.PMC3857068.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/ae/92/clep-5-501.PMC3857068.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/b5/dddt-7-1447.PMC3857069.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1447–1454Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1447Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5253 3P-glycoprotein alters blood–brain barrier  penetration of antiepileptic drugs in rats   with medically intrac table epilepsy aimei Ma1,* cuicui Wang2,3,* Yinghui chen2,3 Weien Yuan4 1Department of n eurology, The  People’s hospital of shanxi Province,   Taiyuan, 2Department of neurology,   Jinshan hospital, Fudan University,   3Department of n eurology, shanghai  Medical college, shanghai, 4school  of Pharmacy, shanghai JiaoTong  University, shanghai, People’s republic  of china *These authors contributed equally to  this work correspondence: Yinghui chen   Department of neurology, Jinshan  hospital, Fudan University, shanghai  201508, People’s republic of china   email yinghuichen@fudan.edu.c n    Weien Yuan   school of Pharmacy, shanghai JiaoTong  University, 800 Dongchuan road,  shanghai 200240, People’s republic   of china   email yuanweien@126.co mAbstract:  P-glycoprotein is one of the earliest known multidrug transporters and plays an  important role in resistance to chemotherapeutic drugs.",Non-OADS,/arxiv_data1/oa_pdf/2e/b5/dddt-7-1447.PMC3857069.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2e/b5/dddt-7-1447.PMC3857069.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/b5/dddt-7-1447.PMC3857069.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813000393 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/S0950268813000393a.PMC3857110.pdf
(http://idsc.nih.go.jp/iasr/28/331/tpc331.html).,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/S0950268813000393a.PMC3857110.pdf
(http://idsc.nih.go.jp/iasr/31/360/tpc360.html).,OADS,/arxiv_data1/oa_pdf/3c/1c/S0950268813000393a.PMC3857110.pdf
(http://idsc.nih.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/S0950268813000393a.PMC3857110.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/df/dddt-7-1455.PMC3857114.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1455–1469Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1455Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5289 0Development and characterization   of gastroretentive sustained-release formulation  by combination of swelling and mucoadhesive  approach: a mechanistic study r sankar1 subheet Kumar Jain1,2 1Department of Pharmaceutical  sciences and Drug research, Punjabi  University, Patiala, Punjab, india;   2Department of Pharmaceutical  sciences, guru nanak Dev   University, amritsar, Punjab, india correspondence: subheet Kumar Jain   Department of Pharmaceutical   sciences, guru nanak Dev University,   amritsar, Punjab, 143 005, india   Tel +91 183 225 8802   Fax +91 183 225 8819   email subheetjain@gmail.co mBackground:  Acyclovir has pharmacokinetic limitations, including poor oral bioavailability  of 15%–30%, high variability, and short elimination half-life of 2.3 hours.",Non-OADS,/arxiv_data1/oa_pdf/80/df/dddt-7-1455.PMC3857114.pdf
Available  from: http://www.colorcon.com/literature/marketing/mr/Extended%20 Release/POL YOX/English/Colorcon_PIB_POL YOX.pdf .,Non-OADS,/arxiv_data1/oa_pdf/80/df/dddt-7-1455.PMC3857114.pdf
Available from: http://www.lubrizol.com/ Pharmaceutical-Ingredients/Documents/Brochures/Pharmaceutical- Polymers-for-Oral-Solid-Dosage-Forms.pdf .,Non-OADS,/arxiv_data1/oa_pdf/80/df/dddt-7-1455.PMC3857114.pdf
Available from: http://www.fmcbio - polymer.com/Portals/ISP/Content/Docs/Alginates%20for% 20 Pharmaceutical %20and%20Medical%2 0Applications.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/df/dddt-7-1455.PMC3857114.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/80/df/dddt-7-1455.PMC3857114.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/df/dddt-7-1455.PMC3857114.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/2e/dddt-7-1433.PMC3857115.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1433–1446Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1433Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5044 8atomoxetine affects transcription/translation  of the nMD a receptor and the norepinephrine  transporter in the rat brain – an in vivo study Patrick T Udvardi1,2 Karl J Föhr3 carolin henes1,2 stefan liebau2 Jens Dreyhaupt4 T obias M Boeckers2 andrea g ludolph1 1Department of child and adolescent  Psychiatry and Psychotherapy,   2institute of anatomy and cell Biology,   3Department of anaesthesiology,   4institute of epidemiology and Medical  Biometry, University of Ulm, Ulm,   germany correspondence: andrea g ludolph   Department of child and adolescent  Psychiatry and Psychotherapy,   University of Ulm, steinhoevelstr 5,   D-89075 Ulm, germany   Tel +49 731 5006 1601   Fax +49 731 5006 1662   email andrea.ludolph@uni-ulm.d eAbstract:  Attention-deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed  neurodevelopmental disorder.",Non-OADS,/arxiv_data1/oa_pdf/4d/2e/dddt-7-1433.PMC3857115.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4d/2e/dddt-7-1433.PMC3857115.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/2e/dddt-7-1433.PMC3857115.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813000733 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5b/2a/S0950268813000733a.PMC3857146.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/de/ijgm-6-863.PMC3857150.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 863–868International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  863OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S5190 6Prevalence of hypertension in three rural  communities of Ife north local Government   area of Osun state, south West nigeria rasaaq a adebayo1 Michael O Balogun1 rufus a adedoyin2 Oluwayemisi a Obashoro- John3 luqman a Bisiriyu4 Olugbenga O abiodun1 1Department of Medicine,   2Department of Medical  rehabilitation, Obafemi awolowo  University, 3Department of adult  education, University of lagos,   4Department of Demography and  social statistics, Obafemi awolowo  University, Ile-Ife, Osun state, n igeria correspondence: rasaaq a adebayo   Department of Medicine, PO Box 1961,  Obafemi awolowo University,   Ile-Ife, Osun state, nigeria   Tel +234 80 3714 9610   email radebayo@oauife.edu.ng,  aderasaaq@yahoo.co.uk Background:  The prevalence of hypertension is increasing rapidly in sub-Saharan Africa, but  data are limited on hypertension prevalence.",Non-OADS,/arxiv_data1/oa_pdf/14/de/ijgm-6-863.PMC3857150.pdf
Available from: http://www.population.gov.n g.  25.,OADS,/arxiv_data1/oa_pdf/14/de/ijgm-6-863.PMC3857150.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/14/de/ijgm-6-863.PMC3857150.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/de/ijgm-6-863.PMC3857150.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/17/ijgm-6-869.PMC3857151.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 869–875International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  869OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S5005 7T elephone-based anticoagulation management   in the homebound setting: a retrospective   observational study samer hassan1,* ali naboush1,* Jared radbel1,* razan asaad1 homam alkaied2 seleshi Demissie3 T erenig T erjanian2 1Division of Internal Medicine,   2Division of hematology/Oncology,   3Division of statistics; staten Island  University hospital, staten Island,    nY, Usa *These authors contributed equally to  this work correspondence: Terenig Terjanian   nalitt Institute of cancer, 256 Mason   avenue, staten Island, nY, Usa   Tel +1 718 667 4700   email tterjanian@siuh.ed uBackground:  Anticoagulation management is currently performed through anticoagulation  clinics or self-managed with or without the help of medical services.",Non-OADS,/arxiv_data1/oa_pdf/5e/17/ijgm-6-869.PMC3857151.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/5e/17/ijgm-6-869.PMC3857151.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/17/ijgm-6-869.PMC3857151.pdf
"Available from: http://www.govtrack.us/congress/ bills/106/hr5661/tex t. Accessed September 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/5e/17/ijgm-6-869.PMC3857151.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/idr-6-235.PMC3857152.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2013:6 235–240Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  235ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S5387 4The β-lactamase inhibitor avibactam (nXl104)  does not induce ampC  β-lactamase   in Enterobacter cloacae christine Miossec Monique claudon Premavathy levasseur Michael T Black novexel, Romainville, France correspondence: christine Miossec   27 Rue stendhal, Paris 75020, France   Tel +33 6 8976 2978   email miossec.christine@gmail.co mAbstract:  Induction of ampC  β-lactamase expression can often compromise antibiotic treatment  and is triggered by several β-lactams (such as cefoxitin and imipenem) and by the β-lactamase  inhibitor clavulanic acid.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/idr-6-235.PMC3857152.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/idr-6-235.PMC3857152.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/idr-6-235.PMC3857152.pdf
"Infection and Drug Resistance 2013:6submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 240Miossec et al to clinical development, currently undergoing Phase II–III  clinical trials in combination with ceftazidime and with cef - taroline ( http://www.clinicaltrials.go v).",Non-OADS,/arxiv_data1/oa_pdf/1f/67/idr-6-235.PMC3857152.pdf
"It is suggested  the predominance of a variant SOD1  transcript with exon  2-skipping or exon 2- and 3-skipping deletions may lead to  a decrease in enzyme activities in the KCN cornea [ 16,17];  thus, in this study, SOD1  was investigated as an intracellular  isoenzyme in KCN and non-KCN corneas.Molecular Vision  2013; 19:2501-2507 <http://www.molvis.org/molvis/v 19/2501 > Received 17 July 2012 | Accepted 6 December 2013 | Published 8 December 2013© 2013 Molecular Vision 2501Analysis of superoxide dismutase 1, dual-specificity phosphatase  1, and transforming growth factor, beta 1 genes expression in  keratoconic and non-keratoconic corneas Samira Saee-Rad,1 Reza Raoofian,2 Mirgholamreza Mahbod,1 Mohammad Miraftab,1 Majid Mojarrad,2  Soheila Asgari,1 Farhad Rezvan,1 Hassan Hashemi1 (The first two authors contributed equally to this work) 1Noor Ophthalmology Research Center, Noor Eye hospital, Tehran, Iran; 2Department of Medical Genetics, Mashhad University  of Medical Sciences, Mashhad, Iran Purpose:  To quantitatively assess the superoxide dismutase 1 ( SOD1 ), transforming growth factor, beta 1 ( TGF-β1 ), and  dual-specificity phosphatase 1 ( DUSP1 ) messenger ribonucleic acid (mRNA) expression levels as the main intracellular  reactive oxygen species neutralizers, wound healing mediators, and immunomodulators (respectively) in keratoconic  (KCN) and non-KCN corneas.",Non-OADS,/arxiv_data1/oa_pdf/1e/ee/mv-v19-2501.PMC3857158.pdf
"Molecular Vision  2013; 19:2501-2507 <http://www.molvis.org/molvis/v 19/2501 > © 2013 Molecular Vision  2502Dual-specificity phosphatases ( DUSP s) or mitogen- activated protein kinase phosphatases (MKPs) are a subset  of proteins, many of which dephosphorylate threonine and  tyrosine residues on mitogen-activated protein kinases.",Non-OADS,/arxiv_data1/oa_pdf/1e/ee/mv-v19-2501.PMC3857158.pdf
"Molecular Vision  2013; 19:2501-2507 <http://www.molvis.org/molvis/v 19/2501 > © 2013 Molecular Vision  2503RESULT Cell culture:  Seven days after tissue cultivation, the cells  migrated out of the tissue pieces.",Non-OADS,/arxiv_data1/oa_pdf/1e/ee/mv-v19-2501.PMC3857158.pdf
Molecular Vision  2013; 19:2501-2507 <http://www.molvis.org/molvis/v 19/2501 > © 2013 Molecular Vision  2504DISCUSSION KCN is a corneal disorder with heterogeneity and variability  in symptoms.,Non-OADS,/arxiv_data1/oa_pdf/1e/ee/mv-v19-2501.PMC3857158.pdf
Molecular Vision  2013; 19:2501-2507 <http://www.molvis.org/molvis/v 19/2501 > © 2013 Molecular Vision  2505the pooled non-KCN samples.,Non-OADS,/arxiv_data1/oa_pdf/1e/ee/mv-v19-2501.PMC3857158.pdf
Molecular Vision  2013; 19:2501-2507 <http://www.molvis.org/molvis/v 19/2501 > © 2013 Molecular Vision  2506high expression of TGF-β1  as a wound healing mediator in  KCN samples.,Non-OADS,/arxiv_data1/oa_pdf/1e/ee/mv-v19-2501.PMC3857158.pdf
Molecular Vision  2013; 19:2501-2507 <http://www.molvis.org/molvis/v 19/2501 > © 2013 Molecular Vision  250726.,Non-OADS,/arxiv_data1/oa_pdf/1e/ee/mv-v19-2501.PMC3857158.pdf
"Autofluorescence measurements were obtained with the  HRA2 Heidelberg retinal confocal angiograph (Heidelberg Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > Received 1 July 2013 | Accepted 6 December 2013 | Published 8 December 2013© 2013 Molecular Vision 2487Homozygosity mapping in autosomal recessive retinitis  pigmentosa families detects novel mutations Béatrice Bocquet,1,2,3 Nour al Dain Marzouka,1,2,3 Maxime Hebrard,1,2,3 Gaël Manes,1,2,3 Audrey Sénéchal,1,2,3  Isabelle Meunier,1,2,3,4 Christian P. Hamel1,2,3,4 (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2488Engineering, Dossenheim, Germany), and fundus pictures  were taken.",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2489For the remaining five families (33.3%), all RP genes in  homozygous regions were sequenced but no mutation was  detected, suggesting that their proband could carry a mutation  in a novel gene.",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2490Table  1.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2491Family # Chromosome Length* SNP/Mb Start Stop RANK Genes 7 10 77 139,122,579 149,147,283 10 16 22 68 54,368,954 76,163,081 11 CNGB1, CDH3 RP670 15 20 67 70,670,532 91,626,291 1 RLBP1, NR2E3 12 5 35 33,095,301 38,783,937 2 11 7 28 47,884,847 55,182,977 3 RP745 18 15 131 59,022,364 74,333,187 1 7 13 96 36,733,691 49,999,517 2 5 27 81 38,657,850 65,932,343 3 7 32 74 70,138,345 102,504,683 4 PEX1 7 20 61 50,006,472 70,113,409 5 11 8 34 47,873,883 55,620,859 6 17 17 33 14,152,804 30,823,007 7 HRG4/UNC119 RP819 16 7 145 6,137,184 12,877,511 1 11 9 106 76,325,821 85,436,868 2 MYO7A 3 17 93 100,042,849 116,695,553 3 IMPG2 10 11 89 99,038,933 110,389,800 4 ARL3 5 20 82 72,943,817 92,857,172 5 RP854 8 7 125 16,489,491 23,287,191 1 12 6 113 102,972,070 108,720,576 2 1 9 97 167,407,517 176,453,828 3 8 24 98 102,458,515 126,789,312 4 8 13 96 53,880,054 67,044,043 5 RP1, TTPA 2 7 81 183,870,146 191,325,255 6 2 8 74 26,097,607 34,429,224 7 ZNF513, C2ORF71 5 16 67 38,414,330 54,391,555 RP855 11 12 119 85,869,911 97,383,737 1 15 5 117 33,415,288 38,491,401 2 10 19 114 105,391,725 123,911,345 3 13 6 106 84,581,120 90,263,015 4 6 8 104 117,641,016 125,607,559 5 5 23 103 101,320,305 123,846,658 6 7 15 103 155,645,303 170,683,241 7 18 9 101 38,011,865 47,209,971 8 5 5 101 26,045,009 31,423,339 9",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2492Family # Chromosome Length* SNP/Mb Start Stop RANK Genes 14 14 96 34,194,336 48,552,897 10 4 25 93 111,252,455 136,022,295 11 BBS12 11 10 89 110,685,226 120,548,318 12 MFRP 2 16 88 148,875,566 164,388,639 13 10 29 87 34,317,035 63,401,422 14 RBP3, PCDH15 20 9 87 53,622,497 63,000,000 15 PRPF6 6 20 84 23,895,019 44,154,325 16 TULP1, PRPH2 21 5 73 42,506,107 48,000,000 17 11 48 72 35,991,050 83,847,610 18 BEST1, ROM1, BBS1, CABP4, MYO7A RP1013 7 15 112 19,386,915 34,648,783 1 KLHL7,PAP1 5 15 110 106,422,649 121,734,393 2 16 15 104 1,889,821 16,730,604 3 ABCC6 8 7 103 25,445,326 32,079,101 4 7 9 92 120,144,923 128,748,534 5 TSPAN12, IMPDH1, OPN1SW 2 36 89 188,652,307 224,429,597 6 8 11 86 58,758,850 69,756,364 7 TTPA 3 53 85 68,243,465 121,132,268 8 BBS3, IMPG2 8 30 85 73,152,837 102,974,357 9 PEX2, CNGB3, C8ORF37 5 48 84 26,788,362 74,365,757 10 7 10 81 137,476,571 147,969,602 11 11 48 70 32,076,832 80,155,054 12 BEST1, ROM1, BBS1, LRP5 2 11 68 23,712,008 34,302,743 13 ZNF513, C2ORF71 RP1077 1 25 106 217,257,837 241,982,430 1 21 21 98 9,764,385 31,185,292 2 4 5 20 48,094,534 53,233,482 3 5 6 16 44,334,983 50,066,049 4 20 5 10 25,506,582 30,680,225 5 16 15 4 31,905,355 46,831,180 6 2 7 3 88,965,501 96,239,773 7 9 33 2 38,703,364 71,244,025 8 RP1324 16 7 100 54,776,161 62,457,005 1 CNGB1 , BBS2 RP1361 5 16 112 145,313,228 162,831,477 1 PDE6A 20 11 112 49,172,235 60,352,153 2 16 16 107 65,223,172 81,678,049 3 OPA8, CDH3",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2493Family # Chromosome Length* SNP/Mb Start Stop RANK Genes 8 25 77 37,328,843 63,110,766 4 RP1, ADAM9 20 22 66 22,782,904 45,359,408 5 RP1625 8 18 142 5,057,818 23,559,224 1 RP1L1 1 13 120 58,394,231 72,327,802 2 RPE65 4 5 98 31,636,008 36,732,290 3 7 7 91 123,580,016 131,407,605 4 OPN1SW, IMPDH1 12 13 90 117,118,028 130,497,472 5 2 7 79 233,929,283 241,117,231 6 SAG 8 32 79 40,071,825 72,824,945 7 RP1, TTPA 12 5 30 34,142,799 39,744,369 8 3 5 27 88,365,050 93,558,926 9 7 7 17 56,665,370 63,796,171 10 RP1682 15 13 89 81,632,077 95,169,873 1 RLBP1 5 5 74 172,682,382 177,906,494 2 For each family, homozygous regions were classified according to the size of the region in Mb, and the coverage (number of SNP per Mb) to give a rank for prioritizing the  molecular screening.",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2494for II:4 from PB15), retinal vessel attenuation and retinal  atrophy in fundus, and strongly decreased ERG responses.",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2495Both patients with homozygous RLBP1  mutations had  less severe RP than the ten other patients and both had early  onset night blindness.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2496improved patient follow up, and prediction of disease course.",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2497Inherited Retinal Dystrophies and Optic Neuropathies in  Southern France: Assessment of 21-year Data Management.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  249821. den Hollander AI, Lopez I, Yzer S, Zonneveld MN, Janssen  IM, Strom TM, Hehir-Kwa JY, Veltman JA, Arends ML,  Meitinger T, Musarella MA, van den Born LI, Fishman GA,  Maumenee IH, Rohrschneider K, Cremers FP, Koenekoop  RK.",Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2499autosomal recessive retinitis pigmentosa families.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
Molecular Vision  2013; 19:2487-2500 <http://www.molvis.org/molvis/v 19/2487 > © 2013 Molecular Vision  2500albescens with mutations in RLBP1  JAMA Ophthalmol   2013; 131::1314--23.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/mv-v19-2487.PMC3857159.pdf
"These models have provided  invaluable insight into the importance of Mdm2 as a negative  regulator of p53 activity in specific tissues or specific cell  types, such as in the spleen, thymus, bone marrow, small and  large intestines, heart, bone, lung, kidney, liver, testis, smooth  muscle, and brain (for reviews with appropriate references,  see references 3 and 11).Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > Received 19 September 2013 | Accepted 6 December 2013 | Published 8 December 2013© 2013 Molecular Vision 2468p53 E3 ubiquitin protein ligase homolog regulates p53 in vivo in  the adult mouse eye lens Gilberto Jaramillo-Rangel,1 Marta Ortega-Martínez,1 Julio Sepúlveda-Saavedra,2 Odila Saucedo-Cárdenas,2, 3  Roberto Montes-de-Oca-Luna2 1Departamento de Patología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México;  2Departamento de Histología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México;  3División de Genética, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social (IMSS), Monterrey,  Nuevo León, México Purpose:  p53 is a transcription factor that plays an important role in preventing cancer development.",Non-OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
"Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > © 2013 Molecular Vision  2469The eye lens is composed of a single layer of epithelial  cells on the anterior surface that divide and differentiate into  quiescent and structurally highly differentiated fiber cells  characterized by changes in cell shape, expression of crystal - lins, and degradation of cellular organelles, thus ensuring lens  transparency [ 12].",Non-OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
"Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > © 2013 Molecular Vision  2470transgenic mice with microphthalmia were mated with each  other, all the offspring were positive for Tg p53 and showed  microphthalmia.",Non-OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > © 2013 Molecular Vision  2471and fiber cells organized in layers were observed (Figure 2C).,OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
"Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > © 2013 Molecular Vision  24722), demonstrating that Mdm2 regulates p53 in vivo in the  adult lens.",Non-OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
"Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > © 2013 Molecular Vision  2473indicate that Mdm2 can regulate p53 to a certain extent, but  p53 overexpression can overcome inhibition by Mdm2.",Non-OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > © 2013 Molecular Vision  2474model.,Non-OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > © 2013 Molecular Vision  24757.,Non-OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
Molecular Vision  2013; 19:2468-2476 <http://www.molvis.org/molvis/v 19/2468 > © 2013 Molecular Vision  2476cells in vivo.,Non-OADS,/arxiv_data1/oa_pdf/a0/4e/mv-v19-2468.PMC3857160.pdf
"It has also been shown that Molecular Vision  2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > Received 7 July 2013 | Accepted 6 December 2013 | Published 8 December 2013© 2013 Molecular Vision 2477Aldose reductase inhibitor counteracts the enhanced expression of  matrix metalloproteinase-10 and improves corneal wound healing  in galactose-fed rats Yoshihiro Takamura,1 Takafumi Matsumoto,2 Takeshi Tomomatsu,1 Takehiro Matsumura,1 Yuji Takihara,1  Masaru Inatani1 1Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho, Yoshida-gun, Fukui, Japan;  2Dainippon Sumitomo Pharma.Co.",Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
"Molecular Vision  2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > © 2013 Molecular Vision  2478corneas of patients with DR show significantly decreased  immunostaining for major epithelial BM components, such  as nidogen-1/entactin, laminins, and binding partner integrin  α3β1 [ 25,26].",Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
"Molecular Vision  2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > © 2013 Molecular Vision  2479Immunoreaction of MMP-10 and integrin α3 was visualized  using a 0.02% 3, 3′-diaminobenzidine tetrahydrochloride  solution (Nakarai, Company, Kyoto, Japan) containing 0.05%  hydrogen peroxide.",OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
Molecular Vision 2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > © 2013 Molecular Vision  2480the intensity of staining; strong expression was observed  on the side of the basal cells.,Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
"Molecular Vision  2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > © 2013 Molecular Vision  2481α3 was diffusely immunopositive in normal corneal epithe - lium, however, the intensity of staining in rats with galactose  exposure was decreased, and this decrease in expression was  prevented by the administration of ARI.",Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
Molecular Vision  2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > © 2013 Molecular Vision  2482Gene expression of matrix metalloproteinase-10 and integrin  α3 subunits: Our finding of decreased expression of inte - grin α3 could be due to either decreased protein synthesis  or increased degradation.,Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
"Molecular Vision  2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > © 2013 Molecular Vision  2483patients with DR, whereas such elevation was not seen in  corneas with keratoconus [ 25].",Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
Molecular Vision  2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > © 2013 Molecular Vision  2484It is probable that these mechanisms are also involved in  the pathogenesis of abnormal corneal epithelium behavior.,Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
Molecular Vision  2013; 19:2477-2486 <http://www.molvis.org/molvis/v 19/2477 > © 2013 Molecular Vision  248519.,Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
Molecular Vision  ####; ###:2477-2486 <http://www.molvis.org/molvis/v ###/#### > © Copyright Year Copyright Holder  248639.,Non-OADS,/arxiv_data1/oa_pdf/29/71/mv-v19-2477.PMC3857161.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/95/ijgm-6-905.PMC3857164.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 905–909International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  905OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S5455 9The prevalence and reliability of self-reported  penicillin allergy in a community hospital Faisal a Khasawneh1 Megan a r slaton2 stephen l Katzen2 ashley a Woolbert2 sean D anderson2 Michelle B Parker2 rachel M anderson2 Krystal K haase3 roger D smalligan4 1section of Infectious Diseases,  Department of Internal Medicine,  2school of Medicine, 3school of  Pharmacy, 4Department of Internal  Medicine, Texas Tech University  health sciences center, amarillo,  TX, Usa correspondence: Faisal a Khasawneh   section of Infectious Diseases,  Department of Internal of Medicine,  Texas Tech University health sciences  center, 1400 s coulter street,   amarillo, TX 79106, Usa   Tel +1 806 354 5480   Fax +1 806 354 5765   email faisal.khasawneh@ttuhsc.ed uBackground:  Penicillin (PCN) accounts for most cases of antibiotic allergies.",Non-OADS,/arxiv_data1/oa_pdf/bd/95/ijgm-6-905.PMC3857164.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/bd/95/ijgm-6-905.PMC3857164.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/95/ijgm-6-905.PMC3857164.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/23/hiv-5-309.PMC3857165.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS – Research and Palliative Care 2013:5 309–319HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  309ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S5061 4Poor immunological recovery among   severely immunosuppressed antiretroviral   therapy-naïve Ugandans Sarah n anzigu1,2 Ronald Kiguba1 Joseph Kabanda3 Jackson K Mukonzo1 Paul Waako1 Cissy Kityo4 Fred Makumbi3 1Department of Pharmacology and  Therapeutics, Makerere University  College of Health Sciences, Kampala,   Uganda; 2Department of laboratory  Medicine, Karolinska Institute,   Stockholm, Sweden; 3Institute of  Public Health, Makerere University  College of Health Sciences, Kampala,   Uganda; 4Joint Clinic Research Centre,   Kampala, Uganda Correspondence: Sarah nanzigu   Department of Pharmacology and   Therapeutics, Makerere University   College of Health Sciences,   PO Box 7072, Kampala, Uganda   T el +256 784 843045   Fax +256 414 532947   email snanzigu@chs.mak.ac.u gIntroduction:  CD4 T lymphocytes remain the surrogate measure for monitoring HIV prog - ress in resource-limited settings.",Non-OADS,/arxiv_data1/oa_pdf/b3/23/hiv-5-309.PMC3857165.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/b3/23/hiv-5-309.PMC3857165.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/23/hiv-5-309.PMC3857165.pdf
"Available from: http://www.who.int/ hiv/pub/guidelines/artadultguidelines.pd f. Accessed Augu st 28 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/b3/23/hiv-5-309.PMC3857165.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/82/ijn-8-4641.PMC3857166.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4641–4658International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4641OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5383 0evaluating the potential of poly(beta-amino   ester) nanoparticles for reprogramming   human fibroblasts to become induced   pluripotent stem cells Nupura s Bhise1,* Karl J Wahlin2,* Donald J Zack2–4 Jordan J green1,2 1Department of Biomedical  engineering, Translational Tissue  engineering center, and Institute for  Nanobiotechnology, 2Department of  Ophthalmology, The Johns hopkins  University school of Medicine,   Baltimore, MD, 3solomon h snyder  Department of Neuroscience,   Department of Molecular Biology  and genetics, and Institute of  genetic Medicine, The Johns hopkins  University school of Medicine,   Baltimore, MD, Usa; 4Institut de la  Vision, Paris, France *These authors contributed equally  to this work correspondence: Jordan J green   Department of Biomedical engineering,  Translational Tissue engineering center,  and Institute for Nanobiotechnology,  The Johns hopkins University school of  Medicine, Baltimore, MD 21218, Usa   Phone +1 410 614 9113   Fax +1 443 287 6298   email green@jhu.ed uBackground:  Gene delivery can potentially be used as a therapeutic for treating genetic   diseases, including neurodegenerative diseases, as well as an enabling technology for regen - erative medicine.",Non-OADS,/arxiv_data1/oa_pdf/99/82/ijn-8-4641.PMC3857166.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/99/82/ijn-8-4641.PMC3857166.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/82/ijn-8-4641.PMC3857166.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/7d/ijnrd-6-269.PMC3857262.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2013:6 269–270International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  269LetteRopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJNRD.S5575 0Hyperuricemia and non-dipping blood pressure Oreste Marrone1 Maria Rosaria Bonsignore1,2 1National Research Council, Institute  of Biomedicine and Molecular  Immunology, Palermo, Italy;   2Biomedical Department of Internal  and Specialistic Medicine, University  of Palermo, Palermo, Italy Correspondence: Oreste Marrone   Consiglio Nazionale delle Ricerche,  Istituto di Biomedicina e Immunologia  Molecolare, Via Ugo La Malfa,   153, 90146 Palermo, Italy   tel +39 091 680 9136   Fax +39 091 680 9127   email marrone@ibim.cnr.i tDear editor The strong association between the metabolic derangements that characterize the  metabolic syndrome with arterial hypertension is very well-known, as it is the  common finding of hyperuricemia in the patients with the metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/71/7d/ijnrd-6-269.PMC3857262.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/71/7d/ijnrd-6-269.PMC3857262.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/7d/ijnrd-6-269.PMC3857262.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2275–2279Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2275Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5269 0Ocular cysticercosis in a 32-year-old man in abuja:  ultrasonic features as an aid in diagnosis Oe Babalola1 a adu2 aO akano3 1Bingham University, New Karu,   Nassarawa state, 2Department of  Ophthalmology, rachel eye Center,   Garki phase II, 3Department of  radiology, National Hospital, abuja,   Nigeria Correspondence: Oe Babalola   Bingham University, New Karu,  Nassarawa state, Nigeria   email bablo57@gmail.co mAbstract:  We report the case of a 32-year-old man suffering from intraocular cysticercosis,  with special emphasis on the use of B-scan ultrasound in the diagnosis and management of the  condition.",Non-OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
Available from: http://www.dpd.cdc.gov/dpdx/html/ cysticercosis .htm.,OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
Available from: http://www.wcume.org/wp-content/uploads/2011/05/ Tsung.pdf .,Non-OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
Available  from: http://www.aios.org/cme/cmeseries24.pdf .,Non-OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
"Available from: http://www.retinareference.com/content/Choroidal%20 Detachment%20-%20djb6-27-2010websiteversion.pd f. Accessed  October 5, 2013.",Non-OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
Available from:  http://emedicine.medscape.com/article/1204683-overview .,Non-OADS,/arxiv_data1/oa_pdf/97/d2/opth-7-2275.PMC3857263.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/57/rru-5-159.PMC3857264.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpResearch and Reports in Urology 2013:5 159–162Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  159Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/RRU.S5271 2sensorimotor polyneuropathy and foot-drop  as result of a prostate cancer paraneoplastic  syndrome John J Bodkin1 Michael Duff1,2 phillip J seereiter Jr3 K Kent Chevli1,3 1state University of New York school  of Medicine and Biomedical sciences  Department of Urology, Buffalo;  2Cancer Care of Western New York,  Cheektowaga; 3Western New York  Urology associates, Cheektowaga,  NY, Usa Correspondence: Michael Duff   Cancer Care of Western New York,   3085 Harlem Rd, Cheektowaga,   NY 14225, Usa   tel +1 716 844 5500   email mduff@cancercarewny.co mAbstract:  Paraneoplastic syndromes (PNS) vary in incidence and manifestation based on  tumor histology.",Non-OADS,/arxiv_data1/oa_pdf/50/57/rru-5-159.PMC3857264.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/50/57/rru-5-159.PMC3857264.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/57/rru-5-159.PMC3857264.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/b5/vhrm-9-763.PMC3857265.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 763–768Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  763ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5069 0Serum lipid profile and correlates in newly  presenting Nigerians with arterial hypertension Umar g adamu1 george a Okuku2 clement O Oladele1 aisha abdullahi3 Joanah i Oduh1 abidemi J Fasae4 1Department of Medicine,  2Department of Haematology,   Federal Medical centre, Bida,   niger state, 3Department of nursing  services, general Hospital, Minna,  niger state, 4Department of Medicine,  Federal Medical centre, ido-ekiti,  ekiti state, nigeria  correspondence: Umar g adamu   Department of Medicine,   Federal Medical Centre, Efu Etsu yisa,   PMB 14, Bida niger state, nigeria   Tel +234 703 048 3770   email ugadamu@yahoo.co mBackground:  Arterial hypertension and dyslipidemia are modifiable cardiovascular risk factors.",Non-OADS,/arxiv_data1/oa_pdf/cb/b5/vhrm-9-763.PMC3857265.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/cb/b5/vhrm-9-763.PMC3857265.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/b5/vhrm-9-763.PMC3857265.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4601–4611International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4601OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5336 4Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
"Or use: http://dvpr.es/H8U6a Gheuristic modeling of macromolecule release  from Plga microspheres Jakub Szlęk1 Adam Pacławski1 raymond lau2 renata Jachowicz1 aleksander Mendyk1 1Department of Pharmaceutical  T echnology and Biopharmaceutics,   Jagiellonian University Medical  college, Krakow, Poland; 2school of  chemical and Biomedical engineering,   Nanyang Technological University  (NTU), singapore correspondence: aleksander Mendyk   Department of Pharmaceutical   Technology and Biopharmaceutics,   Jagiellonian University Medical college,   Medyczna 9 st, 30-688 Krakow, Poland   Tel +48 12 620 56 04   Fax +48 12 620 56 18   email mfmendyk@cyf-kr.edu.p lAbstract:  Dissolution of protein macromolecules from poly(lactic-co-glycolic acid) (PLGA)  particles is a complex process and still not fully understood.",Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
Marvin ChemAxon ( http://www.chemaxon.co m).,Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
Available from: http://cran.r-project.org/web/ packages/fscaret/index.htm l. Accessed Jun 2013.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
Available from:  http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
Available from: http://cran.r-project.org/ web/packages/monmlp/index.htm l. Accessed Jun 2012.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
Available  from: http://CRAN.R-project.org/packag e=rgp.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
International Journal of Nanomedicine 2013:8submit your manuscript | www.dovepress.co m Dove press Dove press 4610Szlęk et al Table  S2 Full data base used in the study The full data base of macromolecules release from Plga microparticles   http://nigella.farmacja.cm-uj.krakow.pl/~kuba/Int_J_Nanomedicine/supplementary_material_s2.xls xSupplementary material Table  S1 list of publications used in data extraction  1.,OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ijn-8-4601.PMC3857266.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/04/ijn-8-4631.PMC3857267.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4631–4639International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4631OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5174 5Immobilized transferrin Fe3O4@siO2 nanoparticle  with high doxorubicin loading for dual-targeted  tumor drug delivery Wence Ding lin guo Key laboratory of Mesoscopic  chemistry of Ministry of education,   school of chemistry and chemical  engineering, Nanjing University,   Nanjing, People’s republic of china correspondence: lin guo   Key laboratory of Mesoscopic chemistry  of Ministry of education, school of  chemistry and chemical engineering,  Nanjing University, Nanjing 210093,  People’s republic of china   Tel +86 25 8359 3262   Fax +86 25 8331 7761   email linguo@nju.edu.c nAbstract:  Transferrin (Tf) was immobilized onto Fe3O4@SiO2 nanoparticles with high  doxorubicin (DOX) loading (TfDMP), for dual targeting of cancer, by chemically coupling  both Tf and DOX with dual-function magnetic nanoparticles (DMPs) using a multi-armed  crosslinker, poly-L-glutamic acid.",Non-OADS,/arxiv_data1/oa_pdf/ec/04/ijn-8-4631.PMC3857267.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ec/04/ijn-8-4631.PMC3857267.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/04/ijn-8-4631.PMC3857267.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijwh-5-811.PMC3857268.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 811–818International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  811RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5384 5Intrauterine contraception after cesarean section  and during lactation: a systematic review Norman D Goldstuck1 Petrus S Steyn2 1Department of Obstetrics and  Gynaecology, Tygerberg Hospital,   Cape Town, Western Cape, South  Africa; 2Reproductive Health and  Fertility Regulation, Department of  Obstetrics and Gynaecology, Groote  Schuur Hospital and University of  Cape T own, Cape T own, South Africa Correspondence: Norman D Goldstuck   Department of Obstetrics and  Gynaecology, Tygerberg Hospital, Francie  van Zijl Avenue, Tygerberg, Cape Town,  Western Cape 7505, South Africa   Tel +27 823 418 200   email nahumzh@yahoo.co mBackground:  All postpartum women, including those who are breastfeeding or have had a  cesarean section, appear potentially suited to intrauterine contraception, a long acting  reversible  contraceptive (LARC).",Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijwh-5-811.PMC3857268.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijwh-5-811.PMC3857268.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijwh-5-811.PMC3857268.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijwh-5-811.PMC3857268.pdf
Availablefrom: http://sterilisatievereniging.nl/publicaties/doc_do wnload/55- nederlandse-w etgeving-voor-de-sterilisatie-van-medische- hulpmiddelen [accessed March2012] 16.RobertKoch-Institut.,Non-OADS,/arxiv_data1/oa_pdf/87/0d/HIC-08-20.PMC3857276.pdf
"(Informationabout NICEinterventionalprocedureguidance;196).Availablefrom: http://guidance.nice.org.uk/IPG1 96/PublicInf o/doc/English [accessed Sept2011] 36.MauzPS,TropitzschA,FunkD,DworschakM,PlinkertPK.",Non-OADS,/arxiv_data1/oa_pdf/87/0d/HIC-08-20.PMC3857276.pdf
"OncoImmunology 2013; 2:e26441; http://dx.doi.org/10.4161/onci.26441Antitumor activity of an immunocytokine  composed of an anti-GD2 antibody   and the IL-15 superagonist RLI Marie Vincent, a gnès Quéméner*, and y annick Jacques 1uMr892-IN serM 6299-CN rs; université de Nantes; équipe Cytokines et r écepteurs en Immuno-Cancérologie; Nantes, France Keywords:  cancer therapy, GD2 disialoganglioside, immunocytokine, interleukin-15, RLI superagonist The use of interleukin (IL)-15 or the IL-15 superagonist rLI as immunological adjuvants presents many advantages  over that of IL-2, including a reduced toxicity and an improved efficacy.",Non-OADS,/arxiv_data1/oa_pdf/ac/8b/onci-2-e26441.PMC3857326.pdf
Science 1994; 264:965- 8; PMID:8178155 ; http://dx.doi.org/10.1126/ science.8178155 2.,Non-OADS,/arxiv_data1/oa_pdf/ac/8b/onci-2-e26441.PMC3857326.pdf
Immunol Rev  2008 ;  222:357-68; PMID:18364014 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/8b/onci-2-e26441.PMC3857326.pdf
Trends Pharmacol Sci  2012 ; 33:35-41;  PMID:22032984 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/8b/onci-2-e26441.PMC3857326.pdf
J Biol Chem 2006 ; 281:1612 - 9; PMID:16284400 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ac/8b/onci-2-e26441.PMC3857326.pdf
Drug Discov Today  2012 ; 17:583-90; PMID:22289353 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/8b/onci-2-e26441.PMC3857326.pdf
Biochimie  2003 ; 85:455-63; PMID:12770784 ;  http://dx.doi.org/10.1016/S0300-9084(03)00006-3,Non-OADS,/arxiv_data1/oa_pdf/ac/8b/onci-2-e26441.PMC3857326.pdf
"OncoImmunology 2013; 2:e26616; http://dx.doi.org/10.4161/onci.26616HLA-DR expression on myeloid cells   is a potential prognostic factor in patients   with high-risk neuroblastoma Madhu Gowda1,*, Kyle K Payne2, Kamar Godder1, and Masoud H Manjili2,* 1Division of Pediatric Hematology and Oncology; Virginia Commonwealth University; Massey Cancer Center; r ichmond, V a US a;   2Department of Microbiology and Immunology; Virginia Commonwealth University; Massey Cancer Center; r ichmond, V a USa Keywords:  high-risk neuroblastoma, immunotherapy, myeloid-derived suppressor cells, prognostic biomarker Abbreviations: DC, dendritic cell; HR, high-risk; LR, low-risk; MDSC, myeloid-derived suppressor cell;   PBMC, peripheral blood mononuclear cell The adaptive immune system has been reported to play a dual role in many cancers, on one hand inhibiting tumor  growth and, on the other hand, promoting disease progression, escape from cancer immunosurveillance and relapse.",Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
N Engl J  Med 1999; 341:1165-73; http://dx.doi.org/10.1056/ NEJM199910143411601 ; PMID:10519894 3.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
Histopathology 2012; 60:1144-55;  PMID:22394107 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
J Clin Oncol 2005; 23:6459-65; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
Oncologist 2003; 8:278-92; PMID:12773750 ;  http://dx.doi.org/10.1634/theoncologist.8-3-278 8.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
Mol Cell Neurosci 2007; 36:343-54; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
PLoS One 2012; 7:e43665;  PMID:22916293 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
J Neuroimmune Pharmacol 2007; 2:251-8; http://dx.doi.org/10.1007/s11481-007-9081-3 ;  PMID:18040858 11.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
"Eur J Immunol  2007; 37:675-85; http://dx.doi.org/10.1002/ eji.200636639 ; PMID:17304628 12. von Boehmer L, Mattle M, Bode P, Landshammer  A, Schäfer C, Nuber N, Ritter G, Old L, Moch H,  Schäfer N, et al.",OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
Int J Biol Sci 2011; 7:651-8; PMID:21647333 ;  http://dx.doi.org/10.7150/ijbs.7.651 14.,OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
Oncoimmunology 2012; 1:201- 4; PMID:22720242 ; http://dx.doi.org/10.4161/ onci.1.2.18113 16.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
J Transl  Med 2011; 9:170; PMID:21978632 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
J Immunol 2011; 187:708-17;  PMID :21670315 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/onci-2-e26616.PMC3857328.pdf
Rattner; Email: barbara@landesbioscience.com Submitted: 05/13/13; Accepted: 05/13/13http://dx.doi.org/10.4161/epi.25270effects of hyperhomocysteinemia have  been proposed to be relevant to the patho - physiology of the disease.,Non-OADS,/arxiv_data1/oa_pdf/b2/ec/epi-8-559.PMC3857335.pdf
"Epigenetics 8:6, 584–590; June 2013; © 2013 Landes Bioscience REsEaR ch papER 584 Epigenetics Volume 8 Issue 6*Correspondence to: Shusuke Numata; Email: shu-numata@umin.ac.jp Submitted: 02/17/13; Revised: 04/05/13; Accepted: 04/09/13http://dx.doi.org/10.4161/epi.24621Introduction Schizophrenia (SCZ) is a devastating psychiatric disorder with a  median lifetime prevalence rate of 0.7–0.8%.1 Elevated plasma  total homocysteine has been suggested as a risk factor for SCZ,2,3  and hyperhomocysteinemia has been proposed to contribute to the pathophysiology of SCZ via various biological effects, such as a partial antagonist of the glutamate site of the N-methyl-D-aspartate receptor, 4 the interferer of oxygen delivery by damaging  placental vasculature,2 DNA damage and cell cytotoxicity,5 neu- ronal apoptosis6 and mitochondrial nitric oxide accumulation.7 Recently, accumulating evidence has shown that DNA  methylation is also implicated in SCZ.8-27 As more attention is  paid to DNA methylation, homocysteine has been recognized as a potentially key substance.",Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
PLoS  Med 2005; 2:e141; PMID:15916472; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Arch Gen Psychiatry 2007; 64:31-9; PMID:17199052;  http://dx.doi.org/10.1001/archpsyc.64.1.31.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Neurochem Res 2012; 37:1057-62;  PMID:22270909; http://dx.doi.org/10.1007/s11064- 012-0707-3.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
J Biochem Mol Toxicol 2009; 23:349-56; PMID:19827130; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
J Cell Biochem 2005; 96:665- 71; PMID:16149054; http://dx.doi.org/10.1002/jcb.20578.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Hum Mol Genet 2006; 15:3132- 45; PMID:16984965; http://dx.doi.org/10.1093/hmg/ ddl253.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Schizophr Res  2011; 129:183-90; PMID:21550210; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Schizophr Res 2008; 101:50- 7; PMID:18276118; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
J Affect Disord 2011; 132:450- 3; PMID:21453976; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Hum Genet 2012; 131:1081-7;  PMID:22198720; http://dx.doi.org/10.1007/s00439- 011-1131-5.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
BMC Med Genet 2006; 7:10; PMID:16483362;  http://dx.doi.org/10.1186/1471-2350-7-10.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Hum Mol Genet  2011; 20:4786-96; PMID:21908516; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Neuropsychopharmacology 2008; 33:933-45;  PMID:17507910; http://dx.doi.org/10.1038/ sj.npp.1301457.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Behav Brain Funct 2006; 2:37; PMID:17132176;  http://dx.doi.org/10.1186/1744-9081-2-37.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Biol Psychiatry 2005; 57:500-9;  PMID:15737665; http://dx.doi.org/10.1016/j.bio- psych.2004.11.046.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
T rends Mol Med  2009; 15:562-70; PMID:19896901; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Hum Mol Genet 2005; 14(Spec No 1):R139-47;  PMID:15809266; http://dx.doi.org/10.1093/hmg/ ddi100.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Psychiatry  Res 2010; 179:24-9; PMID:20471108; http://dx.doi.org/10.1016/j.psychres.2010.04.008.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Hum Mol Genet 2009; 18:4677-87; PMID:19744961;  http://dx.doi.org/10.1093/hmg/ddp428.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Circ Cardiovasc Genet 2009; 2:142- 50; PMID:20031578; http://dx.doi.org/10.1161/ CIRCGENETICS.108.829804.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Am J Hum Genet 2009; 84:477- 82; PMID:19303062; http://dx.doi.org/10.1016/j.ajhg.2009.02.011.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Arch Gen Psychiatry 2008; 65:1286-94; PMID:18981340; http://dx.doi.org/10.1001/arch- psyc.65.11.1286.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Arch Gen Psychiatry  2003; 60:618-26; PMID:12796225; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Pathophysiology  2009; 16:259-65; PMID:19285843; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Lancet 2003; 361:1693-9; PMID:12767735;  http://dx.doi.org/10.1016/S0140-6736(03)13372-7.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Mol  Cell Biochem 2011; 355:35-45; PMID:21523370; http://dx.doi.org/10.1007/s11010-011-0836-z.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Epigenetics 2011; 6:86- 94; PMID:20864804; http://dx.doi.org/10.4161/ epi.6.1.13392.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Mol  Psychiatry 2005; 10:1017-25; PMID:16044173;  http://dx.doi.org/10.1038/sj.mp.4001713.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Am J  Med Genet B Neuropsychiatr Genet 2007; 144B:502- 7; PMID:17427184; http://dx.doi.org/10.1002/ajmg.b.30499.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Am J Hum Genet 1998; 63:1139-52;  PMID:9758604; http://dx.doi.org/10.1086/302046.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Hum Mol Genet 2008; 17:747-58;  PMID:18045777; http://dx.doi.org/10.1093/hmg/ ddm347.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Neuropsychopharmacology  2000; 23:667-75; PMID:11063922; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Schizophr Bull 2012; PMID:22532702; http://dx.doi.org/10.1093/schbul/sbs067.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
World J Biol Psychiatry 2013; 14:114-20;  PMID:21936766; http://dx.doi.org/10.3109/1562297 5.2011.604350.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
J Neurosci  2005; 25:5376-81; PMID:15930386; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
FASEB J 2012; 26:2712-8;  PMID:22426120; http://dx.doi.org/10.1096/fj.11- 202069.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Am J Hum Genet 2008; 82:696-711; PMID:18319075; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
J Hum Genet 2013;  58:91-7; PMID:23235336; http://dx.doi.org/10.1038/ jhg.2012.140.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
J Psychiatr Res 2011; 45:1432-8;  PMID:21820670; http://dx.doi.org/10.1016/j.jpsy - chires.2011.06.013.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Mol Psychiatry 2011; 16:557- 68; PMID:20404824; http://dx.doi.org/10.1038/mp.2010.47.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
J Psychiatr Res 2007; 41:1042-6;  PMID:17049557; http://dx.doi.org/10.1016/j.jpsy - chires.2006.08.006.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
BMC Med Genet 2010; 11:114; PMID:20649982;  http://dx.doi.org/10.1186/1471-2350-11-114.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Am J Hum Genet 2012; 90:260-72; PMID:22305529;  http://dx.doi.org/10.1016/j.ajhg.2011.12.020.59.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
PLoS One 2007; 2:e895;  PMID:17878930; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Hum Mol Genet 2009; 18:4808-17; PMID:19776032; http://dx.doi.org/10.1093/hmg/ ddp445.56.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Genomics 2011; 98:288- 95; PMID:21839163; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Epigenomics  2011; 3:771-84; PMID:22126295; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
Epigenetics 2011; 6:692-702;  PMID:21593595; http://dx.doi.org/10.4161/ epi.6.6.16196.,Non-OADS,/arxiv_data1/oa_pdf/ea/5b/epi-8-584.PMC3857338.pdf
"www.landesbioscience.com Epigenetics 591Epigenetics 8:6, 591–601; June 2013; © 2013 Landes Bioscience REsEaR ch papER REsEaR ch papER *Correspondence to: Rocío Melissa Rivera; Email: riverarm@missouri.edu Submitted: 02/12/13; Revised: 03/26/13; Accepted: 04/10/13http://dx.doi.org/10.4161/epi.24655Introduction Beckwith-Wiedemann syndrome (BWS) (OMIM 130650) is a  pediatric overgrowth condition with an occurrence of 1 in 13,700 natural births.",Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
In vitro production of bovine embryos was  performed as previously described by us 55 and http://www.ani - mal.ufl.edu/hansen/ivf/.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
BMC Dev  Biol 2010; 10:27; PMID:20205951; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
J Biomed Sci 2012; 19:95;  PMID:23153226; http://dx.doi.org/10.1186/1423-0127-19-95 32.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Theriogenology 2004; 61:867-82;  PMID:14757473; http://dx.doi.org/10.1016/j.therio- genology.2003.07.001 33.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Genomics 2004; 84:961- 70; PMID:15533713; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Differentiation 2011; 81:270- 80; PMID:21316143; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Hum Mol Genet 1996; 5:1101-8; PMID:8842727; http://dx.doi.org/10.1093/ hmg/5.8.1101 36.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Nucleic Acids  Res 1994; 22:5354-9; PMID:7816625; http://dx.doi.org/10.1093/nar/22.24.5354 38.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Hum Mol Genet  2002; 11:1317-25; PMID:12019213; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Dev Genes Evol 1998; 208:393-402; PMID:9732553; http://dx.doi.org/10.1007/ s004270050195 41.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Biol Reprod  2005; 73:1275-81; PMID:16120826; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Hum Mol Genet 1998; 7:1149- 59; PMID:9618174; http://dx.doi.org/10.1093/ hmg/7.7.114916.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Hum Reprod 2006; 21:1009-11; PMID:16361294;  http://dx.doi.org/10.1093/humrep/dei405 17.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Hum Reprod  2009; 24:741-7; PMID:19073614; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Am  J Hum Genet 2003; 72:1338-41; PMID:12772698;  http://dx.doi.org/10.1086/374824 19.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Nature 1991;  351:153-5; PMID:1709450; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Nature 2000; 405:486-9; PMID:10839547;  http://dx.doi.org/10.1038/35013106 22.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Rev Reprod 1998;  3:155-63; PMID:9829550; http://dx.doi.org/10.1530/ ror.0.0030155 23.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Theriogenology 2006; 65:178-91;  PMID:16266745; http://dx.doi.org/10.1016/j.therio-genology.2005.09.022 24.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Biol Reprod 2004; 71:1919-26;  PMID:15286036; http://dx.doi.org/10.1095/biolre- prod.104.031427 25.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Theriogenology  2002; 57:181-7; PMID:11775968; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Theriogenology 2002; 58:973-94;  PMID:12212896; http://dx.doi.org/10.1016/S0093- 691X(02)00935-4 27.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Biol Reprod 2006; 75:17-23;  PMID:16554415; http://dx.doi.org/10.1095/biolre- prod.105.043919 29.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Anim Reprod Sci  2010; 122:303-12; PMID:21035970; http://dx.doi.org/10.1016/j.anireprosci.2010.09.008References 1.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Eur J Hum Genet 2010;  18:8-14; PMID:19550435; http://dx.doi.org/10.1038/ ejhg.2009.106 2.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Am J Med Genet C Semin  Med Genet 2010; 154C:343-54; PMID:20803657;  http://dx.doi.org/10.1002/ajmg.c.30267 3.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Am J Med Genet A 2005; 136:95- 104; PMID:15887271; http://dx.doi.org/10.1002/ ajmg.a.30729 4.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Annu Rev Cell Dev Biol 2003; 19:237-59;  PMID:14570570; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Curr Opin Cell  Biol 2007; 19:281-9; PMID:17467259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Am J Med Genet C Semin  Med Genet 2005; 137C:12-23; PMID:16010676;  http://dx.doi.org/10.1002/ajmg.c.30058 8.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Hum Mol Genet  2000; 9:2075-83; PMID:10958646; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Nat Genet 2002; 32:426- 31; PMID:12410230; http://dx.doi.org/10.1038/ng988 12.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
J Biol Chem 2003; 278:9514- 9; PMID:12511562; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Am J Hum Genet 2003; 72:156-60; PMID:12439823;  http://dx.doi.org/10.1086/346031 14.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Am J Hum Genet 2004; 75:526-8;  PMID:15284956; http://dx.doi.org/10.1086/423902,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Eur J Hum Genet 2009; 17:611-9; PMID:19092779;  http://dx.doi.org/10.1038/ejhg.2008.233 54.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Theriogenology 1991; 36:839-53; PMID:16727053;  http://dx.doi.org/10.1016/0093-691X(91)90350-M 55.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Biol Reprod  2003; 69:2068-77; PMID:12930717; http://dx.doi.org/10.1095/biolreprod.103.020347 56.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Hum Mol  Genet 2008; 17:1-14; PMID:17901045; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Nat Genet 2001; 27:153-4;  PMID:11175780; http://dx.doi.org/10.1038/84769 50.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Fertil Steril 2011; 96:e35-8; PMID:21550040; http://dx.doi.org/10.1016/j.fertnstert.2011.04.030 52.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
J Med Genet  2006; 43:902-7; PMID:16825435; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Hum Mol Genet 1998;  7:483-7; PMID:9467008; http://dx.doi.org/10.1093/ hmg/7.3.483 44.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Dis Model Mech 2011; 4:814- 21; PMID:21729874; http://dx.doi.org/10.1242/ dmm.007328 45.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Genes Dev 1999; 13:3115- 24; PMID:10601037; http://dx.doi.org/10.1101/ gad.13.23.3115 46.,OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Nature  1995; 375:34-9; PMID:7536897; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Genes Dev 1997; 11:3128- 42; PMID:9389646; http://dx.doi.org/10.1101/ gad.11.23.3128 48.,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
Nature 1997; 389:809-15;  PMID:9349812; http://dx.doi.org/10.1038/39797,Non-OADS,/arxiv_data1/oa_pdf/dd/4f/epi-8-591.PMC3857339.pdf
"Epigenetics 8:6, 602–611; June 2013; © 2013 Landes Bioscience REsEaR ch papER 602 Epigenetics Volume 8 Issue 6*Correspondence to: Jennifer E. Cropley; Email: j.cropley@victorchang.edu.au; Catherine M. Suter; Email: c.suter@victorchang.edu.au Submitted: 04/03/13; Accepted: 04/10/13http://dx.doi.org/10.4161/epi.24656Introduction Obesity and its accompanying morbidities, such as type 2 diabe - tes, are now pandemic.",Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Front  Genet 2011; 2:27; PMID:22303323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Physiol Rev 2005; 85:571-633;  PMID:15788706; http://dx.doi.org/10.1152/phys- rev.00053.2003.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
J Physiol 2005; 565:3-8; PMID:15695245; http://dx.doi.org/10.1113/jphysiol.2004.079756.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Endocr Rev 2010; 31:680-701;  PMID:20534704; http://dx.doi.org/10.1210/er.2009- 0038.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Obesity (Silver Spring) 2011; 19:492- 9; PMID:20948526; http://dx.doi.org/10.1038/ oby.2010.245.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Am J Physiol Regul Integr Comp Physiol  2009; 296:R1464-72; PMID:19244583; http://dx.doi.org/10.1152/ajpregu.91015.2008.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Diabetes 2005; 54:1899-906; PMID:15983188; http://dx.doi.org/10.2337/diabetes.54.7.1899.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
PLoS Genet 2011; 7:e1001380; PMID:21541011; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Genes Dev 2002; 16:6-21; PMID:11782440; http://dx.doi.org/10.1101/gad.947102.10.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Sci T ransl Med 2010; 2:49ra67;  PMID:20844285; http://dx.doi.org/10.1126/scitrans- lmed.3001262.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Science 1965; 147:1145-7; PMID:14242032;  http://dx.doi.org/10.1126/science.147.3662.1145.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Nat Genet 1994; 8:59-65; PMID:7987393; http://dx.doi.org/10.1038/ng0994-59.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Biochim Biophys Acta  1976; 441:213-20; PMID:952988; http://dx.doi.org/10.1016/0005-2760(76)90164-8.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Dis Model Mech  2010; 3:156-66; PMID:20212084; http://dx.doi.org/10.1242/dmm.003467.19.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Hypertension 2008; 51:383- 92; PMID:18086952; http://dx.doi.org/10.1161/ HYPERTENSIONAHA.107.101477.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Diabetologia 2009; 52:1133-42;  PMID:19288075; http://dx.doi.org/10.1007/s00125-009-1316-9.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Am J  Physiol Regul Integr Comp Physiol 2005; 288:R134- 9; PMID:15388492; http://dx.doi.org/10.1152/ajp- regu.00355.2004.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Hepatology 2005; 41:1313- 21; PMID:15915461; http://dx.doi.org/10.1002/ hep.20701.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Nat Med 1995; 1:1155-61; PMID:7584987; http://dx.doi.org/10.1038/nm1195- 1155.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
PLoS  One 2009; 4:e5337; PMID:19399185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Vitam Horm 2010; 83:151-63; PMID:20831945;  http://dx.doi.org/10.1016/S0083-6729(10)83006-7.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Nat Rev Endocrinol 2012; 8:92-103;  PMID:21912398; http://dx.doi.org/10.1038/nren- do.2011.138.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Endocr Rev  2011; 32:159-224; PMID:20971919; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Diabetologia 2010; 53:2431- 41; PMID:20697689; http://dx.doi.org/10.1007/ s00125-010-1865-y.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Mitochondrion 2009; 9:261-5; PMID:19324101; http://dx.doi.org/10.1016/j.mito.2009.03.003.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Nat Genet 2006; 38:500- 1; PMID:16642009; http://dx.doi.org/10.1038/ng0506-500.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Circ  Res 2007; 100:520-6; PMID:17255528; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Proc Natl Acad Sci U S A 2008; 105:17046- 9; PMID:18955703; http://dx.doi.org/10.1073/ pnas.0806560105.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Diabetes  2013; 62:1320-8; PMID:23209187; http://dx.doi.org/10.2337/db12-0289.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Pediatrics 2012; 129:e1121- 8; PMID:22492772; http://dx.doi.org/10.1542/ peds.2011-2583.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
"J Allergy Clin Immunol 2011; 128:1107-9,  e1-2; PMID:21958587; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Cell 2010; 143:1084- 96; PMID:21183072; http://dx.doi.org/10.1016/j.cell.2010.12.008.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Nature 2010; 467:963-6; PMID:20962845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Genes Dev 2011; 25:1010- 22; PMID:21576262; http://dx.doi.org/10.1101/ gad.2037511.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Am J Hum Genet 2006; 79:67-84;  PMID:16773567; http://dx.doi.org/10.1086/504729.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Am J Hum Genet 2008; 82:696-711;  PMID:18319075; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
PLoS Genet 2011; 7:e1002300;  PMID:21980303; http://dx.doi.org/10.1371/journal.pgen.1002300.,OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
PLoS One 2010; 5:e8887;  PMID:20126273; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
Nat Rev Endocrinol  2009; 5:401-8; PMID:19488075; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/95/epi-8-602.PMC3857340.pdf
"Epigenetics 8:6, 612–623; June 2013; © 2013 Landes Bioscience REsEaR ch papER 612 Epigenetics Volume 8 Issue 6*Correspondence to: Praveen Rajendran; Email: praveen.rajendran@oregonstate.edu Submitted: 12/20/12; Revised: 03/21/13; Accepted: 04/15/13http://dx.doi.org/10.4161/epi.24710Introduction According to the American Cancer Society, about 142,820 peo - ple will be diagnosed with colorectal cancer and almost 51,000  people will die of the disease in 2013.1 Cruciferous vegetables  such as broccoli, Brussels sprouts, cabbage, cauliflower and water - cress protect against colorectal cancer and other leading causes of cancer-related death.",Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Cancer T reat Rev 2010; 36:377-83; PMID:20172656; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Pharmacol  Res 2007; 55:224-36; PMID:17317210; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Mutat Res 2004; 555:191- 202; PMID:15476860; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Crit Rev Biochem Mol Biol 2011; 46:181-99;  PMID:21599534; http://dx.doi.org/10.3109/1040923 8.2011.557713.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Nature 2011; 471:74-9; PMID:21368826;  http://dx.doi.org/10.1038/nature09803.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Clin  Epigenetics 2011; 3:4; PMID:22247744; http://dx.doi.org/10.1186/1868-7083-3-4.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Science 2010; 329:1348-53; PMID:20829486; http://dx.doi.org/10.1126/sci- ence.1192049.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
J Cell Biochem 2009; 107:600-8; PMID:19459166; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
PLoS  One 2010; 5:e11208; PMID:20585447; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Mol Cancer Ther 2008; 7:3285-97; PMID:18852132;  http://dx.doi.org/10.1158/1535-7163.MCT-08-0385.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Cancer Res 2007; 67:5318-27; PMID:17545612;  http://dx.doi.org/10.1158/0008-5472.CAN-06-3996.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Cancer Res  2004; 64:5767-74; PMID:15313918; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Mol Cancer Ther 2010; 9:1596-608; PMID:20484017; http://dx.doi.org/10.1158/1535- 7163.MCT-09-1146.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Int J Cancer 2001; 92:784-9;  PMID:11351296; http://dx.doi.org/10.1002/ijc.1277.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Carcinogenesis 2006; 27:344-9;  PMID:16267097; http://dx.doi.org/10.1093/carcin/ bgi253.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Nature 2009; 461:1071-8; PMID:19847258; http://dx.doi.org/10.1038/ nature08467.22.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
PLoS Genet 2010; 6:e1000828;  PMID:20107609; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
J Biol Chem 2006; 281:13548- 58; PMID:16533812; http://dx.doi.org/10.1074/jbc.M510023200.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Cancer Cell 2010; 18:436-47; PMID:21075309;  http://dx.doi.org/10.1016/j.ccr.2010.10.022.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Mol Cell 2008; 30:61-72;  PMID:18406327; http://dx.doi.org/10.1016/j.mol- cel.2008.02.030.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Cancer Res  2010; 70:4470-80; PMID:20460513; http://dx.doi.org/10.1158/0008-5472.CAN-09-3028.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
J Biol Chem 1998; 273:5858-68; PMID:9488723; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Mol Nutr Food Res 2007; 51:977- 84; PMID:17628879; http://dx.doi.org/10.1002/ mnfr.200700115.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Cancer Res 2006; 66:5828-35; PMID:16740722;  http://dx.doi.org/10.1158/0008-5472.CAN-06-0139.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Proteins 1995; 23:403- 14; PMID:8710833; http://dx.doi.org/10.1002/ prot.340230314.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
J Comput Chem 1994; 15:488- 506; http://dx.doi.org/10.1002/jcc.540150503.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Proteins 1997; (Suppl 1): 215-20; PMID:9485515;  http://dx.doi.org/10.1002/(SICI)1097- 0134(1997)1+<215::AID-PROT29>3.0.CO;2-Q.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
J Med Chem 2009; 52:5635-41; PMID:19719119; http://dx.doi.org/10.1021/ jm900199u.38.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Proc Natl Acad Sci U S A 2005; 102:4842- 7; PMID:15778293; http://dx.doi.org/10.1073/ pnas.0408351102.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Hepatology 2012; 55:1840-51; PMID:22223166;  http://dx.doi.org/10.1002/hep.25566.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Mol Carcinog 2008; 47:137-47; PMID:17849419; http://dx.doi.org/10.1002/mc.20373.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Environ Sci Technol  2011; 45:6887-95; PMID:21766847; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Proc Natl Acad Sci U S A 2010; 107:20003- 8; PMID:21037108; http://dx.doi.org/10.1073/ pnas.1013754107.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Mutat Res 2012; 750:107- 31; PMID:22178957; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Biochemistry 2010; 49:3191- 202; PMID:20205397; http://dx.doi.org/10.1021/bi100104e.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Carcinogenesis 2009; 30:2-10; PMID:18978338;  http://dx.doi.org/10.1093/carcin/bgn250.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Cancer Lett 2009; 274:169-76; PMID:18635312;  http://dx.doi.org/10.1016/j.canlet.2008.06.005.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
J Biol Chem  2010; 285:17417-24; PMID:20385560; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
Clin Cancer Res 2010; 16:4543-52;  PMID:20823147; http://dx.doi.org/10.1158/1078- 0432.CCR-10-0513.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/epi-8-612.PMC3857341.pdf
"Epigenetics 8:6, 624–634; June 2013; © 2013 Landes Bioscience REsEaR ch papER 624 Epigenetics Volume 8 Issue 6*Correspondence to: Kenneth P. Nephew; Email: knephew@indiana.edu; Tim Hui-Ming Huang; Email: huangt3@uthscsa.edu;   Hung-Cheng Lai; Email: hclai@ndmctsgh.edu.tw; Submitted: 03/26/13; Revised: 04/19/13; Accepted: 04/24/13http://dx.doi.org/10.4161/epi.24816Introduction Ovarian cancer (OC) causes more deaths than any other gyne - cologic malignancy.1 Five-year survival rates have only margin - ally improved over the past three decades, and women with  advanced stage OC have a five-year survival rate of less than 25%.",Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Am J Pathol 2001; 158:1121- 7; PMID:11238060; http://dx.doi.org/10.1016/ S0002-9440(10)64059-X 31.,OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Gynecol Obstet Invest  2011; 72:183-91; PMID:21968189; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
PLoS One 2012; 7:e32941;  PMID:22403726; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Gynecol Oncol 2001; 82:299-304; PMID:11531283; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
PLoS One  2012; 7:e40024; PMID:22768205; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Oncogene 2002; 21:5400-13;  PMID:12154403; http://dx.doi.org/10.1038/ sj.onc.1205651 38.,OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Cancer Res 2007; 13:6093- 8; PMID:17947473; http://dx.doi.org/10.1158/1078- 0432.CCR-07-1011 40.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Surgery 2012; 151:564-70; PMID:22001634; http://dx.doi.org/10.1016/j.surg.2011.08.013 42.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
J Clin Pathol 2011; 64:246-51; PMID:21169275;  http://dx.doi.org/10.1136/jcp.2010.082875 43.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
J Biol Chem 2001; 276:6889- 92; PMID:11238441; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Cancer Res 2005; 11:5365-9; PMID:16061849;  http://dx.doi.org/10.1158/1078-0432.CCR-04-2455 16.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Cancer Lett 2012; 318:76-85;  PMID:22155104; http://dx.doi.org/10.1016/j.can- let.2011.12.003 17.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Mol Cancer Ther  2012; 11:1587-97; PMID:22553355; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Cancer Res 2008; 14:7659-66;  PMID:19047091; http://dx.doi.org/10.1158/1078-0432.CCR-08-1414 19.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
N Engl J Med 1983; 309:883- 7; PMID:6310399; http://dx.doi.org/10.1056/ NEJM198310133091503 20.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Carcinogenesis 2009; 30:131-40;  PMID:19028702; http://dx.doi.org/10.1093/carcin/ bgn230 21.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
PLoS One 2011; 6:e16916;  PMID:21347233; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Biochem Biophys  Res Commun 2009; 379:959-63; PMID:19135984; http://dx.doi.org/10.1016/j.bbrc.2008.12.180 23.,OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Nature 2011; 474:609-15; PMID:21720365; http://dx.doi.org/10.1038/nature10166 24.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Oncology  2011; 80:12-20; PMID:21577013; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Cancer Res 2011; 17:4052-62;  PMID:21459799; http://dx.doi.org/10.1158/1078- 0432.CCR-10-3021 27.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Epigenomics 2010; 2:9-38; PMID:22122746; http://dx.doi.org/10.2217/ epi.09.47 28.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Proc Natl Acad Sci U S  A 1999; 96:8681-6; PMID:10411935; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Semin Oncol 2007;  34(Suppl 2):S1-15; PMID:17512352; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
"N Engl J Med 2005; 352:1268-9, author reply 1268-9; PMID:15791705;  http://dx.doi.org/10.1056/NEJM200503243521222 3.",OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Br J Cancer 2002; 87:815- 24; PMID:12373593; http://dx.doi.org/10.1038/ sj.bjc.6600567 4.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
BMC Med Genomics 2008; 1:47;  PMID:18826610; http://dx.doi.org/10.1186/1755- 8794-1-47 5.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Endocrinology 2009; 150:4003-11; PMID:19574400;  http://dx.doi.org/10.1210/en.2009-0404 8.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Cancer Res 2004; 64:6476-81;  PMID:15374957; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1529 9.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Int J Cancer 2008; 123:725-9; PMID:18478570;  http://dx.doi.org/10.1002/ijc.23563 10.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Cancer Res 2004; 10:2687-93;  PMID:15102672; http://dx.doi.org/10.1158/1078- 0432.CCR-03-0510 12.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Cancer Res  2006; 12:2788-94; PMID:16675572; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Cancer Res  2005; 11:7376-83; PMID:16243810; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Cancer Res 2005; 65:8961-7; PMID:16204069;  http://dx.doi.org/10.1158/0008-5472.CAN-05-1187,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Mol Cancer Ther 2005; 4:1505-14;  PMID:16227399; http://dx.doi.org/10.1158/1535- 7163.MCT-05-021649.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Int J Cancer  2010; 127:555-67; PMID:19957335; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Carcinogenesis 2013; PMID:23568951; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
BMC Med Genomics 2009; 2:34; PMID:19505326;  http://dx.doi.org/10.1186/1755-8794-2-3444.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Genet 2005; 67:290-6;  PMID:15733262; http://dx.doi.org/10.1111/j.1399- 0004.2005.00418.x 45.,OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Clin Cancer Res 2012; 18:4313-24;  PMID:22733541; http://dx.doi.org/10.1158/1078- 0432.CCR-12-0037 46.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Nat Rev Drug Discov 2006; 5:1026-33;  PMID:17139287; http://dx.doi.org/10.1038/nrd2086 47.,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
T rends Cell Biol 2007; 17:438-47; PMID:17845852;  http://dx.doi.org/10.1016/j.tcb.2007.06.007 48.,OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
Oncogene 2012; 31:4718- 24; PMID:22266871; http://dx.doi.org/10.1038/onc.2011.610,Non-OADS,/arxiv_data1/oa_pdf/72/c5/epi-8-624.PMC3857342.pdf
"www.landesbioscience.com Epigenetics 635Epigenetics 8:6, 635–645; June 2013; © 2013 Landes Bioscience REsEaR ch papER REsEaR ch papER *Correspondence to: Tomohiro Kono; Email: tomohiro@nodai.ac.jp Submitted: 03/19/13; Revised: 04/25/13; Accepted: 05/01/13http://dx.doi.org/10.4161/epi.24887Introduction One surprising result of the human genome project is the discov - ery that protein coding sequences account for a very small fraction  (~1%) of the genomic sequence.1 Human transcriptome analysis  revealed that only one-fifth of transcription across the genome is associated with protein-coding genes.",Non-OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Genome Res  2013; 23:616-27; PMID:23410886; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Genes Dev 2009; 23:105- 17; PMID:19136628; http://dx.doi.org/10.1101/ gad.495809 30.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
EMBO J 2012; 31:606-15; PMID:22117218; http://dx.doi.org/10.1038/emboj.2011.425 31.,Non-OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
PLoS Genet  2011; 7:e1002422; PMID:22242001; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nat Genet  2004; 36:1291-5; PMID:15516931; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nature 2009; 458:223-7; PMID:19182780;  http://dx.doi.org/10.1038/nature07672 34.,Non-OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Genes Dev 2011; 25:1915- 27; PMID:21890647; http://dx.doi.org/10.1101/gad.17446611 35.,Non-OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Cell 2007; 129:1311- 23; PMID:17604720; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Philos T rans R Soc Lond B Biol Sci 2013;  368:20110325; PMID:23166390; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Genes Dev  2011; 25:1702-15; PMID:21852535; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nat Genet 2013; 45:239-41;  PMID:23334669; http://dx.doi.org/10.1038/ng.2530 40.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nucleic Acids Res 2008;  36(Web Server issue):W170-5; PMID:18487274;  http://dx.doi.org/10.1093/nar/gkn29415.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Development  2012; 139:2792-803; PMID:22721776; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nat Genet  2006; 38:350-5; PMID:16462745; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
PLoS Genet 2012; 8:e1002956; PMID:23028363; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Curr Biol  2008; 18:1735-41; PMID:19026546; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Genomics 2009; 93:461- 72; PMID:19200453; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nucleic Acids Res 2010; 38:4929-45; PMID:20385583; http://dx.doi.org/10.1093/nar/ gkq200 21.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Proc Natl Acad Sci U S A  2012; 109:7332-7; PMID:22523239; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
PLoS Genet  2012; 8:e1002440; PMID:22242016; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
FEBS Lett 2012; 586:827-33; PMID:22449967;  http://dx.doi.org/10.1016/j.febslet.2012.01.059 24.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
PLoS Genet  2010; 6:e1000992; PMID:20585555; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Dev Biol 2011; 353:420- 31; PMID:21354127; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Hum Mol Genet 2012; 21:548- 58; PMID:22025075; http://dx.doi.org/10.1093/hmg/ ddr488References 1.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nature  2007; 447:799-816; PMID:17571346; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nat Rev Genet 2007; 8:413-23;  PMID:17486121; http://dx.doi.org/10.1038/nrg2083 3.,Non-OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
PLoS Biol  2009; 7:e1000112; PMID:19468303; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Genome Biol 2010; 11:R72; PMID:20624288; http://dx.doi.org/10.1186/gb-2010- 11-7-r72 6.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Cell 2009; 136:629- 41; PMID:19239885; http://dx.doi.org/10.1016/j.cell.2009.02.006 8.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nat Rev Genet 2001; 2:21-32; PMID:11253064; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nat Rev Genet 2008; 9:129-40; PMID:18197165;  http://dx.doi.org/10.1038/nrg2295 11.,Non-OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Nature 2002; 415:810-3; PMID:11845212;  http://dx.doi.org/10.1038/415810a 12.,Non-OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Genes Dev 2006; 20:1268-82; PMID:16702402;  http://dx.doi.org/10.1101/gad.1416906 13.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
PLoS Genet 2011; 7:e1001347;  PMID:21455290; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
Science 2012; 338:1469- 72; PMID:23239737; http://dx.doi.org/10.1126/sci- ence.1228110,OADS,/arxiv_data1/oa_pdf/b8/eb/epi-8-635.PMC3857343.pdf
"Epigenetics 8:6, 666–676; June 2013; © 2013 Landes Bioscience REsEaR ch papER 666 Epigenetics Volume 8 Issue 6*Correspondence to: Aleš Kovařík; Email: kovarik@ibp.cz Submitted: 01/23/13; Revised: 03/28/13; Accepted: 04/08/13http://dx.doi.org/10.4161/epi.24613Introduction Both transcriptional gene silencing (TGS) and posttranscrip - tional gene silencing (PTGS) are associated with DNA meth - ylation, often induced by small interfering RNAs (siRNAs) in  a process called RNA-directed DNA methylation (RdDM).",Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Biochim Biophys Acta 2007; 1769:358-74;  PMID:17449119; http://dx.doi.org/10.1016/j.bba- exp.2007.03.001.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant J  2007; 52:1105-18; PMID:17931351; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Curr Biol 2000; 10:1591-4;  PMID:11137011; http://dx.doi.org/10.1016/S0960- 9822(00)00862-9.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Annu Rev Plant Biol 2010; 61:395-420;  PMID:20192747; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
FEBS Lett 2011; 585:2008-15; PMID:20727353;  http://dx.doi.org/10.1016/j.febslet.2010.08.017.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
T rends Plant Sci 2006;  11:199-208; PMID:16546438; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Curr Opin Cell Biol 2009; 21:367-76; PMID:19243928; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Cell  2010; 22:34-47; PMID:20097869; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
EMBO J  2002; 21:6842-52; PMID:12486005; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Genetics  2010; 186:843-55; PMID:20823340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Cell Rep  2012; 31:1283-96; PMID:22532007; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Biotechnol Lett 2010; 32:151-6; PMID:19731043;  http://dx.doi.org/10.1007/s10529-009-0120-4.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Physiol Plant 2012; 146:321-35; PMID:22486767;  http://dx.doi.org/10.1111/j.1399-3054.2012.01634.x.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Physiol 2003; 133:1240- 50; PMID:14551338; http://dx.doi.org/10.1104/ pp.103.023796.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
FEBS  Lett 2000; 467:41-6; PMID:10664453; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Planta 2007; 225:365-79;  PMID:16924537; http://dx.doi.org/10.1007/s00425- 006-0366-1.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Epigenetics 2011; 6:650-60; PMID:21521939; http://dx.doi.org/10.4161/ epi.6.5.15764.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Physiol 2009; 149:1493- 504; PMID:19129419; http://dx.doi.org/10.1104/ pp.108.133165.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Nucleic Acids Res  2006; 34:2280-93; PMID:16670434; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
PLoS Genet  2011; 7:e1002331; PMID:22028669; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Heredity  (Edinb) 2007; 99:5-13; PMID:17487217; http://dx.doi.org/10.1038/sj.hdy.6800964.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant J 1996; 9:183-94;  PMID:8820605; http://dx.doi.org/10.1046/j.1365- 313X.1996.09020183.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Mol Gen Genet 1998; 259:207-15; PMID:9747712; http://dx.doi.org/10.1007/ s004380050806.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Mol Biol 1998;  38:1113-22; PMID:9869417; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Cell Physiol  2007; 48:638-47; PMID:17317685; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Cell 2012; 24:3603- 12; PMID:23001035; http://dx.doi.org/10.1105/tpc.112.103119.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Growth Regul 2011; 63:137-46;  http://dx.doi.org/10.1007/s10725-010-9531-4.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
PLoS One 2008; 3:e3306; PMID:18827894; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
PLoS Biol  2008; 6:2880-95; PMID:19071958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Physiol 2005; 139:275-86; PMID:16113227;  http://dx.doi.org/10.1104/pp.105.061788.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Dev Dyn 2003; 228:113- 20; PMID:12950085; http://dx.doi.org/10.1002/dvdy.10348.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
New Phytol  2009; 184:851-64; PMID:19732349; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Theor Appl Genet 2002; 104:1263-9;  PMID:12582579; http://dx.doi.org/10.1007/s00122- 002-0906-4.11.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
PLoS One 2008; 3:e3156;  PMID:18776934; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant J 2004; 40:699-711;  PMID:15546353; http://dx.doi.org/10.1111/j.1365- 313X.2004.02240.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Cell Physiol 2004; 45:1715-9; PMID:15574848; http://dx.doi.org/10.1093/pcp/ pch184.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Biol (Stuttg) 2012; 14:980-6;  PMID:22812643; http://dx.doi.org/10.1111/j.1438- 8677.2012.00586.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Mol Genet Genomics  2009; 281:407-20; PMID:19132393; http://dx.doi.org/10.1007/s00438-008-0420-8.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Science 1990; 250:959-66; PMID:17746920; http://dx.doi.org/10.1126/sci- ence.250.4983.959.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant J 1997; 12:379-92; http://dx.doi.org/10.1046/ j.1365-313X.1997.12020379.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Epigenetics 2012; 7:1071-8; PMID:22863736;  http://dx.doi.org/10.4161/epi.21644.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant J 2008; 56:539-49; PMID:18643988; http://dx.doi.org/10.1111/j.1365-313X.2008.03624.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant J 2008; 53:65-77;  PMID:17971040; http://dx.doi.org/10.1111/j.1365- 313X.2007.03313.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant  Sci 2011; 180:612-9; PMID:21421409; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
J Integr Plant Biol 2008; 50:886- 96; PMID:18713399; http://dx.doi.org/10.1111/ j.1744-7909.2008.00692.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Mol  Gen Genet 2000; 263:995-1002; PMID:10954085;  http://dx.doi.org/10.1007/PL00008700.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
FEBS Lett 2000; 467:47-51;  PMID:10664454; http://dx.doi.org/10.1016/S0014-5793(00)01077-2.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant J 2007; 51:526-36; PMID:17559516; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Curr Biol 2001; 11:747-57;  PMID:11378384; http://dx.doi.org/10.1016/S0960- 9822(01)00226-3.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Curr Biol  2001; 11:436-40; PMID:11301254; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Curr Opin Plant Biol  2007; 10:528-33; PMID:17692561; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Russ J Genet 2010; 46:511-20;  http://dx.doi.org/10.1134/S1022795410050017.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
J Exp Bot  2012; 63:4233-41; PMID:22511802; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant  J 2003; 34:507-17; PMID:12753589; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant J 2008; 53:1-10; PMID:17971044; http://dx.doi.org/10.1111/j.1365-313X.2007.03311.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Planta 2011; 234:699-707; PMID:21617990; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
PLoS One 2010;  5:e9670; PMID:20351783; http://dx.doi.org/10.1371/ journal.pone.0009670.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Genes Dev  2010; 24:986-91; PMID:20478993; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant Cell 2006; 18:1166- 76; PMID:16582009; http://dx.doi.org/10.1105/ tpc.106.041400.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Am J  Bot 2002; 89:921-8; PMID:21665691; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Plant  J 2008; 54:1049-62; PMID:18315537; http://dx.doi.org/10.1111/j.1365-313X.2008.03475.x.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
Cell 2006; 126:1189-201; PMID:16949657;  http://dx.doi.org/10.1016/j.cell.2006.08.003.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
J Plant Res 2010; 123:299-302; PMID:20364290; http://dx.doi.org/10.1007/s10265- 010-0338-1.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
BMC Plant Biol 2012; 12:51;  PMID:22512782; http://dx.doi.org/10.1186/1471- 2229-12-51.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
FEBS Lett 2000; 467:47-51;  PMID:10664454; http://dx.doi.org/10.1016/S0014- 5793(00)01077-2.,OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
EMBO J 2009; 28:1078-86; PMID:19262562; http://dx.doi.org/10.1038/ emboj.2009.59.,Non-OADS,/arxiv_data1/oa_pdf/26/6f/epi-8-666.PMC3857346.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2013 |  79  | e50589 | Page 1 of 5Video Article Proteomic Sample Preparation from Formalin Fixed and Paraffin Embedded Tissue Jacek R. Wiśniewski1 1Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry Correspondence to: Jacek R. Wiśniewski at jwisniew@biochem.mpg.de URL: http://www.jove.com/video/50589 DOI: doi:10.3791/50589 Keywords: Chemistry, Issue 79, Clinical Chemistry Tests, Proteomics, Proteomics, Proteomics, analytical chemistry, Formalin fixed and paraffin embedded (FFPE), sample preparation, proteomics, filter aided sample preparation (FASP), clinical proteomics; microdissection, SAX-fractionation Date Published: 9/2/2013 Citation: Wiśniewski, J.R. Proteomic Sample Preparation from Formalin Fixed and Paraffin Embedded Tissue.",Non-OADS,/arxiv_data1/oa_pdf/09/0d/jove-79-50589.PMC3857359.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50589/ Introduction Fixing with paraformaldehyde and embedding in paraffin (FFPE) is the standard method for preservation and pathomorphologic investigation of clinical tissue material.,Non-OADS,/arxiv_data1/oa_pdf/09/0d/jove-79-50589.PMC3857359.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Is It Safe to Eat Fish?",Non-OADS,/arxiv_data1/oa_pdf/d9/37/jkms-28-1701.PMC3857362.pdf
"Yu Kyeong Kim,1 Keon Wook Kang,2 Seung Kwon Hong,3 Kyung-Hee Cho,4 and Ho-Sin Choi5  1Department of Nuclear Medicine, Seoul National University Boramae Medical Center, Seoul; 2Department of Nuclear Medicine, Seoul National University College of  Medicine, Seoul; 3Department of Family Medicine, Incheon St. Mary’s Hospital, The Catholic University of Korea School of Medicine, Incheon; 4Department of Family  Medicine & Geriatrics, National Health Insurance Corporation Ilsan Hospital, Goyang; 5Korea Institute of Nuclear Safety, Daejeon, Koreahttp://dx.doi.org/10.3346/jkms.2013.28.12.1701  • J Korean Med Sci 2013; 28: 1701-1702EDITORIAL Medical Imaging After the Fukushima Daiichi’s meltdown in 2011, it has been  still plagued with the mishaps (1).",Non-OADS,/arxiv_data1/oa_pdf/d9/37/jkms-28-1701.PMC3857362.pdf
1702  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1701ing the accurate facts to the public.,Non-OADS,/arxiv_data1/oa_pdf/d9/37/jkms-28-1701.PMC3857362.pdf
Available at http://www.tepco.co.jp/en/index-e. html [accessed on 16 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/d9/37/jkms-28-1701.PMC3857362.pdf
Available at http://www.oecd-nea.org/nsd/fukushi - ma/documents [accessed on 16 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/d9/37/jkms-28-1701.PMC3857362.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of the Safety of Seven Iodinated Contrast Media We aimed to determine the characteristic adverse events (AEs) of iodinated contrast media  (IOCM) and to compare the safety profiles of different IOCM.",Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
"http://dx.doi.org/10.3346/jkms.2013.28.12.1703  • J Korean Med Sci 2013; 28: 1703-1710ORIGINAL ARTICLE Pharmacology, Drug Therapy & Toxicology INTRODUCTION Iodinated X-ray contrast media are the most commonly used  drugs in diagnostic and interventional procedures.",Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
"• Comparative Safety of Iodinated Contrast Media 1704  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1703ther the risks associated with these media are class-specific, os - molality based, or individual medium-specific.",Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
• Comparative Safety of Iodinated Contrast Media http://jkms.org   1705 http://dx.doi.org/10.3346/jkms.2013.28.12.1703pare the safety profiles of different iodinated contrast media.,OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
• Comparative Safety of Iodinated Contrast Media 1706  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1703Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
• Comparative Safety of Iodinated Contrast Media http://jkms.org   1707 http://dx.doi.org/10.3346/jkms.2013.28.12.1703Table 5.,Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
• Comparative Safety of Iodinated Contrast Media 1708  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1703concomitant medication and developed purpura with rash.,Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
• Comparative Safety of Iodinated Contrast Media http://jkms.org   1709 http://dx.doi.org/10.3346/jkms.2013.28.12.1703affected by under-reporting.,Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
Available at http://www.umc-products.com/graphics/  3149.pdf [accessed on 5 March 2013].,Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH_Pro- ducts/Guidelines/Efficacy/E2D/Step4/E2D_Guideline.pdf [accessed on  5 March 2013].,Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
• Comparative Safety of Iodinated Contrast Media 1710  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.170328.,Non-OADS,/arxiv_data1/oa_pdf/e0/be/jkms-28-1703.PMC3857363.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Impact of Combined Acute Rejection on BK Virus-Associated  Nephropathy in Kidney Transplantation BK virus-associated nephropathy (BKVAN) is one of the major causes of allograft dysfunction  in kidney transplant (KT) patients.",Non-OADS,/arxiv_data1/oa_pdf/ed/19/jkms-28-1711.PMC3857364.pdf
A120641).http://dx.doi.org/10.3346/jkms.2013.28.12.1711  • J Korean Med Sci 2013; 28: 1711-1715ORIGINAL ARTICLE  Cell Therapy & Organ Transplantation INTRODUCTION BK virus (BKV) causes a nephropathy in kidney transplant re - cipients that had potent immunosuppressive drugs such as ta - crolimus and mycophenolate mofetil (MMF).,Non-OADS,/arxiv_data1/oa_pdf/ed/19/jkms-28-1711.PMC3857364.pdf
"• BKV Nephropathy and Acute Rejection in Kidney Transplantation 1712  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1711rate (eGFR), graft loss, and death.",Non-OADS,/arxiv_data1/oa_pdf/ed/19/jkms-28-1711.PMC3857364.pdf
"• BKV Nephropathy and Acute Rejection in Kidney Transplantation http://jkms.org   1713 http://dx.doi.org/10.3346/jkms.2013.28.12.1711copies/mL over 1 yr after diagnosis, and renal function was sta - bilized during 1 yr after treatment ( ΔeGFR during 1 yr after  treatment, 2.52 ± 8.01 mL/min).",Non-OADS,/arxiv_data1/oa_pdf/ed/19/jkms-28-1711.PMC3857364.pdf
"• BKV Nephropathy and Acute Rejection in Kidney Transplantation 1714  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.171180 70 60 50 40 30 20 10 0eGFR (mL/min) -3 0 3 6 12 Time (months)BKVAN BKVAN/AR A10,000,000 1,000,000 100,000 10,000 1,000 100 10 1Serum BKV titer (copies/mL) 0 1 3 6 12 Time (months)BKVAN BKVAN/AR B Fig.",Non-OADS,/arxiv_data1/oa_pdf/ed/19/jkms-28-1711.PMC3857364.pdf
• BKV Nephropathy and Acute Rejection in Kidney Transplantation http://jkms.org   1715 http://dx.doi.org/10.3346/jkms.2013.28.12.1711VAN and BKVAN/AR made it difficult to evaluate their treat - ment responses for both conditions.,Non-OADS,/arxiv_data1/oa_pdf/ed/19/jkms-28-1711.PMC3857364.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Clinical Trial and Extension Study of Infliximab in Korean  Patients with Active Rheumatoid Arthritis despite Methotrexate  Treatment Currently, infliximab is given for disease control for active rheumatoid arthritis (RA)  patients despite methotrexate treatment.",Non-OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
"NCT00202852,  NCT00732875) Key Words:  Arthritis, Rheumatoid; Infliximab; Placebo-Controlled Clinical Trial; Extension  Study; Efficacy; Adverse EventJinhyun Kim,1 Heejung Ryu,2   Dae-Hyun Yoo,3 Sung-Hwan Park,4  Gwan-Gyu Song,5 Won Park,6   Chul-Soo Cho,4 and Yeong-Wook Song1 1Department of Internal Medicine, Seoul National  University Hospital, Seoul; 2Department of Internal  Medicine, Gachon University School of Medicine,  Incheon; 3Department of Internal Medicine, The  Hospital for Rheumatic Diseases, Hanyang  University College of Medicine, Seoul; 4Department  of Internal Medicine, The Catholic University of  Korea College of Medicine, Seoul; 5Department of  Internal Medicine, Korea University College of  Medicine, Seoul; 6Department of Internal Medicine,  Inha University College of Medicine, Incheon, Korea Received: 13 September 2013 Accepted: 16 October 2013 Address for Correspondence: Yeong Wook Song, MD Department of Internal Medicine, Seoul National University  College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul 110-744,  Korea Tel: +82.2-2072-2234, Fax: +82.2-762-9662 E-mail: ysong@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.12.1716  • J Korean Med Sci 2013; 28: 1716-1722ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Rheumatoid arthritis (RA) is a chronic autoimmune disease  characterized by synovitis and other system involvement.",Non-OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
"• Infliximab in Korean RA patients http://jkms.org   1717 http://dx.doi.org/10.3346/jkms.2013.28.12.1716cording to the 1987 American College of Rheumatology (ACR)  criteria (11) and had evidence of active disease despite treat - ment with methotrexate (six or more swollen and tender joints  plus two of: morning stiffness greater than or equal to 45 min,  erythrocyte sedimentation rate (ESR) greater than 28 mm/h, C- reactive protein (CRP) greater than 2 mg/dL.",Non-OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
"• Infliximab in Korean RA patients 1718  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1716147-022), and performed according to the Declaration of Hel - sinki.",Non-OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
• Infliximab in Korean RA patients http://jkms.org   1719 http://dx.doi.org/10.3346/jkms.2013.28.12.1716Table 1.,Non-OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
• Infliximab in Korean RA patients 1720  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1716Table 3.,Non-OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
"• Infliximab in Korean RA patients http://jkms.org   1721 http://dx.doi.org/10.3346/jkms.2013.28.12.1716which also did not post a statistically significant difference ( P=  0.220, by repeated measures ANOVA).",OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
"• Infliximab in Korean RA patients 1722  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1716In the situation of clinical trial, infection rate was similar be - tween infliximab group and placebo group (19).",Non-OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
Available at http://www.umc-products.com/graphics/3149.,Non-OADS,/arxiv_data1/oa_pdf/65/8e/jkms-28-1716.PMC3857365.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Role of Regulatory T Cells in Transferable Immunological  Tolerance to Bone Marrow Donor in Murine Mixed Chimerism  Model  Constructing a bone marrow chimera prior to graft transplantation can induce donor- specific immune tolerance.",Non-OADS,/arxiv_data1/oa_pdf/81/8a/jkms-28-1723.PMC3857366.pdf
"A040004).http://dx.doi.org/10.3346/jkms.2013.28.12.1723  • J Korean Med Sci 2013; 28: 1723-1728ORIGINAL ARTICLE  Immunology, Allergic Disorders & Rheumatology INTRODUCTION In order to conduct a successful allogeneic transplantation, it is  crucial to control or minimize host immune responses to the  allogeneic graft which leads to the failure of transplantation and  therefore, rejection of the graft (1).",Non-OADS,/arxiv_data1/oa_pdf/81/8a/jkms-28-1723.PMC3857366.pdf
• Transferable Tolerance Induced by Mixed Chimerism 1724  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1723of TBI and transferable immunological tolerance to donor anti - gens.,Non-OADS,/arxiv_data1/oa_pdf/81/8a/jkms-28-1723.PMC3857366.pdf
• Transferable Tolerance Induced by Mixed Chimerism http://jkms.org   1725 http://dx.doi.org/10.3346/jkms.2013.28.12.1723partment with diverse lymphocyte populations (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/81/8a/jkms-28-1723.PMC3857366.pdf
• Transferable Tolerance Induced by Mixed Chimerism 1726  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1723plantation experiment was conducted.,OADS,/arxiv_data1/oa_pdf/81/8a/jkms-28-1723.PMC3857366.pdf
• Transferable Tolerance Induced by Mixed Chimerism http://jkms.org   1727 http://dx.doi.org/10.3346/jkms.2013.28.12.1723Fig.,Non-OADS,/arxiv_data1/oa_pdf/81/8a/jkms-28-1723.PMC3857366.pdf
• Transferable Tolerance Induced by Mixed Chimerism 1728  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1723resulting in the increased frequency of regulatory T cells which  are specific to C57BL/6 antigens.,Non-OADS,/arxiv_data1/oa_pdf/81/8a/jkms-28-1723.PMC3857366.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Application of the Multiplex Cytokine Analysis to Monitor  Xenogeneic Immune Responses to the Porcine Islet Graft in   Non-Human Primate Non-human primate studies must be conducted prior to the clinical trial of  xenotransplantation.",Non-OADS,/arxiv_data1/oa_pdf/fa/d4/jkms-28-1729.PMC3857367.pdf
"A040004).http://dx.doi.org/10.3346/jkms.2013.28.12.1729  • J Korean Med Sci 2013; 28: 1729-1733ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION   To accomplish ‘bench-to-bedside’ translational medicine, nov - el therapeutic tools developed in basic research must be con - firmed in non-human primates before their application to hu - mans.",Non-OADS,/arxiv_data1/oa_pdf/fa/d4/jkms-28-1729.PMC3857367.pdf
• Multiplex Cytokine Analysis to Monitor Xenogeneic Immune Responses  1730  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1729this study.,Non-OADS,/arxiv_data1/oa_pdf/fa/d4/jkms-28-1729.PMC3857367.pdf
"• Multiplex Cytokine Analysis to Monitor Xenogeneic Immune Responses  http://jkms.org   1731 http://dx.doi.org/10.3346/jkms.2013.28.12.1729TNF-α (1,250 pg/mL) was completely neutralized (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fa/d4/jkms-28-1729.PMC3857367.pdf
• Multiplex Cytokine Analysis to Monitor Xenogeneic Immune Responses  1732  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1729occurred on day 45 after porcine islet transplantation.,Non-OADS,/arxiv_data1/oa_pdf/fa/d4/jkms-28-1729.PMC3857367.pdf
• Multiplex Cytokine Analysis to Monitor Xenogeneic Immune Responses  http://jkms.org   1733 http://dx.doi.org/10.3346/jkms.2013.28.12.17292.,Non-OADS,/arxiv_data1/oa_pdf/fa/d4/jkms-28-1729.PMC3857367.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Association Between the Socioeconomic Status and Thyroid  Cancer Prevalence; Based on the Korean National Health and  Nutrition Examination Survey 2010-2011 The incidence of thyroid cancer has recently increased in most industrialized countries,  including Korea.",Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
"Key Words:  Social Class; Thyroid Neoplasms Seong-Woo Choi, So-Yeon Ryu,   Mi-ah Han, and Jong Park Department of Preventive Medicine, Chosun  University Medical School, Gwangju, Korea Received: 21 May 2013 Accepted: 23 September 2013 Address for Correspondence: Seong-Woo Choi, MD Department of Preventive Medicine, Chosun University Medical  School, 309 Pilmun-daero, Dong-gu, Gwangju 501-759, Korea  Tel: +82.62-230-6344, Fax: +82.62-225-8293 E-mail: jcsw74@chosun.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.12.1734  • J Korean Med Sci 2013; 28: 1734-1740ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION The incidence of thyroid cancer has increased in several Euro - pean countries (1-3), the United States (4), Canada (5), and  Australia (6) during the past several decades.",Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
"• Association between Socioeconomic Status and Thyroid Cancer Prevalence http://jkms.org   1735 http://dx.doi.org/10.3346/jkms.2013.28.12.1734ter the first KNHANES was conducted in 1998, the second, third,  fourth, and fifth surveys were conducted in 2001, 2005, 2007,  and 2010-2012, respectively.",Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
"• Association between Socioeconomic Status and Thyroid Cancer Prevalence 1736  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1734creased height and weight tended to be associated with more  education, which was also associated with higher monthly  household income, residence in urban areas, histories of smok - ing and alcohol intake, and physical activity.",Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
• Association between Socioeconomic Status and Thyroid Cancer Prevalence http://jkms.org   1737 http://dx.doi.org/10.3346/jkms.2013.28.12.1734cer was higher in counties with higher household incomes and  higher education levels.,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
• Association between Socioeconomic Status and Thyroid Cancer Prevalence 1738  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1734Table 3.,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
• Association between Socioeconomic Status and Thyroid Cancer Prevalence http://jkms.org   1739 http://dx.doi.org/10.3346/jkms.2013.28.12.1734and thyroid cancer can be explained by the fact that individuals  with higher SES access health care services more easily than do  those with lower SES (31).,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
Avail - able at http://globocan.iarc.fr [accessed on 21 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
• Association between Socioeconomic Status and Thyroid Cancer Prevalence 1740  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1734nancy in incidentally discovered thyroid nodules evaluated with sonog - raphy and fine-needle aspiration.,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jkms-28-1734.PMC3857368.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Proactive Multifactorial Intervention Strategy Reduces the Risk of  Cardiovascular Disease Estimated with Region-Specific Risk  Assessment Models in Pacific Asian Patients Participating in the  CRUCIAL Trial Despite race, ethnic, and regional differences in cardiovascular disease risk, many  worldwide hypertension management guidelines recommend the use of the Framingham  coronary heart disease (CHD) risk equation to guide treatment decisions.",Non-OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
"gov registration number: NCT00407537).http://dx.doi.org/10.3346/jkms.2013.28.12.1741  • J Korean Med Sci 2013; 28: 1741-1748ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION The Cluster Randomized Usual Care versus Caduet Investiga - tion Assessing Long-Term Risk (CRUCIAL) trial (1) was design- ed to assess, in a real-world clinical practice setting, whether  calculated Framingham coronary heart disease (CHD) risk (2)  could be improved over usual care (UC) if 2 important cardio - vascular (CV) risk factors, blood pressure (BP) and cholesterol,  were targeted simultaneously with a proactive multifactorial  intervention (PMI) strategy based on single-pill amlodipine/ atorvastatin (SPAA).",Non-OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
• CHD Risk Assessment among Pacific-Asian Patients in the CRUCIAL Trial 1742  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1741accurate risk prediction in some ethnic groups (13).,Non-OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
• CHD Risk Assessment among Pacific-Asian Patients in the CRUCIAL Trial http://jkms.org   1743 http://dx.doi.org/10.3346/jkms.2013.28.12.1741tries.,Non-OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
"• CHD Risk Assessment among Pacific-Asian Patients in the CRUCIAL Trial 1744  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1741Risk assessments The absolute percentage change in fatal CHD risk between base - line and Week 52 in the PMI versus UC arms was similar when  calculated using the NIPPON DATA80 fatal CHD model (15)  and SCORE fatal CHD model (14) (LS mean difference -0.5%  [95% CI -0.67, -0.35] and -0.9% [95% CI -1.22, -0.57], respective - ly; Fig.",OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
"• CHD Risk Assessment among Pacific-Asian Patients in the CRUCIAL Trial http://jkms.org   1745 http://dx.doi.org/10.3346/jkms.2013.28.12.1741statistically significant when assessed by the SCORE (14) fatal  non-CHD CVD model ( P< 0.001), but not when assessed by  the NIPPON DATA80 (15) fatal stroke model ( P= 0.283) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
"• CHD Risk Assessment among Pacific-Asian Patients in the CRUCIAL Trial 1746  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1741DATA80 (15) and SCORE (14) in both the PMI (22.0%, 1.3%, 3.3%,  respectively) and UC arms (21.3%, 1.4%, 3.1%, respectively).",Non-OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
• CHD Risk Assessment among Pacific-Asian Patients in the CRUCIAL Trial http://jkms.org   1747 http://dx.doi.org/10.3346/jkms.2013.28.12.1741the risk scores calculated using the different region-specific risk  assessment tools.,Non-OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
• CHD Risk Assessment among Pacific-Asian Patients in the CRUCIAL Trial 1748  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.174117.,Non-OADS,/arxiv_data1/oa_pdf/f6/5d/jkms-28-1741.PMC3857369.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Differential Prognostic Impacts of Diabetes over Time Course  after Acute Myocardial Infarction This study was performed to evaluate the effects of diabetes on short- and mid-term  clinical outcomes in patients with acute myocardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/4e/e0/jkms-28-1749.PMC3857370.pdf
"Key Words:  Diabetes Mellitus; Myocardial Infarction; PrognosisHack-Lyoung Kim,1 Si-Hyuck Kang,2  Chang-Hwan Yoon,3 Young-Seok Cho,3  Tae-Jin Youn,3 Goo-Yeong Cho,3   In-Ho Chae,3 Hyo-Soo Kim,2   Shung-Chull Chae,4 Myeong-Chan Cho,5  Young-Jo Kim,6 Ju Han Kim,7   Youngkeun Ahn,7 Myung Ho Jeong,7  Dong-Ju Choi,3 Other Korea Acute  Myocardial Infarction Registry (KAMIR)  and Korea Working Group on Myocardial  Infarction (KorMI) Investigators 1Department of Internal Medicine, Cardiovascular  Center, Seoul National University Boramae Medical  Center, Seoul; 2Department of Internal Medicine,  Cardiovascular Center, Seoul National University  Hospital, Seoul; 3Department of Internal Medicine,  Cardiovascular Center, Seoul National University  Bundang Hospital, Seongnam; 4Department of  Internal Medicine, Kyungpook National University  Hospital, Daegu; 5Department of Internal Medicine,  Chungbuk National University Hospital, Cheongju;  6Department of Internal Medicine, Yeungnam  University Hospital, Daegu; 7Department of Internal  Medicine, Chonnam National University Hospital,  Gwangju, Korea Received: 23 May 2013 Accepted: 28 September 2013 Address for Correspondence: Dong-Ju Choi, MD Department of Internal Medicine, Seoul National University  College of Medicine, Cardiovascular Center, Seoul National  University Bundang Hospital, 166 Gumi-ro, Bundang-gu,  Seongnam 463-707, Korea Tel: +82.31-787-7007, Fax: +82.31-787-4051 E-mail: djchoi@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.12.1749  • J Korean Med Sci 2013; 28: 1749-1755ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION Diabetes is associated with poor clinical outcomes in acute myo - cardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/4e/e0/jkms-28-1749.PMC3857370.pdf
"• Prognostic impact of diabetes after AMI 1750  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1749been described in previous studies (13, 14).",Non-OADS,/arxiv_data1/oa_pdf/4e/e0/jkms-28-1749.PMC3857370.pdf
• Prognostic impact of diabetes after AMI http://jkms.org   1751 http://dx.doi.org/10.3346/jkms.2013.28.12.17490.05 was considered significant.,Non-OADS,/arxiv_data1/oa_pdf/4e/e0/jkms-28-1749.PMC3857370.pdf
"• Prognostic impact of diabetes after AMI 1752  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1749(HR, 1.23; 95% CI, 1.09-1.39; P= 0.001) and MACEs between  days 31 and 365 (HR, 1.25; 95% CI, 1.08-1.45; P= 0.002) but not  for MACEs within 30 days (HR, 1.16; 95% CI, 0.93-1.44; P= 0.167).",Non-OADS,/arxiv_data1/oa_pdf/4e/e0/jkms-28-1749.PMC3857370.pdf
"• Prognostic impact of diabetes after AMI http://jkms.org   1753 http://dx.doi.org/10.3346/jkms.2013.28.12.1749collected from clinical trials (11, 18-20), and some of them did  not adjust for confounders (10).",Non-OADS,/arxiv_data1/oa_pdf/4e/e0/jkms-28-1749.PMC3857370.pdf
• Prognostic impact of diabetes after AMI 1754  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1749ACKNOWLEDGMENT The authors appreciate the help of Sohee Oh (Seoul National  University Boramae Medical Center) for statistical assistance.,Non-OADS,/arxiv_data1/oa_pdf/4e/e0/jkms-28-1749.PMC3857370.pdf
• Prognostic impact of diabetes after AMI http://jkms.org   1755 http://dx.doi.org/10.3346/jkms.2013.28.12.1749events in 30-day survivors after acute myocardial infarction (from the  Korea Acute Myocardial Infarction Registry).,Non-OADS,/arxiv_data1/oa_pdf/4e/e0/jkms-28-1749.PMC3857370.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357De Vega Annuloplasty for Functional Tricupsid Regurgitation:  Concept of Tricuspid Valve Orifice Index to Optimize Tricuspid  Valve Annular Reduction We evaluated long-term results of De Vega annuloplasty measured by cylindrical sizers for  functional tricuspid regurgitation (FTR) and analyzed the impact of measured annular size  on the late recurrence of tricuspid valve regurgitation.",Non-OADS,/arxiv_data1/oa_pdf/1a/c6/jkms-28-1756.PMC3857371.pdf
"Key Words:  Tricuspid Valve insufficiency; Cardiac Valve AnnuloplastyHo Young Hwang,1 Hyoung Woo Chang,1  Dong Seop Jeong,2 and Hyuk Ahn1 1Department of Thoracic and Cardiovascular  Surgery, Seoul National University Hospital, Seoul;  2Department of Thoracic and Cardiovascular  Surgery, Samsung Medical Center, Seoul, Korea Received: 29 June 2013 Accepted: 22 October 2013 Address for Correspondence: Hyuk Ahn, MD Department of Thoracic and Cardiovascular Surgery, Seoul  National University Hospital, 101 Daehak-ro, Jongno-gu,   Seoul 110-744, Korea Tel: +82.2-2072-3349, Fax: +82.2-762-3566 E-mail: ahnhyuk@snu.ac.kr http://dx.doi.org/10.3346/jkms.2013.28.12.1756  • J Korean Med Sci 2013; 28: 1756-1761ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION Previous studies demonstrated that tricuspid annuloplasty us - ing annular sutures or insertion of a prosthetic ring resulted in  favorable results for patients with functional tricuspid regurgi - tation (TR) (1-6).",Non-OADS,/arxiv_data1/oa_pdf/1a/c6/jkms-28-1756.PMC3857371.pdf
• De Vega Annuloplasty http://jkms.org   1757 http://dx.doi.org/10.3346/jkms.2013.28.12.1756was used due to a concern of too tight reduction (n = 37).,Non-OADS,/arxiv_data1/oa_pdf/1a/c6/jkms-28-1756.PMC3857371.pdf
• De Vega Annuloplasty 1758  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1756board (IRB) of our hospital (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/1a/c6/jkms-28-1756.PMC3857371.pdf
• De Vega Annuloplasty http://jkms.org   1759 http://dx.doi.org/10.3346/jkms.2013.28.12.1756Table 5.,Non-OADS,/arxiv_data1/oa_pdf/1a/c6/jkms-28-1756.PMC3857371.pdf
• De Vega Annuloplasty 1760  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1756plasty have been introduced for functional TR.,Non-OADS,/arxiv_data1/oa_pdf/1a/c6/jkms-28-1756.PMC3857371.pdf
• De Vega Annuloplasty http://jkms.org   1761 http://dx.doi.org/10.3346/jkms.2013.28.12.1756Stat Med 1989; 8: 551-61.,Non-OADS,/arxiv_data1/oa_pdf/1a/c6/jkms-28-1756.PMC3857371.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Prospective Study of Epicardial Adipose Tissue and Incident Metabolic Syndrome: The ARIRANG Study Increased epicardial adipose tissue (EAT) may be closely associated with the development of  metabolic abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/56/9f/jkms-28-1762.PMC3857372.pdf
"http://dx.doi.org/10.3346/jkms.2013.28.12.1762  • J Korean Med Sci 2013; 28: 1762-1767ORIGINAL ARTICLE  Endocrinology, Nutrition & Metabolism INTRODUCTION  Metabolic syndrome is not a single disease but a conglomera - tion of risk factors for cardiovascular disease (CVD) including  central obesity, elevated blood pressure, hypertriglyceridemia,  low high-density lipoprotein (HDL) cholesterol, elevated fast - ing glucose, and insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/56/9f/jkms-28-1762.PMC3857372.pdf
• Epicardial Adipose Tissue and Metabolic Syndrome http://jkms.org   1763 http://dx.doi.org/10.3346/jkms.2013.28.12.1762measured by echocardiography would be a positive predictor  of progression to metabolic syndrome.,Non-OADS,/arxiv_data1/oa_pdf/56/9f/jkms-28-1762.PMC3857372.pdf
"• Epicardial Adipose Tissue and Metabolic Syndrome 1764  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1762Endpoint definition  The study endpoint is the development of metabolic syndrome  at the follow-up visit, defined following the harmonized defini - tion for metabolic syndrome (14) as the presence of at least three  of the following criteria: 1) Abdominal obesity, defined as a waist  circumference ≥ 90 cm for men or ≥ 85 cm for women (follow - ing Korean-specific cutoffs for abdominal obesity defined by  the Korean Society of Obesity) (15); 2) Hypertriglyceridemia,  defined as a serum TG concentration ≥ 150 mg/dL (1.69 mM/ L); 3) Low HDL cholesterol, defined as a serum HDL cholesterol  concentration < 40 mg/dL (1.04 mM/L) for men or < 50 mg/ dL (1.29 mM/L) for women; 4) High blood pressure, defined as  a SBP ≥ 130 mmHg or a DBP ≥ 85 mmHg, or treatment with  antihypertensive agents; 5) High fasting glucose, defined as a  fasting serum glucose ≥ 100 mg/dL or previously diagnosed  type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/56/9f/jkms-28-1762.PMC3857372.pdf
"• Epicardial Adipose Tissue and Metabolic Syndrome http://jkms.org   1765 http://dx.doi.org/10.3346/jkms.2013.28.12.1762not in women (1.51 vs 1.73 mm, P= 0.186).",Non-OADS,/arxiv_data1/oa_pdf/56/9f/jkms-28-1762.PMC3857372.pdf
• Epicardial Adipose Tissue and Metabolic Syndrome 1766  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.17622).,Non-OADS,/arxiv_data1/oa_pdf/56/9f/jkms-28-1762.PMC3857372.pdf
• Epicardial Adipose Tissue and Metabolic Syndrome http://jkms.org   1767 http://dx.doi.org/10.3346/jkms.2013.28.12.1762diographic EAT thickness may be a novel imaging tool to pre - dict the development of metabolic syndrome.,Non-OADS,/arxiv_data1/oa_pdf/56/9f/jkms-28-1762.PMC3857372.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Incidence of Metabolic Syndrome and Relative Importance of  Five Components as a Predictor of Metabolic Syndrome: 5-Year  Follow-up Study in Korea The aim of this study was to describe the incidence of metabolic syndrome and to identify  five components as metabolic syndrome predictors.",Non-OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
"Key Words:  Cohort Studies; Incidence; Metabolic Syndrome; Risk FactorsJun Hyun Hwang,1 Sin Kam,2   Ji-yeon Shin,3 Jong-Yeon Kim,1   Kyung-Eun Lee,2 Gi-Hong Kwon,4   Byung-Yeol Chun,2 Shung Chull Chae,5  Dong Heon Yang,5 Hun Sik Park5   and Tae-Yoon Hwang6 1Department of Preventive Medicine, Catholic  University of Daegu School of Medicine, Daegu;  2Department of Preventive Medicine, Kyungpook  National University School of Medicine, Daegu;  3National Cancer Control Institute, National Cancer  Center, Goyang; 4Division of Health and Science,  Yeungnam College of Science and Technology,  Daegu; 5Department of Internal Medicine,  Kyungpook National University Hospital, Daegu;  6Department of Preventive Medicine & Public  Health, Yeungnam University College of Medicine,  Daegu, Korea Received: 19 July 2013 Accepted: 8 October 2013 Address for Correspondence: Tae-Yoon Hwang, MD Department of Preventive Medicine & Public Health, Yeungnam  University College of Medicine, 170 Hyeonchung-ro, Nam-gu,  Daegu 705-717, Korea Tel: +82.53-620-4374, Fax: +82.53-653-2061  E-mail: luke@ynu.ac.kr  This sudy was supported in part by a grant from Daegu  Metropolitan City (2008, 200807340000).http://dx.doi.org/10.3346/jkms.2013.28.12.1768  • J Korean Med Sci 2013; 28: 1768-1773ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism INTRODUCTION Metabolic syndrome (MetS), clustering of glucose intolerance,  obesity, hypertension, and dyslipidemia, is showing a rapid in - crease worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
• Incidence and Five Predictors of Metabolic Syndrome  http://jkms.org   1769 http://dx.doi.org/10.3346/jkms.2013.28.12.1768City in Korea.,Non-OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
• Incidence and Five Predictors of Metabolic Syndrome  1770  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1768sented additionally in order to help in better understanding of  the incidence of MetS.,Non-OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
• Incidence and Five Predictors of Metabolic Syndrome  http://jkms.org   1771 http://dx.doi.org/10.3346/jkms.2013.28.12.1768significant decrease with age in men.,Non-OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
• Incidence and Five Predictors of Metabolic Syndrome  1772  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1768women according to age were supported by findings of a previ - ous study.,OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
"• Incidence and Five Predictors of Metabolic Syndrome  http://jkms.org   1773 http://dx.doi.org/10.3346/jkms.2013.28.12.1768Im Yu, PhD.",Non-OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
Available at http://www.idf.org/web - data/docs/Metac_syndrome_def.pdf [accessed on 29 November 2012].,Non-OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
Available at http://knhanes.cdc.go.kr [accessed  on 29 November 2012].,Non-OADS,/arxiv_data1/oa_pdf/7b/4c/jkms-28-1768.PMC3857373.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Change in Somatostatinergic Tone of Acromegalic Patients  according to the Size of Growth Hormone-Producing Pituitary  Tumors The aim of this study was to investigate the relationship between somatostatinergic tone  (SST) and the size of growth hormone (GH)-producing pituitary tumors.",Non-OADS,/arxiv_data1/oa_pdf/88/59/jkms-28-1774.PMC3857374.pdf
"Key Words:  Acromegaly; Growth Hormone; Somatostatinergic Tone; Pituitary Gland;  MacroadenomasSang Ouk Chin, Suk Chon,   You-Cheol Hwang, In-Kyung Jeong,  Seungjoon Oh, and Sung-Woon Kim  Department of Endocrinology and Metabolism,  Kyung Hee University School of Medicine, Seoul,  Korea Received: 5 August 2013 Accepted: 16 October 2013 Address for Correspondence: Sung-Woon Kim, MD Department of Endocrinology and Metabolism, Kyung Hee  University School of Medicine, 23 Kyungheedae-ro,  Dongdaemoon-gu, Seoul 130-872, Korea Tel: +82.2-958-8200, Fax: +82.2-968-1848 E-mail: igf1@unitel.co.krhttp://dx.doi.org/10.3346/jkms.2013.28.12.1774  • J Korean Med Sci 2013; 28: 1774-1780ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism INTRODUCTION Somatostatinergic tone (SST) can be defined as the inhibiting  potential of somatostatin against the secretion of various hor - mones including GH.",Non-OADS,/arxiv_data1/oa_pdf/88/59/jkms-28-1774.PMC3857374.pdf
• Change in Somatostatinergic Tone in Pituitary Tumors http://jkms.org   1775 http://dx.doi.org/10.3346/jkms.2013.28.12.1774MATERIALS AND METHODS Patients A total of 167 patients newly diagnosed with acromegaly at Kyung  Hee University Hospital between 1991 and 2008 was initially  screened.,Non-OADS,/arxiv_data1/oa_pdf/88/59/jkms-28-1774.PMC3857374.pdf
• Change in Somatostatinergic Tone in Pituitary Tumors 1776  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1774tests.,Non-OADS,/arxiv_data1/oa_pdf/88/59/jkms-28-1774.PMC3857374.pdf
• Change in Somatostatinergic Tone in Pituitary Tumors http://jkms.org   1777 http://dx.doi.org/10.3346/jkms.2013.28.12.1774Table 2.,Non-OADS,/arxiv_data1/oa_pdf/88/59/jkms-28-1774.PMC3857374.pdf
• Change in Somatostatinergic Tone in Pituitary Tumors 1778  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1774Table 3.,Non-OADS,/arxiv_data1/oa_pdf/88/59/jkms-28-1774.PMC3857374.pdf
"• Change in Somatostatinergic Tone in Pituitary Tumors http://jkms.org   1779 http://dx.doi.org/10.3346/jkms.2013.28.12.1774though larger tumors produce greater GH secretion, the SST re - sponse to hypoglycemia does not differ regardless of the tumor  size in order to alleviate hypoglycemic conditions.",Non-OADS,/arxiv_data1/oa_pdf/88/59/jkms-28-1774.PMC3857374.pdf
• Change in Somatostatinergic Tone in Pituitary Tumors 1780  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1774necessary to confirm the diagnosis of acromegaly.,Non-OADS,/arxiv_data1/oa_pdf/88/59/jkms-28-1774.PMC3857374.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of Complications between Endoscopic and  Percutaneous Replacement of Percutaneous Endoscopic  Gastrostomy Tubes When replacing percutaneous endoscopic gastrostomy (PEG) tubes, an internal bolster may  be retrieved either percutaneously or endoscopically.",Non-OADS,/arxiv_data1/oa_pdf/48/d6/jkms-28-1781.PMC3857375.pdf
"Key Words:  Gastrostomy; Methods; ComplicationsChang Geun Lee, Hyoun Woo Kang,   Yun Jeong Lim, Jun Kyu Lee,   Moon-Soo Koh, Jin Ho Lee,   Chang Hun Yang, and Jae Hak Kim Department of Internal Medicine, Dongguk  University Ilsan Hospital, Goyang, Korea  Received: 17 July 2013 Accepted: 30 September 2013 Address for Correspondence: Jae Hak Kim, MD Department of Internal Medicine, Dongguk University Ilsan  Hospital, 27 Dongguk-ro, Ilsandong-gu, Goyang 411-773, Korea Tel: +82.31-961-7127, Fax: +82.31-961-7141 E-mail: kimjaehak@dumc.or.kr This study was supported by Dongguk University Research Fund  of 2013.http://dx.doi.org/10.3346/jkms.2013.28.12.1781  • J Korean Med Sci 2013; 28: 1781-1787ORIGINAL ARTICLE Gastroenterology & Hepatology INTRODUCTION Percutaneous endoscopic gastrostomy (PEG) is a relatively safe  procedure to deliver enteral feedings to patients unable to feed  by mouth (1).",Non-OADS,/arxiv_data1/oa_pdf/48/d6/jkms-28-1781.PMC3857375.pdf
• Endoscopic versus Percutaneous Replacement of Gastrostomy Tubes 1782  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1781ary 2008 through January 2012 were analyzed retrospectively.,OADS,/arxiv_data1/oa_pdf/48/d6/jkms-28-1781.PMC3857375.pdf
• Endoscopic versus Percutaneous Replacement of Gastrostomy Tubes http://jkms.org   1783 http://dx.doi.org/10.3346/jkms.2013.28.12.1781blood by external compression of stoma.,Non-OADS,/arxiv_data1/oa_pdf/48/d6/jkms-28-1781.PMC3857375.pdf
• Endoscopic versus Percutaneous Replacement of Gastrostomy Tubes 1784  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1781Table 2.,Non-OADS,/arxiv_data1/oa_pdf/48/d6/jkms-28-1781.PMC3857375.pdf
• Endoscopic versus Percutaneous Replacement of Gastrostomy Tubes http://jkms.org   1785 http://dx.doi.org/10.3346/jkms.2013.28.12.1781Table 4.,Non-OADS,/arxiv_data1/oa_pdf/48/d6/jkms-28-1781.PMC3857375.pdf
• Endoscopic versus Percutaneous Replacement of Gastrostomy Tubes 1786  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1781short duration of PEG tube replacement (≤ 6 months) did not  significant associated immediate complication.,Non-OADS,/arxiv_data1/oa_pdf/48/d6/jkms-28-1781.PMC3857375.pdf
• Endoscopic versus Percutaneous Replacement of Gastrostomy Tubes http://jkms.org   1787 http://dx.doi.org/10.3346/jkms.2013.28.12.1781trostomy.,Non-OADS,/arxiv_data1/oa_pdf/48/d6/jkms-28-1781.PMC3857375.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cross-Cultural Adaptation of the Korean Version of the  Minneapolis-Manchester Quality of Life Instrument-Adolescent  Form We verified the reliability and validity of the Korean version of the Minneapolis-Manchester  Quality of Life Instrument-Adolescent Form (KMMQL-AF) among Korean childhood cancer  survivors.",Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
"http://dx.doi.org/10.3346/jkms.2013.28.12.1788  • J Korean Med Sci 2013; 28: 1788-1795ORIGINAL ARTICLE Pediatrics INTRODUCTION Because of remarkable improvements in childhood cancer treat - ment, the 5-yr survival rate of childhood cancer has reached  nearly 80% in developed countries (1).",Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
"• Validation of Minneapolis-Manchester Quality of Life Instrument-Adolescent Form http://jkms.org   1789 http://dx.doi.org/10.3346/jkms.2013.28.12.1788some instruments have been used proxy assessments, com - pleted by parents or physicians (14, 15).",Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
• Validation of Minneapolis-Manchester Quality of Life Instrument-Adolescent Form 1790  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1788the ceiling or floor effect in the questionnaires.,Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
• Validation of Minneapolis-Manchester Quality of Life Instrument-Adolescent Form http://jkms.org   1791 http://dx.doi.org/10.3346/jkms.2013.28.12.1788Table 2.,Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
• Validation of Minneapolis-Manchester Quality of Life Instrument-Adolescent Form 1792  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1788Table 3.,Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
• Validation of Minneapolis-Manchester Quality of Life Instrument-Adolescent Form http://jkms.org   1793 http://dx.doi.org/10.3346/jkms.2013.28.12.1788Table 5.,Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
"• Validation of Minneapolis-Manchester Quality of Life Instrument-Adolescent Form 1794  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1788could not be strong indicators of poor physical functioning, al - though factor loading was the strongest for this domain than for  any other domain.",Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
Available at http://ncc.re.kr/english/infor/kccr.isp [accessed on 29  October 2013].,Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
• Validation of Minneapolis-Manchester Quality of Life Instrument-Adolescent Form http://jkms.org   1795 http://dx.doi.org/10.3346/jkms.2013.28.12.17884.,Non-OADS,/arxiv_data1/oa_pdf/bc/e6/jkms-28-1788.PMC3857376.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Diagnostic Role of Prostate Resection in the Elderly Patients   Who Experience Significant Co-Morbidity with a High Clinical  Suspicion of Prostate Cancer The necessity of routine prostate biopsy prior to transurethral resection of the prostate  (TURP) in elderly comorbid patients with a high prostate specific antigen (PSA) level  remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/68/ee/jkms-28-1796.PMC3857377.pdf
"Key Words:  Prostate Neoplasms; Transurethral Prostatic Resection of Prostate; Transrectal  Prostate Biopsy; Prostate-Specific AntigenHo Won Kang,1 Jin Bak Yang,1  Whi-An Kwon,2 Young-Suk Lee,3  Won Tae Kim,1 Yong-June Kim,1  Seok-Joong Yun,1* Sang-Cheol Lee,1  Isaac Yi Kim,4 and Wun-Jae Kim1 1Department of Urology, College of Medicine,  Chungbuk National University, Cheongju;  2Department of Urology, Wonkwang University,  Sanbon Hospital, Gunpo; 3Department of Urology,  Samsung Changwon Hospital, Sungkyunkwan  University School of Medicine, Changwon, Korea;  4Section of Urologic Oncology, Cancer Institute of  New Jersey, Robert Wood Johnson Medical School,  New Brunswick, NJ, USA Received: 5 July 2013 Accepted: 8 October 2013 Address for Correspondence: Seok-Joong Yun, MD  Department of Urology, College of Medicine, Chungbuk National  University, 52 Naesudong-ro, Heungdeok-gu, Cheongju   361-763, Korea Tel: +82.43-269-6142, Fax: +82.43-269-6144 E-mail: sjyun@chungbuk.ac.kr This work was supported by Chungbuk National University  Grant in 2012.http://dx.doi.org/10.3346/jkms.2013.28.12.1796  • J Korean Med Sci 2013; 28: 1796-1800ORIGINAL ARTICLE Urology INTRODUCTION Prostate biopsy is the recommended diagnostic method for  clinical suspicion of prostate cancer (CaP), eg high prostate  specific antigen (PSA), abnormal digital rectal examination  (DRE), suspicious lesion on transrectal ultrasound (TRUS) (1).",Non-OADS,/arxiv_data1/oa_pdf/68/ee/jkms-28-1796.PMC3857377.pdf
• Diagnostic Role of TURP in Elderly with Co-morbidity  http://jkms.org   1797 http://dx.doi.org/10.3346/jkms.2013.28.12.1796assess the diagnostic accuracy relative to cancer detection and  histologic grading of a TUR-derived specimen.,Non-OADS,/arxiv_data1/oa_pdf/68/ee/jkms-28-1796.PMC3857377.pdf
• Diagnostic Role of TURP in Elderly with Co-morbidity  1798  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1796Cancer detection rate of TUR specimens according to  values for PSA and PSAD  There were five false-negative results from TUR-derived tissue  in patients with PSA values between 4.0 and 10.0 ng/mL (the  diagnostic gray zone).,Non-OADS,/arxiv_data1/oa_pdf/68/ee/jkms-28-1796.PMC3857377.pdf
• Diagnostic Role of TURP in Elderly with Co-morbidity  http://jkms.org   1799 http://dx.doi.org/10.3346/jkms.2013.28.12.1796high PSA levels (mean 51.77 ng/mL).,Non-OADS,/arxiv_data1/oa_pdf/68/ee/jkms-28-1796.PMC3857377.pdf
"• Diagnostic Role of TURP in Elderly with Co-morbidity  1800  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1796Mottet N, Schmid HP , van der Kwast T, Wiegel T, et al.",OADS,/arxiv_data1/oa_pdf/68/ee/jkms-28-1796.PMC3857377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Antibodies to Interferon beta in Patients with Multiple Sclerosis  Receiving CinnoVex, Rebif, and Betaferon Treatment with interferon beta (IFN- β) induces the production of binding antibodies (BAbs)  and neutralizing antibodies (NAbs) in patients with multiple sclerosis (MS).",Non-OADS,/arxiv_data1/oa_pdf/27/7d/jkms-28-1801.PMC3857378.pdf
"Iran Tel: +98.311-7922428, Fax: +98.311-7922431 E-mail: s.h.zarkesh@sheffield.ac.uk This study was financially supported by grant 189112 from  Isfahan University of Medical Sciences.http://dx.doi.org/10.3346/jkms.2013.28.12.1801  • J Korean Med Sci 2013; 28: 1801-1806ORIGINAL ARTICLE Neuroscience INTRODUCTION Interferons (IFNs) were the first agents to show clinical efficacy  in relapsing-remitting multiple sclerosis (RRMS).",Non-OADS,/arxiv_data1/oa_pdf/27/7d/jkms-28-1801.PMC3857378.pdf
• Antibodies to Interferon Beta in Patients with Multiple Sclerosis1802  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.12.1801in Iran.,Non-OADS,/arxiv_data1/oa_pdf/27/7d/jkms-28-1801.PMC3857378.pdf
• Antibodies to Interferon Beta in Patients with Multiple Sclerosishttp://jkms.org   1803  http://dx.doi.org/10.3346/jkms.2013.28.12.1801TaqMan® real-time PCR for  MxA : The gene expression  assay  A TaqMan® real-time PCR system was used to determine MxA   and GAPDH mRNA expression levels.,OADS,/arxiv_data1/oa_pdf/27/7d/jkms-28-1801.PMC3857378.pdf
• Antibodies to Interferon Beta in Patients with Multiple Sclerosis1804  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.12.1801vealed that there were significant differences between the Be - taferon and Rebif groups ( P= 0.018).,Non-OADS,/arxiv_data1/oa_pdf/27/7d/jkms-28-1801.PMC3857378.pdf
"• Antibodies to Interferon Beta in Patients with Multiple Sclerosishttp://jkms.org   1805  http://dx.doi.org/10.3346/jkms.2013.28.12.1801tion were in the general ranges of 5%-30% for patients receiving  Avonex, 25%-45% for those receiving Rebif, and 50%-80% for  those receiving Betaferon (15-17).",Non-OADS,/arxiv_data1/oa_pdf/27/7d/jkms-28-1801.PMC3857378.pdf
"• Antibodies to Interferon Beta in Patients with Multiple Sclerosis1806  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.12.1801Thorpe R, Wadhwa M. An assessment of biological potency and molecu - lar characteristics of different innovator and noninnovator interferon- beta products.",Non-OADS,/arxiv_data1/oa_pdf/27/7d/jkms-28-1801.PMC3857378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Knee Pain and Its Severity in Elderly Koreans: Prevalence, Risk  Factors and Impact on Quality of Life This study investigated the epidemiology (prevalence, risk factors, and impact on quality of  life) of knee pain and its severity in elderly Koreans.",Non-OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
"Key Words:  Knee; Pain; Severity; Prevalence; PopulationHyung-Joon Jhun,1 Nak-Jeong Sung,2  and Su Young Kim3 1Seoul Madi Spine and Joint Clinic, Goyang; 2Joseph  Madi Spine and Joint Clinic, Incheon; 3Department  of Preventive Medicine, College of Medicine, Jeju  National University, Jeju, Korea  Received: 24 May 2013 Accepted: 16 October 2013 Address for Correspondence: Su Young Kim, PhD Department of Preventive Medicine, College of Medicine,   Jeju National University, 102 Jejudaehang-ro,   Jeju 690-756, Korea  Tel: +82.64-754-3859, Fax: +82.64-755-5567 E-mail: suy0202@jejunu.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.12.1807  • J Korean Med Sci 2013; 28: 1807-1813ORIGINAL ARTICLE Musculoskeletal Disorders INTRODUCTION Knee pain is a common physical complaint in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
"• Knee Pain in Elderly Koreans 1808  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1807Data collection A questionnaire was distributed to the participants to evaluate  demographic, socioeconomic, lifestyle, and health status infor ­ mation, including presence of knee pain and its severity.",OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
• Knee Pain in Elderly Koreans http://jkms.org   1809 http://dx.doi.org/10.3346/jkms.2013.28.12.1807justed odds ratio (OR) for knee pain with regard to risk factors.,Non-OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
"• Knee Pain in Elderly Koreans 1810  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1807diographic OA had significantly higher risks for knee pain, com ­ pared with those without (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
• Knee Pain in Elderly Koreans http://jkms.org   1811 http://dx.doi.org/10.3346/jkms.2013.28.12.1807all women without knee pain.,Non-OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
• Knee Pain in Elderly Koreans 1812  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1807have greater cartilage loss and more severe knee pain than men  who do not smoke.,Non-OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
Available at  http://www2.sas.com/proceedings/sugi30/205-30.pdf [accessed on 1  September 2013].,Non-OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
• Knee Pain in Elderly Koreans http://jkms.org   1813 http://dx.doi.org/10.3346/jkms.2013.28.12.180720.,Non-OADS,/arxiv_data1/oa_pdf/75/f1/jkms-28-1807.PMC3857379.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Injuries Associated with the 580 km University Student Grand  Voluntary Road March: Focus on Foot Injuries College student volunteers (n = 142) completed a 580 km road march for 21 consecutive  days.",Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
http://dx.doi.org/10.3346/jkms.2013.28.12.1814  • J Korean Med Sci 2013; 28: 1814-1821ORIGINAL ARTICLE Rehabilitation & Sports Medicine INTRODUCTION Long-distance road marches are usually conducted in the mili - tary to train soldiers (1-4).,Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
• Foot Injuries by Long Distance March http://jkms.org   1815 http://dx.doi.org/10.3346/jkms.2013.28.12.1814about 29 km per day.,Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
• Foot Injuries by Long Distance March 1816  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1814Medical screening The weight and height of the subjects were measured when  they were barefoot and wearing only an underwear.,Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
• Foot Injuries by Long Distance March http://jkms.org   1817 http://dx.doi.org/10.3346/jkms.2013.28.12.1814Table 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
• Foot Injuries by Long Distance March 1818  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1814nificant factor between blister group and non-blister group  (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
• Foot Injuries by Long Distance March http://jkms.org   1819 http://dx.doi.org/10.3346/jkms.2013.28.12.1814Table 2.,Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
• Foot Injuries by Long Distance March 1820  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1814These results mostly coincide with those in Reynolds et al.,OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
• Foot Injuries by Long Distance March http://jkms.org   1821 http://dx.doi.org/10.3346/jkms.2013.28.12.1814of information will be needed to clarify the relation between  hand dominance and injury types.,Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jkms-28-1814.PMC3857380.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Performance Assessment of the SOFA, APACHE II Scoring  System, and SAPS II in Intensive Care Unit Organophosphate  Poisoned Patients This study assessed the ability of the Sequential Organ Failure Assessment (SOFA) and Acute  Physiology, Chronic Health Evaluation (APACHE) II scoring systems, as well as the  Simplified Acute Physiology Score (SAPS) II method to predict group mortality in intensive  care unit (ICU) patients who were poisoned with organophosphate.",Non-OADS,/arxiv_data1/oa_pdf/15/ad/jkms-28-1822.PMC3857381.pdf
"Key Words:  SOFA; APACHE II; SAPS IIYong Hwan Kim,1 Jung Hoon Yeo,1   Mun Ju Kang,1 Jun Ho Lee,1   Kwang Won Cho,1 SeongYoun Hwang,1  Chong Kun Hong,2 Young Hwan Lee,3   and Yang Weon Kim4 1Department of Emergency Medicine, Samsung  Changwon Hospital, Sungkyunkwan University  School of Medicine, Changwon; 2Department of  Emergency Medicine, Bundang Jesaeng General  Hospital, Seongnam; 3Department of Emergency  Medicine, Hallym University Sacred Heart Hospital,  Hallym University College of Medicine, Anyang;  4Department of Emergency Medicine, Inje University  College of Medicine, Busan, Korea Received: 23 May 2013 Accepted: 30 September 2013 Address for Correspondence: Jun Ho Lee, MD Department of Emergency Medicine, Samsung Changwon  Hospital, Sungkyunkwan University School of Medicine, 158  Paryong-ro, Masanhoiwon-gu, Changwon 630-522, Korea Tel: +82.55-290-6560, Fax: +82.55-290-6117 E-mail: galjoun@hanmail.nethttp://dx.doi.org/10.3346/jkms.2013.28.12.1822  • J Korean Med Sci 2013; 28: 1822-1826ORIGINAL ARTICLE Emergency & Critical Care Medicine INTRODUCTION Organophosphate (OP) poisoning is a major medical problem  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/15/ad/jkms-28-1822.PMC3857381.pdf
• Assessment of Organophosphate Poisoned Patients http://jkms.org   1823 http://dx.doi.org/10.3346/jkms.2013.28.12.1822illness severity and the mortality of patients poisoned with OP  who were admitted to the ICU.,Non-OADS,/arxiv_data1/oa_pdf/15/ad/jkms-28-1822.PMC3857381.pdf
• Assessment of Organophosphate Poisoned Patients 1824  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1822Table 1.,Non-OADS,/arxiv_data1/oa_pdf/15/ad/jkms-28-1822.PMC3857381.pdf
• Assessment of Organophosphate Poisoned Patients http://jkms.org   1825 http://dx.doi.org/10.3346/jkms.2013.28.12.1822show goodness-of-fit test revealed no significant differences  between actual mortality and predicted mortality for each of  the scoring systems.,Non-OADS,/arxiv_data1/oa_pdf/15/ad/jkms-28-1822.PMC3857381.pdf
• Assessment of Organophosphate Poisoned Patients 1826  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1822JAMA 1993; 270: 2957-63.,Non-OADS,/arxiv_data1/oa_pdf/15/ad/jkms-28-1822.PMC3857381.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Hemolytic Anemia Case Caused by an Inverted Inner Felt after  Bentall Operation A 26-yr-old male patient reported worsened dyspnea, dizziness one year after an  emergency Bentall operation for type A aortic dissection.",Non-OADS,/arxiv_data1/oa_pdf/ab/61/jkms-28-1827.PMC3857382.pdf
"Key Words:  Anemia, Hemolytic; Aortic Dissection; Inverted FeltHyun Kang,1 Ju Won Choe,2   Dai Yun Cho,2 Dong Suep Sohn,2   Sang Wook Kim,3 and Joonhwa Hong2 Departments of 1Anesthesia and Pain Medicine,  2Thoracic and Cardiovascular Surgery, and  3Cardiology, Chung-Ang University Hospital, Seoul,  Korea Received: 26 February 2013 Accepted: 3 June 2013 Address for Correspondence: Joonhwa Hong, MD Department of Thoracic and Cardiovascular Surgery,   Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu,  Seoul 156-755, Korea Tel: +82.2-6299-1638, Fax: +82.2-823-0160 E-mail: jhong@cau.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.12.1827  • J Korean Med Sci 2013; 28: 1827-1829CASE REPORT Cardiovascular Disorders INTRODUCTION In cases of acute aortic dissection, reinforcing the aorta with a  felt strip is helpful for hemostasis.",Non-OADS,/arxiv_data1/oa_pdf/ab/61/jkms-28-1827.PMC3857382.pdf
• Hemolytic Anemia Caused by an Inverted Inner Felt after Bentall Operation 1828  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1827 Fig.,Non-OADS,/arxiv_data1/oa_pdf/ab/61/jkms-28-1827.PMC3857382.pdf
• Hemolytic Anemia Caused by an Inverted Inner Felt after Bentall Operation http://jkms.org   1829 http://dx.doi.org/10.3346/jkms.2013.28.12.1827dyspnea and dizziness.,Non-OADS,/arxiv_data1/oa_pdf/ab/61/jkms-28-1827.PMC3857382.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Immunoglobulin G4 Non-Related Sclerosing Disease with  Intracardiac Mass Mimicking Mitral Stenosis: Case Report The cardiovascular system may be one of the target organs of both immunoglobulin G4  related and non-related systemic multifocal fibrosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/49/91/jkms-28-1830.PMC3857383.pdf
"Received: 30 March 2013 Accepted: 2 July 2013 Address for Correspondence: Duk-Kyung Kim, MD Division of Cardiology, Cardiovascular Imaging Center, Cardiac  and Vascular Center, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu,   Seoul 135-710, Korea Tel: +82.2-3410-3419, Fax: +82.2-3410-3849 E-mail: dkkim@skku.eduhttp://dx.doi.org/10.3346/jkms.2013.28.12.1830  • J Korean Med Sci 2013; 28: 1830-1834CASE REPORT  Cardiovascular Disorders INTRODUCTION Immunoglobulin G4-related sclerosing disease (IgG4-RSD) is a  new clinical disease entity characterized by elevated serum  IgG4 concentration and tumorous lesions or tissue infiltration  by IgG4-positive plasma cells (1-3).",Non-OADS,/arxiv_data1/oa_pdf/49/91/jkms-28-1830.PMC3857383.pdf
